<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        137-9-16
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CATAFAST 50 MG SACHET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC POTASSIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        9
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Sachet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        18
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="MIPHARM" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            MIPHARM
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 439]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Novartis Saudi Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            NOVARTIS PHARMA AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><!--[if !supportLists]--><strong>1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Serious side effects</strong></p><p style="text-align:justify"><strong>Cardiovascular Risk</strong></p><p style="margin-left:.25in; margin-right:0in; text-align:justify; text-indent:-.25in"><!--[if !supportLists]--><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><!--[endif]--><strong>Non-steroidal anti-inflammatory drugs (NSAIDs) may increase the risk of serious cardiovascular (CV) thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.</strong></p><p style="margin-left:.25in; margin-right:0in; text-align:justify; text-indent:-.25in"><!--[if !supportLists]--><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><!--[endif]--><strong>Diclofenac Potassium for Oral Solution is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.</strong></p><p style="text-align:justify"><strong>Gastrointestinal Risk</strong></p><p style="margin-left:.25in; margin-right:0in; text-align:justify; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>NSAIDs increase the risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events.</strong></p><p>&nbsp;</p><p><!--[if !supportLists]--><strong>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->What Catafast is and what it is used for</strong></p><p>&nbsp;</p><p>What Catafast is</p><p>The active substance in Catafast powder for oral solution is diclofenac potassium.</p><p>Catafast belongs to a group of medicines called &ldquo;non-steroidal anti-inflammatory drugs&rdquo; (NSAIDs), which are used to treat pain and inflammation.</p><p>What Catafast is used for</p><p>Catafast can be used for short-term treatment of the following conditions:</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Sprains, strains, or other injuries.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Pain and swelling after surgery.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Painful menstrual periods.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Migraine attacks.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Back pain, frozen shoulder, tennis elbow, and other forms of soft-tissue rheumatism.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Infections of the ear, nose or throat.</p><p>In migraine attacks, Catafast is effective in relieving the headache as well as in improving the accompanying symptoms such as nausea and vomiting.</p><p>How Catafast works</p><p>Catafast relieves the symptoms of inflammation, such as pain and swelling, by blocking the synthesis of the molecules (prostaglandins) responsible for inflammation, pain and fever. It has no effect on the causes of inflammation or fever.</p><p>If you have any questions about how Catafast works or why this medicine has been prescribed for you, ask your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Follow all your doctor&rsquo;s instructions carefully. They may differ from the general information contained in this leaflet.</p><p style="margin-left:.5in; text-indent:-.25in"><!--[if !supportLists]-->a.&nbsp;&nbsp;&nbsp; <!--[endif]-->Do not take Catafast</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>If you are</strong> <strong>allergic</strong> (hypersensitive) to diclofenac or to any of the other ingredients of Catafast listed at the end of this leaflet.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>If you have</strong> ever had an allergic reaction after taking medicines to treat inflammation or pain (e.g., acetylsalicylic acid, (diclofenac or ibuprofen). Reactions may include asthma, runny nose, skin rash, swelling of the face, lips, tongue, throat, and/or extremities (signs of angioedema). If you think you may be allergic, ask your doctor for advice.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>If you have</strong> a stomach or intestinal ulcer.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>If you have</strong> gastrointestinal bleeding or perforation, symptoms of which may include blood in your stools or black stools.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>If you suffer</strong> from kidney or liver failure.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>If you suffer</strong> from severe heart failure.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>If you are</strong> in the last three months of pregnancy.</p><p>If any of these apply to you, <strong>tell your doctor</strong> without taking Catafast.</p><p style="margin-left:.5in; text-indent:-.25in"><!--[if !supportLists]-->b.&nbsp;&nbsp;&nbsp; <!--[endif]-->Take special care with Catafast</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you have established disease of the heart or blood vessels (also called cardiovascular disease, including uncontrolled high blood pressure, congestive heart failure, established ischemic heart disease, or peripheral arterial disease), treatment with Catafast is generally not recommended.</p><p style="margin-left:17.85pt; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you have established cardiovascular disease (see above) or significant risk factors such as high blood pressure, abnormally high levels of fat (cholesterol, triglycerides) in your blood, diabetes, or if you smoke, and your doctor decides to prescribe Catafast, you must not increase the dose above 100 mg per day if you are treated for more than 4 weeks.</p><p style="margin-left:17.85pt; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->It is generally important to take the lowest dose of Catafast that relieves your pain and/or swelling and for the shortest time possible in order to keep your risk for cardiovascular side effects as small as possible.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you are taking Catafast simultaneously with other anti-inflammatory medicines including acetylsalicylic acid, corticosteroids, &ldquo;blood thinners&rdquo; or &ldquo;SSRIs&rdquo; (see &ldquo;Taking other medicines&rdquo;).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you have asthma or hay fever (seasonal allergic rhinitis).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you have ever had any gastrointestinal problems such as stomach ulcer, bleeding or black stools, or have experienced stomach discomfort or heartburn after taking anti-inflammatory medicines in the past.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you have an inflammation of the colon (ulcerative colitis) or intestinal tract (Crohn&rsquo;s disease).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you have liver or kidney problems.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you could be dehydrated (e.g., by sickness, diarrhea, before or after major surgery).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you have swollen feet.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you have a bleeding disorder or other blood disorders, including a rare liver condition called porphyria.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you recently had or you are going to have a surgery of the stomach or intestinal tract.</p><p>If any of these above apply to you, <strong>tell your doctor before you take Catafast</strong>.</p><p style="margin-left:.25in; margin-right:0in; text-indent:-.25in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If, at any time while taking Catafast you experience any signs or symptoms of problems with your heart or blood vessels such as chest pain, shortness of breath, weakness, or slurring of speech, contact your doctor immediately.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Catafast may reduce the symptoms of an infection (e.g., headache, high temperature) and may therefore make the infection more difficult to detect and to treat adequately. If you feel unwell and need to see a doctor, remember to mention that you are taking Catafast.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->In very rare cases, patients treated with Catafast, as with other anti-inflammatory medicines, may experience<strong> </strong>severe allergic skin reactions (e.g., rash).</p><p style="margin-left:0in; text-align:justify; text-indent:0in">If you get any of the above-described symptoms, <strong>tell your doctor straight away</strong>.</p><p>Monitoring during your treatment with Catafast</p><p style="text-align:justify">If you have established heart disease or significant risks for heart disease, your doctor will periodically re-evaluate whether you should continue treatment with Catafast, especially in case you are treated for more than 4 weeks.</p><p>If you have any liver impairment, kidney impairment or blood impairment, you will have blood tests during treatment. These will monitor either your liver function (level of transaminases) or your kidney function (level of creatinine) or your blood count (level of white and red blood cells and platelets). Your doctor will take these blood tests into consideration to decide if Catafast needs to be discontinued or if the dose needs to be changed.</p><p>Children and adolescents</p><p>Catafast must not be given to children and adolescents below 14 years of age. For pediatric use, other forms of diclofenac can be used.</p><p>The use of Catafast in migraine has not been established in children and adolescents.</p><p>Older people</p><p>Elderly patients, especially those who are frail or with a low body weight, may be more sensitive to the effects of Catafast than other adults. Therefore, they should follow the doctor&rsquo;s instructions particularly carefully and take the minimum number of sachets that provides relief of symptoms. It is especially important for elderly patients to report undesirable effects promptly to their doctor.</p><p style="margin-left:.5in; text-indent:-.25in"><!--[if !supportLists]-->c.&nbsp;&nbsp;&nbsp; <!--[endif]-->Taking other medicines, herbal or dietary supplements</p><p>Tell your doctor, pharmacist, or healthcare provider if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>It is particularly important to tell your doctor if you are taking any of the following medicines:</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Lithium or selective serotonin-reuptake inhibitors (SSRIs) (medicines used to treat some type of depression).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Digoxin (a medicine used for heart problems).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Diuretics (medicines used to increase the amount of urine).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ACE inhibitors or beta-blockers (classes of medicines used to treat high blood pressure and heart failure).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Other anti-inflammatory medicines such as acetylsalicylic acid or ibuprofen.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Corticosteroids (medicines used to provide relief for inflamed areas of the body).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->&ldquo;Blood thinners&rdquo; (a medicine used to prevent blood clotting).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Medicines (such as metformin) used to treat diabetes, except insulin.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Methotrexate (a medicine used to treat some kinds of cancer or arthritis).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Ciclosporin, Tacrolimus (medicines primarily used in patients who have received organ transplants).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Trimethoprim (a medicine used to prevent or treat urinary tract infections)</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Quinolone antibacterials (medicines used against infections).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Voriconazole (a medicine used to treat fungal infections).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Phenytoin (a medicine used to treat seizures).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Rifampicin (an antibiotic medicine used to treat bacterial infections).</p><p style="margin-left:.5in; text-indent:-.25in"><!--[if !supportLists]-->d.&nbsp;&nbsp;&nbsp; <!--[endif]-->Taking Catafast with food and drink</p><p>It is recommended to take Catafast before meals.</p><p style="margin-left:.5in; text-indent:-.25in"><!--[if !supportLists]-->e.&nbsp;&nbsp;&nbsp; <!--[endif]-->Pregnancy and breast-feeding</p><p>You should tell your doctor if you are pregnant or think that you may be pregnant. You should not take Catafast while pregnant unless absolutely necessary.</p><p>As with other anti-inflammatory medicines, you must not take Catafast during the last 3&nbsp;months of pregnancy, as it could harm your unborn child or cause problems at delivery.</p><p>You should tell your doctor if you are breast-feeding.</p><p>You should not breast-feed if you are taking Catafast, as it might be harmful for your infant.</p><p>Your doctor will discuss with you the potential risk of taking Catafast during pregnancy or breast-feeding.</p><p>Females of child-bearing potential</p><p>Catafast may make it more difficult to become pregnant. You should not take Catafast unless necessary if you are planning to become pregnant or if you have problems to become pregnant.</p><p style="margin-left:.5in; text-indent:-.25in"><!--[if !supportLists]-->f.&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Driving and using machines</p><p>Effects on ability to drive and use machines Patients who experience dizziness, vertigo, somnolence or other central nervous system disturbances while taking Catafast, including visual disturbances, should not drive or operate machines.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Follow your doctor&rsquo;s instruction carefully. Do not exceed the recommended dose.</p><p>How much Catafast to take</p><p>Do not exceed the recommended dose prescribed by your doctor. It is important that you use the lowest dose that controls your pain and that you do not take Catafast for longer than necessary.</p><p>Your doctor will tell you exactly how many sachets of Catafast to take. Depending on how you respond to the treatment, your doctor may suggest a higher or lower dose.</p><p>Adolescents</p><p>For adolescents aged 14 years and over, 50 to 100 mg daily are usually sufficient given as 1 to 2 divided doses. Do not exceed 150 mg per day.</p><p>Adults</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->For adults, the recommended dose to start the treatment is generally 100 to 150 mg daily (to be taken in 2 to 3 doses). In milder cases, 50 to 100 mg daily are usually sufficient (to be taken in 1 to 2 doses). Do not exceed 150 mg per day.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->In painful menstrual periods, start treatment with a single dose of 50 to 100 mg as soon as you feel the first symptoms. Continue with 50 mg up to three times a day for a few days, as needed. If 150 mg a day does not provide sufficient pain relief over 2 to 3 menstrual periods, your doctor may recommend you to take up to 200 mg a day during your next menstrual periods. Do not exceed 200 mg per day.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->In migraine, take Catafast at the first symptoms of a migraine attack. The initial dose is 50&nbsp;mg. If relief is not obtained within 2 hours, take a further dose of 50 mg. This may be repeated at intervals of 4 to 6 hours, but you should not take more than 200 mg per day.</p><p>When to take Catafast</p><p>It is recommended to take Catafast before meals.</p><p>How to take Catafast</p><p>The contents of the sachet should be dissolved by stirring in a glass of non-carbonated water. The solution may remain slightly cloudy, but this should not influence the efficacy of the medicine. The solution should be swallowed preferably before a meal.</p><p>How long to take Catafast</p><p>Follow your doctor&rsquo;s instructions exactly.</p><p style="margin-left:0in; text-align:justify; text-indent:0in">If you take Catafast for more than a few weeks, you should make sure to visit your doctor for regular check-ups, to ensure that you are not suffering from unnoticed undesirable effects<strong>.</strong></p><p style="margin-left:0in; text-align:justify; text-indent:0in">If you have questions about how long to take Catafast, talk to your doctor or your pharmacist.</p><p style="margin-left:.5in; text-indent:-.25in"><!--[if !supportLists]-->a.&nbsp;&nbsp;&nbsp; <!--[endif]-->If you take more Catafast than you should</p><p>If you have accidentally taken more Catafast than prescribed, tell your doctor or pharmacist or go to the hospital emergency unit at once.</p><p>You may require medical attention.</p><p style="margin-left:.5in; text-indent:-.25in"><!--[if !supportLists]-->b.&nbsp;&nbsp;&nbsp; <!--[endif]-->If you forget to take Catafast</p><p>Do not take a double dose to make up for forgotten individual doses.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>As with all medicines, patients taking Catafast may experience side effects, although not everybody gets them.</p><p>Some side effects could be serious</p><p><strong>Uncommon:</strong><em> may affect up to 1 in every 100 people, especially when taking a high daily dose (150 mg) for a long period of time</em></p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Sudden and oppressive chest pain (signs of myocardial infarction or heart attack).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Breathlessness, difficulty of breathing when lying down, swelling of the feet or legs (signs of cardiac failure).</p><p><strong>Rare or very rare: </strong><em>may affect up to </em><em>1 in every 1,000 people or up to 1 in every 10,000 people</em></p><p style="margin-left:17.85pt; margin-right:0in; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Spontaneous bleeding or bruising (signs of thrombocytopenia).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->High fever, frequent infections, persistent sore throat (signs of agranulocytosis).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Difficulty of breathing or swallowing, rash, itching, hives, dizziness (signs of hypersensitivity, anaphylactic and anaphylactoid reactions).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Swelling mainly of the face and throat (signs of angioedema).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Disturbing thoughts or moods (signs of psychotic disorders).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Impaired memory (signs of memory impairment).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Seizures (signs of convulsions).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Anxiety.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Stiff neck, fever, nausea, vomiting, headache (signs of aseptic meningitis).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Sudden and severe headache, nausea, dizziness, numbness, inability or difficulty to speak, weakness or paralysis of limbs or face (signs of cerebrovascular accident or stroke).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Difficulty of hearing (signs of impaired hearing).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Headache, dizziness (signs of high blood pressure, hypertension).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Rash, purplish-red spots, fever, itching (signs of vasculitis).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Sudden difficulty of breathing and feeling of tightness in chest with wheezing or coughing (signs of asthma or Pneumonitis if fever).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Vomiting of blood (signs of hematemesis) and/or black or bloody stools (signs of gastrointestinal hemorrhage).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Bloody diarrhea (signs of hemorrhagic diarrhea).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Black stools (signs of melena).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Stomach pain, nausea (signs of gastrointestinal ulcer, bleeding or perforation).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Diarrhea, abdominal pain, fever, nausea, vomiting (signs of colitis, including hemorrhagic colitis, ischemic colitis and exacerbation of ulcerative colitis or Crohn&rsquo;s disease).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Severe upper stomach pain (signs of pancreatitis).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Yellowing of the skin or eyes (signs of jaundice), nausea, loss of appetite, dark urine (signs of hepatitis/liver failure).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Flu-like symptoms, feeling tired, muscles aches, increased liver enzymes in blood test results (signs of liver disorders including fulminant hepatitis, hepatic necrosis, hepatic failure).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Blister (signs of bullous dermatitis).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Red or purple skin (possible signs of blood vessel inflammation), skin rash with blisters, blistering of the lips, eyes and mouth, skin inflammation with flaking or peeling (signs of erythema multiforme or if fever signs of Stevens-Johnson syndrome or toxic epidermal necrolysis).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Skin rash with flaking or peeling (signs of exfoliative dermatitis).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Increased sensitivity of the skin to sun (signs of photosensitivity reaction).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Purple skin patches (signs of purpura or Henoch-Schoenlein purpura if caused by an allergy).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Swelling, feeling weak, or abnormal urination (signs of acute renal failure).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Excess of protein in the urine (signs of proteinuria).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Swollen face or abdomen, high blood pressure (signs of nephrotic syndrome).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Higher or lower urine output, drowsiness, confusion, nausea (signs of tubulointerstitial nephritis).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Severely decreased urine output (signs of renal papillary necrosis).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Generalized swelling (signs of edema).</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Coincidental occurrence of chest pain and allergic reactions (signs of Kounis syndrome)</p><p>If you experience any of these, <strong>tell your doctor straight away</strong>.</p><p>Other possible side effects</p><p><strong>Common: </strong><em>may</em><em> affect up to 1 in every 10 people</em></p><p>Headache, dizziness, vertigo, nausea, vomiting, diarrhea, indigestion (signs of dyspepsia), abdominal pain, flatulence, loss of appetite (signs of decreased appetite), abnormal liver function test results (e.g., level of transaminases increased), skin rash.</p><p><strong>Uncommon:</strong> <em>may affect up to 1 in every 100 people</em></p><p style="margin-left:84.95pt; margin-right:0in; text-indent:-84.95pt">Palpitations, chest pain.</p><p><strong>Rare: </strong><em>may affect up to 1 in every 1,000 people</em></p><p>Drowsiness (signs of somnolence), stomach pain (signs of gastritis), liver disorder, itchy rash (signs of urticaria).</p><p><strong>Very rare: </strong><em>may affect up to 1 in every 10,000 people</em></p><p>Low level of red blood cells (anemia), low level of white blood cells (leukopenia), disorientation, depression, difficulty sleeping (signs of insomnia), nightmares, irritability, tingling or numbness of the hands or feet (signs of paresthesia), trembling (signs of tremor), taste disorders (signs of dysgeusia), vision disorders* (signs of visual impairment, blurred vision, diplopia), noises in ears (signs of tinnitus), constipation, mouth sores (signs of stomatitis), swollen, red and sore tongue (signs of glossitis), disorder of the tube that carries food from the throat to the stomach (signs of esophageal disorder), upper abdomen cramp specially after eating (signs of intestinal diaphragm disease), itchy, red and burning rash (signs of eczema), skin reddening (signs of erythema), hair loss (signs of alopecia), itching (signs of pruritus), blood in urine (signs of hematuria).</p><p><strong>*Vision disorders:</strong> If symptoms of vision disorders occur during treatment with Catafast, contact your doctor as an eye examination may be considered to exclude other causes.</p><p>If any of these affects you severely, <strong>tell your doctor</strong>.</p><p>If you notice any side effects not listed in this leaflet, please inform your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Do not use after the expiry date shown on the box.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Do not store above 30&deg;C.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Country specific: storage condition, depending on container</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Store in the original package, in order to protect from moisture.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Keep out of the reach and sight of children.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->The <strong>active substance</strong> in Catafast powder for oral solution is diclofenac potassium.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->The <strong>other ingredients</strong> are potassium hydrogen carbonate, mannitol, aspartame, saccharin sodium, glyceryl dibehenate, mint flavour, anise flavour.</p><p>This information might differ in some countries.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Catafast powder for oral solution is supplied in sachets. 
Each sachet contains a homogeneous, white to light yellow powder. 
Each sachet contains 50 mg of diclofenac potassium.
This information might differ in some countries.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Marketing Authorization Holder for this Product is Novartis Pharma AG</p><p>www.Novartis.com&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                09/2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><!--[if !supportLists]-->1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الآثار الجانبية الخطيرة</p><p dir="RTL" style="text-align:justify"><strong>المخاطر القلبية الوعائية</strong></p><p dir="RTL" style="margin-left:0in; margin-right:.25in; text-align:justify; text-indent:-.25in"><!--[if !supportLists]--><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><!--[endif]--><strong>قد تزيد العقاقير غير الستيرويدية المضادة للالتهاب (</strong><strong>NSAIDs</strong><strong>) من خطر الأحداث الخثارية القلبية الوعائية الخطيرة (</strong><strong>CV</strong><strong>)، واحتشاء عضلة القلب، والسكتة الدماغية، والتي يمكن أن تكون مميتة. وقد يزيد هذا الخطر مع مدة الاستخدام. قد يكون المرضى الذين يعانون من الأمراض القلبية الوعائية أو عوامل خطر الإصابة بالأمراض القلبية الوعائية أكثر عُرضة للخطر.</strong></p><p dir="RTL" style="margin-left:0in; margin-right:.25in; text-align:justify; text-indent:-.25in"><!--[if !supportLists]--><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><!--[endif]--><strong>يُمنع استخدام محلول ديكلوفيناك بوتاسيوم الفموي في علاج الآلام المحيطة بجراحة طعم لتحويل مسار الشريان التاجي (</strong><strong>CABG</strong><strong>).</strong></p><p dir="RTL" style="text-align:justify"><strong>المخاطر المعدية المعوية</strong></p><p dir="RTL" style="margin-left:0in; margin-right:.25in; text-align:justify; text-indent:-.25in"><!--[if !supportLists]--><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><!--[endif]--><strong>تزيد العقاقير غير الستيرويدية المضادة للالتهاب من خطر الآثار العكسية المعدية المعوية (</strong><strong>GI</strong><strong>) الخطيرة بما في ذلك نزيف المعدة أو الأمعاء، وتقرحها وانثقابها، والتي يمكن أن تكون مُميتة. هذه الآثار يمكن أن تحدث في أي وقت أثناء الاستخدام ومن دون ظهور أعراض تحذيرية. وتجدر الإشارة إلى أن المرضى من كبار السن أكثر عُرضة لخطر الإصابة بالآثار المعدية المعوية الخطيرة.</strong></p><p dir="RTL" style="text-align:justify">&nbsp;</p><p><!--[if !supportLists]-->2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ما هو دواء كتافاست وما دواعي استعماله</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">ما هو دواء كتافاست</p><p dir="RTL" style="text-align:justify">المادة الفعالة في مسحوق كتافاست المخصص للمحلول الفموي هي ديكلوفيناك بوتاسيوم.</p><p dir="RTL" style="text-align:justify">ينتمي كتافاست إلى مجموعة من الأدوية تُسمى &quot;الأدوية غير الستيرويدية المضادة للالتهابات&quot; (NSAIDs)، والتي تُستخدم لعلاج الألم والالتهابات.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">دواعي استعمال كتافاست</p><p dir="RTL" style="text-align:justify">يمكن استخدام كتافاست كعلاج قصير الأمد للحالات التالية:</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الإجهاد، أو الالتواءات، أو الإصابات الأخرى.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ألم وتورّم ما بعد الجراحة.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الدورة الشهرية المؤلمة.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نوبات الصداع النصفي.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ألم الظهر، والكتف المتجمد، ومرفق لاعب التنس، وغيرها من أشكال روماتيزم الأنسجة الرخوة.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->التهابات الأذن، أو الأنف أو الحلق.</p><p dir="RTL" style="text-align:justify">في نوبات الصداع النصفي، يُعتبر كتافاست فعالاً في تخفيف آلام الصداع وكذلك في تحسين الأعراض المصاحبة مثل الغثيان والقيء.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">كيف يعمل كتافاست</p><p dir="RTL" style="text-align:justify">يُخفف كتافاست من أعراض الالتهابات، مثل الألم والتورّم، عن طريق منع تخليق الجزيئات (البروستاغلاندين) المسؤولة عن الالتهابات، والألم والحمى. وليس له أي تأثير على أسباب الالتهابات أو الحمى.</p><p dir="RTL" style="text-align:justify">إذا كانت لديك أي أسئلة حول كيفية عمل دواء كتافاست أو لماذا تم وصف هذا الدواء لك، فاطرح هذه الأسئلة على الطبيب.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">اتبع جميع تعليمات الطبيب بعناية. فقد تختلف عن المعلومات العامة الواردة في هذه النشرة.</p><p dir="RTL" style="margin-left:0in; margin-right:.5in; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->&zwnj;أ.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->لا تتناول كتافاست</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>إذا كنت تعاني من</strong> <strong>حساسية</strong> (حساسية مفرطة) تجاه ديكلوفيناك أو أي من مكونات كتافاست الأخرى المدرجة في نهاية هذه النشرة.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>إذا سبق أن</strong> عانيت من رد فعل تحسسي بعد تناول أدوية لعلاج الالتهابات أو الألم (مثل حمض الأسيتيل ساليسيليك، (ديكلوفيناك أو إيبوبروفين)). قد تشمل ردود الفعل الربو، وسيلان الأنف، والطفح الجلدي، وتورّم الوجه، والشفتين، واللسان، والحلق، والأطراف أو أي منهم (علامات الوذمة الوعائية). إذا كنت تعتقد أنك تعاني من الحساسية، فاطلب المشورة من الطبيب.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>إذا كنت تعاني</strong> من قرحة في المعدة أو الأمعاء.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>إذا كنت تعاني</strong> من نزيف أو انثقاب في المعدة والأمعاء، والتي قد تشمل أعراضه وجود دم في البراز أو براز أسود.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>إذا كنت تعاني</strong> من فشل كلوي أو كبدي.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>إذا كنت تعاني</strong> من قصور حاد في القلب.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>إذا كنتِ</strong> في الأشهر الثلاثة الأخيرة من الحمل.</p><p dir="RTL" style="text-align:justify">إذا انطبق عليك أي مما سبق، <strong>فأخبر الطبيب</strong> دون تناول كتافاست.</p><p dir="RTL" style="margin-left:0in; margin-right:.5in; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->&zwnj;ب.&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->توخِ الحذر الشديد مع كتافاست</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت قد أُصبت بمرض في القلب أو الأوعية الدموية (يُسمى أيضًا مرض قلبي وعائي، بما في ذلك ارتفاع ضغط الدم الخارج عن السيطرة، أو قصور القلب الاحتقاني، أو مرض القلب الإقفاري، أو مرض الشريان المحيطي)، فلا يُوصى باستخدام عقار كتافاست بشكل عام.</p><p dir="RTL" style="margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت قد أُصبت بمرض قلبي وعائي (انظر أعلاه) أو إذا كان لديك عوامل خطر كبيرة مثل ارتفاع ضغط الدم، أو ارتفاع مستويات الدهون بشكل غير طبيعي (الكوليسترول، والدهون الثلاثية) في الدم، أو مرض السكري، أو إذا كنت تدّخن، وقرر الطبيب وصف كتافاست، فيجب ألا تزيد الجرعة عن 100 ملغ يوميًا إذا كانت مدة علاجك أكثر من 4 أسابيع.</p><p dir="RTL" style="margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->من المهم بوجه عام تناول أقل جرعة من كتافاست التي تخفف من الألم و/أو التورّم لديك ولأقصر وقت ممكن من أجل تقليل خطر الآثار الجانبية القلبية الوعائية قدر الإمكان.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت تتناول كتافاست بالتزامن مع أدوية أخرى مضادة للالتهابات بما في ذلك حمض الأسيتيل ساليسيليك أو الكورتيكوستيرويدات أو &quot;مرققات الدم&quot; أو &quot;العقاقير غير السيترويدية المضادة للالتهابات (SSRIs)&quot; (انظر &quot;تناول أدوية أخرى&quot;).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت تعاني من الربو أو حمى القش (التهاب الأنف التحسسي الموسمي).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت قد عانيت من قبل من أي مشكلات في الجهاز الهضمي مثل قرحة المعدة، أو النزيف أو البراز الأسود، أو عانيت من ألم أو حرقة في المعدة بعد تناول الأدوية المضادة للالتهابات في الماضي.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت تعاني من التهاب القولون (التهاب القولون التقرحي) أو القناة المعوية (داء كرون).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت تعاني من مشاكل في الكبد أو الكلى.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كان من الممكن أن تُصاب بالجفاف (على سبيل المثال، بسبب المرض، أو الإسهال، أو قبل أو بعد جراحة كبيرة).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت تعاني من تورّم القدمين.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت تعاني من اضطراب نزفي أو اضطرابات الدم الأخرى، بما في ذلك حالة كبدية نادرة تُسمى البرفيريا.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت قد خضعت مؤخرًا أو ستخضع لجراحة في المعدة أو القناة المعوية.</p><p dir="RTL" style="text-align:justify">إذا انطبق عليك أي مما سبق، <strong>فأخبر الطبيب قبل أن تتناول كتافاست</strong>.</p><p dir="RTL" style="margin-left:0in; margin-right:.25in; text-align:justify; text-indent:-.25in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا عانيت، في أي وقت خلال تناولك كتافاست، من أي علامات أو أعراض لمشكلات في قلبك أو أوعيتك الدموية مثل ألم في الصدر، أو ضيق في التنفس، أو ضعف، أو تلعثم في الكلام، فاتصل بالطبيب على الفور.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->قد يقلل كتافاست من أعراض العدوى (على سبيل المثال، الصداع، ارتفاع درجة الحرارة) وبالتالي قد يجعل من الصعب اكتشاف العدوى وعلاجها على النحو الملائم. إذا شعرت بتوعك وكنت بحاجة إلى زيارة طبيب، فلا تنسَ إخباره بأنك تتناول كتافاست.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->في حالات نادرة جدًا، قد يعاني المرضى الذين عولجوا بدواء كتافاست، كما هو الحال مع الأدوية الأخرى المضادة للالتهابات، من ردود فعل تحسسية جلدية<strong> </strong>شديدة (مثل الطفح الجلدي).</p><p dir="RTL" style="margin-left:0in; text-align:justify; text-indent:0in">إذا ظهرت عليك أي من الأعراض المذكورة أعلاه، <strong>فأخبر الطبيب على الفور</strong>.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">المتابعة أثناء فترة العلاج بدواء كتافاست</p><p dir="RTL" style="text-align:justify">إذا كنت قد أُصبت بمرض قلبي أو كنت مُعرض بشكل كبير لخطر الإصابة بمرض قلبي، فسيقوم الطبيب بإعادة تقييم ما إذا كان يجب عليك مواصلة العلاج بدواء كتافاست، خاصةً في حالة إذا كان استمر علاجك لأكثر من 4 أسابيع.</p><p dir="RTL" style="text-align:justify">إذا كنت تعاني من أي قصور في الكبد أو في الكلى أو قصور في الدم، فستخضع لاختبارات دم في أثناء العلاج. سوف تراقب هذه الاختبارات إما وظائف الكبد لديك (مستوى ناقلات الأمين) أو وظائف الكلى لديك (مستوى الكرياتينين) أو عد الدم لديك (مستوى خلايا الدم البيضاء والحمراء والصفائح الدموية). سیأخذ الطبيب اختبارات الدم هذه بعین الاعتبار ليقرر ما إذا کان يتعين إيقاف كتافاست أو إذا کانت الجرعة تحتاج إلى تغيير.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">الأطفال والمراهقون</p><p dir="RTL" style="text-align:justify">يجب عدم إعطاء كتافاست للأطفال والمراهقين الذين تقل أعمارهم عن 14 عامًا. لاستخدام الأطفال، يمكن استخدام أشكال أخرى من ديكلوفيناك.</p><p dir="RTL" style="text-align:justify">ولم يثبت استخدام كتافاست في الصداع النصفي لدى الأطفال والمراهقين.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">الأشخاص من كبار السن</p><p dir="RTL" style="text-align:justify">قد يكون المرضى من كبار السن، خاصةً أولئك الذين يعانون من الضعف أو انخفاض في وزن الجسم، أكثر حساسية لآثار كتافاست عن البالغين الآخرين. لذلك، يجب عليهم اتباع تعليمات الطبيب بعناية بشكل خاص وتناول الحد الأدنى من عدد الأكياس التي تخفف الأعراض. ومن المهم بصفة خاصة بالنسبة للمرضى من كبار السن الإبلاغ عن الآثار غير المرغوب فيها على الفور إلى الطبيب.</p><p dir="RTL" style="margin-left:0in; margin-right:.5in; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->&zwnj;ج.&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تناول أدوية أخرى، أعشاب أو مكملات غذائية أخرى</p><p dir="RTL" style="text-align:justify">أخبر الطبيب، أو الصيدلي، أو مقدم الرعاية الصحية إذا كنت تتناول أو تناولت مؤخرًا أيّة أدوية أخرى، بما في ذلك الأدوية التي يتم الحصول عليها من دون وصفة طبية.</p><p dir="RTL" style="text-align:justify">ومن المهم بشكل خاص إخبار الطبيب إذا كنت تتناول أيًا من الأدوية التالية:</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الليثيوم أو مثبطات إعادة امتصاص السيروتونين الانتقائية (SSRIs) (الأدوية المستخدمة لعلاج نوعاً ما من أنواع الاكتئاب).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ديجوكسين (دواء يُستخدم لعلاج مشكلات القلب).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مُدرات البول (أدوية تُستخدم لزيادة كمية البول).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مثبطات الإنزيم المحول للأنجيوتنسين (ACE) أو حاصرات بيتا (فئات من الأدوية تُستخدم لعلاج ارتفاع ضغط الدم وقصور القلب).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الأدوية الأخرى المضادة للالتهابات مثل حمض الأسيتيل ساليسيليك أو الإيبوبروفين.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الكورتيكوستيرويدات (أدوية تُستخدم لتخفيف المناطق المصابة بالالتهابات في الجسم).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->&quot;مرققات الدم&quot; (أدوية تُستخدم لمنع تجلط الدم).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الأدوية (مثل الميتفورمين) المستخدمة لعلاج السكري، باستثناء الأنسولين.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ميثوتريكسات (دواء يُستخدم لعلاج بعض أنواع السرطان أو التهاب المفاصل).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->سيكلوسبورين، تاكروليموس (أدوية تُستخدم في المقام الأول في المرضى الذين خضعوا لعمليات زرع الأعضاء).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تريميثوبريم (دواء يُستخدم للوقاية من عدوى المسالك البولية أو علاجها)</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مضادات البكتيريا الكينولونية (أدوية تُستخدم ضد العدوى).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فوريكونازول (دواء يُستخدم لعلاج العدوى الفطرية).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الفينيتوين (دواء يُستخدم لعلاج نوبات التشنج).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ريفامبيسين (مضاد حيوي يُستخدم لعلاج العدوى البكتيرية).</p><p dir="RTL" style="margin-left:0in; margin-right:.5in; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->&zwnj;د.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تناول كتافاست مع الطعام والشراب</p><p dir="RTL" style="text-align:justify">يوصى بتناول كتافاست قبل الوجبات.</p><p dir="RTL" style="margin-left:0in; margin-right:.5in; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->&zwnj;ه.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الحمل والرضاعة الطبيعية</p><p dir="RTL" style="text-align:justify">يجب أن تقومي بإخبار الطبيب إذا كنتِ حاملاً أو تعتقدين أنكِ قد تكونين حاملاً. يجب ألا تتناولي كتافاست في أثناء الحمل إلا إذا كانت هناك ضرورة قصوى لذلك.</p><p dir="RTL" style="text-align:justify">كما هو الحال مع الأدوية الأخرى المضادة للالتهابات، يجب ألا تتناولين كتافاست خلال الأشهر الثلاثة (3) الأخيرة من الحمل، حيث قد يضر بالجنين أو قد يُسبب مشكلات عند الولادة.</p><p dir="RTL" style="text-align:justify">يجب أن تقومي بإخبار الطبيب إذا كنت تُرضعين رضاعة طبيعية.</p><p dir="RTL" style="text-align:justify">يجب ألا تقومي بإرضاع طفلكِ رضاعة طبيعية إذا كنتِ تتناولين كتافاست، لأنه قد يكون ضارًا لطفلك.</p><p dir="RTL" style="text-align:justify">سيناقش معكِ الطبيب المخاطر المحتملة لتناول كتافاست في أثناء الحمل أو الرضاعة الطبيعية.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">الإناث في سن الإنجاب</p><p dir="RTL" style="text-align:justify">إن تناول كتافاست قد يجعل حدوث الحمل أكثر صعوبة. لذلك، يجب ألا تتناولين كتافاست ما لم يكن ذلك ضروريًا إذا كنتِ تخططين لحدوث الحمل أو إذا كنتِ تعانين من مشكلات في حدوث الحمل.</p><p dir="RTL" style="margin-left:0in; margin-right:.5in; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->&zwnj;و.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->قيادة السيارة واستخدام الآلات</p><p dir="RTL" style="text-align:justify">التأثيرات على القدرة على القيادة واستخدام الآلات: يجب على المرضى الذين يعانون من الدوخة، أو الدوار، أو النعاس، أو اضطرابات أخرى في الجهاز العصبي المركزي في أثناء تناول كتافاست، بما في ذلك الاضطرابات البصرية، عدم القيادة أو تشغيل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">اتبع تعليمات الطبيب بعناية. لا تتجاوز الجرعة المُوصى بها.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">ما مقدار الجرعة الواجب تناولها من كتافاست</p><p dir="RTL" style="text-align:justify">لا تتجاوز الجرعة المُوصى بها التي وصفها لك الطبيب. ومن الأهمية بمكان أن تستخدم أقل جرعة التي تسيطر على الألم وألا تتناول كتافاست لفترة أطول من اللازم.</p><p dir="RTL" style="text-align:justify">سيُخبرك الطبيب بالضبط بعدد أكياس كتافاست التي يجب أن تتناولها. بناءً على مدى استجابتك للعلاج، قد يوصي الطبيب بجرعة أعلى أو أقل.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">المراهقون</p><p dir="RTL" style="text-align:justify">بالنسبة للمراهقين الذين تتراوح أعمارهم بين 14 عامًا وما فوق، عادةً يكفي إعطاء 50 إلى 100 ملغ يوميًا كجرعة واحدة (1) إلى جرعتين (2) مقسمتين. لكن، لا تتجاوز 150 ملغ يوميًا.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">البالغون</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->بالنسبة للبالغين، تتراوح الجرعة الموصى بها لبدء العلاج بشكل عام من 100 إلى 150 ملغ يوميًا (يتم تناولها في شكل جرعتين (2) إلى 3 جرعات). في الحالات الأخف حدة، تكون عادةً الجرعة من 50 إلى 100 ملغ يوميًا كافية (يتم تناولها في شكل جرعة واحدة (1) إلى جرعتين (2)). لكن، لا تتجاوز 150 ملغ يوميًا.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->في الدورة الشهرية المؤلمة، ابدئي العلاج بجرعة واحدة من 50 إلى 100 ملغ بمجرد شعورك بالأعراض الأولى. واستمري في تناول 50 ملغ حتى ثلاث مرات في اليوم لبضعة أيام، حسب الحاجة. إذا كان 150 ملغ يوميًا لا يوفر تخفيفًا كافيًا للألم على مدى 2 إلى 3 دورات شهرية، فقد يوصيكِ الطبيب بتناول ما يصل إلى 200 ملغ يوميًا أثناء الدورات الشهرية التالية. لا تتجاوزي 200 ملغ في اليوم.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->في حالة الصداع النصفي، تناول كتافاست عند ظهور الأعراض الأولى لنوبة الصداع النصفي. وتكون الجرعة الأولية هي 50 ملغ. إذا لم يتم الحصول على تخفيف الألم في غضون ساعتين (2)، فتناول جرعة أخرى تبلغ 50 ملغ. وقد يتم تكرار ذلك على فترات زمنية من 4 إلى 6 ساعات، ولكن يجب ألا تتناول أكثر من 200 ملغ يوميًا.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">متى يجب تناول كتافاست</p><p dir="RTL" style="text-align:justify">يُوصى بتناول كتافاست قبل الوجبات.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">كيف تتناول كتافاست</p><p dir="RTL" style="text-align:justify">يجب إذابة محتويات الكيس عن طريق التقليب في كوب من الماء غير الغازي. قد يظل المحلول غائمًا قليلاً، ولكن ينبغي ألا يؤثر ذلك على فعالية الدواء. ويجب ابتلاع المحلول ويُفضل قبل وجبة الطعام.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">كم من الوقت يجب أن تتناول كتافاست</p><p dir="RTL" style="text-align:justify">اتبع تعليمات الطبيب بالضبط.</p><p dir="RTL" style="margin-left:0in; text-align:justify; text-indent:0in">إذا كنت تتناول كتافاست لأكثر من بضعة أسابيع، فيجب عليك التأكد من زيارة الطبيب لإجراء فحوص منتظمة، للتأكد من أنك لا تعاني من آثار غير مرغوب فيها غير ملحوظة<strong>.</strong></p><p dir="RTL" style="margin-left:0in; text-align:justify; text-indent:0in">إذا كانت لديك أسئلة حول مدة تناول دواء كتافاست، فتحدث إلى الطبيب أو الصيدلي.</p><p dir="RTL" style="margin-left:0in; margin-right:.5in; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->&zwnj;أ.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا تناولت كتافاست أكثر مما ينبغي</p><p dir="RTL" style="text-align:justify">إذا تناولت جرعة أكثر من الموصوفة من كتافاست عن طريق الخطأ، فأخبر الطبيب أو الصيدلي أو اذهب إلى وحدة الطوارئ بالمستشفى على الفور.</p><p dir="RTL" style="text-align:justify">فقد تحتاج إلى رعاية طبية.</p><p dir="RTL" style="margin-left:0in; margin-right:.5in; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->&zwnj;ب.&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا نسيت تناول كتافاست</p><p dir="RTL" style="text-align:justify">لا تتناول جرعة مضاعفة للتعويض عن الجرعات المنفردة التي نسيت أن تتناولها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">كما هو الحال مع جميع الأدوية، قد يعاني المرضى الذين يتناولون كتافاست من آثار جانبية، على الرغم من أنها لا تُصيب الجميع.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">قد تكون بعض الآثار الجانبية خطيرة</p><p dir="RTL" style="text-align:justify"><strong><em>غير شائعة:</em></strong><em> قد تُصيب ما يصل إلى شخص واحد (1) من كل 100 شخص، خاصةً عند تناول جرعة يومية عالية (150 ملغ) لفترة طويلة من الوقت</em></p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ألم مفاجئ وخانق في الصدر (علامات احتشاء عضلة القلب أو النوبة القلبية).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ضيق التنفس، صعوبة التنفس عند الاستلقاء، تورم القدمين أو الساقين (علامات قصور القلب).</p><p dir="RTL" style="text-align:justify"><strong><em>نادرة أو نادرة جدًا: </em></strong><em>قد تُصيب ما يصل إلى شخص واحد (1) من كل 1000 شخص أو ما يصل إلى شخص واحد (1) من كل 10000 شخص</em></p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نزيف تلقائي أو كدمات (علامات قلة الصفيحات).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->حمى شديدة، عدوى متكررة، التهاب مستمر في الحلق (علامات ندرة المحببات).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->صعوبة في التنفس أو البلع، طفح جلدي، حكة، شرى، دوخة (علامات فرط الحساسية، تفاعلات تأقية وتأقانية).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تورّم الوجه والحلق بشكل أساسي (علامات الوذمة الوعائية).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->أفكار أو حالات مزاجية مزعجة (علامات الاضطرابات الذهانية).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ضعف الذاكرة (علامات ضعف الذاكرة).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نوبات تشنج (علامات التشنجات).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->القلق.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تيبس الرقبة، حمى، غثيان، قيء، صداع (علامات التهاب السحايا العقيم).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->صداع مفاجئ وشديد، غثيان، دوخة، خدر، عدم القدرة على الكلام أو صعوبة في الكلام، ضعف أو شلل في الأطراف أو الوجه (علامات لحادث وعائي دماغي أو سكتة دماغية).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->صعوبة في السمع (علامات ضعف السمع).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->صداع، دوخة (علامات ضغط الدم المرتفع، فرط ضغط الدم).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->طفح جلدي، بقع حمراء أرجوانية، حمى، حكة (علامات التهاب الأوعية الدموية).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->صعوبة مفاجئة في التنفس والشعور بضيق في الصدر مع أزيز أو سعال (علامات الربو أو الالتهاب الرئوي إذا كانت حمى).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تقيؤ الدم (علامات القيء الدموي) و/أو البراز الأسود أو الدموي (علامات النزيف المعدي المعوي).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الإسهال الدموي (علامات الإسهال النزفي).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->براز أسود (علامات التغوط الأسود).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ألم في المعدة، غثيان (علامات قرحة معدية معوية، نزيف أو انثقاب).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إسهال، ألم في البطن، حمى، غثيان، قيء (علامات التهاب القولون، بما في ذلك التهاب القولون النزفي، والتهاب القولون الإقفاري، وتفاقم التهاب القولون التقرحي أو داء كرون).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ألم شديد أعلى المعدة (علامات التهاب البنكرياس).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->اصفرار الجلد أو العينين (علامات اليرقان)، غثيان، فقدان الشهية، بول داكن (علامات الالتهاب الكبدي الوبائي/فشل كبدي).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->أعراض شبيهة بالأنفلونزا، الشعور بالتعب، آلام العضلات، زيادة إنزيمات الكبد في نتائج اختبارات الدم (علامات اضطرابات الكبد بما في ذلك الالتهاب الكبدي الوبائي الخاطف، النخر الكبدي، الفشل الكبدي).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->بثور (علامات التهاب الجلد الفقاعي).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->جلد أحمر أو أرجواني (علامات محتملة لالتهاب الأوعية الدموية)، طفح جلدي مصحوب ببثور، تقرحات في الشفتين، والعينين والفم، التهاب الجلد مع تقشر (علامات حمامي متعددة الأشكال أو إذا كانت علامات الحمى من متلازمة ستيفنز جونسون أو تقشر نتيجة التحلل السام لأنسجة البشرة).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->طفح جلدي مصحوب بتقشر أو تقشير (علامات التهاب الجلد التقشري).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->زيادة حساسية الجلد للشمس (علامات تفاعل الحساسية للضوء).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->بقع جلدية أرجوانية (علامات الفرفرية أو فرفرية هينوخ شونلاين إذا كانت ناجمة عن حساسية).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->التورم، أو الشعور بالضعف، أو التبول غير الطبيعي (علامات الفشل الكلوي الحاد).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فرط البروتين في البول (علامات البيلة البروتينية).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تورم الوجه أو البطن، ارتفاع ضغط الدم (علامات المتلازمة الكلائية).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ارتفاع أو انخفاض وتيرة إخراج البول، النعاس، الاضطراب، الغثيان (علامات التهاب الكلية النبيبي الخلالي).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->انخفاض حاد في وتيرة إخراج البول (علامات نخر الحليميات الكلوية).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تورم عام (علامات الوذمة).</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->حدوث عرضي لألم في الصدر وردود الفعل التحسسية (علامات متلازمة كونيس)</p><p dir="RTL" style="text-align:justify">إذا عانيت من أي من هذه الأعراض، <strong>فأخبر الطبيب على الفور</strong>.</p><p dir="RTL" style="margin-left:0in; margin-right:85.05pt; text-align:right">الآثار الجانبية الأخرى المحتملة</p><p dir="RTL" style="text-align:justify"><strong>شائعة: </strong><em>قد تصيب ما يصل إلى شخص واحد (1) من كل 10 أشخاص</em></p><p dir="RTL" style="text-align:justify">صداع، دوخة، دوار، غثيان، قيء، إسهال، عسر الهضم (علامات عسر الهضم)، ألم في البطن، انتفاخ البطن، فقدان الشهية (علامات انخفاض الشهية)، نتائج غير طبيعية لاختبار وظائف الكبد (على سبيل المثال، زيادة مستوى ناقلات الأمين)، طفح جلدي.</p><p dir="RTL" style="text-align:justify"><strong>غير شائعة:</strong> <em>قد تصيب ما يصل إلى شخص واحد (1) من كل 100 شخص</em></p><p dir="RTL" style="margin-left:0in; margin-right:84.95pt; text-align:right; text-indent:-84.95pt">خفقان، ألم في الصدر.</p><p dir="RTL" style="text-align:justify"><strong>نادرة: </strong><em>قد تصيب ما يصل إلى شخص واحد (1) من كل 1000 شخص</em></p><p dir="RTL" style="text-align:justify">النعاس (علامات النُعاس)، ألم في المعدة (علامات التهاب المعدة)، اضطراب الكبد، طفح جلدي مصحوب بحكة (علامات الشرى).</p><p dir="RTL" style="text-align:justify"><strong>نادرة جدًا: </strong><em>قد تصيب ما يصل إلى شخص واحد (1) من كل 10000 شخص</em></p><p dir="RTL" style="text-align:justify">انخفاض مستوى خلايا الدم الحمراء (فقر الدم)، انخفاض مستوى خلايا الدم البيضاء (قلة الكريات البيضاء)، توهان، اكتئاب، صعوبة النوم (علامات الأرق)، كوابيس، تهيج، وخز أو تنميل في اليدين أو القدمين (علامات المذل)، ارتعاش (علامات الرعاش)، اضطرابات التذوق (علامات خلل الذوق)، اضطرابات الرؤية* (علامات ضعف الرؤية، تشوش الرؤية، ازدواجية الرؤية)، أصوات في الأذنين (علامات الطنين)، إمساك، قرح الفم (علامات التهاب الفم)، تورم، احمرار وتقرح اللسان (علامات التهاب اللسان)، اضطراب في الأنبوب الذي يحمل الطعام من الحلق إلى المعدة (علامات اضطراب المريء)، تقلصات أعلى البطن خصوصًا بعد تناول الطعام (علامات مرض الحجاب الحاجز المعوي)، إثارة الحكة، طفح جلدي أحمر وحارق (علامات الإكزيما)، احمرار الجلد (علامات الحُمامى)، تساقط الشعر (علامات الثعلبة)، حكة (علامات الحكة)، دم في البول (علامات البيلة الدموية).</p><p dir="RTL" style="text-align:justify"><strong>*اضطرابات الرؤية:</strong> في حالة حدوث أعراض اضطرابات الرؤية في أثناء العلاج بدواء كتافاست، فاتصل بالطبيب حيث قد يتم النظر في إجراء فحص العين لاستبعاد أسباب أخرى.</p><p dir="RTL" style="text-align:justify">إذا كان أي من هذه الأعراض تؤثر عليك بشدة، <strong>فأخبر الطبيب</strong>.</p><p dir="RTL" style="text-align:justify">إذا لاحظت أي آثار جانبية غير مدرجة في هذه النشرة، فيُرجى إبلاغ الطبيب أو الصيدلي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->لا تستخدمه بعد تاريخ انتهاء الصلاحية الموضح على العلبة.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->لا تخزنه في درجة حرارة أعلى من 30 درجة مئوية.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->خاص بالبلد: حالة التخزين، حسب الحاوية</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->احفظه في العبوة الأصلية، لحمايته من الرطوبة.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->يُحفَظ بعيدًا عن متناول ومرأي الأطفال.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>المادة الفعالة</strong> في مسحوق كتافاست المخصص للمحلول الفموي هي ديكلوفيناك بوتاسيوم.</p><p dir="RTL" style="margin-left:0in; margin-right:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>المكونات الأخرى</strong> هي كربونات هيدروجين البوتاسيوم، والمانيتول، والأسبارتام، وسكارين الصوديوم، وديبهينات الجلسرين، ونكهة النعناع، ونكهة اليانسون.</p><p>قد تختلف هذه المعلومات في بعض البلاد.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">يتم توفير مسحوق كتافاست المخصص للمحلول الفموي في أكياس.</p><p dir="RTL" style="text-align:justify">يحتوي كل كيس على مسحوق متجانس، أبيض إلى أصفر فاتح.</p><p dir="RTL" style="text-align:justify">يحتوي كل كيس على 50 ملغ من ديكلوفيناك بوتاسيوم.</p><p dir="RTL" style="text-align:justify">قد تختلف هذه المعلومات في بعض البلاد.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مالك حق التسويق لهذا المنتج هي شركة نوفارتس فارما إيه جي.</p><p dir="RTL">www.Novartis.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            09/2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                CATAFAST 50 mg powder for oral solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active substance
The active ingredient is diclofenac potassium. 
One Catafast sachet contains 50 mg of diclofenac potassium.
Excipients
Potassium hydrogen carbonate; mannitol; aspartame; saccharin sodium; glyceryl dibehenate; mint flavor; anise flavor.
Information might differ in some countries.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for oral solution.
Homogenous, white to light yellow powder.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Short-term treatment in the following acute conditions:</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Post-traumatic pain, inflammation and swelling, e.g., due to sprains.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Post-operative pain, inflammation and swelling, e.g., following dental or orthopedic surgery.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Painful and/or inflammatory conditions in gynecology, e.g., primary dysmenorrhea or adnexitis.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Migraine attacks.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Painful syndromes of the vertebral column.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Non-articular rheumatism.</p><p style="margin-left:17.85pt; text-align:justify; text-indent:-17.85pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->As an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis . In keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. Fever alone is not an indication.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dosage regimen</p><p>As a general recommendation, the dose should be individually adjusted. Adverse effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms (see section Warnings and precautions).</p><p>General target population</p><p>Adults</p><p>The recommended initial daily dose is 100 to 150 mg. In milder cases, 50 to 100 mg daily are usually sufficient. The daily dose should generally be divided in up to 3 separate doses.</p><p>In primary dysmenorrhoea, the daily dose should be individually adjusted and is generally 50 to 150&nbsp;mg. A dose of 50 to 100 mg should be given initially and, if necessary increased over the course of several menstrual cycles up to a total maximum of 200 mg/day. Treatment should be started on appearance of the first symptoms and, depending on the symptomatology, continued for a few days.</p><p>In migraine, an initial dose of 50 mg should be taken at the first signs of an impending attack. In cases where pain relief within 2 hours after the first dose is not sufficient, a further dose of 50 mg may be taken. If needed, further doses of 50 mg may be taken at intervals of 4 to 6&nbsp;hours, not exceeding a total dose of 200 mg per day.</p><p>Special populations</p><p>Renal impairment</p><p>Catafast is contraindicated in patients with renal failure (GFR &lt;15 mL/min/1.73&nbsp;m<sup>2</sup>) (see section 5 Contraindications).</p><p>No specific studies have been carried out in patients with renal impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering Catafast to patients with renal impairment (see section Warnings and precautions) .</p><p>Hepatic impairment</p><p>Catafast is contraindicated in patients with hepatic failure (see section 5 Contraindications).</p><p>No specific studies have been carried out in patients with hepatic impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering Catafast to patients with mild to moderate hepatic impairment (see section Warnings and precautions) .</p><p>Pediatric patients (below 18 years)</p><p>Catafast 50 mg powder for oral solution is not recommended for use in children and adolescents below 14 years of age. For treatment in children and adolescents below 14 years of age, oral drops and suppositories of diclofenac 12.5 mg and 25 mg are available.</p><p>For adolescents aged 14 years and over, 50 to 100 mg daily are usually sufficient, given as 1 to 2 divided doses.</p><p>The maximum daily dose of 150 mg should not be exceeded.</p><p>The use of Catafast 50 mg powder for oral solution in migraine attacks has not been established in children and adolescents.</p><p>Geriatric patients (65 years of age or above)</p><p>No adjustment of the starting dose is generally required for elderly patients. However, caution is indicated on basic medical grounds, especially for frail elderly patients or those with a low body weight (see section WARNINGS AND PRECAUTIONS).</p><p style="text-align:justify">Established cardiovascular disease or significant cardiovascular risk factors</p><p>Treatment with Catafast is generally not recommended in patients with established cardiovascular disease or uncontrolled hypertension. If needed, patients with established cardiovascular disease, uncontrolled hypertension or significant risk factors for cardiovascular disease should be treated with Catafast only after careful consideration and only at doses &le;100&nbsp;mg daily when treatment continues for more than 4 weeks (see section Warnings and precautions) .</p><p>Method of administration</p><p>The contents of the sachet should be dissolved with stirring in a glass of natural (non-carbonated) water. The solution may remain slightly opalescent, but this should not influence the efficacy of the preparation. The solution should be swallowed preferably before meals.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Known hypersensitivity to the active substance or to any of the excipients.
•	Active gastric or intestinal ulcer, bleeding or perforation (see sections 6 Warnings and precautions and 7 Adverse drug reactions).
•	Last trimester of pregnancy (see section 9 Pregnancy, lactation, females and males of reproductive potential) .
•	Hepatic failure.
•	Renal failure (GFR <15 mL/min/1.73 m2) .
•	Severe cardiac failure (see section Warnings and precautions) .
•	Like other non-steroidal anti-inflammatory drugs (NSAIDs), Catafast is also contraindicated in patients in whom the use of acetylsalicylic acid or other NSAIDs can precipitate asthma, angioedema, urticaria, or acute rhinitis (i.e., NSAID-induced cross-reactivity reactions). (see sections 6 Warnings and precautions and 7 Adverse drug reactions) .

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gastrointestinal effects</p><p>Gastrointestinal bleeding, ulceration or perforation, which can be fatal, have been reported with all NSAIDs, including diclofenac, and may occur at any time during treatment, with or without warning symptoms or a previous history of serious gastrointestinal events . They generally have more serious consequences in the elderly. If gastrointestinal bleeding or ulceration occurs in patients receiving Catafast, the treatment should be discontinued.</p><p>As with all NSAIDs, including diclofenac, close medical surveillance is imperative and particular caution should be exercized when prescribing Catafast in patients with symptoms indicative of gastrointestinal (GI) disorders or with a history suggestive of gastric or intestinal ulceration, bleeding or perforation (see section 7 Adverse drug reactions). The risk of GI bleeding is higher with increasing NSAID doses and in patients with a history of ulcer, particularly if complicated with hemorrhage or perforation and in the elderly .</p><p>To reduce the risk of GI toxicity in patients with a history of ulcer, particularly if complicated with hemorrhage or perforation, and in the elderly, the treatment should be initiated and maintained at the lowest effective dose .</p><p>Combination therapy with protective agents (e.g., proton pump inhibitors or misoprostol) should be considered for these patients, and also for patients requiring concomitant use of low-dose acetylsalicylic acid (ASA) or other drugs likely to increase gastrointestinal risk .</p><p style="text-align:justify">Patients with a history of GI toxicity, particularly the elderly, should report any unusual abdominal symptoms (especially GI bleeding). Caution is recommended in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as systemic corticosteroids, anticoagulants, anti-platelet agents or selective serotonin-reuptake inhibitors (see section 8 Interactions) .</p><p style="text-align:justify">Close medical surveillance and caution should also be exercized in patients with ulcerative colitis or Crohn&rsquo;s disease, as their condition may be exacerbated (see section 7 Adverse drug reactions) .</p><p>NSAIDs, including diclofenac, may be associated with increased risk of gastro-intestinal anastomotic leak. Close medical surveillance and caution are recommended when using Catafast after gastro-intestinal surgery .</p><p>Cardiovascular effects</p><p>Treatment with NSAIDs including diclofenac, particularly at high dose and in long term, may be associated with a small increased risk of serious cardiovascular thrombotic events (including myocardial infarction and stroke) .</p><p>Treatment with Catafast is generally not recommended in patients with established cardiovascular disease (congestive heart failure, established ischemic heart disease, peripheral arterial disease) or uncontrolled hypertension. If needed, patients with established cardiovascular disease, uncontrolled hypertension or significant risk factors for cardiovascular disease (e.g., hypertension, hyperlipidemia, diabetes mellitus and smoking) should be treated with Catafast only after careful consideration and only at doses &le;100 mg daily when treatment continues for more than 4 weeks.</p><p>As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the lowest effective daily dose should be used for the shortest duration possible. The patient&#39;s need for symptomatic relief and response to therapy should be re-evaluated periodically, especially when treatment continues for more than 4 weeks.</p><p>Patients should remain alert for the signs and symptoms of serious arteriothrombotic events (e.g., chest pain, shortness of breath, weakness, slurring of speech), which can occur without warnings. Patients should be instructed to see a physician immediately in case of such an event .</p><p>Hematologic effects</p><p>Use of Catafast is recommended only for short-term treatment. If, however, Catafast is used for a prolonged period, monitoring of the blood count is recommended, as with other NSAIDs.</p><p>Like other NSAIDs, diclofenac may temporarily inhibit platelet aggregation. Patients with defects of hemostasis should be carefully monitored .</p><p>Respiratory effects (pre-existing asthma)</p><p>In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e., nasal polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract (especially if linked to allergic rhinitis-like symptoms), reactions on NSAIDs like asthma exacerbations (so-called intolerance to analgesics/analgesics-asthma), Quincke&rsquo;s edema or urticaria are more frequent than in other patients. Therefore, special caution is recommended in such patients (readiness for emergency). This is applicable as well for patients who are allergic to other substances, e.g., with skin reactions, pruritus or urticaria.</p><p>Hepatobiliary effects</p><p>Close medical surveillance is required when prescribing Catafast to patients with impaired hepatic function, as their condition may be exacerbated.</p><p>As with other NSAIDs, including diclofenac values of one or more liver enzymes may increase. During prolonged treatment with Catafast, regular monitoring of hepatic function is indicated as a precautionary measure. If abnormal liver function tests persist or worsen, if clinical signs or symptoms consistent with liver disease develop, or if other manifestations occur (e.g., eosinophilia, rash), Catafast should be discontinued. Hepatitis may occur with use of diclofenac without prodromal symptoms.</p><p>Caution is called for when using Catafast in patients with hepatic porphyria, since it may trigger an attack.</p><p>Skin reactions</p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs, including Catafast (see section 7 Adverse drug reactions). Patients appear to be at highest risk of these reactions early in the course of therapy, the onset of the reaction occurring in the majority of cases within the first month of treatment. Catafast should be discontinued at the first appearance of skin rash, mucosal lesions or any other sign of hypersensitivity. As with other NSAIDs, allergic reactions, including anaphylactic/anaphylactoid reactions, can also occur in rare cases with diclofenac without earlier exposure to the drug.</p><p>Renal effects</p><p>As fluid retention and edema have been reported in association with NSAID therapy, including diclofenac, particular caution is called for in patients with impaired cardiac or renal function , history of hypertension , the elderly, patients receiving concomitant treatment with diuretics or medicinal products that can significantly impact renal function, and in those patients with substantial extracellular volume depletion from any cause, e.g., before and after major surgery (see section 5 Contraindications). Monitoring of renal function is recommended as a precautionary measure when using Catafast in such cases. Discontinuation of therapy is normally followed by a recovery to the pre-treatment state.</p><p>Geriatric patients</p><p>Caution is indicated in the elderly on basic medical grounds, especially in frail elderly patients or those with a low body weight.</p><p>Interactions with other NSAIDs</p><p>The concomitant use of Catafast with systemic NSAIDs including cyclooxygenase-2 selective inhibitors, should be avoided due to the potential for additive undesirable effects (see section 8&nbsp;Interactions).</p><p>Special excipients</p><p>Catafast contains a source of phenylalanine and may be therefore harmful for patients with phenylketonuria.</p><p>Masking signs of infections</p><p>Like other NSAIDs, diclofenac may mask the signs and symptoms of infection due to its pharmacodynamic properties.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following interactions include those observed with Catafast powder for oral solution and/or other pharmaceutical forms of diclofenac.</p><p>Observed interactions to be considered</p><p><strong><em>CYP2C9 inhibitors:</em></strong> Caution is recommended when co-prescribing diclofenac with CYP2C9 inhibitors (such as voriconazole), which could result in a significant increase in peak plasma concentrations and exposure to diclofenac.</p><p><strong><em>Lithium:</em></strong> If used concomitantly, diclofenac may raise plasma concentrations of lithium .</p><p>Monitoring of the serum lithium level is recommended.</p><p><strong><em>Digoxin:</em></strong> If used concomitantly, diclofenac may raise plasma concentrations of digoxin Monitoring of the serum digoxin level is recommended .</p><p><strong><em>Diuretics and antihypertensive agents:</em></strong><strong> </strong>Like other NSAIDs, concomitant use of diclofenac with diuretics or antihypertensive agents (e.g., beta-blockers, angiotensin converting enzyme (ACE) inhibitors) may cause a decrease in their antihypertensive effect. Therefore, the combination should be administered with caution and patients, especially the elderly, should have their blood pressure periodically monitored. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy and periodically thereafter, particularly for diuretics and ACE inhibitors due to the increased risk of nephrotoxicity (see section Warnings and precautions).</p><p><strong><em>Ciclosporin and tacrolimus:</em></strong><em> </em>Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin and tacrolimus due to the effect on renal prostaglandins. Therefore, it should be given at doses lower than those that would be used in patients not receiving ciclosporin or tacrolimus.</p><p><strong><em>Drugs known to cause hyperkalemia</em></strong>: Concomitant treatment with potassium-sparing diuretics, ciclosporin, tacrolimus or trimethoprim may be associated with increased serum potassium levels, which should therefore be monitored frequently (see section Warnings and precautions).</p><p><strong><em>Quinolone antibacterials</em></strong><strong>:</strong> There have been isolated reports of convulsions which may have been due to concomitant use of quinolones and NSAIDs .</p><p>Anticipated interactions to be considered</p><p><strong><em>Other NSAIDs and corticosteroids:</em></strong><strong> </strong>Concomitant administration of diclofenac and other systemic NSAIDs or corticosteroids may increase the frequency of gastrointestinal undesirable effects (see section Warnings and precautions).</p><p><strong><em>Anticoagulants and anti-platelet agents:</em></strong><strong> </strong>Caution is recommended since concomitant administration could increase the risk of bleeding (see section Warnings and precautions). Although clinical investigations do not appear to indicate that diclofenac affects the action of anticoagulants, there are reports of an increased risk of hemorrhage in patients receiving diclofenac and anticoagulants concomitantly. Close monitoring of such patients is therefore recommended .</p><p><strong><em>Selective serotonin reuptake inhibitors (SSRIs):</em></strong> Concomitant administration of systemic NSAIDs, including diclofenac, and SSRIs may increase the risk of gastrointestinal bleeding (see section Warnings and precautions).</p><p><strong><em>Antidiabetics:</em></strong><strong> </strong>Clinical studies have shown that diclofenac can be given together with oral antidiabetic agents without influencing their clinical effect. However, there have been isolated reports of both hypoglycaemic and hyperglycaemic effects necessitating changes in the dosage of the antidiabetic agents during treatment with diclofenac. For this reason, monitoring of the blood glucose level is recommended as a precautionary measure during concomitant therapy.</p><p>There have also been isolated reports of metabolic acidosis when diclofenac was co-administered with metformin, especially in patients with pre-existing renal impairment.</p><p><strong><em>Phenytoin:</em></strong> When using phenytoin concomitantly with diclofenac, monitoring of phenytoin plasma concentrations is recommended due to an expected increase in exposure to phenytoin.</p><p style="text-align:justify"><strong><em>Methotrexate:</em></strong><strong> </strong>Caution is recommended when NSAIDs, including diclofenac, are administered less than 24 hours before or after treatment with methotrexate, since blood concentrations of methotrexate may rise and the toxicity of this substance be increased.</p><p style="text-align:justify"><strong><em>CYP2C9 inducers: </em></strong>Caution is recommended when co-prescribing diclofenac with CYP2C9 inducers (such as rifampicin), which could result in a significant decrease in plasma concentration and exposure to diclofenac<em>.</em></p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Female fertility</u></strong></p><p>As with other NSAIDs, the use of Catafast may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of Catafast should be considered .</p><p><strong><u>Male fertility</u></strong></p><p>There is no human data on the effect of Catafast on male fertility.</p><p>Diclofenac administered to male and female rats at 4 mg/kg/day (approximately 0.16 times the MRHD based on BSA comparison) did not affect fertility .</p><p>&nbsp;</p><p><strong><u>Pregnancy</u></strong></p><p>There are insufficient data on the use of diclofenac in pregnant women. Some epidemiological studies suggest an increased risk of miscarriage after use of a prostaglandin synthesis inhibitor (such as NSAIDs) in early pregnancy, however the overall data are inconclusive . Diclofenac has been shown to cross the placental barrier in humans . Use of NSAIDs, including diclofenac, can cause uterine inertia, premature closure of the fetal ductus arteriosus and fetal renal impairment leading to oligohydramnios .</p><p>Because of these risks, Catafast should not be used during the first two trimesters of pregnancy unless the expected benefits to the mother outweigh the risks to the fetus.</p><p>In addition, Catafast should not be used during the third trimester of pregnancy (see section 5&nbsp;Contraindications) .</p><p>&nbsp;</p><p>In animal reproduction studies, no evidence of teratogenicity was observed in mice, rats, or rabbits given diclofenac daily during the period of organogenesis at doses up to approximately 0.41, 0.41, and 0.81 times, respectively, the maximum recommended human dose (MRHD) of Catafast, despite the presence of maternal and fetal toxicity (see Animal data) .</p><p>Clinical considerations</p><p><strong>Fetal Adverse Drug Reactions </strong></p><p><strong><em>Premature Closure of Fetal Ductus Arteriosus</em></strong></p><p>As with other NSAIDs, use of diclofenac during the third trimester of pregnancy is contraindicated owing to the possibility of premature closure of the fetal ductus arteriosus (see section 5 Contraindications).</p><p><strong>Oligohydramnios/Fetal Renal Impairment</strong></p><p>Risk of fetal renal impairment with subsequent oligohydramnios has been observed when NSAIDs (including diclofenac) were used from the 20<sup>th</sup> week of pregnancy onwards .</p><p>If an NSAID is necessary from the 20<sup>th</sup> week gestation to the end of the 2<sup>nd</sup> trimester, limit the use to the lowest effective dose and shortest duration possible (see section 4 Dosage regimen and administration). If Catafast treatment extends beyond 48 hours, consider monitoring with ultrasound for oligohydramnios. If oligohydramnios occurs, discontinue Catafast and follow up according to clinical practice.</p><p><strong>Labor or Delivery</strong></p><p>There are no studies on the effects of Catafast during labor or delivery. As with other NSAIDs, use of diclofenac during the third trimester of pregnancy is contraindicated owing to the possibility of uterine inertia (see section 5 Contraindications) . In animal studies, NSAIDS, including diclofenac, inhibit prostaglandin synthesis, cause delayed parturition, and increase the incidence of stillbirth .</p><p>Data</p><p><strong>Human Data</strong></p><p><strong><em>Premature Closure of Fetal Ductus Arteriosus</em></strong></p><p>Published literature reports that the use of NSAIDs during the third trimester of pregnancy may cause premature closure of the fetal ductus arteriosus.</p><p><strong><em>Oligohydramnios/Fetal Renal Impairment</em></strong></p><p>Published studies and post-marketing reports describe maternal NSAID use at about 20 weeks gestation or later in pregnancy associated with fetal renal impairment leading to oligohydramnios. These adverse outcomes are seen, on average, after days to weeks of treatment, although oligohydramnios has been infrequently reported as soon as 48 hours after NSAID initiation. In many cases, but not all, the decrease in amniotic fluid was transient and reversible with cessation of the drug .</p><p><strong>Animal Data</strong></p><p>Reproductive and developmental studies in animals demonstrated that diclofenac administration during organogenesis did not produce teratogenicity despite the induction of maternal toxicity and fetal toxicity in mice at oral doses up to 20 mg/kg/day (0.41 times the maximum recommended human dose [MRHD] of Catafast, 200 mg/day, based on body surface area (BSA) comparison), and in rats and rabbits at oral doses up to 10 mg/kg/day (0.41 and 0.81 times, respectively, the MRHD based on BSA comparison) .</p><p>In a study in which pregnant rats were orally administered 2 or 4 mg/kg diclofenac (0.08 and 0.16 times the MRHD based on BSA) from Gestation Day 15 through Lactation Day 21, significant maternal mortality (caused by gastrointestinal ulceration and peritonitis) was noted. These maternally toxic doses were associated with dystocia, prolonged gestation, intrauterine growth retardation, and decreased fetal survival.</p><p>Administration of NSAIDs (including diclofenac) inhibited ovulation in the rabbit and implantation and placentation in the rat, and led to premature closure of the fetal ductus arteriosus .</p><p><u>Lactation</u></p><p>Risk Summary</p><p>Like other NSAIDs, diclofenac passes into the breast milk in small amounts. Therefore, Catafast should not be administered during breast feeding in order to avoid undesirable effects in the infant.</p><p>Human Data</p><p>Diclofenac was detected in a low concentration (100 ng/mL) in breast milk in one nursing mother treated orally with a diclofenac salt of 150&nbsp;mg/day. The estimated dose ingested by an infant consuming breast milk is equivalent to a 0.03 mg/kg/day.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects on ability to drive and use machines Patients who experience dizziness, vertigo, somnolence or other central nervous system disturbances while taking Catafast, including visual disturbances, should not drive or operate machines.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tabulated summary of adverse drug reactions</p><p>Adverse drug reactions from clinical trials and/or spontaneous or literature reports (Table 7-1) are listed by MedDRA system organ class. Within each system organ class, the adverse drug reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse drug reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse drug reaction is based on the following convention (CIOMS III): very common (&gt;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000).</p><p>The following undesirable effects include those reported with Catafast powder for oral solution and/or other pharmaceutical forms of diclofenac, with either short-term or long-term use.</p><p>Table 7-1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Adverse drug reactions</p><table cellspacing="0" cellpadding="0" border="0"><tbody><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Thrombocytopenia, leukopenia, anemia (including hemolytic and aplastic anaemia), agranulocytosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Immune system disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Hypersensitivity, anaphylactic and anaphylactoid reactions (including hypotension and shock) .</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Angioedema (including faceedema) .</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Psychiatric disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Disorientation, depression, insomnia, nightmare, irritability, psychotic disorder.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common:</p></td><td style="vertical-align:top; width:318.0pt"><p>Headache, dizziness.</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Somnolence .</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Paresthesia, memory impairment, convulsion, anxiety, tremor, aseptic meningitis, dysgeusia , cerebrovascular accident .</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Eye disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Visual impairment, blurred vision, diplopia .</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Ear and labyrinth disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common:</p></td><td style="vertical-align:top; width:318.0pt"><p>Vertigo .</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Tinnitus, impaired hearing .</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Cardiac disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon* :</p></td><td style="vertical-align:top; width:318.0pt"><p>Myocardial infarction , cardiac failure , palpitations, chest pain.</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Frequency not known</p></td><td style="vertical-align:top; width:318.0pt"><p>Kounis syndrome</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Vascular disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Hypertension , vasculitis .</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Asthma (including dyspnea) .</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Pneumonitis .</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common:</p></td><td style="vertical-align:top; width:318.0pt"><p>Nausea, vomiting, diarrhea, dyspepsia, abdominal pain, flatulence, decreased appetite .</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Gastritis , gastrointestinal hemorrhage, hematemesis, melena, hemorrhagic diarrhea, gastrointestinal ulcer (with or without bleeding, gastrointestinal stenosis, or perforation, which may lead to peritonitis).</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Colitis (including hemorrhagic colitis, ischemic colitis and exacerbation of ulcerative colitis or Crohn&#39;s disease), constipation, stomatitis, glossitis, oesophageal disorder, intestinal diaphragm disease, pancreatitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common:</p></td><td style="vertical-align:top; width:318.0pt"><p>Transaminases increased.</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Hepatitis, jaundice, liver disorder.</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Fulminant hepatitis, hepatic necrosis, hepatic failure .</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common:</p></td><td style="vertical-align:top; width:318.0pt"><p>Rash .</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare</p></td><td style="vertical-align:top; width:318.0pt"><p>Urticaria .</p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Bullous dermatitis, eczema, erythema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell&#39;s syndrome), exfoliative dermatitis, alopecia, photosensitivity reaction, purpura, Henoch-Schoenlein purpura , pruritus .</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Acute kidney injury (acute renal failure), hematuria, proteinuria, nephrotic syndrome, tubulointerstitial nephritis, renal papillary necrosis</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:456.0pt"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td style="vertical-align:top; width:138.0pt"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare:</p></td><td style="vertical-align:top; width:318.0pt"><p>Edema .</p></td></tr></tbody></table><p>* The frequency reflects data from long-term treatment with a high dose (150 mg daily).</p><p>Description of selected adverse drug reactions</p><p><strong>Arteriothrombotic events</strong></p><p>Meta-analysis and pharmacoepidemiological data point towards a small increased risk of arteriothrombotic events (for example myocardial infarction) associated with the use of diclofenac, particularly at a high dose (150 mg daily) and during long-term treatment (see section Warnings and precautions).</p><p><strong>Visual effects</strong></p><p>Visual disturbances such as visual impairment, blurred vision or diplopia appear to be NSAID class effects and are usually reversible on discontinuation. A likely mechanism for the visual disturbances is the inhibition of prostaglandin synthesis and other related compounds that alter the regulation of retinal blood flow resulting in potential changes in vision. If such symptoms occur during diclofenac treatment, an ophthalmological examination may be considered to exclude other causes.</p><p>&nbsp;</p><p>To report any side effect(s):</p><p style="margin-left:.25in; margin-right:0in; text-indent:-.25in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Saudi Arabia</p><p style="margin-left:.25in">&nbsp;</p><p style="margin-left:22.5pt; margin-right:0in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->The National Pharmacovigilance Centre (NPC):</p><p style="margin-left:22.5pt">&nbsp;</p><p style="margin-right:-22.5pt">o Fax: +966-11-205-7662</p><p>o SFDA call center: 19999</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p><p style="margin-left:22.5pt; margin-right:0in; text-indent:-.25in"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Patient Safety Department Novartis Consulting AG - Saudi Arabia:</p><p style="margin-left:22.5pt">&nbsp;</p><p>o Toll Free Number: 8001240078</p><p>o Phone: +966112658100</p><p>o Fax: +966112658107</p><p>o Email: adverse.events@novartis.com</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Other GCC States:</p><p>-&nbsp; Please contact the relevant competent authority.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms</p><p>There is no typical clinical picture resulting from diclofenac overdosage. Overdosage can cause symptoms such as vomiting, gastrointestinal hemorrhage, diarrhea, dizziness, tinnitus or convulsions. In the event of significant poisoning, acute renal failure and liver damage are possible .</p><p>Therapeutic measures</p><p>Management of acute poisoning with NSAIDs, including diclofenac, essentially consists of supportive measures and symptomatic treatment. Supportive measures and symptomatic treatment should be given for complications such as hypotension, renal failure, convulsions, gastrointestinal disorder, and respiratory depression.</p><p>Special measures such as forced diuresis, dialysis or hemoperfusion are probably of no help in eliminating NSAIDs, including diclofenac, due to the high protein-binding and extensive metabolism .</p><p>Activated charcoal may be considered after ingestion of a potentially toxic overdose, and gastric decontamination (e.g., vomiting, gastric lavage) after ingestion of a potentially life-threatening overdose.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Catafast has been found to exert a pronounced analgesic effect in moderate and severe pain. In the presence of inflammation, e.g., due to trauma or following surgical interventions, it rapidly relieves both spontaneous pain and pain on movement and diminishes inflammatory swelling and wound edema . Clinical studies have also revealed that in primary dysmenorrhoea the active substance is capable of relieving the pain and reducing the extent of bleeding.In migraine attacks Catafast has been shown to be effective in relieving the headache and in improving the accompanying symptoms nausea and vomiting .</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption</p><p>Diclofenac is rapidly and completely absorbed from diclofenac potassium . Mean peak plasma concentrations of 5.5 micromol/L are attained after 5 to 20 minutes after ingestion of one sachet of 50 mg .</p><p>Ingestion together with food is expected to have no influence on the amount of diclofenac absorbed although onset and rate of absorption may be slightly delayed .</p><p>Since about half of diclofenac is metabolized during its first passage through the liver (&quot;first pass&quot; effect), the area under the concentration curve (AUC) is about half as large following oral or rectal administration as it is following a parenteral dose of equal size .</p><p>Pharmacokinetic behaviour does not change after repeated administration. No accumulation occurs provided the recommended dosage intervals are observed .</p><p>Distribution</p><p>99.7% of diclofenac binds to serum proteins, mainly to albumin (99.4%) . The apparent volume of distribution calculated is 0.12 to 0.17 L/kg .</p><p>Diclofenac enters the synovial fluid, where maximum concentrations are measured 2 to 4&nbsp;hours after peak plasma values have been reached . The apparent half-life for elimination from the synovial fluid is 3 to 6 hours. Two hours after reaching peak plasma levels, concentrations of the active substance are already higher in the synovial fluid than in the plasma, and they remain higher for up to 12 hours .</p><p>Biotransformation/metabolism</p><p>Biotransformation of diclofenac takes place partly by glucuronidation of the intact molecule, but mainly by single and multiple hydroxylation and methoxylation, resulting in several phenolic metabolites (3&#39;-hydroxy-, 4&#39;-hydroxy-, 5-hydroxy-, 4&#39;,5-dihydroxy-, and 3&#39;-hydroxy-4&#39;-methoxy-diclofenac), most of which are converted to glucuronide conjugates . Two of these phenolic metabolites are biologically active, but to a much lesser extent than diclofenac .</p><p>Elimination</p><p>Total systemic clearance of diclofenac from plasma is 263 &plusmn; 56 mL/min (mean value &plusmn; SD). The terminal half-life in plasma is 1 to 2 hours . Four of the metabolites, including the two active ones, also have short plasma half-lives of 1 to 3 hours . One metabolite, 3&rsquo;-hydroxy-4&rsquo;-methoxy-diclofenac, has a much longer plasma half-life. However, this metabolite is virtually inactive .</p><p>About 60% of the administered dose is excreted in the urine as the glucuronide conjugate of the intact molecule and as metabolites, most of which are also converted to glucuronide conjugates. Less than 1% is excreted as unchanged substance. The rest of the dose is eliminated as metabolites through the bile in the faeces .</p><p>Linearity/non-linearity</p><p>The amount absorbed is in linear proportion to the size of the dose .</p><p>Special populations</p><p>Geriatric patients</p><p>No relevant age-dependent differences in the drug&rsquo;s absorption, metabolism or excretion have been observed .</p><p>Renal impairment</p><p>In patients suffering from renal impairment, no accumulation of the unchanged active substance can be inferred from the single-dose kinetics when applying the usual dosage schedule . At a creatinine clearance of less than 10 mL/min, the calculated steady-state plasma levels of the hydroxy metabolites are about 4 times higher than in normal subjects. However, the metabolites are ultimately cleared through the bile.</p><p>Hepatic impairment</p><p>In patients with chronic hepatitis or non-decompensated cirrhosis, the kinetics and metabolism of diclofenac are the same as in patients without liver disease.</p><p>Clinical studies</p><p>Catafast is a well-established product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data from acute and repeated dose toxicity studies, as well as from genotoxicity, mutagenicity, and carcinogenicity studies with diclofenac revealed no specific hazard for humans at the intended therapeutic doses. &nbsp;</p><p>For more information, see section 9 Pregnancy, lactation, females and males of reproductive potential.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:.25in">Potassium hydrogen carbonate</p><p style="margin-left:.25in">Мannitol</p><p style="margin-left:.25in">Аspartame</p><p style="margin-left:.25in">Saccharin sodium</p><p style="margin-left:.25in">Glyceryl dibehenate</p><p style="margin-left:.25in">Mint flavor</p><p style="margin-left:.25in">Anise flavour</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p><p>Store in the original package in order to protect from moisture.</p><p>Catafast powder for oral solution must be kept out of the reach and sight of children.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Each package contains 9 sachets of 50 mg Catafast.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Marketing Authorization Holder for this Product is Novartis Pharma AG. 
www.Novartis.com 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                09/2022 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="data:image/png; base64,iVBORw0KGgoAAAANSUhEUgAABqQAAAiYCAIAAAA&#x2B;NVHkAAAABGdBTUEAALGPC/xhBQAACjFpQ0NQSUNDIFByb2ZpbGUAAEiJnZZ3VFPZFofPvTe9UJIQipTQa2hSAkgNvUiRLioxCRBKwJAAIjZEVHBEUZGmCDIo4ICjQ5GxIoqFAVGx6wQZRNRxcBQblklkrRnfvHnvzZvfH/d&#x2B;a5&#x2B;9z91n733WugCQ/IMFwkxYCYAMoVgU4efFiI2LZ2AHAQzwAANsAOBws7NCFvhGApkCfNiMbJkT&#x2B;Be9ug4g&#x2B;fsq0z&#x2B;MwQD/n5S5WSIxAFCYjOfy&#x2B;NlcGRfJOD1XnCW3T8mYtjRNzjBKziJZgjJWk3PyLFt89pllDznzMoQ8GctzzuJl8OTcJ&#x2B;ONORK&#x2B;jJFgGRfnCPi5Mr4mY4N0SYZAxm/ksRl8TjYAKJLcLuZzU2RsLWOSKDKCLeN5AOBIyV/w0i9YzM8Tyw/FzsxaLhIkp4gZJlxTho2TE4vhz89N54vFzDAON40j4jHYmRlZHOFyAGbP/FkUeW0ZsiI72Dg5ODBtLW2&#x2B;KNR/Xfybkvd2ll6Ef&#x2B;4ZRB/4w/ZXfpkNALCmZbXZ&#x2B;odtaRUAXesBULv9h81gLwCKsr51Dn1xHrp8XlLE4ixnK6vc3FxLAZ9rKS/o7/qfDn9DX3zPUr7d7&#x2B;VhePOTOJJ0MUNeN25meqZExMjO4nD5DOafh/gfB/51HhYR/CS&#x2B;iC&#x2B;URUTLpkwgTJa1W8gTiAWZQoZA&#x2B;J&#x2B;a&#x2B;A/D/qTZuZaJ2vgR0JZYAqUhGkB&#x2B;HgAoKhEgCXtkK9DvfQvGRwP5zYvRmZid&#x2B;8&#x2B;C/n1XuEz&#x2B;yBYkf45jR0QyuBJRzuya/FoCNCAARUAD6kAb6AMTwAS2wBG4AA/gAwJBKIgEcWAx4IIUkAFEIBcUgLWgGJSCrWAnqAZ1oBE0gzZwGHSBY&#x2B;A0OAcugctgBNwBUjAOnoAp8ArMQBCEhcgQFVKHdCBDyByyhViQG&#x2B;QDBUMRUByUCCVDQkgCFUDroFKoHKqG6qFm6FvoKHQaugANQ7egUWgS&#x2B;hV6ByMwCabBWrARbAWzYE84CI6EF8HJ8DI4Hy6Ct8CVcAN8EO6ET8OX4BFYCj&#x2B;BpxGAEBE6ooswERbCRkKReCQJESGrkBKkAmlA2pAepB&#x2B;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&#x2B;jp9DL6Yfp1&#x2B;jtVLVVPVb7qJtU21Suqr9XmqHmo8dVK1NrVRtTeqTPUfdTT1Lepd6nf00BpmGmEa&#x2B;Rq7NE4q/F0Dm2OyxzunJI5h&#x2B;fc1oQ1zTQjNFdo7tMc0JzW0tby08rSqtI6o/VUm67toZ2qvUP7hPakDlXHTUegs0PnpM5jhgrDk5HOqGT0MaZ0NXX9dSW69bqDujN6xnpReoV67Xr39An6LP0k/R36vfpTBjoGIQYFBq0Gtw3xhizDFMNdhv2Gr42MjWKMNhh1GT0yVjMOMM43bjW&#x2B;a0I2cTdZZtJgcs0UY8oyTTPdbXrZDDazN0sxqzEbMofNHcwF5rvNhy3QFk4WQosGixtMEtOTmcNsZY5a0i2DLQstuyyfWRlYxVtts&#x2B;q3&#x2B;mhtb51u3Wh9x4ZiE2hTaNNj86utmS3Xtsb22lzyXN&#x2B;5q&#x2B;d2z31uZ27Ht9tjd9Oeah9iv8G&#x2B;1/6Dg6ODyKHNYdLRwDHRsdbxBovGCmNtZp13Qjt5Oa12Oub01tnBWex82PkXF6ZLmkuLy6N5xvP48xrnjbnquXJc612lbgy3RLe9blJ3XXeOe4P7Aw99D55Hk8eEp6lnqudBz2de1l4irw6v12xn9kr2KW/E28&#x2B;7xHvQh&#x2B;IT5VPtc99XzzfZt9V3ys/eb4XfKX&#x2B;0f5D/Nv8bAVoB3IDmgKlAx8CVgX1BpKAFQdVBD4LNgkXBPSFwSGDI9pC78w3nC&#x2B;d3hYLQgNDtoffCjMOWhX0fjgkPC68JfxhhE1EQ0b&#x2B;AumDJgpYFryK9Issi70SZREmieqMVoxOim6Nfx3jHlMdIY61iV8ZeitOIE8R1x2Pjo&#x2B;Ob4qcX&#x2B;izcuXA8wT6hOOH6IuNFeYsuLNZYnL74&#x2B;BLFJZwlRxLRiTGJLYnvOaGcBs700oCltUunuGzuLu4TngdvB2&#x2B;S78ov508kuSaVJz1Kdk3enjyZ4p5SkfJUwBZUC56n&#x2B;qfWpb5OC03bn/YpPSa9PQOXkZhxVEgRpgn7MrUz8zKHs8yzirOky5yX7Vw2JQoSNWVD2Yuyu8U02c/UgMREsl4ymuOWU5PzJjc690iecp4wb2C52fJNyyfyffO/XoFawV3RW6BbsLZgdKXnyvpV0Kqlq3pX668uWj2&#x2B;xm/NgbWEtWlrfyi0LiwvfLkuZl1PkVbRmqKx9X7rW4sVikXFNza4bKjbiNoo2Di4ae6mqk0fS3glF0utSytK32/mbr74lc1XlV992pK0ZbDMoWzPVsxW4dbr29y3HShXLs8vH9sesr1zB2NHyY6XO5fsvFBhV1G3i7BLsktaGVzZXWVQtbXqfXVK9UiNV017rWbtptrXu3m7r&#x2B;zx2NNWp1VXWvdur2DvzXq/&#x2B;s4Go4aKfZh9OfseNkY39n/N&#x2B;rq5SaOptOnDfuF&#x2B;6YGIA33Njs3NLZotZa1wq6R18mDCwcvfeH/T3cZsq2&#x2B;nt5ceAockhx5/m/jt9cNBh3uPsI60fWf4XW0HtaOkE&#x2B;pc3jnVldIl7Y7rHj4aeLS3x6Wn43vL7/cf0z1Wc1zleNkJwomiE59O5p&#x2B;cPpV16unp5NNjvUt675yJPXOtL7xv8GzQ2fPnfM&#x2B;d6ffsP3ne9fyxC84Xjl5kXey65HCpc8B&#x2B;oOMH&#x2B;x86Bh0GO4cch7ovO13uGZ43fOKK&#x2B;5XTV72vnrsWcO3SyPyR4etR12/eSLghvcm7&#x2B;ehW&#x2B;q3nt3Nuz9xZcxd9t&#x2B;Se0r2K&#x2B;5r3G340/bFd6iA9Puo9OvBgwYM7Y9yxJz9l//R&#x2B;vOgh&#x2B;WHFhM5E8yPbR8cmfScvP174ePxJ1pOZp8U/K/9c&#x2B;8zk2Xe/ePwyMBU7Nf5c9PzTr5tfqL/Y/9LuZe902PT9VxmvZl6XvFF/c&#x2B;At623/u5h3EzO577HvKz&#x2B;Yfuj5GPTx7qeMT59&#x2B;A/eE8/vsbQFrAAAAIGNIUk0AAHomAACAhAAA&#x2B;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&#x2B;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&#x2B;kGA31HyoB8AAAAAOBjtdntzc7PT6XS73Waz2Wu0i8n81riTy&#x2B;UeeuihZ5999qAfEPjcYvP5/KCfAQAAAPhitdvtTqezubkZQtjc3Gy326VSqVwul8vltbW1SqWyvLwcn8TDa1eGL118Z7z1P5KXl5aWnn/&#x2B;&#x2B;dXV1YN&#x2B;duBzEPsAAAAgUtrtdghhMbLX7/fr9fpwOCyXy5WPVavVRCLxG3/9tf70xfXh65f&#x2B;6sF6u91&#x2B;9NFHjfjBHUTsAwAAgDvYzZG9WCy2sbHR6XQWRa9UKlWr1bW1tUwmE49/zlf2z0J46/rohYubjWv/UL42n8&#x2B;fe&#x2B;6506dPfzF/AmA/iX0AAABwZ7h1ZG&#x2B;xkDuZTBZpr1wuV6vVUqn0ubveZ2iO5i9t7L26&#x2B;YPj2&#x2B;/UNs6fP2/EDw4/sQ8AAAAOo5vXMxKJxMWLF7vd7s0l3EXaS6fTt&#x2B;M5ftEYv3CxdeHqX5/aGo/HtnrhkBP7AAAA4IB9&#x2B;npGsVi8GfWq1ery8vJ&#x2B;jux9Xr1ZeHlj76cbL&#x2B;W2Xx5snDhx4vvf/77DHXA4iX0AAABw&#x2B;3z29YxF3Usmkwf9mL/Ohc7kxfXhW5f//KFar9cz4geHk9gHAAAAX5TPvp5RrVaz2exBjux9XsMQXrs8fGn97en1/xHfTKVSzz//vBE/OFTEPgAAANgHn3E942bgu5O63me42p&#x2B;&#x2B;eHH4xuW/erDebreN&#x2B;MGhIvYBAADA53ZzZC8ej6&#x2B;vr9&#x2B;8nnHzLXu36XrGQZmG8NbW6IWL682tH5SuhhCee&#x2B;6506dPH/RjAWIfAAAAfKbPvp5RqVQKhUJERvY&#x2B;r8Zo/tL63mubf3&#x2B;8/m5t/fz580b84MCJfQAAAHDDZ1zPWLxlb21tLZFIHPRjHjLvNMYvXGhcvPrfTl0fj8e2euFgiX0AAAB8Sf2m6xk3V3EzmcyXdGTv8&#x2B;rOwssbez/d&#x2B;Elh&#x2B;5Xu&#x2B;smTJ7///e873AEHQuwDAAAg&#x2B;n7T9YzF1F61Wo3O9YwDdKEzeeHi8K0rf/5wrdfrGfGDAyH2AQAAEDW3Xs/Y2tqq1&#x2B;s3R/Yqlcra2lrEr2ccoGEIr14evnTx5/Pr/yNsptPp559/3ogf3E5iHwAAAHewz7iesRjZW1zPmM1mBvdunyu96Yvrwzcu/9cHa51Ox4gf3E5iHwAAAHeGz7iecfNFe8lk8qAfkxBCCNMQ3twavXBxvbP194XL8Xj8ueeeO3369EE/FkSf2AcAAMBh9JuuZ9y8iut6xh2gPpy9tDF8bfPv76q9e33j/PnzRvzgiyb2AQAAcMA&#x2B;vYq7vLy8WMJdjOy5nnFne7s&#x2B;fuFibfPq39x1fTwe2&#x2B;qFL5TYBwAAwG3VbrcXq7jdbrfZbPb7/XK5vFjCXbxrz/WMCOrOwkvre69s/nhl&#x2B;6edC&#x2B;fOnXvmmWcc7oAvgtgHAADAF&#x2B;UTI3utVuvmK/YWg3v5fN7I3pfIR&#x2B;3JC&#x2B;vDty7/l4dr/X7fiB98EcQ&#x2B;AAAA9sGt1zMGg0GtVhuNRotJvVKpdOTIkXK5rOsR9kJ49dLw5fU359s/jm2mUqnnn3/eiB/sI7EPAACAz&#x2B;3myF48Hl9fX&#x2B;92u4uX6y22cSuVSjabPehn5BC73Ju&#x2B;eHH4xuW/erjRbreN&#x2B;ME&#x2B;EvsAAAD4LJ&#x2B;&#x2B;nlEsFhdXcSuVytra2srKipE9PrdJCG9ujV68eGHn2v9XuBqLxZ577rnTp08f9GPBHU/sAwAA4IZbV3F7vV6j0RgMBtVqtVQqLeb1KpXK0tLSQT8mEVIbzl5aH7526e9O1d7f2jh//rwRP/g9iX0AAABfUjdH9mKx2MbGRqfTWeS8W1dxjexxO/y8Pnrhwvbmtb85eW06ndrqhd&#x2B;H2AcAABB9t47sLRZyJ5PJoustruKWSiVdj4O0Ow0vbey9svGj1dqrnYtf&#x2B;cpXnnnmGYc74Hcg9gEAAERNu91edL1ut9tsNvv9/s3TGYv/TafTB/2M8Ot82J68cLH3s0t/&#x2B;VB9MBgY8YPfgdgHAABwB/vE9YxWq7UY1iuVSmtra5VKZXl52cged5K9EF65NHx5/Y341o&#x2B;mm5lM5vnnnzfiB789sQ8AAODOcOsqbr/fr9frw&#x2B;Hw5lv2FmlP1yMiLnWnL64P37z8lw/WdnZ2jPjBb0/sAwAAOIw&#x2B;cT1jZ2dnsYR783pGJpOR9oiySQhvXBu&#x2B;ePHD3a1/Wr4Sj8efe&#x2B;6506dPH/RjwWEn9gEAABywT6zittvtlZWVm6czKpVKsVjU9fiS2t6bvbQxfG3zb&#x2B;&#x2B;pfXBt8/z580b84LOJfQAAALfPrau4vV6v0WgMBoPFK/aq1eoi7S0tLR30Y8Ih87Pa6IWL169c&#x2B;dsT25PJxFYvfAaxDwAA4IvyiZG9TqdTKpVuHdnL5/NG9uC3sjOdv7Q&#x2B;fGXzh6XtV9sXz50798wzzzjcAZ8m9gEAAOyDW0f2FnVvMpksTmcs0l6pVNL14Pf1QXvywoXuO1f&#x2B;4r7rw&#x2B;HQiB98mtgHAADwud0c2YvH4&#x2B;vr691ud3EVt1Qqra2tVavVdDp90M8IETUI4ZXNvZfXX4tf/8l0I5vNPv/880b84CaxDwAA4LN8&#x2B;npGsVhcHMZdjOwVCgUje3C7bXanL14cvnn5Lx&#x2B;q7&#x2B;zsGPGDm8Q&#x2B;AACAG25dxe33&#x2B;/V6fTgcLqLeYiG3Wq0mk8mDfkwghBDCOIQ3rg1fvPhBd&#x2B;sfc5eSyeRzzz13&#x2B;vTpg34sOGBiHwAA8CV1c2QvFottbGx0Op2bq7jVanVtbS2TyRjZg8Nue2/24vrw9Ut/c8/2drdtxA/EPgAAIPo&#x2B;vYq7vLy8SHuLhVzXM&#x2B;Dw6I7DaBLSSyGTDInf5hfMQ/h5bfSTC1tbW3979Np0OpX8&#x2B;DIT&#x2B;wAAgKhpt9uLVdxut9tsNvv9frlcXizhLtKe6xlwgMYh/NOb1//17Sujyewrp8qP3bv24IlCNhHmIbyxsfN3r6y/&#x2B;mGt0x&#x2B;mU4mH7io/9eCx84&#x2B;cOL7yW0S/zmT&#x2B;0sbeqxv/Wq6/2vjw0UcffeaZZxzu4EtI7AMAAO5gnxjZa7VaN1&#x2B;xt7C8vGxkDw7cPITheDYJ8eF43h9OPrzW/r//5f3//vKF7es7hXz68YeP/y/P3v8H507WdwZ/8cMPX3xv63g59/TDxwvZ1JsXar3R9NzpyvmHjz98d2kt/2/9dX6/NX7h4u47l//qgdre3p4RP76ExD4AAODOcOv1jMFgUKvVRqPRzSXcI0eOlMtlXQ9uv&#x2B;E8pGO/8Z&#x2B;OQ3hrvfMvb13&#x2B;6Qfb3b3xqbXl3f4omYjvDsZb7f7F7Z3d3uj&#x2B;oyvf//bZ733rnrPHilca3R&#x2B;9c/XtjUa9M2h1h7u9YXI0HSfjiVQyn0nee2z1jx&#x2B;76z9&#x2B;&#x2B;3TuM0b9BiG8srH38sZryesvTDYzmczzzz9vxI8vD7EPAAA4jG6O7MXj8a2trStXrqysrJw6dWqxjVupVNLptLQHB2sYwo/e3v7bVzbev9w6upp7&#x2B;uFjqaXEB1c6ze5edSXzwInS/XetFrKpK/Xuqx9uv3&#x2B;1vZpPnTtVqRSzH15tv/z&#x2B;9SuNbqc7vFbb7Q0nZ0&#x2B;u/uGjd//PT993/uFKMoSPant/8/LFH75ztZhLf/3eI2ePFNr90b/8/PK7l1trK9k/ffzUf/j22ROfvdu7sTt9cX345uU/f3C72&#x2B;0a8ePLQ&#x2B;wDAAAO2KevZxSLxcVV3Eqlsra2trKyouvBIdEZhubucDCaTKazXGYpHmIfXuv84I3Nv3tlfX1752gxd/&#x2B;J1VIhk0zERpNpY2ev1hnE5vNMKjmezUMIxVw6l0m2e8PpdD4YTQaj8XA8G&#x2B;6NO7t7pVL&#x2B;Tx8/VS6k/8MTZ09W8qlE/GebjX/9&#x2B;ZWLWzvdvXFjZzAbTk4cXfn6/Uef/cqJx8&#x2B;uVXK/eZ5wYRzC61eHL118f3D9nzOXE4nEc889d/r06dvxZYKDI/YBAAC3z62ruL1er9FoDAaDarVaKpUW83qVSmVpaemgHxMIIYTRPPRHIREL6VRIhbA7Cm&#x2B;tN//&#x2B;tc0fv331Wn03m11aLaRTycTxUv6xM9VYPPbPb11551LjoZOl//VPHvmP3zo5DuFHb9f&#x2B;4kcf/vdXLl650o7NQ3o5fayy/MDJ1SceOPromcpyJtXq7l1u9Dq9UWopPhhNPrrW2bi&#x2B;0&#x2B;4NK4XM//H9R//ka3cfLSQ6g9mleje9tJTPJjNLiUI2nvq3Kt&#x2B;vuD6Yvbi&#x2B;9/ql/&#x2B;e&#x2B;Rr3TNOJH5Il9AADAF&#x2B;UTI3udTmeR8xY3NKrVajabNbIHt9neLGxu9y/Vulvt/t54ks8snawsn6wsHyulFy/Cu1gfvvz&#x2B;9R&#x2B;&#x2B;fWVjs9kbjMapZGUle1d1uVzIpJPx7mC8MxhVC9lnv3Li3uOr7f7ww6ut4Wh6tJQbjmY/eHPzn968nErG/vMfPfyf//ihSi62tTv9y5989Jc//uC1D7fTS8lvP3jsq/dUEvFYc3fY6u01dga11qC0kv13Xz35J4/f/cCJUgjz7t44FmK5dLKQi6X25c88D&#x2B;Fn26MXLl7Zuvp3a9fm87nkR4SJfQAAwD64dWRvUfcmk8nNrrf4P7oeHKzdcXjx3e2/f23jrYv1bn8cD/NqMVsspDv90bVm/2Rl&#x2B;U8eu/uZR453&#x2B;sMfvH7pjQv10nL68bNrp8r5Zn/4419c&#x2B;/Evrl262p6OJ9Vq4bH7jv7Zt&#x2B;75918/df&#x2B;RbAihNwmvfdRYv74znc3bveE/v3X53cutr56u/O/fPfedR4&#x2B;GEH56ofPnP/7glfevV4vZ//jk2W/cdzSE&#x2B;dVmbzialpbTJ8r5lVyqmAmfa2Lvc2tP5i&#x2B;v772y&#x2B;S9r22821s&#x2B;dO/fMM8843EH0iH0AAMDn1m63F10vkUhcvHix2&#x2B;0uit7iNm61Wk2n0wf9jPClszMMje5wPg/LmaXV/K/Zdb3UGv3D65f&#x2B;&#x2B;c1L7d7w7PHVpx489rWz1Xx6aTCeXmns1tqDlXzqq6er&#x2B;Wzy5&#x2B;vNf3xj8/WLtXgslk8v7Y2n3cF4MJpcbXavNXqj3jCXSz10pvqt&#x2B;4&#x2B;eO12552gxnYi/9MHWT35xbTKbP/Pw8a&#x2B;eWdu4vvPi&#x2B;1vpZOJ73zj93W/evZwMIYTdcZjNQnopZA6w/L/XGr9wofPelb&#x2B;&#x2B;d3s4HBrxI3rEPgAA4LN8YhW31WqVP7a2tlapVJaXl43swQG63p2&#x2B;9N71H7y&#x2B;&#x2B;fovro36o1k6mcmmjlfyD5xY/YNzJ//w3NFby9rVzuSvX7zwgzc2L9W68zDPppInyvliLj0PYSkRS8Tjg9F4Obv0tTNrj9xd2RtP/unNy29crFUKmfMPnyjm0xvbnRff23r5/a1ae&#x2B;/uI4WvnamurWRb3eHm9s7uYHSslP/qPZVnvnLiW/cfPba6FA9hGkIshOTBfXF&#x2B;vf48vLK59/L6q&#x2B;nrP9nbyOVyzz//vBE/IkPsAwAAbrh1Fbff79fr9eFweHMJd21trVwuJxKJg35M4Fdc7Uz&#x2B;7tWNv3t1o97pnztd&#x2B;aNzJ88cK757tfUXP/rwrYuNM8dW/vMfPfSdr586VvjlX94rnclPP7i&#x2B;sb2bTydPVPK59FIshOl8PpnOf7HZ/H9fXX/zYv2utcK/f/zUSi71zqXmmxdqe&#x2B;PpycpyaTkdC2E2n6eSiWI&#x2B;9cjd5a&#x2B;dXTtRyaeSiWwqmYjHcumQ/ry7uI1R6AxCLhWOZff3K/NvuNaf/ujC8LXN//Lgdq/Xe&#x2B;CBB5566qlkMpnJZG7rY8B&#x2B;E/sAAOBL6ubIXiwW29jY2NnZWSzhLvZwK5VKJpMxsgd3hK3u7P/6&#x2B;5//&#x2B;Q8/jCfCdx479b1vnTlRyb3xUe2/vXjhR29fDfH4nz5213966r4nHzpW&#x2B;jhkdcfhB29c&#x2B;Ze3Ljd3905W8meOFe&#x2B;q5tPJ5LVG953LrQ&#x2B;utZeSiScfPPZn37zn9JFMa3f6/pXW&#x2B;vbueDo7Uszde7x4vJRbzuzTyN7OdP7jj4bvXU9WlpNPnw33Fvfld/03DGZhOgsXWpO3r47e235tfOmHy9djsdh3vvOdr3/967fjAeALI/YBAED0fWIVt91ur6ys3DydUa1Wi8Wirgd3uve2&#x2B;v/81uU3L9Y3tne3Wr3pbJZNLfWHk2v13Vgi/vTDx/&#x2B;373zlP3zjxK2Dd9d2Jq9/VPvgWmer2dtq9640&#x2B;mE&#x2B;X04lyoXMI/dUn3zo2LnT5ZX9OYj7b9nYnb&#x2B;2Oe0MkvdWw7fuCfs7Xbc7C9290BmEZn/e6k3be/PRdD4YzfqjWCoZSyaW7l/bSc/&#x2B;ZvPlWr32jW98w1v8uKOJfQAAECm3ruJ2u91mszkYDCqVSqlUWszrVSqVVOr2/OwOHICN5uil97Y&#x2B;uNJOJOJrxexqLtXsDd/4qLYzGD12tvpn37zn4eP5X/sLxyFMpmE2D8nE51/F/f0NQ7jY6v7Du7s/vRRfWyk990jqj0/9Lr/PXgjdYdjdC81&#x2B;aPWnzd58MJ5PZvPJNMzm8UImXsjEC&#x2B;mQT4fBeFrfHY8muyuhd2QpVs61dzuvv/lmv98/e/bsd7/73f3&#x2B;E8JtcujekgkAAPz2Pn09Y/F&#x2B;vXK5fPfdd1cqlXw&#x2B;b2QPvlROl1Mrj51azaffvFh740Jtq9Xb3N6djifnzh45VspXCr/xvXhLISzdnndyTkLoT0NvGBq90OzPmr3ZYBzG09h0tpQMmaOF3Xe3r/&#x2B;frdUPtgv/09dCdek3/j7TELqT0B2GVj&#x2B;0&#x2B;rNmb7azt&#x2B;h688ksnkqGzFK8kE4cL8ZKuVDOjjPxQWLaHfWvN2vFbKJRq69f&#x2B;EVzu/Zh7dJecnrPiTOjwfDP/uzPHn300dvyVYAvisk&#x2B;AAC4M9w6sjcYDGq12mg0WrxlbzGyVy6XdT3gpnkIrX5odPfG02khm8qmkiu52AGM9fZDGIxCqx&#x2B;avXmzP9sZzIeT&#x2B;d5kNpzEs0vxXCqWT8ULmVDOh3I&#x2B;VHIhEwuDEH5xbfrutRCLJR6/OzxSDSGE4TQMZmF3OG/2Q6M73x3Odgbz0SSEWEgl5r1hLJtKFLPxQiY8eDSUc5P0tLfbbfQ6jd12rVZvbde7sfHl5vb6pJ2NJROdvdLPGrneNHFvJX/u1NrJ44nd2cX3P/re974n9nGnM9kHAACH0c2RvXg8vr6&#x2B;3u12FzmvUqmcPXt2cT3joJ8RONRiIZRzoZy7jZ8VoxAGk7CzF5q90OxPm7353mQ&#x2B;nMyH4xCLxfOpeD4dX8nGyrlQzodYCKu5UEiFpRA&#x2B;sTWcD&#x2B;GbxxOFzPgnH03&#x2B;9p3pfx0nipl4LjWfzuaTaXw5vdjGTZ4ohnI&#x2B;lHOhtNTvDzq77e1uu9W61vjZz3fnw06z/V776l5yHs&#x2B;l0su53LFSJbty98OPPpZfKcYzhXfa6dHVaZiFb59c&#x2B;cbZ8mrltX/58cXb95WCL5DYBwAAB&#x2B;zT1zOKxeLi5XonT56sVCpPPfWUkT3gcJmFMJiF3ig0FyN7vfk8zPvD&#x2B;Wg2H0/DfB7PLsVLuXBsJbaaC2vLoTsK5VzIJ0PyU2nvN3mwtPTgN0NtGLZ2wnASckuhnA/l7CiMOt1uvdtqdK81LjUar9R68cmV5val6U5uKT0tZbJHVivZlfKpu57JPryazhfT&#x2B;WI6V0zni&#x2B;n8Svh4tHGnHTbyg&#x2B;w88cjZVLkcQliK/&#x2B;Z9YbijiH0AAHD73LqK2&#x2B;/36/X6cDhczOstDmg89dRTyaTv0oHDYR7CfB5mIUznoT8JrUFoD&#x2B;bt/rzdD8nEvDea7U3mw3G8kFlM7YUbo3b5kEuET6SzI7/LgOF0Nh0W5435pL7TrNXrzQ/r/djkUmPrw249vbQ0WU3lCsurp1bL2dJ92VPfyiz/sutl8sV47rPqXSIVEslsdinkVn6HB4PDzLcRAADwRbk5sheLxTY2NjqdzmJer1QqnTp1qlqtZrNZI3vAobM7Dd3hYmRv1uzN&#x2B;uMbq7jTeSyfiudS8XwqtpoLD&#x2B;QT5VwoZkLqtx7W&#x2B;0x7o&#x2B;HuoFfvNGutRnO73g3jdqP5Xvtqdz6O5VLp5WzuaKmcXTl678MPZwvFdH41nVtJ54vp/OpSLvd5&#x2B;8ZkbzobJ2JLIX57jpLA7SP2AQDAPlh0vYXFKu7y8vIi7R05cqRarT799NO6HnDo/NrrGcPJbG8SzyzF86lYPpU8thLKuVDKh3I&#x2B;ZGL7EhIm00l/tFdvNxs7rXqt0bxe6yUmlxvbF/ea2aXUbDWTObJazhYqR49&#x2B;O3vfamb55h5uMZ0rxjL7kBZns1mYx8M8Np&#x2B;FoPcRKWIfAAB8bu12e7GK2&#x2B;12m81mv98vl8uLq7j33nvvE088kU6nD/oZAX7V4nrG7l5ofDyyN5wsDmiEWIgvRvZWsrFS7sbVi0Iq7NPt3v5wr9PbqbWbzVazsV3fnQ/bzfb77avDZIjnUulCLn&#x2B;8XMkWTj306GOZwi/3cNO5YiKf3pehwV9rHuYzsY8IEvsAAOCzfOJ6RqvVWrxir1wunzx5slqtLi8vG9kDDpdZCIN56I9CsxeavXmjP&#x2B;sO58PxbDiZj6aLPdx4PpVcK4TFYdxSLqRD2I9PstF41BsOGjutWrvRrDWb2/XdMLrS3L483c0tpWeL6xm5lfLpu/8g80gxky&#x2B;m86vpfDGdW0nlC598zx/wuxD7AADghluvZwwGg1qtNhwOF6u41Wq1Wq2eP39e1wMOnWEI/XHoDBZv2Zu2&#x2B;otV3PlwEpLxeD4Vz6UTldyN0xmlXMgn96WqTWfT4WTU7LRrnWa90Wher/Vik83G1sV&#x2B;I5VITlfTuZXC6t2r5Wz5gezpb996PSOdL8azpungCyL2AQDwJXVzZC8ej6&#x2B;vr&#x2B;/s7FSr1cUq7pkzZyqVSjqdlvaAw2USwmAWusPFyN6s2Z/1R7/mesbJ1bDYxl39oq5nNK7XB0uzxfWMeC6VWc5lj5Yq2cKJ&#x2B;x45lyncWMJddL1kLmtPFm4jsQ8AgOj7xCpuu90uFouLVdzjx49Xq9WnnnpK1wMOnUEI/VFo90OzP2/0fnk9YziJp5OxfDqeSyWPFm6M7JVzIRPfr&#x2B;sZg9Gw3m7Wd5r1WqNVq3dj48uN7fVhM5tMz0qZzJHVygOFSrbwZPb&#x2B;1Uz&#x2B;5sjeajq3EryxFA6Y2AcAQKTcuorb6/UajcZgMKhWq6VSabGN&#x2B;&#x2B;STTy4teS0UcMiMQ&#x2B;hPwu4tI3t74/lwMt&#x2B;7Hdczdvq7tXaj3mo2r9e7sVGn2X63dWWUDPFcKrOczx8rV7KFMw&#x2B;f&#x2B;HpmeSWdW715FTeR92EKh5DYBwDAHewTI3udTqdUKq2trZVKpbvvvrtSqeTzeSN7wOHyK9cz&#x2B;vNmb9YdzoeT2d54PprEc&#x2B;kb1zOqi1fs5UM5F1L7czB2NBn39vrN3fb1VqNVazS367345FJ968qsm1tKz1YzuWOlSrZQvvvuf5f7SjF1y1XcpXxeQIA7hL&#x2B;rAADcGW4d2VvUvclksljFPXLkSKVScT0DOIwW1zN29kKjF5q9abs/37vlekYuFc&#x2B;nEzdO4uZDeT&#x2B;vZ&#x2B;yNhq3dTn2nVavXW7XGThhdrm9dGNQzidR0NZNfWV49tVrOlh969PSTt6ziFtP5YizjwxTuXGIfAACHUbvdXnS9xfWMbre7uIpbLpfPnDnzxBNPpNNeCwUcMtMQ&#x2B;rPQW6zi9mfN3rw3mi263nQWy6UWI3ux46thUfeKmZDet&#x2B;sZ3b1evdOqt5v1re3mdqOfnL7XutILk0QunS7kckdLlezKXfed&#x2B;2pmebGHe2MhN5lLB2UPIkXsAwDggP3a6xmLw7gnT56sVCquZwCH0SCEwSi0BqHZmzd7s87efDi&#x2B;5XpGKp5LJ44WEovrGaVcyO7n9YxGp1XrNOv1emu70Y2NLje2N4at7FJ6/svrGStPZx9YvbmHm84XU/nCvgwNAoeb2AcAwO1z6ypuv9&#x2B;v1&#x2B;vD4bBcLlc&#x2B;9vTTTycS&#x2B;/FiKoB9NA6hPw27ezdH9m5czxhOQgjxXCqWT8VX0rFSOSwOaKzs2/WMwXCv09utdxqNVqu5Xd8No3aj9UHn2l5iHs&#x2B;nM8u55ePlcnbl7CMnv5FZ/uUebjpXjOf8wA9fTv7uAwDwRbk5sheLxba3t&#x2B;v1ei6XW6S948ePr6ysLC8vZzIZU3vAITIPoT8Pg1Fo9kOzN298fD1jOJ7vTeL5VDyfjudSyUo&#x2B;LEb29u96xngy7g0HjU6r3m42avX69dogPrncuL4&#x2B;bicTS&#x2B;Pi0tLaSiVbKK&#x2B;Vz2VPn1k9WkznV9P5Yjq3spTP7csTAJEg9gEAsA8&#x2B;vYq7srJys&#x2B;uVy&#x2B;Wnn35a1AMOnZvXM5q90OxNW/35cLI4oPHx9YxUYjGst3jL3n5ezxjtdDvXO81Gvd7YbvRi40uNres7rd3EZLiylCnkVo4WK9mVtQe/8lC2sHrjgMbHC7nBS0uB30jsAwDg87l1Fbfb7TabzcFgUKlUSqVStVqtVCrf/va3U6l9WmAD2C&#x2B;/vJ7RD83er1zPmExj&#x2B;XQ8n4rnUrHjxRuHcVczIRX25XbF3mjY2&#x2B;vXO816u1m/Xm/V6t3Y&#x2B;P3OtdZ4MM0mlpaz6bWVcrZQuev0N7LnSpnlX&#x2B;l6ibzPU&#x2B;BzEfsAAPgsnxjZa7Vai5O4i&#x2B;sZ1Wp1eXnZyB5w6Hz29YxcKp5PJ44WEqWPR/b273rG3mjY2GnX2vVGvdnYrg3ik0uN7Y/6tUQiOSouLVUL5bsKlezKw9mT5Wzh1q63msrn/ZAO/N58jgAAcMOtI3uDwaBWq41Go8VV3Gq1ura2dv78eV0POHTGIfQnYXe4WMWdNfu/vJ4xD/F8KpZPxQvp2KnSjbfsFVL7tQW7N9rr9Lr1TrPRbDZqte583Go0P&#x2B;hca8&#x2B;HIbe0lM9mjqxWsoXymfv&#x2B;NPt4KbO8ks6t3qx7sazPU&#x2B;CLIPYBAHxJ3RzZi8fj6&#x2B;vr3W53MbI0W1NgAAAgAElEQVRXqVTOnDlTrVYzmcxBPyPAr5qFMJiH/mjR9ebN/o3rGXvj&#x2B;WgSz91YxU1W86G0/9cz&#x2B;sO9&#x2B;k6z0W7Xtreb2/V&#x2B;bHylWbs4bC0tJcfFVGptpZJdKR&#x2B;pPJq9p5wt/Mph3GQ&#x2B;sy/7wAC/BbEPACD6Pn09o1gsViqVxfWMarX61FNPGdkDDp29EAbj0Bks3rJ343rG8OPrGflUPJdOLJZwF9u4&#x2B;3Q9I4TQ2xvsdDvbnWaz0axdr/Xik3aj&#x2B;X7nWi8xGxWXVtLZzNFSJVs48tAjD2ULHw/r3djGXQlesgccJLEPACBSbl3F7ff79Xp9MBhUq9Wb1zOeeuqpZNI3gcAhMwmhP731esasP168ZS9M57F8anEYN3ZyNSxu4y6uZ8T24d88HI&#x2B;6e/16u9loN2qL6xnxyfvtq81xP7OUnq6mmrnZVyqnK3cdfyLzQCmzvDiMe2MhN57zeQocNj6XAADuYDdH9mKx2MbGRqfTWczrlcvl06dPL1ZxjewBh05/Hgbj0OyHVm/e6M129&#x2B;Z7kxvXM7JL8Vwqlk8lj62Ecu7GNm4mto/XM5q77e12o1FrtGqNXmx0qX79o0E9mUiOi6nsyvLK3cVKduUrn7qeMZ5NKukVBzSAw8/nFADAnWHR9RYWC7mTyWSR9o4ePVqpVJ5&#x2B;&#x2B;mldDzhcxiGMpqE3Cp290B/Pm715dzjvDmeDcZjPQwixRDyeT8VWsvET6VgxG4qZsJIJ&#x2B;aWQ3IepvcX1jMZOq96sN7Yb3TBuN5rvt692wihkU&#x2B;nlTObIajlbqJx94L7sN1dv6XrFdL4YS&#x2B;/H1CDAARD7AAAOo3a7vVjF7Xa7zWaz3&#x2B;&#x2B;Xy&#x2B;XF9Yx77733iSeeSKf36ZYkwH6ZhjCYhd4t1zN6w9niLXvj6WIPN55Lx&#x2B;9aTSyu4payIRX263DFZDoZTsav/fyNZqPZ2K7Xe53mqHsl1k8llyaldHptpZwtVI5UH8&#x2B;dKWWWf6XrJXKpfdkHBjgcxD4AgAP2iesZrVZrEfXK5fLJkycrlUqhULjzRvbmIYR5iMXCeBy2t8OVq6GzE5KJsHYk3HM6LOcP&#x2B;vmA39sghME4tPs3rmd0BvPhZL43mQ/HsVRy8Za9RHX5Rtcr50I2sS/XM6az6XAybnZa9Z1Wo15v1Brd&#x2B;fByc/vabnOQmI&#x2B;KS9lCfuV0sZI9cTpbePxXV3GLqdzyfp3wADisxD4AgNvn1usZg8GgVqsNh8PFKm61Wq1Wq08//XQikTjox/z9TCZhfSO8/0HY2Aw7O2FvL3R25q3WvN2eD/Ziq8X4174a/uAPwxPfDEu&#x2B;F4U7xDiEwTTs7v3yesZgfOMq7nwez6djuVR8OR27q3Sj662k9&#x2B;t6xt5o2B306juterNR3661thu9xPT91pXWbC/kllL57I1V3NNn78l&#x2B;7ZMje7HMnfbfSQD2gW&#x2B;wAAC&#x2B;KDdH9uLx&#x2B;Pr6&#x2B;s7OTrVaXWzjnjlzplKppNPpO29k76br22Hreuj3QiIRstmQy4fCckgmw3Yt/Pzt8MILk9ffnLfbYSkZW1mJr66GXDaEMGs05z/8ceLqtbC&#x2B;Hp49H07dfdB/DOBXzRfXM0aLrjdv9ma7w8XpjPlwHM&#x2B;l4rlULJ9OnszfuIpbzod0CPvxHykm08lgtFfvtOqdZqPWaG7Xe7Hx5eb2hUFjKZmcrKZTayvlM4VKdvXR7KlPdr1kLrNf&#x2B;8AAdzixDwBgH3xiFbfdbheLxVKpVK1Wjx8/Xq1Wn3rqqdvd9Xa7YbgXBnthPA7TSZiHkEqF0mooFj/3b7WzE65cCVevh/ksrKyEeCw0W&#x2B;HSpfD&#x2B;&#x2B;7MrV&#x2B;e12rw/iFWriQcfCI88Eu46GVZXwsMPJ8N8&#x2B;uGFebcbr1Ti998XTpwIYR4uX559dGHy3gfxa1vxjz4Kf/BseOKbIZf7Av78wG9hGEJ/HHb2Fm/Zm7b6i3m9&#x2B;d4kJOOLt&#x2B;wlSrlfXsXNJ0Nqf/7N/eFgp7db6zQbzUZju7E7H7Ubzfd3tnqxSSyXSi9nM0dWK9mVI/c//FC2sJrOFzO/XMUt7NdDAESR2AcA8Pncuorb6/UajcZgMKhWq4u0V6lUnnzyyaWlg3snVLMVrl4NFy&#x2B;GjUvhypV5oznf6YT&#x2B;YD7YC5l0/Pjx2GOPhie&#x2B;FR5&#x2B;KOR/84vzavWwsREuXwntdhjshe5u2K7Nt2uzTidMxiGZimVSIZEMsVhILsWOHQs73fnOzuSVV&#x2B;Obm/H77wv33ReOHQ2F5USlOnvvvdAfhN3dkEyEu&#x2B;4Kd90dP3Ei/ot3pxubkx/&#x2B;KHHpUuzDj8Kzz4QH77&#x2B;NXyP4UpqEMJiF7jC0eqHZnzV7895ocT0jTKaxfDqeT8VzqdjxYijnQykfVjP7dT1jNB519/r1TrPe/nhkLz650tjemLSzS&#x2B;npajq9WMU9efyJ7AO3juytpvMr8ayfWgE&#x2B;Fx&#x2B;bAACf5RMje51Op1Qqra2tlUqlU6dOVSqVXC53W0f2BnthMAiDQWg2Q60edndDNhPuvTfcezaEEOqN8NLL4YWXpm&#x2B;/Pd/eng8G88k0XliO5fMhmZh3e5NXXw0/&#x2B;1ny5Z/Gnn4ynD8fHnwgJH/dN4SZdBiNwzu/mL340mzr&#x2B;jwej&#x2B;WysWw2ViiEeG6&#x2B;uzu7VJvPpvFjxxKPfjV89VxIp8Ply&#x2B;Gtn003L01ffS2&#x2B;XYs99GA4fSo8/lj8yJHw7ruzS5dDoxl/8P5w//3hzJlQLieOHpm99/5041J8Zzder4evPx6e/HZYKdy&#x2B;ryRE2yCE/ii0&#x2B;qHVnzd6s53BYmRvNpzE08lYPh3PpRJHC4nyx9u42fi&#x2B;/HQ4nU4H42Gz0651Go1Go1Vr9mKjS/WtD/v1ZCI5Li7lCssrd61WsoXT5048ninc6HqZfDGVLy7lsvuyDwzw5Sb2AQDccOvI3qLuTSaTxVXcI0eOVKvV8&#x2B;fPH8Ar9sbj0GyGa1vh&#x2B;nZoNkOrHZrN0GjMd3bn3e6s0Zh3dhJ3nYx/9zvhe/8&#x2B;HDkajh8L2WwsHp&#x2B;n0/Hl5Vi1Gn/wgfC1R8OJE6HZCD/80eSHPxm/8lr86lZyfTM8ez58/evh6JFP/ksLhfD0k&#x2B;HIWvz0qfiPfzL5&#x2B;dvzViuWTscfuD88&#x2B;UQoFsNrr0//8Z9nH344r9eTg0F49pnw7SfC2bOJf/3h9P0Pphub8Z2deKNxY8SvVIofuzh/973ZL96L73bD44&#x2B;Fcjl84xvxo0fj7703vbA&#x2B;&#x2B;cd/Srz9duy998Kzz4bHHr3dX2G4041CGEzCzi3XM25cxZ2EWFjM68VXsrGb27grqf3agt0b7e30u/VOq96sN7Yb3TBuN5vvta7uhFEsl1pcz6jkCpV7Hvhu9purmVuu4qZzxZDen4cA4FeJfQDAl1S73V50vcX1jG63u7iKu7ie8cQTT6TTh&#x2B;MH0fEkXN8Ob74VXn9j&#x2B;t4H83Y7xGIhnYqlM/FqJfnII2E5H/L5kEiGK1fDaik89tj/z96dBcdx33mC/2VmVWZlZmVl3YUq3PdFELzA&#x2B;5AoiRJlHZbdsmy57Z7u9rgdDnt2Hjb2YWOfdmK31x3dGx0TGzuxHdPT0zPj9tG2bOuw7pM3CYIkAOK&#x2B;CijUmZl1533sQ0ESpZYPqiFRov&#x2B;fNymIQuFggPjW7/f7gmnitZp9/rwlirhtYwE/JogwOABje&#x2B;HECddrrzu//JU5PqG/8JJrLYkvr8CRwzA4CJ5/8fH2dIOfh0jEFQ5bMzPW0rL92uuuWg177BF46knixDH8//6P5vXr5rnzhKJiXZ2wZxc89hixuABXJ6yVVXN8gthMYwP90NkJQ4NYNIrNzdtra7C8gu8YguYWUDVoaydI0l5NWoKInzmHr2/AygocOfwR&#x2B;SOCIABgA8g2yLe0Z9Tebc/QrcaJPZwlXREOggw0pvbI7WnPMExT1hShIonlopAXpLwg4&#x2B;aGmFvVJI&#x2B;bMv0kFeFDNBeMRfbSXR9sz2B4gr1zpw0QBEH&#x2B;4GCO49zp54AgCIIgCPLJ&#x2B;sj2jEYxbuPKHsdxd6oVt2pAXbXqqiFW1VxRLpQVRbf8LNmT8A&#x2B;1&#x2B;7n3XpldWYGJ6zBxzV5ctAURc7nwjg5s1ygc2A&#x2B;9PcBxgGMfeFxBhGeft198yVxYwCgKb20l&#x2B;vtg/xicvAc8NMzPw0svma&#x2B;&#x2B;aWeyeChI7NmNHTkEu0ehq&#x2B;ujn&#x2B;XmJly5CmfOmRMTdiaDd3S4HnkYHnoIOBbOnrOf&#x2B;ZU1PY0xDLFnD3bsCHR0QLUKU1P2tRu2IGAMTXR2QP8AJJrAMGF9HeYW7NVVq1bDaA/GMIBh4AAoqmOZmNuNDwxgoyPQ1QV7doHX&#x2B;wl&#x2B;6hHks08FUAwoKVvtGaWtVVxHM8GN4wyFsyTOUlu5XpAFhoBtCtXqqlypV/MlSRQFqSBWHa0klRYqGZVwDJ7kKJqJBYK0L0RzQZr7QCuum2HRTAnyuTAlGBdXiQCN39cPATcAvPXWW5cuXTp9&#x2B;vTOnWjGHPl8Q2EfgiAIgiB3lVtXcWVZFgRB07RgMBh6VzgcJohP9SaUaoNUNbMluVzT3C68KcB2RD2NX4UtgHNz4rmZ9FyqWFeNiqJXZR0AaMoV45nhttDunshId6zNhwMAyDLMzsHlcbh&#x2B;3UptgmXhrW3Yg/fDvj3AcaBpkMmBrIBjAcuCzwcuF1y/4bz0ijVxzQHAfBzR3oaNjMCRwzA6Ag7AhQvwi18ZFy85qkb0dBOHDsCRwzAyAtxHRWyqCnNzcO6ife68NT8PjuPauxf7oy/Bvr2QzcBzvzZffsXOZonOTuLoYRjbB7wfkkkYv2rNzTuqgofD&#x2B;EA/9PRAwA&#x2B;aDrksrKw5ubxjWRjLYDQDbheoqi2ItiBgOE50dsKhA3DsKHS0f4pfKwS5c0wA2YKaBtJWe4atGI5mOKoJtoOzJMaSOENhfhqCLAQZ4D1AAmC/&#x2B;4F/J1XXGu0ZYkkSckKxINZwY6G4WbQ1xkVaAY8n4g8xXJDmQh7O7/G&#x2B;n&#x2B;tRDI95tuMpIMidgMI&#x2B;5O6Fwj4EQRAEQT7H3hvZwzAsmUyWy&#x2B;XQLcLhsMfjuVMje&#x2B;&#x2B;pGnBlMf/rK8k3J1PpXCUS8p7e2/5HR3vHungAqJlwM1lc2CwtZcpzKWluQ6opBkW6CALDHKwpQO/piT24t&#x2B;NAX4ghAGwL5hfhwkW4fsMRRFsUAcexYBDjfeA4UJftUsmpVsG2Ma&#x2B;X6OuF0Z1AkrC6Zk9OWskNwDA8FiF6emDvXjh2BJqbIZWCl1&#x2B;2nvu1tbCIBQLuXTvhyGE4dBA6OwD7qF/hCwWYuAZnzllXxq1UCguF3A89CI8&#x2B;ArEIXJ1w/vkZ88oVcLlcozuxEydgoA80HWZmnBuTdi6PsSze0Q47hmF4CMJhqJRhegYmp5xcAaPcEAyAzwe2DRspay3p1Op4OIjv2Q0njsOe3UBu04ExBPkscAAUB2Sj0YrrSHW7or7fnkG7cZbEGBL3eSDAbkV7HmxbVnFNy1R0TaoUCyVJFEUxV1Bwa0PMLcsC6XKbfpLmvP6AP0hzIZoL3DKy56cYH8FS2xIuIshnBAr7kLsXmq9GEARBEOTz4V&#x2B;u4vp8vsbIXjweDwaDhw8fvuO53kfi3DDWE8VxzLTtF2V9fk1Yy5SvLOUePdD1Z/cPchQ0&#x2B;Vkcw3oS/I724FyqlJHqFVkrlJUNoTaVFKuKQbkIn8e9t9MHOAGDA9DdBfv2YhPXiOs3rKUVe23NsSzAcMxDYV4vHgw6tu3U68bVCXxhEW9pxiIRvLMLaNpObdq5vFOp4bkcvrYGhw/B3t3wJ39CjI4Sv/iV&#x2B;fYZ/cw5Yn2DWFqGY0dg1ygEgx/&#x2B;YCIRuO8ktLUSnZ34mbPm5KTxP35ITE7hX3oC7j2BDQy4X3zZeuVVc26eqFbx4mHYPwb3n8QOHSSyOVBVYFmIRSEaBZ4HHIeAHyjSkSQzkwbAMC&#x2B;LezyObYOuYwQOtgO1OkgSSBI0Nd2JLx2CbAet0Z6hNK7sWZLsaMbWKi6Ob7Vn&#x2B;GnsvVZcr3u72jMUTa3I1UJJEouimBdrjl6SivOVTB0MjCYpL0PH/EGai/YMDn5gFZfhSda7XfvACIIgyKcOTfYhCIIgCPKZc&#x2B;sqbq1WkyRJUZRQKBQIBBon9kKhEPk5HPVaEbSXJ5LPXlq9PJ8t11Q/R/dEubifDge9O7vC&#x2B;/ubPG7iZlKc3Sh6SCIeYG1wVM30MVR/c2BHh5/90Ku0&#x2B;TxM34Sr15y5eTuTdVQVj0bwXaOwbw/EYrCZhivj9syMXSxjNIUHQ&#x2B;BlQZbtfN6Rio5l4cEg0d0Fe/fCkcPQ3Qm5PLz6mv38r82bMxjtcQ0PY4cPwuFDMNAPH7n1XCrB5BScu2Bfv2Fns3jAj584AV84DYkEZLOwuATVKgSD0N4GiQSwzEd/RhwH1jdgYREWFmA1aYsiGAaGYRjLQjAA4RA0J6C/H3p7gGU/3ue8boJQ0TNSPS3VNcMKcZ7WCNcaYbzoJW/kk2ABKDbUNChuteI6dd1uXNkzLJwlG1f2MJ7easUN0EACbMeLFLqh1zVFrBSFkiTmBSkv1ggzJWTXzTLtpkw/5YnyIdrXGNnzU17ew/Dk1iquH6c/i6&#x2B;TIMgnDU32IXcvFPYhCIIgCHKHfWhkr1gsNipxG1N74XDY6/V&#x2B;CiN7DoDtgO0Ajm/LttyHmQAbonZ&#x2B;JvPc5dULk6lCSTYwABzHbMeDQTjEnhrr/Po9/Qf7Q41xGsUGzQDbBrcLuN8yYZPahPUNEETQdSDdEA5DRzsk4gAAuTy8cwbOX7CWVxxdxzkvFgiA2w2VipXLO7UaRpJ4KIS3tEBfL3R2AIbD8pIzcd1aXHSqNSwace3dA/fdC/vHwOf76PcuSZBKgSCCYYKPg0QCmhPg&#x2B;lhBmuNAQYByBTAHPB5gGPB6/zXbu3NZ&#x2B;VcXV96YTBWrKgBWU3TdshwbaMrVE&#x2B;fv39X6xKHuZj&#x2B;aXUL&#x2B;FRQARYeiAsU6iLJVbrRnGI5mYqQLY0mcJXGvZyvXC7LA4NuyWGXZlmYaYqkoVqSCKEg5sY7pKSG3pAgunDB4kuG8/LuruEGa&#x2B;8CJPRfr2ZZwEUHuAijsQ&#x2B;5e6DVNBEEQBEE&#x2B;PbeO7CmKUigUdF1/rxU3EokcOXLkjqzibpaNhc3iarqcLtRMHPpbgid3tsS4jxP6rUv67Ia0mCpuiDWxqlRVE8cwv5dKBNmeuD8WYJ441BXh6VeureeEmmxYNo65GTIR4cI&#x2B;2k0QhgluFwAAjQNN/R7vr6UZWpoBAKpVkBWQJFhdg6VlCAagvQ0eewT6eonX37AvXralImbZREc7jI66bAvWN&#x2B;yNlCMVTUmCmVnMQ2Gk2zFNp66A42BeFgOwMxl8bh4iYRgZgY/8ugSDH7Hq&#x2B;/FgGEQjEI00/ksFyNWhXjEoAvN6XLgDabE2sZRfSBe9HvLBPa37Ov0AUFLh6lL&#x2B;0kL25opQrOlBP93XHBjrje7oCHVEmT862iNr5j&#x2B;9NS&#x2B;UlR0dobG&#x2B;WIRnxIoyvpj7v3529cdnFr/14PBXjnYxn2pfC/L5ZADIFlTV99sz1HdXcR3Yas/gKKwtAI1tXB&#x2B;1Xe0Ziq5W5bpYKRYkUSoINTBKgjRfTldsHWNI0kvTUX&#x2B;Q5kKdfafpfR/I9SjWt137wAiCIMjnCgr7EARBEAT5pLw3sofj&#x2B;NraWq1Wa4zshUKhzs7ORnvGnX6O4ABcS1aev7T60tW1tXVJKiumZpA8c2p/x7ceGD69N3FrEFTSIFdShLKiGCbpIljKxXrcPEP5WYImwAaY3qi&#x2B;cGXtlYnkzVVBEuoADmAAjoNhmANAe9w7B&#x2B;LfPDn47x/f/e8f33XmZvqlieT4Qn5DqF5dKpiWw1KuEEf1xujb/jAsC1bX4Mw5e3zCyaSdStXBcdfIDuzoYejtgdFRXNOd8at2atMRJaJWx/bshgeHcMuCbAY2Np18zhFEW5RA1RySxAMBLBTCW1uguxt6eyAa&#x2B;&#x2B;iyjk&#x2B;SByC5Lv74nfmppBji6N5mf9hHy6oxt1G8OJ/9&#x2B;1du/sl9g0/f08eQ7tVc5eJcVqioQS9FgHN9pfDS1bWKrLdHuUcPdP3xPf0nd7b&#x2B;9zfn3pxMnb2ZOTnasrMzPNQWvLpUeHsq9b//6PK5mfRfPDSyr5P/lD9A5LPLbrRn6I1cz5Hqdk1zNNPWDEc1cZbEWQpnSFfo3eqMAAsUbMs8sGGaiq6IlZJQkgoFoZgX6riZErMrqtRYxaWifIjmgtHIXror8H4rLsNTLI8z6Fc7BEEQpAH9REAQBEEQZBv8y/YMnucbx/Xi8Xg4HD506NBnsz0DA&#x2B;hq8u3sCM&#x2B;mpOXNkqmbmItgvKRu2SmptpSV&#x2B;5u27s2tCNqV&#x2B;ezEUmFmU8qI9UpdU1UDcJz2uBJB77EdiS8e7O5J&#x2B;I6PNC9sFq8v5cG2cMYTi3jbIt6Al1I0s1zVTcO&#x2B;upRvDrHHdiS&#x2B;cU/Xvt7oy9fWX7m6fn21cHUpn8xXri7lnzjUfXpfe5C&#x2B;nXyNIGDnCMTjeH8fXLtm35y1Uynr&#x2B;nWYn8cDAXC7HFUDWcZ8HMYwAA7oOkQjMNAPvA90AxMFTBDxag1sGzwUBAIQCf/G1d1PWEWHtCSnxXpaqntpUtaM8fnsr98x/H5moCt8oC820Bq8tpz/4VtzF&#x2B;YyD&#x2B;xq83tJH0stZcrxIPPVe/oPDcZzReW5K6s/PbPwv/7j&#x2B;aNDiX/74PD/8uU9&#x2B;/ui//W12R&#x2B;9vbCzM3x0KH6grykeYN6cTP383PK1FeFbp4aePtHnQ1NQf4A0ANmA8rvtGUW5Ma/naCa4cJwhcZYktvZwGQiywLq2q7hC1pRyvZovisWiJOQKNcwoS6X5ckbBbZwhKY5mYoEg7Wvu3zlyyyqun2J8bpb5RI4NIAiCIHcJdLMPQRAEQZDbc&#x2B;sqrizL1Wp1c3MzFos17uvF43GGYWiadrs/pWtoigWaAQDgdgHj&#x2B;phrc2ui/tZU6tfja5fmsmmhCrYTCjA9MV97jB9sDx3dEe9u4hfT5X98beaXZxbqQh1o0uOlOIakCLymGpWyYqs6E/F99Xjv4we7GNL90kTyh2/MZdcEcLvCMV9bmGO9FEO5moPs7p7Izs5IfzPvZ3AXQEmFi/O5F8ZX35neXEqXNcMaagk8vK/ji4e7DvZ8rA3ZcgXWkjAzA9MzztqaLUlOXQZdB5bGm5rwri4YHoKebmhvh0j4Y322Pr51ybiymBtfytVVY0939P7RVookMlK9LOtRnuluoi0HLi9Ivzi/9OvxNamqDreHDg/G3S7i3M3NuVSxNcLdO9q6oy1U14yJxfz5&#x2B;Uyxqva3BAZbg8WaNr6Ytx37S4d6Hh5rJ3D89eup164nZc08Opx46ljfri7/&#x2B;JL0n1&#x2B;6eXkxFw&#x2B;w94&#x2B;27uuNehlSVg1VNwNeT2&#x2B;zP8x82gOMyKfKBFAsqGmNXM&#x2B;W6rbcWMU1wHIwhsRZEmdJjGe2cj3eA9T2rOJqhl5X5UJJEsuSWBClvFDDjE0pn7KrtIuyA5QnGmjc1wvRnN/D3rqKy8Pvs8&#x2B;PIMjtQzf7kLsXCvsQBEEQBPl9Xbhw4cyZMxRF&#x2B;f3&#x2B;kZGRcDjcWMW9UyN7guzcTIpXl/KL6VJF1lnaPdIeGuuNjXQEPlxc&#x2B;66aCVXFsm3HRWBeD/HeH1MtuLIkPnd59YXLq2tJUXcchyAIF0ZjeJyjdvTHHznYuaM9tF6oPnN&#x2B;6fVrqVpdbYpw&#x2B;3piXXHeNO25zeLlhWx&#x2B;XcIwrG8w/m/uGzy1py1XlH9yZuHtG6lySZZNW1N0cICgXF6a5H0ehnJFefrQUOKLB7sHWnihqr12feOFK6vji/lcSeY85IGB2FeO9j1&#x2B;oDP4r0mg8nnI5KBWBQwHhoZAAKKx3&#x2B;8W4CdCsWF8UXz24uqzl1ZXc&#x2B;XBtuCRobgLxy7OZbNF&#x2B;d7Rlm&#x2B;f2jHWH9wUtJ&#x2B;8s/iLC0ubUu3YUPP3HtvVGvY&#x2B;f2X1v78&#x2B;W6iohwbjh/qb/F5qo1A9P5OZTAohr&#x2B;e&#x2B;XW07O0MpsXZ5PpsvKbppl6uqoVuREHtytPWJQ11jXf7Gc0hXTEUzwz6Pj9qWGAf5rJIdUIxGK64jyXal0Z5h2qqJe9xb7RmcBwLM1jauZ3vaM0zLVA290YorCIKUFxXCXC9kl2WBcrtNP0VzXn/A34j2Ah7vrbmen2BRZQyCfHpQ2IfcvVDYhyAIgiDI76tUKk1NTZ07d&#x2B;7hhx/u7e2l6ds/Lbfd1iXt5&#x2B;dXnjm/NDGX1WTDH2WPDjWf3tt&#x2B;fEfzYJy59U/WTVjO1CZXhel1cSVbrsm6bdkYjnlZqj3iG2gJdMd9pJtIi7WrS4Xry4XVTGlDquu61RXnH9jT9vjBrhMjMQpgVdDOz2VmN4p1xcBwDDAQSsp6oZrMlYWioiqao5lkgHnsQNd3vrDz0EDYceDmRvniXPbacmF2QxLKSl0xqrKuaaZZ18C0Yp2Rb5wcePJoT1uEW0iXnr&#x2B;0&#x2B;sZkaiYpKhXVw5J9zf6OqC8R43a0hx/c09YZ&#x2B;tzM&#x2B;BRVWEyXbqwUFtKltFgnCKw94htqCyaCjGbYq7nK&#x2B;GLuymK&#x2B;qui9CX9/SyAr1aeTUshHPX2i/2sn&#x2B;hgKztws/LfX5169vu5jyK&#x2B;d6Hv8YFelrv&#x2B;XV2fenEq5cLy/JdAV9/EMmRbrl&#x2B;dzumk9PNbxp/cPDbRyhbIxv1nKSjUArMlPdyf8rSEKLT3ezXQA2XyvPcOS6o5qbo3sYVjjyh7GkNh7rbice7uKKxRdrcg1oSyJkiTmhRoYJVGaL2dqYOAMSXlpOhYI0VzQw4UYH0&#x2B;&#x2B;e2LPw/JulkUnlRDkzkJhH3L3QmEfgiAIgiC3p1Qq/ejVX9ST4unTp4eHh&#x2B;/00wEb4PWp3DPnl1&#x2B;6mtwo1DwU0RHldnZGhloDLSGuLcr1xPmAl1zJ1Z45v/TCpZXUZqmqmzoGbgJ3TNvULYfAfD56Z0f44X0dD4&#x2B;1DzV7DQcuLwi/vLjy4nhycbPoo6njI81fOdp7el&#x2B;7/91OkZoBNzdKZ6fTb93YuLpSKJRksB2SJGzHMWoaGHa8M/z0if6vHu/rjHGL6dK5mczyZlGoaRiOeT1uWTNXcuVrSwUjWyY5z5H9nd96cPj03kp6E/cAACAASURBVDbddM7cTL88kRxfyiWzFUM2LHBMwwLSdf/u1j87NfyFsZbP1GW5qgH5klqq66Zlc7S7NcxyJADA9Gbt11fW3phMiVW1yc/Eg6zjgFBR8mVZ0S0/S3U38T6GXM1VppMi6cJ3dUW8HvfshrQh1Pb2RL56vH&#x2B;oLbiYLv783PJL48lKRTmwo/m7Xxg5vqN5JVv&#x2B;9ZW1C/NZoaz2NfOHBxODrQGacrsJrC3CtfjRaNRdzQaQbajrUHy/PcNuXNnTrcYeLs6QGE9vteIGGKAAtmP4WDcNWVWESlGqSIW8IOWEGm5uSvmkXqTdlO33NNozQrQv&#x2B;O4qrp9ifY2RPcyDxkgR5DMHhX3I3Qu9moQgCIIgyO3x&#x2B;/3do8Mv5159/tUX3nzzze9973sf40HKGhTKar5UrymGYTsYjtMkEeboeJD5nXfTnA8e0cIBjg/HHAcIHHv9RmotXZpbk5Y2S8/hOE27g5ynr9l/78623gTfFGASYe9itmJadjTk7Y7zTQHWwZyNQn05Uzo/m15IF6&#x2B;vFL5yrPe&#x2B;Xc3H&#x2B;sN7u8MH&#x2B;5v&#x2B;&#x2B;ezS29Op5y6tTK2JlxeyTxzuPjYQxgC8bqjJ&#x2B;mRSODuTruaruMcdi/t2dIQjPjot1W8s5jLLhb9Jl96Z3nzyaE9vwm/ZzpWVws0bKUszybC3JcEzlLslyGYwsA1rdlX42dlFF47dv6v1ibHmJ8aaC7KzlC6t5ipiWXUch6ZdUY5ui3KKBuSnMt63Jmor2UpN1YMc3RHlEn73hwKTpKSfm0m/OZVaSJVk3XThEOWZ4fbQ/v6m9iiXFusbhVq&#x2B;JLtd&#x2B;FBb8KnjfaPtvpoOl&#x2B;Zzz19ae/laciYp9ST4Xd2R5hA7sZw/O5PujPn29cXG&#x2B;mJXl/L/89&#x2B;fcbkInnUHWGq0K6zoJoDzxo0UQ7mODScO9wZNANMGAt&#x2B;usgTkM0kFkA0oyVCUQaxbZeX99gw30cj1iLCXeK8VlyG25RvCsi1V18q1Sr4sFQShWBBlMNbFXKYi6W4w/SRHMWxzMERzHcOJPbeu4npYnmDRgjiCIAhyZ6GwD0EQBEGQ27a37F1KGu5W3s8Hf/CDHxw4cOCee&#x2B;75fd7QAFgX1KtL&#x2B;asL2bn14oZQK1bUSl0t13U35QqyVDjI7uqKnN7XfnpvO//BSCsp6SvZylq&#x2B;kivJumZijoO7XE1BujPGx/xMkPOMdkUqio5jWDJbUhXDcuG4C3e7iJCP5miXn6UiPM1QZHuUX8uVbccJcR6epWzbcWzQVN0xLKGkvDC&#x2B;upor31gtPH6we1cb9&#x2B;TBtuG20M/Ph567tHptpfCfX7o5nRSfPNr7yP7OBO/qSQT29zZlJPkKjlfFWiFXzXCe/kRgX090T1fktesbs3OZK&#x2B;eWZtelr9/b/&#x2B;Uj3QcHmp69tPrsucV0ury4XLAsG0wbSCIR5/f3NR0ZSrRFfa53100jDBbpCRzqCWzzF&#x2B;/3hgH25mTqH1&#x2B;fKdX0e0dbv3Sk&#x2B;54dze3B98cKXQSumXZGrK/mKyzpGutrSgQZoSj/8sLyUFtwZ2f48FCiJOvvTG/&#x2B;9OxStiR/8WDXWF9sX2/M43bhOEwsFzwkQRJ4T7M/4qPfnEotpEuO43z1eN/T9wzUVX0pXS7LGs9SHVGuM8bHg6Qbe39CywXg&#x2B;izWOyMflwGgWFBV323PkG1F38r1HAdnSIylcC&#x2B;FtQS2cj2eAnJ72jNUXaupslAShXJRygtCNi8T9lxps&#x2B;roOE1SXsYT84doLtTZy1lmjz8eYnx&#x2B;iuUpxkeyHEqbEQRBkM8etMaLIAiCIMhtS5&#x2B;5du3axEJVKFXKZthLkpQfXN/97nd/ZwNvpmZems397OziW1OpfLZiK7rH6/H5PV6vhyDwiqwLhZpVrDFB772Hur/78MiDo00A4ADMbNZevb7x1vWN5Q1JlHXFsnXN1CoK2I4v7N3V33RsKLG7KxLhPVXFuL5aeON6amIpX65rPi811BY8vbfj1J620Q7eDaA5IFUtWTWKdW1iKX9hJnNlKb&#x2B;SLemKDjaAC3dRroiP3t8X&#x2B;9LhnlN72iMsptnw2o3MP59dfGMylRZqzSHvF/Z3PHW0b09v2LDgzPTmc5dWz89m1rJlXTNZhgz7GZcLl1VT0U1Z1vS6zrDk8d3tf/HwjntHEpYN00lpZl1MiXXdtDiabItwXU2&#x2B;zhgf992xy3KZirWaKydz1Q2hVpa1gJcabA2EOHoqKf7szOL0utgW4U7t7XhoT9toZ4B592nWDFjJ1cYXc5fnczMbUrGmelyEpRmbVdXHUvt7Y73NAVU3Nwq1fEVWNYt04aQbN01bqKoYBgMtwYfHOo4PJ4JeslQ3M1Jd1c1YgOmM0ShBuZs5jfYMvZHrOZJsV1VHMxvbuDjtxlkSYymc82y14gYY8GCwHX85TMtUdE2sFAslUSgIxYJYw4yUmF9RRNpNWX7q1lXcwIdacXEaXX5EkLsKWuNF7l4o7EMQBEEQ5LZpz12fm5sz24Isy764dK1SKfubo7KsdEVjTz311G95Qxvg7ZnCP7w688KllXK&#x2B;SvqZzoT/8GDT0cF40EdrhnVmevOFy2trM2nQzcRg/M8eGvnzB4dbA&#x2B;6FvPKjt&#x2B;d/dnZpfk0E245HfE0hrwNOoaIIRVm37DDP7OqOPLi77aG97Z0xej2vPn9l9efnl8cXc6bldDVxhwYTp3a3HRmKtwVIALAAriyXnjm/9OLl1Y11qWbakYh3oDUQ4uh8WZlLFUsVtSPue2Ss88tHeo70BQFgvag/c375lxeWL81nbcPe1Rd96ljfYwe6OqOetYL26rX1129sXJzPZjaLoJkur6e12b&#x2B;vN9oa5hxwFM1iKddAa2B/X1N/82/qCv6USApUZC1XUuZTxWxRZml3lKfFijqxnL&#x2B;ZFBnKFeSoYk3fEKqsx727O8IznqV06cZaARwY642dHus4NpzoiXjee8C6CdPJ0rnZ9Gq2QpOu5hBr28652cz8ZrErzj861nnvzpawz1ORjcV0aX6zWKgoOGCJINOd8A&#x2B;0BGJeFKHc1TQAxYSystWeUZQdzdga2cPxrSt7LPV&#x2B;Ky67fe0ZmlqqVwolSSo22jP0slSaK26qLgdnSMrLMLFAI9cL0VzjuB5PMX6K5V2sZ1vu/CEI8lmGwj7k7oXWeBEEQRAEuW2Ux7O6tubzE3uPH9fbArNzM5lKUSgIVrn2N3/zN1/72tcSicRHviEOcGgwgmPDPpZ67tLq5nJ&#x2B;vlCVVcPPUE8c6hrpDA62Bu/Z2fLc5dX5pKRXlStz6RBPf2GsozlIP7S7vaaYlJvIleRYwDvUHmoJs7phzW1IM0kpI9TemUqlhNpCuvT4gc6DA7E/PzW4oz30z&#x2B;eWXhxfW85U8mV1YbM4myo&#x2B;uKdtd1eQISDi80R4mvdSScoFiixkyxs0uaM9fGpP&#x2B;3qh&#x2B;tr1jcmVwt&#x2B;/cnNyTfjyke5HxrrbAuS/&#x2B;8Lgrq7wT88uvjqxcX25kBbrsxvSk0d7jwzGvnOq95v39U6vlS4vZBczZcdx2qK&#x2B;0Y7QYGsw5v9dE4&#x2B;fmKIKpbqGAeZnSb8HbIALC&#x2B;IP31p448aGrBkM5SZwnGfJrpgvEfJ6afdwe8hNYFE/y1CutVzl7Ez62YtrAy3&#x2B;kY5QU4C5vpI/M5NeyZZn1qUH97bt6436SQAA1gU7O/1hHz2zLt5YFa4s5VOFalnWWyPcQEsgEWQ5huQp4Cl3ayBycjhyhz4ZyKfCAUhWoKw4qgkV1ampjmZaZRVMC2MpnCFxlsSafFu5np8GcpvaMwy9rimNkT0xL4q5Qh03N4uFDbPCuEk74PFEAyGaC7U2H6UH/NQHRvZ82xUuIgiCIMhnA5rsQxAEQRDkttWubLzy8suF1fXHH3&#x2B;8qbcHXK61tbm5ufmpaiqTzbYMdnsc7Lvf/e5veYTFvPL6jdSvLq68di3p5KtMkD1xoOtbp4YfHWvGAVQbkgXl&#x2B;nKhryXgoVxNnCfAYABQ0WAhXc4W67Jq1nU9W1Rm1qXrK8JGrqzUdcs0wU2EA97Rrsip3a0P7evoTbCFsvni&#x2B;No/n128NJ&#x2B;VNSseZA4Nxh870PXgnrYQja0J2k/OLP7y4srMulhXDBwcnvM0h708Q1UVfbNQK9U1woW3RbwnR9u&#x2B;fLj72I4oCVDW4MzN9JWFXFqSvbR7tDO8rzfal/CSn5mj/DbA9WTlpfHkO9ObWaFqAHAM2dXk29cb29kRrqvGry6uvnhlRSjKrU38A3vaTu/rGGoNKLp1banw9vTm/GYRMIgH2KYAW6wqNzeKqmYOtATaotxKtnx1Ma8a1q6uyGMHOh/c2z6cYD/03lUbqortJnCKBApH81F3LwVA1qEkb7XiltXGyJ6tmTjlwlgSZyicoyDAgm5CkAE/AyHqX/8NYVmWYmjFSlmoSAVBKOaFOmZsiLmlukC53JafpDnOH/SHaC7o4QIeb6MYd6sVF2fQsAOCIFvQZB9y90I/7BAEQRAEuW26rjmAOY6TTqcpFxFobWtuaW5ONFsL414vV7H0mqb&#x2B;1V/91YMPPjg6OvqRj9AbpRP39o60h3Z2hp6/tDo/m3nxxamJ5cLV5aE/e2C4I0T2x&#x2B;j&#x2B;WNuH3opyw64OHjp4G2A2VX1jMiVV1HKprhkm5SWDPh9LuWuKMb6UW8mVr68KXzzYfXK05Y/v7dnRHnrm/PIvLy6vZMovXF5dSBXfmd48PNDUFvXt6AgRBNYd5xc2S&#x2B;v5ilisF/NVzO3yBehEkO1rCZAunHDhNUW/viJ4aXJnh5&#x2B;n4JE9iUf2JCzYljNiH0dJBbGqluqaWFF10w5x1EBrMPDuZq1mQamuFSpyRdV5H32wLzbaE8kWldeurf&#x2B;nF6a749xoZ/SxQz2X5rMpsTqxVGgNcwPNgdFWLsh5UmL1xmohW5QxgPYot7MzHPbRF&#x2B;ezk2sFWTN2dkX2dEfqmkW6sIDXY5h2zQTvB/9F6cHBw6KI7&#x2B;6iAyjmB9oz1HdXcQEa83q4j8ICwa1tXI6EbeqMVnWtLFfFclEoSUK2IONmSZTmipt1MBuruHQsEKK5pu7BIdrHv7uKy1Ms72aZO/YXFEEQBEHuJDTZhyAIgiDIbZs/P3vx4qVmh&#x2B;rs7PTVTdM0QrEw2dYGHkss5J&#x2B;9frZUKlYMhSJJlmW///3v/5aH2iybb02lfnVx&#x2B;cXxpJIUSR998EDnXzw08tThraRPc2BytfTO1ObaUj6nGs0Jfqwv1h7hkoXa2ZnNVybWU9myqZks5&#x2B;lpCezujgY5z1q&#x2B;emO1UKxqHTHu1O72xw927Wjny3XrlYnkj99ZvDyfLddUzHbcOEZ76Yif7m/x7&#x2B;wIdzfxlu3MpYo3VgWpqnTEfPt6Y7u7I50xnqZcNEkEaOyOJFiyBboJDAkkBjbAck45N5u5MJe5vlzIlGSeIbub&#x2B;MGW4J7eyMH&#x2B;eGtga2M4WTT&#x2B;yys3f3Z2qSxrhwbi3zw5cGIkUVHMn7yz8D/enDdM6&#x2B;hQoj3mm12X3rm5qenW4cH40/f0n9rd4nbB5FrpzM3Na8tCWqrRlLs15O2I&#x2B;VrC3paQtz3KtYQp1J5xN7MBFBvqOkgyFOuOKNs1zdEMWzMd3cQZqnFlD/N5IMhCgIUgA&#x2B;T2xN6GacqaIlaKQlkSCoKbotYyG8up9TRWp12UHaA8UX&#x2B;Q5kK0L0RzjT1cv2erFZfHqM/MZC2CIJ8TaLIPuXuhyT4EQRAEQW4bTdM8zyeYYHdvL9RNNZstFot4pRIZGwhFw0988fFr125cmrra3tISjzX95V/&#x2B;5djY2P333/&#x2B;RD9XMu/7oSMdAS2CkM/LsxeVr0&#x2B;l3Xp&#x2B;bXsqfnRn89kMjIy0shcFIh//KYv7Npfzc5VWwneBI81dP9B0ciI&#x2B;0hVOFWrpQBQwDHJdq2qZQ0w1LUQ03YKqsTyzkckV5cbP4hbHO&#x2B;3e1/vGJrvtGW6eT4vUVYSFdTAs13bT9Xk97lGvys51N/GBr4Jsnux0Ax4FPZyfXBpjZrJ&#x2B;bSV9eyOXLSnfc98i&#x2B;jqPDMQCYWC6&#x2B;NbUxvliQKoph214P2Z3wDzTzPobSTCsWYOJBNleShbLa3eTf0Rna3RWN8O&#x2B;ncO0B9//21K4d7aH/&#x2B;trshbnMzIY01hsd7Qh7Pe6jQ/Ebq4VsqX54MP6VIz2zqeIvLyxPr4s/P7dkWPaJHc37u/z7u/yNp4cBoAzlbqYCKAaU3m3PKMmNeT1HM8HVaM&#x2B;giBD7fisu64JtynplTSnXKrmSKEhiKS/VQCuKxYVy1iDB8FM8SbNNoWA71zew/4DH&#x2B;4FWXIJFN/YQBEEQ5LdAk30IgiAIgty2woWliYmJeHfbzgMHgQIzV5ZW1ivlspkvdnR2euJRcBF1Bv6PH/1/HOcbCkdTYsEwjO985zsej&#x2B;c3PaYgO2duphsjfuJyHne7hkZbv35v/9fv6U/wLgfgjen8379687kLK8pmkQ5xh/e2P36wqyXMXlnI/ezc0vKqYDtA0G6KIDy027JtisDBdtxuwuelhlpDJ3Ykjg0n&#x2B;lu491I8xYa6arsI3L9N&#x2B;4YfQ7Kovz25&#x2B;esLyxfnMmmxhruIwyMtXz7cPdQWTOarb06lljPliM&#x2B;ztyca8zO5snxjRVxKlyqK3hRgR9pDOAZTSTFXlPf3x/6nx3ePdfL/8l2oNkyulm6ui9NJcXajmMxXDc3wMuTu3ujJ0Zb7RtuaOAIANBtwHFx3Y7SnOaCbIFX1mXVpKimmhBrpIjpi3O6u6I72AH/nvvqfNhNAtqCmNXI9W6rbitG4sgeWgzVacRkK89Nb7Rm8B8jt&#x2B;YbQDL2m1IWyVChJYk6Q8gXZZW9K&#x2B;bRTp12kE6CZWKBRiRuifR9oxSVZFk0nIAjyCUGTfcjdC/3sRBAEQRDktlm2rWl6vVoHVQXK44rxUaIvqirlueVsNusUC21tbSbF3nfffRMTE7lsXsxmH3r0kb/9279ta2t7&#x2B;umnP/Ixwwz2&#x2B;FjzYGtgrK/pF&#x2B;eX3ppYn7688h&#x2B;Swms31h/a09HfEijW1JifHe6IzBFYTaq/fmEpI9W&#x2B;fXrHN&#x2B;4bfOp435mZ9OvXN26sCIViHXeczjg/2hEeagvFg2y2JId99KGBpgDjct2SXNA40MyntJhrAJTqdq4or&#x2B;YqUk1LBNmR9lCTj/DRJO8lWc7j83pKFdXEMRzDvDQZ4em0JGeL8kahxnnItojv4X0dYRbL1&#x2B;xXrq0/c3754nwmW6zv6Y7u72tKFqpnpjOTa&#x2B;LXjvd&#x2B;&#x2B;6GREPOBeMaDw/5u//5uP0C3A5CtWKpucjTJejD6ltVL6m45sidbIFSM1Wx5Q6gmC7WVTDlXkk3L9pAuDEA3Lc2wpZpSKKs4jg23hh7a23bvzpaBFu9dtZvsACgOyAYU61vtGRW1Ma9nayZOu3GGxFjS9V4rboAFD7YtvxmYlqnomlQuFipFoSBIBaGOmSkxu6KItJuy/B7W5&#x2B;W7/SHaN0h3HfLcMq9HsTzmuVu&#x2B;DREEQRDkTkKTfQiCIAiC3Lbq&#x2B;YXLly9TbdGxfWNUawAAwAIAgDLU0&#x2B;n8/JqqKLHmZm884tjWxekLq2trJg4D/f03NpY1TXvyySdbW1t/y&#x2B;NXNPindxb&#x2B;4dWZyalNw7BcPM3RpAvAkHW5pummBZQrEGR3dUdP7&#x2B;94dH9nb5QGAAMgWzKEsqLoltfjioe8EeYOjKk5AKLsmJbNswSNgw1wfl786ZnFq0t5zbBk3VR0szXEPbSv/UuHuweamMZbrYrapfncC&#x2B;OrZ2cyER/9zZMDj451bgi1v3t5&#x2B;o0bGz6GvGdHy0P72obbQoWy8sZk6sz0pmnZw&#x2B;3h0a4w7SYmVoSLcxlVN0/saP7m/YMjzd5P/wP/5MgWCBUdAGsOuP/laTgTYG6zfmkhO70mAkDYR&#x2B;umdW25MLUmkC6iJ8G3R32qbq5ky4vpkmE5B/tj3zg5FOU9r9/YeOb8slTT7tnR/MVD3UeG4s385/OFcA1AMaGiglQHqW5JjVVcw9FMwLHGlT2MJbHAu9u4Xjds0x6srKkVuSpWioIoigWhamvlYmmhlFFwG2dIimPYWCBI&#x2B;0I0F/B4/dQtrbguZht6eREEQf410GQfcvf6fP6DBkEQBEGQO0rTNAzHPR4P9d5argPgAGga25no5KPC7OzGxnoHz3Act3vP7q7u7jOXLoyPj9dN/dixYz/84Q99Pt93v/vd3/T4Pgq&#x2B;80Dfo/u73plOjS/mVwvVjFjPCDUcgGVJhibb43x3c2C4PbSnJxLz0423cgO0&#x2B;t2t/k98Qqusw/OX116&#x2B;ul5Tjd1dkeMjzXt6QpwL5rPKW1Op165v5KS6g2EUSfTE&#x2B;bHeWEeMG2oPzaWKk4t5RTc7WgJdcV9nzOdn3t8g7QxRrYfb&#x2B;hL&#x2B;oZbgc5dX/8&#x2B;fXnllYv1bDw7/hz8&#x2B;&#x2B;K1Tw&#x2B;/c3JxcFf72V9crsq4ZFoFhluPEA2x7lNvfFxtKsF890l7WQDVsnsHvmhm9hlzNPnsz/dyllXOzWTeBPX6o&#x2B;2B/U74sT64KLgI/tbvtyFBTIsiypGshVbwwlyFwfE9PdKg14CGJqTVBqmknR/knDnXTJHFhLvuTdxbfuZlKFmrfPDnw9In&#x2B;kztb/&#x2B;6Vm2/dSN1clx4Z63h4rHN3d4D5LDe4Wo39c&#x2B;29VlynrtmNK3uGtdWKy1JYk2&#x2B;rFTdAAwnbkqrpplFXZalaKhRFsSBKeaGGmykhm7KqtJtyAh466g/SvlBry1F6kL91ZI9kue2684cgCIIgyO8BTfYhCIIgCHLbll&#x2B;/PDs7297VOTK2H3gPAGgk2AA6AADwBiiyTU9mnPEVjGGsB1oIArNcxMTVq&#x2B;M3J0vl8omHHjh8z/EzZ86cO3fud9b13kE2gGzA&#x2B;JKwXqhqhiVVVaGizG0Ul7PlIOdJBJiaaibzFammtYa9Y32xEOdZyVauLGQFqU573D6vB8MxN4BhWriL6IrzO9pDlg3XlnPTSZFyu&#x2B;4dbXl0f&#x2B;fBgXiT98NhTKpkrGQrmWKddBFdTfxAi/eurBp1AOoGAADtBgKgZsLVReHFq2sTS4VssW5YTiLo7Wrytcd8MT9Nky6xol5dyo0v5TXD2tEW6mzybQi12Q0pwtP/5r6hR/d3YBj26vWNH789f3khh2PYcHuoN&#x2B;HPleTxpTzncX/tnr4/OTkY4V0X58RfXFyeTootIe/jh7qODCZcOCZWVbeLCHrdd2ah12gc1FNBrIMk28XGQT3T0UxwHJylMJbEGRILMFsFuD5q2w7qaZqiKFKxKEiiIBQKhYKBO6vSZtWUa7hVd1uCRzcwXMMcE4cAwzX6cN89scf5PV6eYv3vruL6cBpNEyAI8vmAJvuQuxcK&#x2B;xAEQRAEuW2b525MTU0nWlp27t4NER8AaCQAgAqgOxDWAXMBCABvLkK5fMmfbW5pCcTCJOmRwXzrzTdvrixEIpGm9tZjx45NTU2dO3duz549p06dulMfjglg2oDjoBkwt1E&#x2B;P5dZy1WaQ&#x2B;xQWxAAm1wTzs9kZjekQlmhSZduWj0J/7HhxFeP93Y18apuPXt55cfvLGQkuS/h728JihXl4nwmK9Z5mhxsDx0YbEoE2JpqbAg1gsCPDMSbgszVxfyvLq1sCNXRzsgTh7qPDiVa/H8oCYkFkBTUiWXhykJ2JVs2LBvHsSBL7&#x2B;4Odyf85br&#x2B;6rXk&#x2B;dkMhmEH&#x2B;mPtYU7VzLJi4DgW4KgYz5AufF2oXVnIzaWKAS850hGhSWJ6TcyW5f7mwOGheJClFtPlS/OZm2uCZdo9bYGjgy0Rv6dc1zAM39cTuXdna9xHAIADYMKdGDmzGwf19EZRhiPV7ZrmaKatGY5qNloycJbEfJ6tAtwgCxTAdswbmqap63qxVJSKxYJQyBcKJmZtirnNesHCQCKNAmUYLjDA0TCM8XgauV6IbgR8XNDD8Z735/V4N0Nvy9NCEAS5I1DYh9y9UNiHIAiCIMhtW7o6e/nKlQOepu5TD8gxx03gju0QOEaoAA7UaBsHnAHQyjVZrgdezUNRyvqwptZWrTtA0cz5tek333jDAisQ9H/vL/5iamryzJkzuq5/&#x2B;9vfZln2E33mDoBsAoFDowigasDrNzbfuJHaFGs8Q/W3&#x2B;BNBNlOUX7mWvDyfi/mZvT3RME&#x2B;npfpqtkzgWNhH66a9nC27CfwL&#x2B;zr&#x2B;5s8PWBZgOLw9nfvROwtnptOU27WvJ9rRxLkJwrTssqynhGqhrCiaadpOPMAc39H8wK62oTYOMCjVbBzHeAb7/K44qjbMpaqL6ZJh2e0RrrOJT/i20h/FhkJJX81X5lPF9XxVM02/lw6wFO0m8iX5RlKc25Bkzexq8u3oCEd8dKmu1RQj6qeDXk&#x2B;prs2livObxbpqMG7CZTsl2dDAwTDM63F3J/juJr9UVS7O56Sqsq&#x2B;36dTuVseBK4vZqTWpqhotIbarydce8cUCTJin2yNcdxPvu1O5lAYgG1BWGou3VrFxUM90NBNc&#x2B;HuLt&#x2B;8XZXhd2xVAqqpaq9XEoiRKoiCKiqUVi8VkMVMFrY5bdZeV9xgGDgbmgNvVuKy3let5uBDj2yrNaLTiUowP/nB6ixEE&#x2B;cOAwj7k7oXCPgRBEARBbttvDPsUANuusDYBBAsY6JZtGviEBaVSVc4qilLp9IfCoSqH0yx77sLZpcVFQ1F27Bg&#x2B;duxIY8Svubn5G9/4xu0&#x2B;H9mEZK6&#x2B;lq9kinJF1gkX3hxgh9qC3XHGDSBbsJaTry7lLsxlFlJFB8O8HneEp4dag3t6ojxDrmTL52ezk2uCUFFxDAvxnhDnKde0jUJVM22OdjsAOaFWrKrxKHdytLU3zi9sliZWCqZl9yb4jpjPTeBpsX5jVayruod07e&#x2B;LHR6IH9uRaI8ylg35klaWdcpNxIMMQ21XNcJnxUbR&#x2B;LuXp3/09kJBqrdHuNHe6IG&#x2B;2GBbyDCtyVVhfKkgazpNujAM6qpZrGmFsiKUZBoDjqd5r4dyEw6Abtqyohum7QB0xfkDfbGOJl&#x2B;ppqeEmockuuP&#x2B;oJeaTRXP3kxnivWAl9rTFemK&#x2B;2uKPrshybq5pzv60N72riavaYFu2G4XTrnhDpzeMwEUC2rvH9SzZX0ruoYjVAAAIABJREFU17NsbCvXIzGe2SrK4D3bdlBP11VVLZZKYlEUBCGfLxiYlRZzOb1kYiBReoEyDcLRwDEwzM9431vCfa8945ZWXIYn2M9vAI0gCPL7QmEfcvf6Q1kYQRAEQRDkU4LjOIADjuMARhA4QdSOAgDLrHkzK8vMYgbS1bZoBLzOF4cOZtjEs9MXVheWby7MP/300yMjIz/84Q//&#x2B;q//&#x2B;sknn2xvb//t70e1YTFdu7qUvzSfvb5SqJRVBweSICjShbmwmmKYlt3VxB8ZinfEfMWqdm0lv5avMpR7oMXfGuHqmvn29Ob/&#x2B;8Ikx5AH&#x2B;puODTd/YX&#x2B;HWFYuLeReu75x5lqScCAQ9PY2&#x2B;3sTfreLmFwTJqY3k9ObPysrX72n/yvHev7dY7uWMqULc5n5zZKmW1GefvxQV1eTrznobQ55XQTWFqU9GAAOnWEK7papqJoBxZqhGhaBQ8DrIV1QqqlRnu5L8LJqLGwW1zdL00nxob3tB/qa&#x2B;lsCmmEtpEuUi4gGaAxgLVeRNSPrOEXT9hPEUGuwo8nnOIBjWCxA06RrYbN0fjbzw7fmB1oDD&#x2B;xu29sTWctXXr&#x2B;&#x2B;viHUynUt4KV2tAX39sQO9Md64n4/i7kA7FvjMhfAp1ZQIgMoOhRlkOqOJNsVpZHr2ZqJUy6MpXCWdMU4CLJbU3sefFv&#x2B;6W1Zlq7rpVJJKhUFsVAoCAZmpYTsRrVgYY5E6jW3XXFbJg4a51CUJ0RzQTq6691t3CDNbU3qUSxPsX43w6DfCBAEQRDk7oJ&#x2B;tCMIgiAIsn0wAAAccACwbYsA4t3/B0SU7/PuBHtlc31DSyZDoZDhDoTDka985SvXrl87f238pz/96b7RXV//&#x2B;tenpqZ&#x2B;9KMfeb3e733ve7/lXXlwSITYxTSp6tamUM9K9baY76Gx9qfv6WsJc8l85dlLK8&#x2B;cX5pKivt7o/2tQc2wV7MVjnYfGYo/dbw/5sUBRp6fyPynX08&#x2B;c37pykLuq8f6HzvYeXpf21PH&#x2B;37y9sLPzyxsLOYyG5K2t/3fPjj8pw8Mzm1Iz11eW81VDMuuqWZziN3Z6v3S/pbG83G2pyzhs2suK781mTozk17NVopVzQEnHmTbIlxziG0Je7/36C6Gcl1bLvzs3OJKtjKXKg21hg70xUY7w1Nr4gvja2/eSGE4NtASOL23Q6yok0lhIVX88dvzvNcz0hHqbwmU6qpYVaWqqmimh3JRbhdHk0eHm58&#x2B;2qFYINVMAKDcBENhHxrZ&#x2B;zSyPR1AMaGiNq7sWVLdURuruAZgWGMPF/fRWOO&#x2B;XpABjtyuAU5N0&#x2B;r1erFUFCSxIAiqo0uilCxmyrYiE2aNsAXK0AjHpMBiiBDNhehg&#x2B;3vbuLTP//68HstTDI957u7vUgRBEARBAIV9CIIgCIJsp1sSLwzDwLSAIEQAFbQIQ7gZl/dIX1N/2JzekMolz40S094eMF0n&#x2B;b6dD/dcvXr1tbfPvnn2/P0njnznO9954YUXfvCDH5w8eXJsbOw3vbcQjX1pf8twe2hvT/T5y2tXl3P/9PbcQrp4oDfmY0ndsJpD3kJZkWqarBp7e6IRnn5rKvX/PD95cT779Xv6D/Q3dcf5Lx7qIgh8NVu5sVbobeabQ81jnfxY59g3Tg68Pb05l5JM21F0i/W4v36s8&#x2B;vHOuE35Hqf9wzFBpBkp1CWV7KVZL6azFfLNc3Hkr0Jvr8lyDFkSqimxFqxqvkY9707Ww4Pxgkcm0sV35pM/cNrs36W&#x2B;vLhnqeO957a3faPb8z&#x2B;4vzyfEo6Odp6fDjOUO6OmG8lU55LFQkMC3o9bVHO5cI5mkzmKrphuQm8J86PdITBgbKsuwg8HmRaw14/66IJAACagGb&#x2B;0/pXqw0g2x9qz7AbV/Z0C2fJxpU9LMptteIGGKC2J3E0DEPTtMbIXkEo5PN5HeyMlNtUBBvDRFIr0KaBOTqOG36b83hDdCBIc13vduMG6FtbcRkfwVKf&#x2B;&#x2B;9KBEEQBEE&#x2B;DnSzD0EQBEGQ2/Ybb/ZVTXC5ZBoAgHYczHQAx9YIDAfwAwA4PgUDACiYkE6bG7l8Pm/72ZahIWjyqpp6bm126uZNtSqxLPun3/7Wtcvj586do2n6&#x2B;9//Po7/tjRFtuDCXOHlieTbk5tL2ZKqGiGWao1yfpZqi/l2dkZGuyLdCR4HWM1Vz9zcvDiXzRVl23EU3bQt28GwKE8f6I/fO9oy1hPm7rKjer8HE2AhXT87m3l1Yn1iJa9qVkvYmwiyBI5XFV3RDcO0a7JerqqqZcfD3gP9TV862H10uMnrhvWS/vyltR&#x2B;/s7CaK&#x2B;/pjn77oZHRztDlhdx/e2Pu0lzWdpx4kO2O850xH4Hj2WJdVg0P6QpxntYo19fsbw174wGvl8bZO/IatNpoz5BBkkGsW2Xl/fYMN7HVnuG9pT2DIbalPcO2bV3Xq9WqWBQFSSrk8xqYkiQli5kaZhRJ3cQhTxkGjmm443aT7/XhNnK9EM194MQeyXrvRKswgiDI5xu62YfcvdBkH/L/s3enQXad533g/&#x2B;979nPufm/vG9BAo4EGQBAkQJAgRUqkSUmkFouWJx7JiRwrrsGMLU/NpCo1n6fmg62o4m&#x2B;ZzDhlOXGUOMqUHUukRVIWuIAbCBDEvjTQAHq53X33fTnb&#x2B;86H202CEikJVBMwoedXrBbUuLjndLNVOvXH8z5/QgghZOPcEMkxxsAZgAnhM847YJ708oa0uBUdUzEyrg6n4qup8sX52beO9U&#x2B;MJUZGPz0w/VB667NvvFCt1f76//nuls1bDh06dObMmW9/&#x2B;9u7d&#x2B;9&#x2B;6qmnPuyytoLHdvZtHYrPjKWePXb99Qsrbc/PJOz/9ct7H93Zd&#x2B;Mr&#x2B;ybj903G8cWZfFNkS81ivdt2A9tQR9LORJ9zR7YSSCDXCK&#x2B;t1meXK6uVVigwkopsHoxNDSeG1ptzVWBm2HGMcUtTVM5eu7BSqHYO7hj62iPbRtKRC4vl508svHR6aTHfaFbb9VqnVO/OZqv3nOrbt6V/KOXYhjY1HJdSMsYWCrU9m9NP3zf62N2j78wVT10t5qptQ1O2jSR2b8qM9zm2DuW2DEL6QCdEo/tee0ZnvT1DSm7rzDF4xGCjybVcL25A35gb9Tyv0&#x2B;mUK&#x2B;VStVIsFPL5vMfE9fJyNWi1lbCphCXLdzl8zoJ&#x2B;pKxo2urPWLHp9YAvaUZihh3XnYTZO4pr3aqthIQQQgj5RKKwjxBCCCEbR1lLIdYKOgCAMc4D3&#x2B;9wYSkmZzyEkAGYymE7ztQWJz7YuXp1IZerVmuxTSOpvsxTTz11fWH&#x2B;yJtvnDlz5s2zp/7ZP/3deDx&#x2B;5MiRP/uzP/vmN78Zi8U&#x2B;7OITKf3rn56cHIpP9Ef/7s2rr51erHe8&#x2B;UdnfufhSetniln7I7w/EgM&#x2B;9N0&#x2B;ieoeGp1ACAmGmK3FdQAoteWRc9ln3rp26mqJMcQdgzMonKei5q5N6Yd3juyaSKVtBmAirf&#x2B;ThzfvGEvtPrHwd29d/a&#x2B;vzM5mK//jI9MPTA9&#x2B;6cBmxlnU1lxfDCTtib5ozNarLfe/Hrm8Um41u74QcjjlbB6Ijqajpq4AiOv49I7Mp3dkbsM3QgJtiY7Xy/VkuS0a3V51hnQDbmnc0ZljqMPxtfaMpA2TYSPae4MgWGvPqFWKxWI&#x2B;n/cQLJVyy&#x2B;1SCFHS/YLpB4z5XLoxOJaVtmIpM7bJiqbtaMqMpqzo&#x2B;1bsqY55S3YSEkIIIeROQmEfIYQQQjYeA2PvjkRJqapqKmQIJCAAhBoHUM0IHYqVdNzRqeGzTqFQ0C9k27OrmBmYTgxNP/07x9986&#x2B;j5U4e//8Otd&#x2B;/sFXf823/7bwcHB3/v937vw66rAQ9Pp/dPpf/wqbtKza7C2FDKMTcixPlHRa5/7OVAy/Xg7cv5l89mLy2Vqw233PYYMJC079qUuXdrn6mr5xfKxXrX1PnUaPLJezd9ateIpau1pttyfZXzWstjzEhZAKAD&#x2B;zbHJ/p27tqU/tHx60fOZf/VX7zaF7cHkpbrhc2uH3P0qeHkZ&#x2B;8Zv3drJqbDB1YrfrPr24bqGFrEYuatz6ZcoBOg1llrz6i0peuvjexxzh2dO7qStPFue4ajbVR7RrfbbbVapUq5Uq3k8vmu9Cvl8rXyckO6vZG9gh34kL4JFlXTVixl9e36mfaMmOHEDTthONGNui1CCCGE/HqjsI8QQgght4cORQChgGma5sRENJmAUgqq1bnFxb6&#x2B;vgiS&#x2B;x44sPWe3T9&#x2B;4R&#x2B;ef/75E&#x2B;&#x2B;8M7Z966FDh773ve995zvfefrppycnJz/snS2OzRljc8a4lV/Ox8oHyg2Rr7WvrdYXCo2lUiMI5Ug6sntzet/W/tVyu9x0QyFjtrFpILZrPKWp6uHTi3/35tXnjs/fM9WXjJiBEAuF5kq14/lhEIqHd40MJI2LS91nTly7sFhJRY2DO4YOTA9OpHQAfRH&#x2B;pXuHtwzGd2/K/PidhWOzuVy1tXtT5usPTO4az0wOxkYyZu8oqQaMJTXcsoVxIdAWaLm9XE&#x2B;UW7Ll9eb1EITMMdbaMwZja7lewoK&#x2B;Ye0Z3W63Wq0WK6ViqVTI510ZrJTzq14lAEq6VzIDj8Nl0k8haUfTVjxtRbdZ0ZQV6x3Ffd/IHrfpKZwQQgghHxN6zCCEEELIx0xyAFib9GMAFAEAUY4wDBFC0RSkFaRTIqZWy5o6282v5KqVWiaTNizztz/7xbuuXTl&#x2B;/Fh5duFIqfWlL3zl&#x2B;sLc97///Wg0&#x2B;od/&#x2B;Ie376vaAJUu6m1PU3lyvXYWgCtRqPn1tu8FgWVoMUsPhZxbrb55cfWlM0sXFisKZ2OZKIBnj13vesHW4cSB6cGBhD2ccjSFF&#x2B;udH7w1b&#x2B;pKEIiRdGQ&#x2B;Xz9ybmVmLLlzLL1jNH1lpbpYaP7ff3/mPx6&#x2B;mImZABYKjVK9O94XHe&#x2B;P3u2HN97ezhFnOL1tajjxd&#x2B;mrzx6/dnw2l3SMh3eNbO03b9E3qAO0PVTba624tW5vZE&#x2B;4ATdUZuvcMZSBqNJrxU05sPiGPNuGYRgEQaVaqVSrhVKxUCh40s8VC/PNnIewrPsNNWzowof0IjBNK21FU9bAmBlN27GUFU2Z0d6k3lorrubYG3JCmBBCCCHkl0NhHyGEEEJuDymloig3Tl3xeCwTi2WcTGN5eSm7lM1mB0dHLMsaHR0ZHRl&#x2B;7vVXlpeziz/84dTU1kOHDj377LPf/va3P/WpTz3wwAO374v4iBYr/uFTiz9869rZa0Wm8IM7Br98/&#x2B;TO8XSj4x&#x2B;7nDt6afXiUrne9tNRqy9uxWw9YmqOqe2ayCicn71eFFL&#x2B;zsNTuyYyb1/J//Urs//5pUt7J/vu3drfF7cK9U6t7TY7bPfm9Gfvnag0uiuV1vMn5i8vVzf1xx7YPrR3S6Y/Ybc6/vnF8txqzTa0VNTcOZHau7lvvM/6qftMmnh8d//kYOzgjqHXL66slls/ePNqEGw6sDW5wQ0bHtAJ0OiN7LVEuS2660dxAW7rzNF5zGDJ1Npp3KiODRrcdF233W6Xq5VSuZQvFHqtuNdL2VrYaatBUxFF03e59DXIflWE4fb&#x2B;8RTj&#x2B;xKDvfaMxHsje3bccOIbdVuEEEIIIR8VhX2EEEII&#x2B;ZiFHICvAYALAHAAAKzDAEAKCOnpPmOsYmkA&#x2B;gci0b5tU/3p&#x2B;fn57PxiOVcc6R8wk6nfeuJLl46//eKpY9n6hXeOv/Mv/&#x2B;X//vqx115&#x2B;&#x2B;eVjx4790R/9Eef/2HsM5Hqza7EtT18vHp3NXVmuZnN1t9VttLqmrnq&#x2B;5AyXstXLy7WYZTy6e8y2tPl84/Rc4XK2HAI7xtL3bO2b6I&#x2B;9M5f/8&#x2B;fOPXnfpt/99PbP3DX6Vy9e/NHx&#x2B;YVi496t/bauRi19oVD/u6PXfnJysS9ux2x9ZjxlamoopGUoY33RqZF40mCfu3vwl7zzLX3mlr6Jrz00sTHfCAF0BFoeKm2UW7LUFk1Xur5wA&#x2B;kF3DZ6W/bUTK86w0HKho6Nas/odrvVWq1cLReKvZG9YLmUW&#x2B;4UfcYqulcwfF&#x2B;FCxkkETMjaSuVtqJbrGjaiqat2ForruEEItgeHxFMJhV7A26LEEIIIWRDUdhHCCGEkNtKSDCm671qAhlCABwCaiq5xTSr&#x2B;uLi0tL8/Hy62UwO9k/v3D19cP&#x2B;rR15ZPv/Od//yP2zdu&#x2B;vQoUNnzpz50z/90127dn3xi1&#x2B;8XV&#x2B;EK3Ap23j94ur5hVIqYn723vEHtqYAlDs4MZd/48LK2auFStvvS1p3bcpsG04YuvLwruGxvsipueJbs6tdL1gptcrN7uRgfPdEerXcevX88pHTSzFDzaQd29InhxJcSt8LZrPV6ZHUI7tGTl0v/sUL5154e&#x2B;EPPrfrn//Gjj2bMn91&#x2B;OLLZ5b2bun/6oNbN/fHNJV3vCAIRdwxxvqicUeL6LfjNGkX6PiodlBpodQOq&#x2B;3evJ50A6i99gxDSdvvteI66kYtAOx2u41Go1QplyrlQqHQFX6pXJqvLLdYUNE9nyFv&#x2B;gGXXoTrST1lRdNW/x4rmrZivQKNuG7HzfUVe5rj0GMzIYQQQj4h6KmFEEIIIR&#x2B;vhgasT/NFAgBrhQmeJQRkAMHBTEgA/YGA74eWJgQ0l8NxEtHtiZHh2oW5/FKuU6iODA9zmX5o9/6R8bETb7994vCrc2&#x2B;f/cJvPTk&#x2B;Pv7MM8/8m3/zb37/938/kUjc&#x2B;q&#x2B;RcViGamjK1dX6fzx38a9evPi7n9n&#x2B;jcd2WIY6n28cv5JfrbSGkxFTUd6&#x2B;kv/B0auVZnckHXn6ga1/8vsHi7Xunz937vCZxZVa&#x2B;9O7Ru/anPnSgcmtw4mXexv6GNu/pX/7eLLZ8RcKDSHRlzA39cd2b8rs29J/dqH02vll21SfuGf8tx/aXKj7DDIR0aO3qjDjfQKgHaL5XnuG6Pi9LXsIJXP0XrTHRhJr7RlxE/r6uOOvxvO8TqdTrlbK1Uo&#x2B;ny8WCh4TK&#x2B;Xcql8LIUuGXzR8T2E&#x2B;F2G/krKiaSs5YMV2rBfjvtueEevt2mPmBh9SJoQQQgi5hZiU8nbfAyGEEEI&#x2B;Ya68feGtY8cOmINbnni8PSA1hUshFc6ULgC0TQCwAYQA0FCA9bCP3xD2NeFqXA0hASihJ6U0oYDxjtB0jSke4El0AZ2hFiCXq&#x2B;fyS0uLSio2vWsXknbXc18/d/L428c7YXvnzp0HDx6cm5t77bXX&#x2B;vr6vvnNb/7qX2Oli1bX73jBtdX6mfmSH4T3bRt8dGdf73cv5zpvz&#x2B;VPzBXmc3VDUwYS9mDSjkeMIBQL&#x2B;ebxK/m55dpEf&#x2B;SJeybitvH6heU3Lq1uH01884ldn9o5XG95//3Nuf/26uX5fGP/1MChJ3fNjKcPn1r67j&#x2B;cn1up7ZpIf&#x2B;HApgemhyKWvlRsnLxauJqr56udXLmlcgylI/dNDx7cPjQ1koiZ4EB4W/7yVgIdibaPSmutPaPRld1grT3D0ta27EXNtVwv6cBkG9We4bputVqt1KqFUrFYKLjSzxZzi&#x2B;2igCzpXkMLG1roceYzGTGd3gnc1NpR3GjSjK4t1zOduGHHFcfYkLiREELIJ86Zov/mNSVp8cemkdQAvPTSS0ePHv385z9/11133e6bI&#x2B;RXQmEfIYQQQm7axZPn3nrr2P3W4LbHH2/0Q&#x2B;OKlFJlTHMBoGUAgCMBAeDmt6397LOJAICw2FhaWqpeW4LEVHrITibBNNjm/3vi2Xw&#x2B;73jYObPjvoP3fe973&#x2B;t2u1/4whemp6c/2le3WPF/cmrp&#x2B;RPXL2UrEVOfGU913ODY5Xyj7T1136Y/fPKuzYORY5eLf/PaldPXi5xjPBNNxy0w1u4Ghsb74pahKldX629cXKm13KmRxM6JdKPlHZ1d5Yx9/t6JL9&#x2B;/RVH5C2/PHz612Oh4B2eGv/bI9I6xxNn5yr9/4dzLp5cycfMrD2z50oHJmeFeRop2iFAAEpoK89YvJ3QBBbhWQcuT3UAsVaQbrI3scdbbssccnb3bihvRoG/QlV232WxWatViuVQoFDrCq5TL89WVWthtK2FLCXOmFyjc5VLTtNT6Cdz02she7H2tuLoT3agTwoQQQu4AFPaROxcd4yWEEELIJ4MSiUxs2TIeSWWXs/lcXq9WhxMZiPjnP/vZS7Oz51976&#x2B;zZs2deP/oH/&#x2B;JfnFq88rd/&#x2B;7eO43zrW9/65d&#x2B;/0sVioXEpW722WruyWis33GrTu7BQuZ6r75saeGLv2FKp&#x2B;eKpxdPXik/sHd88EFdVXqx3bEO7e0vfP3l423BMBVBoifl8Y7ncSsesoZRz8mr&#x2B;3HwpX&#x2B;s8sXf8X/3WvpVy89jl3P/27494fuj7YbvjJxKmpasAYjoOTiUPTj2Ub4quH8RsPXJDrautbExDxS8WrrdnrLfiypYrelv2/JDba0dxpabw/ZtgcNg60iY2In/0fb/XnlGslIrFYiGf7x3FXemWA4aS7hVN32fMZTJIsaQZTVuJjB3dZkXTZuzGo7hrH7l1GxYUEkIIIYT8I0CTfYQQQgi5abMnzh87duw&#x2B;a2Dq8cebA9C5IoRQOVddAGgbwA3HeD9aSiVv&#x2B;Mh7/9E7AuxDFMr1xdVGo6F4IWNsqG8MTgQp5bVXXv5R9lwqmdp&#x2B;z&#x2B;6Dk9ufffbZbDb74IMPPvjgg7/wcq0Ar1/IP3Ps2hsXVrwgHMtEB5J2KMRstnppqRoIMTWcuHdrn2PoZ&#x2B;aL13ONwaR992RfGIqjs7lq031wZuhrn962fTS1WGi8fmHljYsry5X21HBiLBNdrbTeuLDiBuEX9m/&#x2B;xmM79myOV5rhhaXKarkNhqG4vWU4kYmpxm0pE&#x2B;4AHQ/VTm/LXljtvDuyx3R1bctexEDSWTuNaykbMhsnhPB9v1qtlmuVYqlULBS6wsuWcovNQiDDku431bChCZ/DZbBNa31S7732jF4rbqIX7anOxsSNhBBCfq3QZB&#x2B;5c9FkHyGEEEI&#x2B;IcTasj/el0rEUolSuXTl2uLiotUKE4NDbd3et2&#x2B;fdWD70TffeO655142X/yff/vri9fnjxw5cvz48W9961uc/7w8SFEQCNHq&#x2B;k3XTzjGgenBpw9u2TrsFGvBi2eWnnnr&#x2B;hsXV3741vXdE&#x2B;mZsdRwyjl5tfj8ifmHdw7/T5/bVWt7x2dz/&#x2B;d/eUvh3PWDrh&#x2B;qjG8dTjwwPXjP1r6&#x2B;uN12/XLDNTVlNB3RgP6I0r89c4u&#x2B;ae/ye&#x2B;0ZXZRaqLzbnhFIN4CU3DGYo/OowcaT6J3GjRm/enuGEIJz7rpup9MpVyqlarnXnuFzca28XAvbLR621DBvBT6kr0n0a2krmrYyk1bs3YBv/Rzu2shebKNOCBNCCCGE3KEo7COEEELITeMSTEIRDIIpQnIOQHKgt12Pre3qk2C9kbybS2d6f0bc8GvJACAIXV3RmcYAgAHDqXREj28dKZy4Wl2aNxvRwZGRe2LJe/Z//rXYqbNnz37vr/7Lgw8&#x2B;eOjQoTNnznz729&#x2B;enp7&#x2B;yle&#x2B;8mEXNRk&#x2B;v2dQCrlaaR&#x2B;fzf11a7bR8X7zgS27J5JP7duUiZmGxn/09vxLJxcvL9f2T/UfmB44da30/ImFWtv7F0/s/OMvzbS7uJStLhYaLTeImNqmgejkQDxh9eIyE4je1DfhVyJ67Rm9o7htWW6JpivdQLi&#x2B;7Abc0Xtb9tQRBykHSRspB8bGHBMOgsDzvEq1WqqUSuVSLpcXGssWVxYb&#x2B;QAo6V7JDLpM&#x2B;hx&#x2B;HAk7kraSKTO21Y6mrWjKjKas6PtacblNj6qEEEIIITeLjvESQggh5KZdefv8W8eO3W8OTj7&#x2B;eGdAaqoiRKhyhbsCQMcQACxICAkA/FcN&#x2B;3rjZcq7h3kDAcnB1l80V0K9sbCabTabiYmh4fGxrsVarc5/P/LjcrkUanxmx44909PPPPOM67rf&#x2B;MY30un0z7l6xcX/9&#x2B;qV599euLJaDUMxnHLSMZMB9Y5fa3nVptvxgomB2IM7hu7e3GcZCmdsKOVMjUTM29Xp6gJtH7UOym2UW2Gl3ZvXk24Alb&#x2B;7Ze&#x2B;9VtyIulE1Fd1ut9FslCuVcrVcKBQ6oVeuVK5XVprwWkrQUsO86fuQHodpmKn3t&#x2B;L22jPeG9nTHPsWbSUkhBBCANAxXnIno78uJYQQQshNUyRTBeMSkGCQHJCyF8m9P6ljH&#x2B;XvFOXPfFx7u95IHw&#x2B;lJlW&#x2B;NkcoOh2&#x2B;O93pJEcXIrnVVTaXW71aGJyYMLds&#x2B;ebBL8zPXf7R7In5kxdz2dWnfvOri1dn//zP/zydTv/BH/zBh109aeAPHtv6jce2rpS8udXa2fnSfL7Rdv3hVGRqJDE1ktzUH01FDFOHcevTvQDohGi6vVxPlNui7a3leqFga7mezoYTa624cRM6NmSdned53W63Uq2UqpVCoVDI512EK&#x2B;Xcql8LIUuGVzQDl8uAM9HH01YsZSUHrejM&#x2B;pa9XqiXMNdacRPM&#x2B;MWXJIQQQgghHwmFfYQQQgj5ZPADX1M1RVEAIBDgHAC3LAC6xnk6PeQ4QKS2vJxfWNBzudhdWyZmZn53/84XfvzCqWuzzz77zM4dM4cOHfre9773r//1v37qqadmZmY&#x2B;7Fo6MJHWJ9J9j&#x2B;7s24Bbz7blO4thsalOZrB/AtYv96faQMdDpY1yS5bbot5rzwiEG3BDZY7BHV0djK2dw03ZMPmGPNmFYeh5XrVaLVcrxXIxny/4LMwWVxcaOcFYSfcaWtjQQo9zPy5iZiRlxdJWdMv61F7SjNy4Yi&#x2B;uOLRjjxBCCCHkVqKwjxBCCCEfgbzhn/c&#x2B;xcAACCghAlVIjX/0g5ls/T3fpaiaWK/kZSoHwHp9HQEUACkGWEhvUsvxYHZpJV&#x2B;Qp&#x2B;eSmUwklXj6ns8&#x2B;svPen/zDj5/58Y/fOX/usYMP1pqNH/zgB4cPH/6jP/qjj3yHN2HEZokp9fVr/tmsslLlD0xi/P0r/DygE6DeXWvFLbdkt3cU1wdjvXO4PGax3jnclI2ovlE1Fa7rtlqtcrVSrpTzhUJHeuVS&#x2B;XpluR5222rYVMKC6ftcegbXIlrKiqat/uG1Ytxo2orF1o7i2gnDieuOQ8&#x2B;WhBBCCCG3Gz2QEUIIIWTjBAEUBYBURZuBAAAgAElEQVQCVeUCQogw5NoGrYj7Od49UavCSSadMZ5IJCtn5yqFgtFt24lEZDj2P3zt686lY0deOXLy5Mm&#x2B;TObQoUPPPvvsn/zJnzzwwAOPPPLIx36HDsfjW7Rt/f6RudZ/PKakbHNbP4/oqHXCWmetGNcLuaP3tuyx/uhae0bShrExR3F933ddt1qrlirlQrGYz&#x2B;d9HmaLueVuWTAUNa9k&#x2B;y6Dz2SQWjuK229Ft68fxU2YN8zrGU6cmRtxU4QQQgghZINR2EcIIYSQmyYhJELJJJiUjAlAMM4ArukAQgBAAEUF2M0/a7C1Sl/g/fN9N0753fgZLhggoXAwSB3QwbbEFRF3MnYul&#x2B;tmi0q9M8oC2N2nMjuf&#x2B;vr&#x2B;//TDv8gVaj&#x2B;cz46Pju1&#x2B;cveRI0dOnjz5rW99i/OPP7yaiGrpPZ3/dnr5P58U5beT&#x2B;0cSD23SxhJK3ELCQtKBrWxIe4YQwvO8eqNerpSL5VIhX3BZkC2s5uqlFvyS7gVMFszQVaTvsEja6k3qbbaivTO5STOSMJxeK27ccBKqbWxI3EgIIYQQQj5&#x2B;FPYRQgghZONJIBBSY7esw4IBEgICjHEwABzWQGpTPN5RneXl5cXFRce2R/oHoRu/&#x2B;0//2auvHDn6zvFuu5OoV/7Jl5&#x2B;&#x2B;cO3Kt7/97a1bt371q1/92O80wmL/fE/ss9v8V66EqzUlqmPvKGK/0iOZ53mdTqdUKVdqlXy&#x2B;kM/nPRZeL2erQaethE0lLNiBD&#x2B;mqUAe0lBVN25lBM3qXFesV48ZvHNnTnehGlfUSQgghhJDbgcI&#x2B;QgghhNw0wWWoQDAJJkPGFCBkjKEX8qGjQwPAmSfB2E1HR&#x2B;xDfn2jGyf7PF0A0AXAoPgSAAwVQEHpWnHT3Due2JriZ7PFYrE9t6gv5PiuoYd23fvQvgcO//i5N0&#x2B;eri3n9z78QK&#x2B;448/&#x2B;7M&#x2B;&#x2B;9rWvDQwM3OQt37xhS/ud3dqxZf/EQvCf3tLvHce&#x2B;UfwSGw6DIPA8r1KtlqvlYqnYG9lbLuay7WIAlAyvaHo&#x2B;4y6TQRxJO5qy4hkrtm1txV40YUbihpNYP4ob4xY9CxJCCCGE3GHoAY8QQgghGydEvVJbbfmJRMLSVcbg&#x2B;/i4V/ZJSPZuKsgYpISQYExX9V4aGI9G1KmpZCKB89lSsdhY8BOJRLQ//eiXvrR93z0vvvjiD3/4w&#x2B;hLL33uN79ULpW&#x2B;&#x2B;93vJhKJQ4cObfyN&#x2B;kDDR7OLchuVtqi0RNOVvhDNrncqqzOO3cM/VdTb7XabrWa5UilVyoVCviP8SqVyrZRtwm2posmDghP4kJ7FrISZsqJpa3B8vT0jZfZG9tbm9eKabf0yaSIhhBBCCPmEo7CPEEIIITdNMgEmJAMYJCAA0du0p2FpefXFhUsRJ3Lf9j3Tm9Pso&#x2B;RL8gN/eaPe&#x2B;eBewqcKH0CHMwYIXQFgyhBSxl0NADo&#x2B;GENUhTPQHLC79QH9xJXF87NWPrF1aqovmvjKk0&#x2B;9fvH0pYsXn/vRjw4cONAr7vjOd77zuc99bteuXR/h7tduuxmi4aLWQaUty62w2paBkL5AEEJXedRQoqbaH0OvYDdj&#x2B;fA7rVq1UC3VqoVCIZ/L&#x2B;YrIFnKrQTWUKBle3vR9Dp9JDKgpK5Y2o8N2dJcVTZvRtB1bK83oteIadgzGR7xzQgghhBDyCUdhHyGEEEI20tJS9if/8A9Cys7B2paxr6gf/7OGwhUADJKB9Ub8eG9vX7sNXYO&#x2B;PljIEIlFI9EoPDOzurpQyl04f94cygwPDx247/4tmyefe/WlV1555dW3ju7cOTM&#x2B;Pv7MM88cPnz4j//4j3/xHXSApotGF&#x2B;UWKu2w3JZdXwZCBiEkeNTgUVMdSSJhIeUg5YS29FrdfL1aadRKlYXC5YIrvWwpt9gsBlKUDa&#x2B;uiKYRupB&#x2B;lCXsSG9Sb&#x2B;sN7Rk3tOLaccWhHXuEEEIIIeRdFPYRQggh5Kb5atdXu047g44WbQE6WkaeQV3RUvWhgevGF4QQR88E31IrECFYBgCkDwAQEAJMB&#x2B;cBY1ifzlOEDwCiBQA88fOufWNB79pnFADmz74yZX/wO2xOyWFnfCGxnM2WlwutUn17/&#x2B;jmkYmvPPT4Sy&#x2B;/fPnCpVyb7xiY&#x2B;l&#x2B;e/O1TteU//dM/ve&#x2B;&#x2B;&#x2B;z7zmc&#x2B;s/dkQaAZouKi0UG6LSls0ujIQ0g9lILit8ajJkzaLmb1cDynddd1avV6p18qNpfyFnAdRLBWvlbP1sNtWw6Ya5k0/4HA1aQyaaSuasvpHrGjaiqWsaMqK9lbsxQwnbjgJzbbp4Y0QQgghhPxc9LxICCGEkA2jAKZp2rYzPDz0wHC8WalEksn1Ng25fviWA4AQUG7TCjmFGbaJ/v4JTYtEI/V6fXV1Va6suEOxZqPZN9Bn29b169fn5683v3T35z//&#x2B;SNHjpw&#x2B;ffobU4/GWhAtT3R96YdMU3jc4jFTnUgjaSNlI&#x2B;UEWtButKv1arlRKa5czp/KeyzMFleX3XIoZcnwi4bvKcznIkwraSuaspIDVmymt2XP7LVn2O8eyI0z85aVGRNCCCGEkDsGhX2EEEIIuWmKUBTBA9WDAqGCqwAMQHEAO/RkfTYzae27b7KpmBocg0FKsF5vBg8BgHGEIVcUAAF6n&#x2B;j190Zvxd1zAICtMbs/k0k6hUL1WrZYLF6&#x2B;vLyYX1m8Nn/gwH3b0v2zly4ffenFwcHBB3fvPnPmzL87/WxSmr&#x2B;n38NjpjoY4xPpTpzVFL/abRQr2eJ8sSO9cqk8X11pwS/pbsBZ3vQ8zn1HRNNOb1Jvcq09I5a0Iu9bsac4xoc2DxNCCCGEEHITKOwjhBBCyEaSUlZr1cuzl69t377nUw4AKcA4wDnCEEKAc2C9YuN2CAIhpdRCBQpgaNbosKVamUymlrvKOS&#x2B;XS2fOnEmkJoeGh&#x2B;Jxt1gs/mRuKRaLASjK1nfcVyfameC6CFZxzStVRUcwWTL8vOH7nLmK1Ab1tBVNWX1DVvRuK9Zbt/e&#x2B;FXu6EwEt2fu1IIFyG82uzxgUhUUtNXY7/s13BMqNoO36nPF0zEhQdwshhBByp6OwjxBCCCE3TQ1VNVQ9owsVbR26AsCWUJwQMbc9bC5rzeJrb6pbt/&#x2B;WoWPAgGPC4hq4xv0OGAcEZMhveMPePj/OFADahzTwgn3ob9zUzQuVA0AA8PU/OpDUUvH7d49fL6y8ferk9dzyaIsv51ea8THdMrV2CFs7x3JtJrjgx5VSXpfgUOKaYZgpK5qxYtNrI3vRpBmJGXZcd&#x2B;KGkzDtOLP4z70ZcgdbqYdHL62eXSiFQqYixraR5PaR5Ghav5XP34WWvLJcPX4lHwgRs419U/2J0cgtvD4hhBBCbgMK&#x2B;wghhBCykTqdTiKRnN4&#x2B;3RebeP75V4MgeHzf5OZN41YvYZAfFtjdchwQAFvP&#x2B;zTOEB588EGv0X7xpRffeeudVCrdmbZ1w0iokUKtMj&#x2B;ppu1oJwy2JocORNJpK5qyop4IdqTGdEVJW7G46pigZI&#x2B;8Z3ap8qPj1186vcSAobSzZ7K/UOveM9m3bcT&#x2B;VSb8XAk/hMJgKr8g516uhW9cWn359OLZ&#x2B;VI8Ym4djm8digMU9hFCCCF3OAr7CCGEEHLTFKHwUA0VH0rgKqoAeO9oaiBSKh9NdB/eOzQ2te9f/V/fbzQa5U73fi/2qd0JU4MlTVVygwtwpVfcodwQVygSAOQNn1n/pbjh4vKGjz039zzThWRgOgd6/8i1N2siHN26&#x2B;cmnv2zGI5eaf&#x2B;/7QTMIZ69dGt&#x2B;&#x2B;Z6gv838cPJgwnJjhxA07qdqCI8boPCT5UKsNcfJa4eil1WtXC1B5odxqdPxAiLitDybt9A1N0cHN/ASfXGicXyx7vhhIWBMD0Yl&#x2B;x/mgnptsPbi6Unv7Sv7YpfzpufxKrT2UiWwaiCmc8mhCCCHkzkdhHyGEEEI20vDIcCaTtiyrL4YwDDOZzOuvvx6LxqYH9mUyuur5nBvorfC7TXhvX2AvR2SABEIBIa2oDqC/r3/Pnj32&#x2B;dV2ux3bORRxHMZYyok/Obr3dt0w&#x2B;cTxJC4tVU5fLy0XmwgFgEatkzXU&#x2B;kRaV7l2wwP49bJXabpDSWcw&#x2B;ov/F7HaCJ97e/4npxbDUG4bTdy9ObN/2&#x2B;CeTbGfeqCfzXVePpt98&#x2B;LqyauFpVy9UW4FjCVjFqS8fasyCSGEEHLrUNhHCCGEkI2UGht/7LHfkFIAcF13//79sdHhw2euTk5NYwmsMLtz58yezXE/gKkCgAwhAY0LGQQQLlTVhaEpvOt6pqGHYagqiu8Huqaz98339XzEQ8ESa2Gf4AAHBwfgQnIwXWPjmzcZO2Zardb2R/aWdpWP/f0L/4hOH5NPgnJTXMpWL2Ur9UoHgQDnkNIytMnB2I7xVExfe5krcepa8cpybWo48eDMUNr6gLdyBaodIYWUwNFLq0fOZY&#x2B;eW&#x2B;ZAodFpdX3H0icHY0lz7cUecGGx9eLphcOnlk7O5QvFZtD24AYwVMaYrim6SpN9hBBCyJ2Pwj5CCCGEbCgpUqlkJp0RwMT4xMmTJ0dntgNoNpulUunqGz9ZWVke/&#x2B;2nkgkTQLPlRx2t1XI1W2OqisCHEFzhAFRVBRAEgaoouqb//GtuCF8EBtcAGIaRSCTi8bgxNjk4OHjs71&#x2B;4BVcnd5JW16&#x2B;13SCQqqEABtcVTde2j6fumeyfSL63r6/aEifnCkdnc0vFZipi3juV/Kk&#x2B;l3IX5&#x2B;dLZxbLrbavKOzqSu3Kcq3T6AJYLbdKmUgQCL4&#x2B;rNcM8PqF/AsnFo7Ors5lK8VqR4YCpqY7ejRuz4ynto0k&#x2B;mIfFCgSQggh5M5CYR8hhBBCblrIQ6EESqghVI0QugIfPqBA4fl86Xpbjad1BXji/sm//MsjxaTTqZVc1xVCLpUaTr6WrYeIoVGVni8nHASG0Wx3HcdkYQhdB0cIMIULIBRcrC/WU3r1F2szdr0pPwncbBnv&#x2B;0o01t6MAYDKtd6nFDCLKVzhHDA0&#x2B;2fegJBfQFP5cNq5f/tgX8ysVlqtQDi2ft&#x2B;2gS3D8RtftlRqnl8sn7xaqLe96ZHkxEB0LPHew7kErmSrL7yz8Mq5bLXpmbrScYPVcgteAAmVs/H&#x2B;2LaRZHx9deTp65W/fWPuR8ev50qtwAsgpWpo6bg1nna2jace2jXy0MzwaPpW5OaEEEIIub0o7COEEELIxmFYWlp67eL86OhvGgz77p24cOHAOyst23F0XY/FoiMjI3vuuiuZdC5cWL10/lw8EXfu3ZNJaUqoAgBbC&#x2B;L8AKoCxqAba2NQYSAV9ePdN/Zuz4EQIvADIYUN&#x2B;CL8WC9KPnFCoNAIO15oGUrKUfQP&#x2B;qnMxLQD2wanhhLZYuPiYnml0o44xv3bB8cyzruvqbm4uFhZLDQqje6Cwi4vV4r1gbFE9N0XlDs4ea3wytnsO7M5LxSarnKFiTC0TJ2rfOtw4qEdQ3dtTvZefL3svXpu&#x2B;bULy8srNekHTFVs2xjqj86Mp/Zszuyd7Lt7S/&#x2B;NSSIhhBBC7mD0f/mEEEIIuWmBEgRKoAcmAtgeuA5faTMoLSWyGshXz3XSJ9ozcXvvRPP3nty96Z1FP/CnMur8fDZu63fNTJlRLJZaf/PKqaGhoTcvrfzu17&#x2B;4Kam2AceINNuI2AgEQgFDB&#x2B;cIRa8vl/Wm8NajlRum/G4yA1wL9W4cCpQAICAVMAhoTHW4FoahIWHgg7pOya&#x2B;xagcXFstL5VbKMbYNJ6cGzJ99ja1ga5&#x2B;BPiOYjI/3x67l6oaubBtOxG&#x2B;Yq1soNM8vlEqNrghFreEuFhvVpgu8F/aV6p0LS5XLi5V2vQtDNU0&#x2B;kLDSUcsCFIXfPT24Z7IvqgFApYtjs7mjl1azxZYUEpoST9g7JzL3TQ/cM9m/bSy5uT&#x2B;a/IDbJIQQQsidicI&#x2B;QgghhGyYEOCcN&#x2B;qNN998U4yMmJ3GwQP7PpMc5hwIUavVY7GY40QAdLtd13MVRZm9dOnV1zat9NmDg4PTw07EBgBFQaPmrjYaoyMZhYOvFeh&#x2B;vCSkAIMEFKYoSigEcNNJIrnjFevdk9eKp66V&#x2B;uOmFBjNDFkfHgirQH/CrrZc1w2K9a5takNRBYAE8tXOUrHV7PoyEF2/W6x3225w45&#x2B;ttdxyvdNue3B9bmhDKfuhmeE9k5morvmhGO2PTfStzQlWmu7FxcrV1Vqj7SEUXFVH&#x2B;6IP7x7&#x2B;3D2bdm9KRrUPuDFCCCGE3MEo7COEEELITQt5GHKhejpC8ADggOICahtoKlpN9B15Z2VURnj/dQNbppwEAAFmbx8wMJN2lBagmhEtNZEYn6krib95&#x2B;Z1BhyUSyS8&#x2B;su&#x2B;&#x2B;vYNKC46DcqX2zjsnRXj3xET/2lVvbMT9Fdpxb5zsu3F/n/7utKAA/FB0PQRAQMd4yfvkKq2Tc4XjZ5bTaXsgYd83PWBFPrTittSWZxdKZ&#x2B;YKxUJTd/Tdk5kHdwyNJjQJcM4sXbE0lUkpO36r63nv/2ELJRKOMZCJBFJm0pH7pgef3Ldp37YBR1f9UDgWd9ZDxq4X1lpuqxtIKXvN0ZauxW19MGFT0kcIIYT8GqKwjxBCCCEbRgFEKMIwzC0tsb1Tw8PDvc/LMOz4cnAgvcdIJaLIA/39/V236/t&#x2B;Jp0&#x2B;fPhwMBzP5XKjMUVV929LWxHHqdVqZ8&#x2B;eHezPjI72Q0EYQrk1B2oFIKWU66d8VTrGS94TAMuV1qVsdeF6odqOLhSalZbbH/ngittSCy&#x2B;fW37uxPyp2VwpV1di5vVCHcDje8eTJkYzkd2bMxeXKivZitf1u55YGyZdl4oY&#x2B;7YOMMazpWZ/wn5wZmj/toGReO/p/X3xYiCE64dBGEICnEug1OicuV7eNFAYSI069CNMCCGE/JqhsI8QQgghN417/czr75oVGMK3XE3VFJlWmNIXYlTw/RNZsXpytWSZm/&#x2B;4AiTDJvM8x4pC&#x2B;nFbUcEiwOSotWfb4Km3XogP75AQRfSlYumj5Ux&#x2B;Fs82q5s2OykZz2LkyuLcgw/fo6ChqAgRCikFSwIIGACEApyhd5SR9YaiehN/qgDgo/vuJ3TYAOABQKg3fPi2ZnqBa4ZRQPqq1mg3UzzidcKmrgiBGLcsy/JUOsVL3qfSkkuFZq7c7Na6MLVSvVOqdzDwwWHfxWz5&#x2B;RPzPzl2fTVXD5pd1IwwCE1D64tbn5rpm&#x2B;w3758ePDlXOH1&#x2B;2RMyFOsR87qRjPXIXaM7xlOFWtcylMnB&#x2B;HrSh5qLUCK1voaPAZwzhTPGmeRMCrlcbL5xcYVzFgq5f2pgM5XwEkIIIb9OKOwjhBBCyEYSQjiOvWvXrkwmo6pYycOWJSOV6v2uoa9NJKUiuHffva7nXlysWJYVT8QPHnygXO2cOXOmtLAyPDs0nfGkkMlEEkCIUAHnUMCED&#x2B;H5voCha1A&#x2B;9PTkzycVKAAUVUUI2ekiokXtiPShGwpUAMztdMIwFB4MCknIDQq1dq7W9vwQHAJou0Gl5bqA8TOv7AhcWCwfv5xbXqkGgYChQcqlXP34bG77aHJmPDUYUTYNRIfStmFqDc4AvD/rg6PASWrjybiPuLjhEtUuXj2/4gXh/m0DYwkNgGWombiVjFjL5bYHCYFu118qNF87t9zqBo229&#x2B;jdY5tT9KNMCCGE/LqgsI8QQgghN02Vvip8RYaQIZMCkBKKAAIGptvSiE3tnmBtdvqqPHfurCrcA/dPbB0FWw8s7BCagi/fPbA3deD5104tp4Nss7W7j18X8uLqxdVu7PLp2Vm9MjwygvjmBmAjoQAKJAPTpTA1gwsBySBCALKX&#x2B;bEb&#x2B;nkFB8C4hp9a7tebBwRXoIYwQwiV8UuLtbodbJ1IOtraG3Q8JESbGQbUDsJfYTsgueO4Qagp3LF12AZXeRAK1wsDAeNncudssXtxqZrNN4KWB5XDUAGE3WC13Lq4VLmyXBvcllI4SziG5RjQNcYgPuRn7afW7l3LNQ6fXuy4oaEqmbuHLI5UxJweSV4YKmdLzWLbE0IiFF7bu5attLo&#x2B;mOScBzNDU/3UyEsIIYT8WqCwjxBCCCEbRyIajaqqOjY2WluuvXrkyNVr15auXaw36uYTD4&#x2B;NrD14aAoCAV3F1OSwEh&#x2B;uVKqHj13RdN0wjEazaTtDlUq11Cxn&#x2B;vq4wgF4nmCca9IzNIOt9fIyyJ8ZhfrlCEil170rhZD81OnT50vle&#x2B;655&#x2B;G7ZgwDXAEDGOfQVACQ4he9H/k1ko5ak4Pxsb7YYrbGVCWUEvIDqqK7AheWKldWap2uz3SF2zrTVeGHQviuF1xdrZ&#x2B;dL20fTXLGEo4RdXToCmOQv9zP8/V8/ex8qd72h1L25GB8x7CdsrB7IrNYaCwUm17Xb3V8PwwRCBnIQrl1/FIOAprC0tFNqQ8&#x2B;cEwIIYSQOwqFfYQQQgi5aRxCQcgRAiFb668FA/wQfX39A0Mj45sm2077h9//m06n88o1Y&#x2B;mNir3JvdtWzXK3L2NOxWAwiFaNW9Z0ROrpxFjiriAIbK8ca1293LQE96VmhoreCKOlEM08z63m9u4YiGmQHWZZYJ06UxQoHQACUQAK69UQaEDvdqDcMNnX&#x2B;9h7iS41lSldMDC1Dpydb33/&#x2B;MXji8FCQd&#x2B;&#x2B;feueKUAHNFP6IRNd8I94VJh8rCTgSpi3fKXiaFLbMZaaGo6fnS95XiCElOwDFjvOFzonrxYWcjVFV2emBzcPJzpBePZaMVdouH54PVe/sFheqbRHUk7E1G1Dg8IZ2C8T9a02w9lsdSHfqLa909dLd23qm&#x2B;i3bRVbhq17p/qXSk1dYdWW1&#x2B;x65YbbbHZDL1xerh4Tsj9pbxqI7d2Sor4OQggh5I5HYR8hhBBCNoymoq8Pd99998SEGSRMIUUQBlCU&#x2B;fn5U6dOdjrbuldf3bJly/hndmqawi0LkIqiAOjP6BK6r09&#x2B;6uGHFy8otVqtOTe3vLzsuq6hYKVef&#x2B;XIKwPx31DGkl61ZllxZhoAg&#x2B;ggFD99yvEXUZmC9TZTVUEQBsvLy7Varb60PLNzpvUbezdvnugHmG2DcwgBQEgJQAItH9WGV&#x2B;/6EUsfT97khckGafi4vNwoN7pjfZHpDynH&#x2B;JhwYDjpjPdFMwkrX24L&#x2B;dOtGj0L&#x2B;ea5&#x2B;dJyvh61jcfunXhwZvhqvp4tNXPFZuCHhXLzWq5eqndG046hKZrCwX&#x2B;p2DIE5pZrV1aq1ZZXbblXV2qXlyv3TQ/YMUUHZsZSjba/eSDm&#x2B;qJQb59bKF&#x2B;4XiqUmkHby1daZ68XR9KOpav3bIpR7QwhhBByZ6OwjxBCCCE3LWBawPUQCqAAAQBV&#x2B;gpTuFAA7Nts6oCM4tE9m86fO3fYijLwucVyqXExd3G270pF5Xxqamoirdk2tzW46yvPplL4/S8/nNnenZube7FxRg1zlgxsIBDOwlLtUtavCeSXKwdicUuY8Shspa8bdhlUAMraXFQIAFLBej8vV4B3J/u4B4DLEABnGoAuwJ2hTmRzs9stZsXJ0pWz5ebu3dWvLlS2Tm1N8bjgANDs&#x2B;H/9&#x2B;mK15ZbrnUq52RZy3/Tgbx2cjFHnwS3nSpybr7xybnmp0NzUH13e2jc5lBhLardsAtMylGTUjNt6qdr5wHO3IVCot&#x2B;fzjVq1PRw1UzHTMlU/CP1QgDMZCrfp5qudRscPhcS7h9E/aELwp3QCFOqdWtsTUoYdL5dvXM83mh0PMQtAf4R/atfQfdMDqsJXK61js7k3UpFzC6WV5epq052bL72oq30xa6wv0u/QvCohhBByJ6OwjxBCCCEbqdOQepIB0FT8xmOPhUGgnr7qRJwgDEqlUrFYzOVyr0Y9IcSFenb3Xbt3bRtlHJ4PXQOAkZGRzwxj164tDkc&#x2B;n3ccx5cIgsAwDNfzlpdzJ956KwiCfrs7MzNjJ7lpmi6Cm75LKXvJSiBgGEY0GqsGgW1YjXr93PlyuVyOX1ksl8t7H80MZmIAKs3uf/jbE9WW63c8v9aWtqHpypP3TsR0OhJ5i4RACCjA9Xzn6Gzu5TPZ&#x2B;dVa3FLPZ8tP7J1I7B2L/2wh7seDc6arXOXsZ1f19QQStZZXqneCjt9qe2/P5edW61dXaoVqB4xBSOkGra7f6HjNjt/1AiHX1/79orSPM5i6GrM121CrXlirtMqNTnhDr0fCQC84T1vOWGZyrC/65oXoEW2xfDlfLLVOKYXp4cTMeCq5laZSCSGEkDsZhX2EEEIIuWkeM11mBkwD0wAXYKr0GQRCxVL9CPQQSAIpp/tPH78n2zQvXbo0MpH0XPfsO4wz/aI3sPDWaqdedM4e/cqj3uc&#x2B;M2kraHlI63AM7AUwhj1P789ms6ru9kkMpoxWaeXU7Pzdd&#x2B;89sex7qRZj3VeWLz/6qemJQaShAvAFGBDhIXr/ReG9cT62PjYFoDeECL8LRZFd6AYg0G23q&#x2B;WGGU83AhuOVVPC2mpgLMizYvXZH5w9cP/9ANpd//TZpTCUCAXaLktHul4of/EkFtkYuaa4sFBWVR61tLPzpdfPL5&#x2B;&#x2B;VsyVmlyImhfunsh8WO72cZASQkop8WEr9iTg&#x2B;qEXhJCoN90jZ5fdIPS8MAwlJCAkpPQCUWt5pUa31fUlfqmxPgC2gm0jyb2T/ddW6pXVetcNvECoygeP6XGOuGPEHF3RVcaZ7wW1avvycvXiYnkkHaFD6IQQQsgdjMI&#x2B;QgghhGwoVWXrTxiqqmb6&#x2B;59&#x2B;evDs2W1aNJXP54feOZ/NZivlisKVdqulcP7CCy9EIk8/tb8/ZADgBz64pnAkk8lYLMZVhXNIAcM0z5&#x2B;/wLkihOh02qXS8tW5q5mYGgRbfKcbj5l2b8au153LGcIQyoeM3SkKsDZKJQRs24KmdldXkdkCxqFICNbpdhcXFi69Hqysrn4akBIhGDQOhSMUuqkZmvLLrVkjvyoJvH0lf/jUkq6wqK2fXywfvZTLFxqy60PlpqYmI0b04z9P3RUIBQwVQSh6Fc3rtdAflNMxKJxD5b4X1qpt2UuGFc4Vrpqa4AyQ9bZbbbkdL5TrGyGFkPIXjfdNpvX7pwcuLVUuz5e6pZbri2K9u6XfbLiotf1a26u13ErTbbS9RtdfLivd6M4AACAASURBVDUvLlWu5uquH0DlAig1uguFZrHepbCPEEIIuYNR2EcIIYSQmyYZwCDB1j4CsjecxIDALzZ927IiiqIaBjgODuOuaF9NNfL5wdn5vW&#x2B;95btatAlTG9qxaXr7udefeeaNC5/Z399miAAutDgLIaEqITQGKBAY78dTj&#x2B;75Tz85feXS8XpHy1UqzdButMOjVxoX8ldHtcbIyMgjezLpGBRA4QpHAAS98t3eZJ9cS1BCoJfzSZVLBuYITA9H92yKnzo1r3kl3/dhJaAbXmS44borS8FcafHT&#x2B;wHOYOsAEAiEoaJwfitnyX6NCeDSSvu18ysvnV0SXqBqarHRLTc6koM5el/K2bulb2o48XH/y6i5OH29HITheH9UhAglOGecM4UxhbOfin05g2OoiYixaOoyFDIQYAwMTGWJmBU31EbT5Yy13aDjBUEoGADGglDUWl7TR/TnpnASCEOpqUw1NehKvtp&#x2B;7sT8O1fz1aZbanQrDbfc7JYbbq3lBkHY7frNjt/yAj8IoXBw5vphy/W9QHyc3y1CCCGE3GYU9hFCCCFk4wjRrtXenrsQi8X2jGweTicAQMC2DaEhstl84olPJ5Opa021Wq12PHd8YiAsb19aWqp2YJqot7zFxcWpvngsHuv1k7rttqqqjq0/&#x2B;ugjOT5w9syZZo0VCwWXGQBareZyNnsmeyaTyZjdez/96b0RLoUUHICifugxSwBByBUGQNOwc&#x2B;fOJ3wnGo2evVqr1mrodKGppmlalrViKxDh&#x2B;pcmISUCAS9w3cD1b1yVRj4uy9Xg1fMrb15cuTRfDppdpilO3B7ri3Vdv&#x2B;2HO8bT928f3DwQ&#x2B;7hv4&#x2B;JS9fDpxTCQ&#x2B;6f7MzHbD/9/9u7zSa7zzhf79wknd&#x2B;7pyXkwwCBnZhEkJVLihrsr3t27K9e11/a6rl/47f0r/Nb3hatsl8v2i72uu9butaxd7opiBBNAxMFgMDPApJ7cOZ3uk57HL3oAkhKDAEFaiXw&#x2B;xSoeTnWfDmeqcPDlL0SMEAJIst&#x2B;Y&#x2B;9l6PA70peyJ/sTqbqNebKATUJ1rBs9k7GOTuYSp39moBEJ4QRRGQnbHR1LS8aONYnNlt3Vs&#x2B;NP1GSFQdWWt5VdbXrXl1V2/4QZLW5XZ1VKzE0hC1vbq//GdBQr4Xuj5oe&#x2B;Fvh96fhiGEUBACBgFp/vLp2X31b502qCiKIqiKN8MKuxTFEVRFOWhGaJjiI4mDYiw28joU5ODMY7dtvYPn6wQgrmx4I&#x2B;/&#x2B;0Q2Bae8aaVSpnQowbOHMZE8Mb/jXbly5fU3Ly8kYRAvbJZLdYxZuH5v5913P8j2TJ4&#x2B;ffrktK1RWDGt7bUNIGEHP3xpZmYQKyXy5ps/v31vnVLq5JKh1/h4y7y5UurLrkydOJ3t4x4QJx3g/k7eX2qLDKkZaZFBAMCRODJK/6vkxNme9tsf3Ll7r/nRbqVZqXgVy7Ed8D4QDWhDSrR9AIgE/DAKo0gIfFWaqDwea3v1929v3VwtdmpttH2atA4Np89P91abXqXlnT3Qe266ry/&#x2B;ab/2XkvuVd2YpY1kfq3lKeU2CjXX1HlfSi83oxsrhQ/ndwAZd/SDQwhCQSkBIX4oGu2g1ZGm9emvGQUm&#x2B;pLnp/vqbrBsa77rxxJWLuOcnMienuqtuX6h5e2WW0G438BLKeWMup1gPl9&#x2B;d3Zzr5LSNFZ3/WrLqzS9SrNTbnjlRqfc6FSaXqPtu65fa/stL5RAtd4u79XxIHh&#x2B;EONRtt9gTAAhEUn4ISgRQv6K8wEVRVEURfn9pcI&#x2B;RVEURVEeG0IgpNjc3HTbbnFlty&#x2B;RfP47h3pSaQBRBMKhE4wPgWaNzc3&#x2B;RCK&#x2B;uLCQchgICQMJkM3Nzdu3b0tstFot2Zw8efKAxWEapgQooykHT5ydmYxACLHT92q1WjweL&#x2B;ztUUrbu7tzc97m1g9O9dkMEGFA&#x2B;Vc0QxJG7gdBEiDoz5LE00cHxo7O3lqgs/euXbuGlXKz2UArBk0DACl1zgyD65waKSvRm5joS1pqFe9vXt31q67PGLUTJjW1zEDi2SMDL58ebXths&#x2B;0fGEwdGoo9iK4EsLBRublazCbMYCo32Wt94RXabYq66/WnrS9rmN1tRm/d3NyptI6MZAjNbBab8/nyve2qztl2pdWbssJIMEog0XD9nYpbqneylvXZMxwcckIxNpSNbRabfjvQTT7QEzs0lE7HzUuLO0QKKSSlpEtjRNOY6wXzayXXC9&#x2B;bM/xQdDM&#x2B;zw8eFOt1DyIhQQk4A6cgVEgJSvYzbYLPHXweZZRrzDa4pXONf/FOD0VRFEVRvhlU2KcoiqIoykMzRNsQLpcWpN/9iU&#x2B;YANoMDZ5uxcdiA87Odvt//dntSvLQvzvpm4bpuQ0jFu/2W06bWDYqp3Iik8mEoKZlxmOEAK40OsSWw8&#x2B;/sxUu7F2/4CX/4GxWN2gKLgfgeQnDMZn&#x2B;2nPTZ8eGtre3vQ79qLa&#x2B;WDgEPdwqlVe2muFpG0BEAwoCEgCA/MXdDS40AA4AgEkfEj2g0DA0yo8mJwbGez7qETuVxY18fpW0IToAM3Tt6XNj2biZto2Myfp7E88cHUoav50v&#x2B;1stmzBPT&#x2B;Y4I6WKG/rR2FDqiem&#x2B;89M5jSESiGmfy7R8gXvbtQ/nt&#x2B;O2LoW09KHh1C/e65ba8qOFnUqz89ShgZl&#x2B;C19kZafx9s2NcrOTihmDPbHtSmuz5DbagWPB86MgFAA4JVLKUr29vFvfrrQO9n3uVAbBoeF4T8KsNLxird3sBDFbJwQrO7W5leJesRlJaJwySjROHVOzdFZreBu79b2KS6UMg8j3gqDbiovPh3f0fk9uJIEIUn76ky4CAsIYZYwwThmjjFFGoBMaixmT/cmBjBMz1XYORVEURfkmU2GfoiiKoiiPTRhBCpFKpU6cOLG&#x2B;tPvjv/nbvv6&#x2B;lxw9kUwQFkvE4gCCCISBcV4sFl999VVu2pqm5VKIAMYZ4&#x2B;yJZ5557733bty4kclmzo8ejSfilNUN0ygUCnxA86HHLDI15aRSBxiBZZrv18uVakXTmq7bigAGSCFBv7TH9hcXnnqeG0nbssMIqaR&#x2B;LpW1rZfuriQZpWaSBEEA&#x2B;NmE&#x2B;e&#x2B;/fyblGElHT9l6Ksa/uGZM&#x2B;fVUO9ittW2dj9zfFTszkrINfngkvbpT6wRivC9xciKX7Oa3v3QJOj42y81bq0UKaIyO9SaGU&#x2B;lfeMziZuW9W5uuH00NpL4s7MsXG4ubFT8Urhf6QdTxIyGlximn3V0aYJTonAmJSq2zvFNb3qnPDGf6YhRAM0C1FdZcr&#x2B;4GzY5fanj5QqNUb4eRcP1wp&#x2B;wurpU2dqo9fUmNMY2zmKWlHMM2eLXqep3A6wSQcr9BvNuKi/vNueQzXboApAQhIIRSwruJHu9mfFTnzNSZpXNT55bOLZ2ZOrc0loqZB4fSh4ZTmbj5a1wlRVEURVF&#x2B;16mwT1EURVGUh1bn2Trv8akJanFZgYwSUROM2VEikfanzOYBuzVwIPfPsrW9cO0/jf55X1/v3Zvv/at/NTjZDyGQZOgZzCTTZGHpk7/&#x2B;r/9Nq4U04Id4ZjB7pVO7s16O9x/42Qdv&#x2B;7cLT77c186jmZ8dHx/3lzory8VXng&#x2B;jwHNoXzaLZqc69FQ8MBr//LPCxkp5IrEjxQShIDwXAJqEiAQVHigj6K4f1QEkmQDur&#x2B;nVKDSLENIGLApI5CJ8b9J&#x2B;9qj5SmbyWG/n/YvvA31JW//Byb5/ue/7W2G3Ia4u7&#x2B;ULzcn&#x2B;ZF861w30EhqODcX6087WcDqIZC5hDqe/tCqt3PR2K&#x2B;7GXiNqeYmY&#x2B;fyxIeBzYV/Nx9JW7c5mxdJ5&#x2B;CUbaXebYnGruldrmxpre6EfCoPzhG0YnAEgBBqjtsEdU6cEruut79YvL&#x2B;5KibilVVteuemVG51ay6u7frXlF&#x2B;vtZsvveEEYRr4XdTpBu&#x2B;2LUGRykhBonOaS1lDWyTjmLm0KARAJQsDIF7TiEhBCGKP70d79wj1L5/dzvf2AzzG1mKnFTM2xtJipxSzNNjRLYwnH6E/bwz2x7BeHnIqiKIqifEOosE9RFEVRlMcnECxuv/LKy04strhYDsNQN4z19fz8/J2dlSuEkO9/59DQYI4BY2MjBw8eWlldubdcmJjIAdA5EonEwYMH//fr1zWN65puGHqtinod64uLhULBW9ieOXwYSDFNkx1BNOo4NgE5dfpQIpnIL98dGx2NImgUAJqtIG1rlFEQDtzfpfGLRX2fJwQolUIA1DTN8fHxl58ZPjg9PfvmP6r1pb9plQ4&#x2B;Xtx5d26z40eZmCk/f6V6bNJjx77&#x2B;JM1OteU1mx1RbW8Um7tVtxXB&#x2B;UwB4E6lvbJTrzX9WFZj7AuuqQBurZVurZVKjU46Zu5U3a1Ss9kJIaWUkhBKKTE1zhlNxXSNUeFHu6XWe3Nbs6tFLxDNtt&#x2B;drOcHoe&#x2B;Hvhd5fghKAUDeLzWVEpBRJPxAGJz1Je2Z4cziZnVtt1ZzfQDdej0Qwth&#x2B;pd6Dwj1Du1&#x2B;mdz/dsw0tZmqOqcWsTwM&#x2B;x9AcU3MMbpvdY27oXOfU0qhtQHXwKoqiKMo3ngr7FEVRFEV5aEwGTAZE6oAAKAiThBDCwSkIjk5lmxE6texw2o4Rr9jpzC8t8UC8&#x2B;cnNkPh9/f1xmz7z7MyJZ/7wo7n/5fr82uhULpDgBLke&#x2B;w9&#x2B;cGHjJ5/U6/XMYNSj71V3Wq7rbtT8Bjp3Fop1q/GKayRtyzBACCh0z49SBo5MDwymkomEHdMAgAGOoUkhCSWg3bCHCfmgD/IzHb7dw8/EPoxSAkRRaMTiYwOZsYHM7Jv/&#x2B;Fv7Yr&#x2B;1VnYbH93ZubpUODCYilma9kjhahhJIaWMhAyilhdUGp1KI3BS&#x2B;&#x2B;lWK8KttdLtfLnWaPemrOCXKvsC4NZa4&#x2B;Ltrdv5crMTaIzdyVfCSHS8aHmr0uoEWYNzSm2T65ymYwZjBFHktrzljQrCKPCCB4HeZ7biUpDPlOkRIIwgZBhGXhgZGh3tddp&#x2B;dmW3tl12NziPokhIgFHOqWVwy/g03bMelOxZnwZ8zv04zzG0brRnG9zQmM6pocHg6l5fURRFUb6N1A2AoiiKoiiPDwUABsQZpg7oFy48n0wm81Gq1Wr1xg0/CBYWF&#x2B;fm5hyL1Gq1J86fTcTjm5ubDOcogRciafIjRw78uTm5urqy7dYLhb3FxcVKuRIiPHL4cP1e0/O97e1tbWys3WCQyGZAGdvcC9bW1jQZnjgxg&#x2B;5MQCE1jchQEkkAiEhIQtnXTtmTEgDjABAGIWu7v9GvSvmse9vVi7e3OkHUn3FGc7FHWxabjpl9KTuVidUDwRjtBJF/P9ELgJur1Q/mt28uF0rlViphre3VC&#x2B;PZhE3rrqy1vKrr5feaV&#x2B;7uXZzfyheaXhDV2/6t1dLd7VrbC5q1tidkb9rmlNi6Frc0x9AAAiFFKHyECMX9iryv3IpLQChlHIbOdc4snSc0HBxKPnd00ND4eqFZdzvtThhJaeg8YesP6vU&#x2B;k&#x2B;tpjqHZJu8eGxozNGpwomswVPmpoiiKoigAVNinKIqiKMoj0KSnSY/CghQR0Ri4TxgDgwDnKLTRYyFF8aM//q5pGv&#x2B;05r3/oSjUqqZp5kvS9/2R0fFPFiu&#x2B;vh2YY8s7hZ02Ji1QDoIIIM&#x2B;Nuecd1koeXFiQ/9s/7q7fvhabjA&#x2B;MTQ4d1ZqtVkGkqxvtrdtb7XbnyXMTU2Px9c3yxQ&#x2B;vZ2J6/9BEesiIQgRRoGs64RRAIBAKITXKCCIgAuLyF0MRAglARoIwBgFCofH9bPCL57opj5UP5AuNvWo7mzCnB5KjOefRzjPeZ5470Htno3oLIJSEQvhh5APNNhY2q2/dzF9a2FnbrUWdcLPUvHh7q9ryKKGVlldpdMqNzk7FzRcbe9W22wmklO1O4LV9GYoojCAEs3QJgBBDo3FbS9p63NKYxiIhEQpQst&#x2B;u&#x2B;wAB8GkrbnfKHmdUAzEIGRtI9qdtx9QAJHU8ebBvvC&#x2B;5V3X3qm6l6QWRNHWWsPWYqdkG7wZ8ls51jRoaNTh09svrSRRFURRFUfapsE9RFEVRlMeGUhSLwdtXrxw5evTUaPzY4XgQ4dlh/d69C9cvX6rVapubG7FY/ODBg9PT07dmb3S8Tjmff&#x2B;ede875sb4sJyBBFOqAEY8Tyzlz6sxSqx1Gkeu06/VGo9EQQsRise2d7WvXrm9vb1WLw3/xF3/WbDYLhULC6PU9r9U2HAsG9CCA3m3ppQDn4f0cRogvHdtHNA1AGApdpwQghNKvHPGnPC6bJX&#x2B;j1OoEYTZhjuZisUedKqcD432JoyOZ/G6t2vZ3q&#x2B;715cLdLX236s5vlD9ZKixuVQMvBFCod96&#x2B;ufn&#x2B;/LYMZeCHnh/6Xuj5oRdGklIwCkKEEEIICAkAEjISfihCITijSdsY7U0cHErtFRqlqiv8CJRR&#x2B;unSjO4/GqcP9mZ8ukNDY6bGx/uTM8PppG1033nSQLLXnO41y&#x2B;1Msx1IQGPU1Fm3FVdN2VMURVEU5aGosE9RFEVRlIfGZcBFQCAAERFGwQLKBKAxrG8X33z7nRuztwqnzv/5KydlhAM6/t2fnr4ypN2cnb1y3WeURZ3wwLhz915PbXU3YvY/vfWhX1r8y7981WQUTEcUwjAD0dGp/sKTVsq8UAq3HDMwgnoYhhqlrVo90pI8Lj5ZrvRe3yjUxHqNTh8b07KJWgBmgQDbpUbCEIlEkjFwBuCXuyq7R58f2idBpKCSBmEQQX71Pg/lsQiAlZ16vtjw/IhTKuXXP&#x2B;UXhEDNlVXXL9XbCxuVUqPTjoTbCW6tlmpNL4xksd7ZrbbKjY7rBgABJR3X32x2hB9&#x2B;5voTEIASAJASEpACkUAkASCSIpJhJKQEoyThsJnh9DOHBzwvurdTbdU9n0imcdvgtvHpYlzb2G&#x2B;//eygPVNjpq71p6yJ/kT681txCZC1kLVUuKcoiqIoyq9FhX2KoiiKojxOnU6nUqnOz8&#x2B;769svnTuZzaAgMZxF6nvHBoeGBkfW8/n83O25waFB27ZardbE8Mjq6urVa2vf//73cz0AAN&#x2B;Hrge&#x2B;Tw0ShkZPNjbcf9AysbWiraystFqtQqHQ29d3YHr6xtylUqm8U6rv7GxzztNJuAXsFGGGjeXle/0Zm1KaTMYBCLkf4zDyuf0cnyMlyP1lCoR2lyw82vA45VdXc7FRapbqHT8SlWZnfqMy0huf6jG&#x2B;7PENH1U3qDY9XWO382UviOpusF1ulhtepdnZKrfWC43diusH0WK&#x2B;spKvhEHkB1EQiv3glhIQSCmlACjdX9C8f9nRHcMHEKYREB7JECLSOOMa57aWdPSYyTVGbYbRnPH8seFM3Frdq&#x2B;&#x2B;VmhXXjySStt7tvXXuR3vd7Rn2/Vl7lsE0TnXOHBOmCpIVRVEURfnNUGGfoiiKoii/DiIBCSIACoQS8WS67rYHR8adZPb9j6&#x2B;/&#x2B;uqpKRIIiD5uHDiePj&#x2B;Wvn6d5Sxj7cobucnjtmhNTx49eujAT/7mf1rJb032DIfAzXoqnUbMRFHg5rXywsLCC89mx6cP/tvnez/Qyv26&#x2B;8xM/&#x2B;sXK&#x2B;1W8&#x2B;yFV&#x2B;fvzK/vNqvCura8e2AVOQtXPrlz9tDg/Fb9&#x2B;s2bP/ovfpQEgjAwuAAAEUFEYPHPvH8KgOyP5pMAdJ1BQIY&#x2B;sxK4HxEqvzltP2y0/TASQoi13fp7c5u2zuixobEew5eoNkXN9aotr9byqy2v0vQqzU654ZUbnXKjU2l65UbH8wLGaLnSiiLZ9gI/EoJREOJ6IcJugSZAKSgxTM02tUjKRjuQItzP&#x2B;B5cYwIqia6zWMLqTVmOpYlIRkIYnBEhucZH&#x2B;uIjubhjaQTQgJNj8Ym&#x2B;eKnhbRWb29WWH8mkpSVs/X60x3WNGZwZGnQN&#x2B;r/gV6woiqIoyreMCvsURVEURXlspIQQoq&#x2B;vb/rA9ExucH5&#x2B;/rnnTmmWZ3BDAhKIx/DUU8ec/mO3b99u0Xgu15NIJIaHhg5MH&#x2B;i0261A&#x2B;J5/8&#x2B;ZKsVh8&#x2B;QfPJBJsbW1te3vr2rX1memDTgynTs2k&#x2B;xGLxVIpcfXatfVWM5VKbW9vp1Mpy7QgUSp5ly5fTpDD7bZbr1VtSwPQbrf1uAEABPj6pbzfVmEIKaH9tntICSE6ZzFLAyG7xeblhR0Ae7V2KmY22v6DRK/c6JQbXqvt&#x2B;58Zsef7YRCE&#x2B;83W3VZcSsAohAQBumGtJBACoeBxY2o4PdoTr7nevZ1audZGIBgjTGOUUcYoZzRm8v60PT2UmRlO9aZsTmkohB&#x2B;EzXYgJDJxc2Y4k46Z3XfOgLSJtGmM5IxqKy2EtHRmajCo6v5WFEVRFOVfkgr7FEVRFEV5aCHRQ6pFYAAlCAkkk93&#x2B;SLSazXYgrUT63IVn/sP/eOvyYv21s5oUHqIO4VwnBjQ8OUVnctP5msiSsUSPnrbDjGO3a9XIp4GHn8w1lhbXFhrhmTOnl/IFL9IdHsmgbcEazUIgcFLGycPjm8u3FwtbI4O5jEPgGDMzU4kE8pVoMb/TDnzTMNGKKoAGCDMBKWQUEiqAzw/rw6c/6K7khSSAoFJCCvptqOxrt7G&#x2B;gd1ddHeaZLMYHEQq&#x2B;Vt7fVOjSUdPOQZnpNkJtgqND4S8tVaOIrG/OuNBtOeFn140cv/CULZ//ciDyA/7WzXu/5ASQjmGcvHnjw0dG8nu1d2&#x2B;1WK&#x2B;0Gy1fUaIbnBTY6bGLEPrT1sHh9KnJnMzw&#x2B;neJNeAVoiaG1abfhAJW&#x2B;c9STNt/uJHMIA&#x2B;RzV8K4qi/L5h3/g/45VvLxX2KYqiKIry2FAKSomIomajMZJDEAR37tzB2eNSShFFnFJQGYUR5Xo2relppNPnKk247U48HmeMGQZKZXdzY6Mnl7s9N7e3t8v23FgsduLkScYYfIChWq&#x2B;kEunpaefll1/Obm5ns1lQ7fbt29PTQ&#x2B;k0tjd5MpXKr&#x2B;cNQ9eD2tVraz94YszQ7kd7YbS/rUPparZw6TI&#x2B;voR8HlxDOoWRIYyOYWgQY6OIxb7m6UKgUECpAl3D8CBM62se/0Uck/SnrEzcpIQgFH4n2Ck0tv2qCKP9RzzYq0LJ/hqNB/s0Pr9ypftgQsiDfbicUUNjFqc6p987O/7K6dED/UnXDw8Oplb2GsWaKyV0nTmG5hha3NL6M/ZUf/LAgP2gvtHhcBJ8MMHVthZFUZRvmkgC8ksn&#x2B;SrK7zMV9imKoiiK8tB8YvjEFISBcCo9AsolOGEAbEOzEukQzAUqNL1Sw1LN6knCYvAB6jVMw7TgiShKMjuZRM6GEKZ76kgyFbcFuOuFbf/o6XOBn3nrrbc0VzfNYC&#x2B;wB6muGRACghshmFfH5HBq8miq2ZCnc36iGuZoZ4iaS1zEbS159Nze3t7aeuf//MdLucGxyWH4gmpcd&#x2B;QvTU7bv8XfrwfbP5AgUgKSfrMXdAiB2Vt45x1x&#x2B;aool4nj0HSKbG/j9h1MjOOpp3D2NOhXfgG353H1KvKb6MnizCkcOwbrofM&#x2B;i2KoJ5aNm5RQCAFBolBASlD6acneZ2v3HiAACGOfi/YYI4bOTJ1bGjd1HjO1TNwYSjljffHjk7kzU7m0iVYkp/pjawW32vIiIXTObIM7pmbpPGFrqS9ZDaKSPkVRlG8iAkOlIso3kPq1VhRFURTlcWq5rWajUavXCy0IIbZ3du7ML6RSqcm&#x2B;WDbtmMZ&#x2B;DyRlrFu4xTk4wZkzp5vNFmPoHxjoyeV2dnZOnBiuVqtOGLMs69bcraMzI54H30MqGQdw4&#x2B;YtQsiFV45mHGL0DwvxPOccgG2ZURSdPH58fv52vVzcyOevXr0eRieHDW&#x2B;w/5faL7/lFhbxwQdi9paoVBBF0uuISgWVigxDViySRAL9fRgZ/tKnt1qYv4N33hMbW2Sgj9TraLo4feoRWoAH0uZwT2y4x/GqbtMPZCQAgH1m9F23sI92Qz3yINrjnFo6t3Ru6szSuWXsB3wxU3NM7pha0jH6U/ZoLjHc4wxlDYMAgMMIGEmNxFwRa3tIGCBU3RMriqJ8W/nhv/Q7UJTHT93YKIqiKIry0EKih0QXYCDdVbaSy4BBQGoJ2yRcX8tvvf7OXl1aK8s7by6MVKubM33su9&#x2B;9cDynRRDcK&#x2B;mGpcEHwKRJCTVjrMMtQ8Kw8fLp6TfeeGMn7ukiEHpqZPqkn0xtRCguYXe3dPJQe3BgsLS3uZHPP/fsTNJhsah6NNmSaREDhnsxPpDZLFZ8oidGjgwM9M9ttbe9xRHDc2KxZ46MDfazmATul/R9QbmW7P5cAiDym1vPVani2nV59ZrY3YOuEU2TUSjdNqIQfiALRbK8gqFBmCZyPV98Bs/H9rbY2BSlMgl8UqvTMMLgwCOEfTbDkdHsC8eHTYJb6&#x2B;VmvUMoYRpljDFGGN&#x2B;P9kydW92qvfsBn7Of62kxS9vP&#x2B;CzNMTTb1GyD2YaWsPRM3EzHmfVFF9KmsB&#x2B;l81hRFEVRFOV3mgr7FEVRFEV5nI4eGTp&#x2B;/Ph77733&#x2B;j&#x2B;97nXY3t7e4uJCvV73d714PNb/9Fgu06MblpRRFAZcMyilYRRyyixbg4D0cf786LVr2d3d3Ww2W2/SXG/u1KkpjeHq1Zu3bs3Vd3HhhQu2bVdrtVK5lHR6d9fW8xv5E8OHa81ONmaeOHnyP/zfP09n0slk37PPnvvk7bdu3Lhxz92p1qr2n/&#x2B;B&#x2B;dS52G9v&#x2B;cTvqiDE/B3Mzoq9PaJrJJUGpcR1ZRDA8yRjiCK5nifzd9A/8KVhn&#x2B;ui3pCeB0A2W6Jao0MDcN1He0dHR9NBOB43uWkb67s1IcA4NTRuGffTPWO/ZC9mac6DA0NzTM02NMfk3WNL57pGDU51DQaDGtCoKIqiKMq3kAr7FEVRFEV5aPGoGA&#x2B;LXO&#x2B;FDELCCXhEBMCYAID/9tWnJsz2lY&#x2B;X9HgqnY0KLv/eD/7Nyq1Lf/f2wunTZ0OBDEl6HaQ1CRAInxPSqW2byRQYiBY&#x2B;NRjP/Tdn71x6Z1kPPyj4Q87GaWeKB/jENRajmHd9Z7O1KHomZ8nuUoH0jKDOp&#x2B;b2SlgqDAzk/CaeOz5eLR6Yvz0/MNQ3pDfWejIffnCxEIdRXgAAIABJREFUVGcdL9z68epfp8/9D08CAAciie4MvwBEAIwzQhAAEpQSxsD06HdvG68fIPDhOL/WSfJ5XL8pV9eJadKBAYyOQDfQdpHfFGvr8DoyCOT2DlvLo1L50pOUy2i5AMAohAC6i3Ef8ftKGTg/3WMafCAbW9&#x2B;tV1t&#x2B;KGS3di9uaY6lxcz9kj3nfrRnG5qhUUNjugaDQ/v6F1EURVEURflWUGGfoiiKoiiPjw/oGB9M/NEf/9Fw//LWVvXo0aOf7AS1Wu2ll1766U9/&#x2B;v7Fy6&#x2B;9dv7SlQWv03nu1GQ8Fpdem5mWmUwBgBDdjRAjI8NZ7dmZmRkzbzixGGMwNUiAUXbhwoVSqfTBtWvtdntubm5i4oVDo061erBYLN66dWvq6OGjB/vPnTs/ODhYckk6Hdc0LQgCIQmltFgsXrq08N&#x2B;fP8ApQ3ffw/0dq79rmd4XkBL37uHuPVCGI4cxPPTop9rcxNKSKFfYUD/OnsXpk0gm4bbx3kWqaWJjQ9brsl5How7f/&#x2B;IzhCHaHegacRzp&#x2B;TIIwDlME9qjZ24Ox7nJ1ERvYrfi7lTbfhgaGndMHjM0x9QMjRkaMzSicxj09&#x2B;F6KYqiKL9voij6&#x2B;gcpyu8DFfYpiqIoivLQAqoHTI8IA2GSCAlCEVEQcAqBGBBLsNEXpne2pNtq&#x2B;Rc/yS&#x2B;&#x2B;i8GX4qx9c2ntgnv&#x2B;9ZtbiwsLV9fKTz/99JnpJAFigJSA19FNkwAGRXqgf2ig3xox641WPIpMycbj0Xp9fXr8BZ2KyidLpmm&#x2B;8cG1is/&#x2B;5LvfyU4M&#x2B;Xs9n7x1uRMGJw72nxyNHR8&#x2B;VKh6/Rnk&#x2B;/QjffpyEXu7Zbcqa4X1yB/hhsEIY9if0NfdOEslCEAIJCC7wwjJb6yyLwjAtYeLrO4s4M23gpuzNJ1iUQjHQTr1KC8dRSgUZbEEEaEnh8MzOHsGjAEAo0gl6cckWliE7yMWA/&#x2B;Se0XGkEhgeIhubUvfRxSRRBzp9CNs4/0sDvTFaF8sNjEQExE0Dp2pu1VFURTlt4QxNf5B&#x2B;YZQt0&#x2B;KoiiKojxmAcAAzjA2Qqr12Okzpzc3N//2b/&#x2B;fWDyW7emtVhEEwd27d9cWZ1ut1uGRP7JNAAgj2KYpo0hyJgCEAbjWk0Iy6WgRhMCRI0fefuvtGzduxBOJZDJpWXazsXHx4kWvVHrth386MWKYprm5udEOYGmoVJqcWwBmDh149dVXL98p/fznP282PcZYGIaarn8atMnf4lfTaCKfx94e2h0YOnI5jI8jHvv6J&#x2B;bzeOvt9t//fbSxwYZHDcehyRTOnIL58CuGWy3Uqui0QQgsE7aNB3&#x2B;3OX4M9ToWF6FpJJFAJo1s5otPQgiGBnHkCHyfOQ7qNWQzODSN5OMZiBjn6i5VURRFURTlEanbKEVRFEVRHlpEeER4BA5CBagE3V9c22nBNE0wACKApkG48ntHk3px7P/4u4VBx&#x2B;gZHRYEQWxA6zsgJPnptc3jzwTHj2t6EwCGExCcCSACBNGIIAkGEDC0IPHilLNyLLc8e3l8YtyEF&#x2B;P6ue99/4MPP3jjWl4fuPev01MsPdEqzksOHZifna0Udy5cuHCkPzP00tmJ0RJvrl2bX3eCLSojJiNIAnTrCUl3kUM3/SPdAyKBbonf47Ozi0uXo48&#x2B;itbWZRRRy2QHDtDnnsWT52F&#x2B;ZUGc6&#x2B;LaDe/ixWD2FrwOJAlnb&#x2B;lDw5g&#x2B;8ChhX72OlgshAQK3g40NJOJwHGgadneR30ClAkbZQD/Gx5HNful5EnHMHIJtY2Ic7Q7iMUxMPGKxoaIoiqL8C/pt/m8/RfmtUGGfoiiKoiiPj2lCiJYfObpuaCgWcfXq1YOHh59&#x2B;&#x2B;mm7f6pWq4XJ8Z4etNvtRCJx5uz5H//4x/PzdwYHj2/MLtVrtWdOHJieSkVAtRamHZAHFWeRAKOJBF577bUPL77LNZ51AwDnzh9dz6/P3bkyOzt74fyUZZm75dL6escYMNtt9&#x2B;aNG6dPn07nMskYjh/PatpfTM4u&#x2B;0HAOaefdueSR94p8XDKFXz4kf/3/9l7511RLBDDILbDV9f1TodFIU6dRib9pc&#x2B;9PS8uXYrWN4imS0DUG&#x2B;HqGs/naaP5patyv4LbRncmURjKvQK5fh2ra3Ac7O7CdbG7J7a3iWXhwAEcOvillX1d2QwyKUxPwffBGGKx7shFRVEURfk9IYHfi8G9ivJwVNinKIqiKMpDYzJiMqQQkPvlbyHVBJhG4TWCD/NrUsrpsZlGA/98ZWlr88Zf/dVfPXNioNUZqEZIWZhMs05MHBnre8ckm9t7S8vtD67c29srLBeDPzCfphSzs3fPj8SPHh5KSCACfA&#x2B;m2RticJQNff/ZYrHUPxptbW/1cAzFpAjDWrXaCkGs9O3d8D/&#x2B;7OrhA/27NXs7ShVJzyAQABmGZ44mDvUddd2WrumUMEhAdN87YZASAmCQIIQSQADdmX3isfwFIIpway742c87b70Vbm&#x2B;AMhr6pNMJ7xEZBnqrxTs&#x2B;nnkKqS8qi9vdw4cf&#x2B;9dvQERsYEDUaqJcjorFaG&#x2B;PNhqP8mYYBedgVPq&#x2B;3N1Boy6lhGGIzS2EASJBDJ2NDGNmBgemoOtfczZCEfsV2pAVRVEU5XeNH6qcT/mmUmGfoiiKoiiPT4gwDDc2NmZnZ5fHd86cfq5UKt1rbTWbzVgmad1vOT1z9qznebphJBLxvULh3t27lUpFiOj23Fw8Hp&#x2B;Y6Ll48SIO9AwODiQSFAzdNRGcQ0rkenTDGOiZwcJiRgjZ39fPGY&#x2B;i0PNACHFd99KlS6tLGgERnWa1Wo0Qe7ByN5nUentSHBEBAWS3h7f7lh5PB4/bxs4Omg3oJgb6Ph1gV61heSXa2CCU895BomkIQ9lui1pNzt&#x2B;RHQ&#x2B;R5L6Hc2cxPPy5E1aq&#x2B;PiS9&#x2B;GH4b1loutE1yGE9DwpISoVVKuP8iYdB7EYOEMYyHpDNpqQQgahDENCCXEcOjSAw4cxc/CLw0dFURRF&#x2B;WbQVR6ifGOpX25FURRFUR6aLjp61GEygAy68&#x2B;18wjgADR0jdnm1emutdnnlVu7UCwVjxBSNupbsDqVLAZHE96cwFgyYSbEyQne9zpmx1JtvFp9//jurxc7bs2u7frTVtv6/SysnX6YDcVAKSVKIoFFBpOSUJWxoQGJQIzqxJ2MXjvQKEcBvpWxttYYMY33nXnzvvfcMJEbXid6DQ6Owu69OIyJZQFij1ck4pqCMSgmg47dM3YQU3ZZeAoFu4R95mBBwZwfvfyiuXhOtJhsYIGdO48yZ/TZYypBJ62fPaEePgDFRKoVLd6PVlahQkq4b5fPexYuy09ZcF6dPw7YBoNXC3h7W1oOPPg7mbotSiXAOyqTXkV6HQMhGA9UK/AC69nAXL5FAOk2SSRKPIYwgBAQhhklNg8QcMjCImYM4ewaTEw93WkVRFEVRFOV3gwr7FEVRFEV5nBoNz/M8KWVhb29zs53NZusrjWKxNhBP&#x2B;hIgEAKhxMzMRMXF889/Z71Obdse6O/f2ysYVjYMgkajWa/XSNje2ChHPRlKoXV7SSVAiBDgDAA4Z5qO4eHh1374w9XVVcMwKpWKaZqWZQ0MDLz04kuv/&#x2B;Q/ffD&#x2B;&#x2B;7zcVzl75tnxWDZJCGVh4EPXbcsEQCkQCFD6GOr6PA&#x2B;XPvF//Hf&#x2B;xx9LKdnIqFEqsSjC&#x2B;XPIZpFK4sxpevAgTAONBpu9RRhH4MswkvW6dN1wdRVCyEaD31mg6QwMQ9br4eZmtLoa3r0XbW7JTguSEM5BKGQIwaXvo9lC24X&#x2B;kAtwbRujozh2lBk6ylVRLkMChk57ezE2goOHcOwIJiehqbvEfd3ol339A79YCDQ6qDS9VifQOOtNWZmH36qiKIqiKIryq1O3cYqiKIqiPLRuxRt58F/dQjhAMHgRPMF8yVtRWGlHQo/d3In&#x2B;r3&#x2B;6&#x2B;t/96xf7c4gDOoPWqoFYOYN878zEtqt7XufC2ekPPvxQJD3RLmUTk46uB0hu18Kqj1YFkQPHwYCkALbbSNhIi8DRJKToT9I/PJ/bGJAkx&#x2B;8SY3ww67ZazXY4OjnNEgNX7uT9RuXGSmnv9NCzzzx5IANL1wNAUDAgCGGHBAbhhinBQKIHnwNEPFxr7&#x2B;JS9NFH/pWr4foaYbpstuC1DUIYoThxDOkMenqQ6wFj2NpCOk0H&#x2B;mlhjzYaURCg2YLvR5ubolwJbt&#x2B;m2SwxLdnpiGIxKpVErQ7Pg6TEMolpgjG0OeEaKEUUIggf5fpNTYIAA/1YXaOra&#x2B;AcsTjGxzA1iakpDA8&#x2B;yjm/iQJguxJUGp5l8IN9JoDlordZaqVixnjOiX/lPMOah/VCc6PY3Ku3a01/o9Sou34uaT95qO/8dF9fTG0yURRFURTlN0WFfYqiKIqiPE7JpDEyMrK5uen7JUIIY9y27CuffHJiJHXh&#x2B;dM2FTGHwrSE61LLBueZNAOc575zam19faUSDg0NTU5Mrq2tNcqlwcFe28bNm8uLO83h4eEnRwyv4y1VOseODqY5QAiCAJqm6xgZ6W1pmJnJvfTii7Ozt9bW1tbX1zVNgx84trO2tvbTreubm5t/&#x2B;OTM&#x2B;fNHJAEBhIQQAKMAGFiE6NHvigoF3JqLNjaJZbGBIdlqiVotXLoLTTcAVq1ibBS6jnYbzSYqVRSLstGQUQSAgIASKYh0XdlsiVqNFkvQOCIhfR9SslwPy/WQTIYaphSR9ANRLML3aSoNx&#x2B;lOM3xo8RiOH0dPDwYHMXMIlCKeQH8fcj1IJB75a/jm2auFHy7sLG1Wp/qTPcnRRtv/m3cW59ZL56f7f3Bu7HC/BaDoypWd&#x2B;m7NbbaDuKVPD6ZGc6Yf4fJS4c0b&#x2B;bl8ueOHGmN7NbdUb6djphdE2bjZd&#x2B;DLly8riqIoiqL8elTYpyiKoijKQ/OJEVAjJByESyK7TY4MQAv9Sbz85JG4qKN8yWysD/JGYex4Mpm8sVLr6NuH&#x2B;wzDMGb6rHQqxQWCEJyBAMdy&#x2B;LffP3vp&#x2B;tzo2GhuwNhy2h&#x2B;tlYczAEGx2vyfX58dGCiuHUu5rnu3gZedwT&#x2B;f1ihBFHWIDDU91EjEhJE08dffm7ozTP/p4zuXP7nMKl4PwuOHX87nY1c/KcwXrm937Ltk8uyImUojZwA6EAFABNIJpUEpCAikfFDfB/kr7enbK8itLRKP6U&#x2B;cj/b2wltzotWSHS&#x2B;6t&#x2B;yFkVYs0uFhAKJalY0mfF8GoWw2o0JB1GoyDEAotO6sQIBS6fnwfTBGDINm0tqRw/pTT2FqEn6AUlFWa9H2NtptNjGBsVHEnEe8hJRgaBCZDEQEw3jE0PAbLQKWtmpvXs9fXy6cP9ifTZhre/W//2h5q9zKxs2ON&#x2B;RJ7FaDn1/PvzW7sVFs&#x2B;qE4MJB87sjg8YksAZ1dLX64sDOfL/cmrSMjWY3F3E64WWrdXCmenux54kD6kfuCFUVRFEVRvpq6sVMURVEU5bExDACYnEjlcj/o6znY6bBioVAsFc&#x2B;dO5efv/LTf/iH2pGBRr1xPRa99tprIznT0CEAIRFKHD08ZCazmYxpmBgeHm58PJ/PN6dTsTAMNzc3a7VarOh5XmcrsoeHh/3RYdPkmnl/&#x2B;BmlQQCuoSeFJ56YaGk9lm29c3lOCDEwMGDZ1rUrl7fy&#x2B;dmbs1EUFQbYxMTEkZHByYk4ABECDAbXIKJH/NiVimg0aDJFU0kAkXGXGAYiIao1GSyLZpMu3UUkRLOJIIAQABBFMggQBIRzGAZhjHAOxgilIASGQW2bJJN8bIQ/&#x2B;wxe/h56e9HuYHeHVGu8VkUkkevB2OivG9JZ38bpcatlP19o6JyP98f7nC9op&#x2B;0IhALre62Ltzffu5Ff2WtIQAixXmjc3arGLN3gzI/E2l7n6r29n11fv7FSlFJyRu9u1whBoeam41ap0fGDiBJM9iVfPDnMKHnzxsY7sxvb5Vax3o5&#x2B;jSGAiqIoiqIoX02FfYqiKIqiPDSfmh41Q6KDkO5sOy4jThgkokrLbddtw3h2Kk1hvl9d&#x2B;mmjs1eo1HxtbmWXG46u6zeXt7yexe8/ezyTJjkDhMDyXN00T/QLyBaE8&#x2B;qJoaWlaa&#x2B;Yr1UPM0pldmqr0bhdaESh3GHm5Y3OWsXLZnjS0AigCxeExPQIUppCA/BHB40XBk&#x2B;cHorvbO&#x2B;ks7GRtPN3PZMoR3e83PqdZmNz/c7y5mJf5sUXXnxyMkUpxKefbP/j3C/n&#x2B;9Uq&#x2B;5otUSrLVktWq9HGpnRdQpkEQIgMfVEoiFIJkUAUgjHCGHSd6DqNxcA5MQxi28SyiG0Ry6SWTWyLxGI0Hkc6jZFhHD&#x2B;O3l4AsEyMj0NISAGmkqJHtNeS/&#x2B;9Hyxfnt8dziVfPj&#x2B;kTPaaOUj0UkP1JLZT4ZKm0ulNPOkax3v5wfmdtuxaFYrfizm9U6i2PM5J2dE1jO&#x2B;XW/Hr5o8Wd3Yp7dCxzZCTjh9GdjeriZmW77E4NJB2DGzpL2saBweSTh/oZJfe2axpjnSD0AvH1b1RRFEVRFOVRqbBPURRFUZTHqVav3VqY293ZSZl9/&#x2B;WPXgn8Jw4uR6tra7bOGOPNZvOpp57aW/UXFxdjqI&#x2B;OjBwbTQ32J3XTbDUajqMhirxQHJge&#x2B;5M/zfm&#x2B;n0jANMx4PF7Pb6AHhBAQsre7u7XJalVnJGenUimdEQCIIjDWXarhOHrMybz6amZxodqIJUwTQ0NDe3uFIApra2v0BF1bX9tbXsjlckd7n81kSAh0wsh6tJUJnodqVWxsBnfvwvdFtSpdF5wTyyaGDkIIIAkhlELXqeMQxyG2RUyLODZNJGg6RZJJ4jiIxZCIIx6H48C24TiIOUimYBqfezlKVE3Yr6Pc6Hy4sPOza&#x2B;tPTPednOyJGdpOtXVjpZSw9e&#x2B;fGZUS//mj5ZvLxeMTPbbBXS&#x2B;0Tc0TMh03ZobTQRh1gogQeEG0uFm9tVZa3KoMpp0/eXLymcODhZr7dx/eW96u7VTausYm&#x2B;xIE0DhNx8zBjE0JSTm6rjEC&#x2B;esvf1YURVEURfkKKuxTFEVRFOWhZf1Cj19wuIHIgzQAuIRxQCdYbRjvzReWlpYdufvKD18ZO5L493/cf&#x2B;XKlULHPvjc8NyWBGPP/dlfvvHG7deXGtvvXvvLV889/3xyQKd2PMkAj3pJRhHi&#x2B;SN2vcF9G0efmblwY&#x2B;GNe3dhnqNAbwfH&#x2B;kZ/dle23bKlLZ06ffqPjyQAhCzSCZOiaDCDCQdAVoinJ8y20fQ97y&#x2B;eSho7lbvFHpcZO83mD//sR5ff&#x2B;MfXL370Ry88ZxMEgORMSpDummEQIikkYZJ&#x2B;fa62ti7vrUTr6&#x2B;HdJRkGgCSE03icDw/TVAq6TgydWjZxbBKL0WSCODEZRTIKaTyBkWH09SKT2U/3HBv6V254VR5GpYOtcqtU70ggEzPHep2EjjASrhcGoeCMen60vFv/6M7OO7MbU4PJ01M9jND5fGV2rdSbso&#x2B;OZQ6PZNptf6Pcmh5I/cG58VYnWN6uFRttP4hW9uqzq8VGOzgz1XtsPDuR1R2D96ZsRknbD/0wlFICoITonFo6JQBnlBAIQEopf7WaUUVRFEVRlEegwj5FURRFUR4bxpCIx&#x2B;v1um1ZlrSuXKlceDb95LmTfX19JT/WarU6H65ub23DGYnFYnduz&#x2B;3u7ly6JBOJ5M3K7KmTJ48POwY3IIEQkUCtVm2KjGHwF198MYqirZJDQBbml9Pp9Pb2XD6fN&#x2B;hex/Oeyr2SSsOPPN2yOeMA0M3toghScnBu8GeffRrAh/Op2dnZbLY8PDTknTy5trradjtSmiCPektUruD6jWBuLqpUYBrMyRDHYYkUmxjXDhygPT1wbMRiSCSQiMNx4DgQgqysknwehg7HQTaL4eFv5&#x2B;y8X4UPrO11Wp0g5RgDGd34ooCsI1F3hRdEpsZzzv4jbm62Pr6zfe1eYbfiGjo7PJJ57sjgmQM9fhiZnCUdI2ZpErLW8rbKza1yqzdtCyEZkyAgAOe0P&#x2B;2kHHOv1iq7fl/aPjSc3qu6us4IqJCy3g6qLY9QxEzN0jkACYSRFFJqnJoap5RGkYyEFBJCQkp4QdT2IkJEEAlV3KcoiqIoym&#x2B;OCvsURVEURXloIeUh5ZJQgFIICsoBBlAJU&#x2B;exRMoPo6GBI/Mb5f699Hd6cXy4tyWplDG/5b3&#x2B;&#x2B;uu3313lnJmineDN20tLiWx2Y/XOvbq&#x2B;ee54LmccTiHQUCrj/avLQVgcHR198VSij/1grXB3a2urunM3aL0dSsOPqro1c&#x2B;WW&#x2B;97kwqFDh&#x2B;o12duL4Z4UARyGCLB0ARAamYzicBb9Lzx9bMa9NlbKl/RcXBeDua2VhWpxe3J0opu8kP1/Adiv75P7B19ua0vcuhWu54ll6aOntMMzfHSU5HoxMoS&#x2B;PiSTsMz9qr0HU/ZKJczdDufviI7LVtfZyRPQdYyN/oau1O&#x2B;7T5bKP7m04naicwf7nj8yMJb9tPKxI7G6076dL60XGs1OqDEy3pd87sjAUJLfK3pvXFu/eHtrbbfuBxHntNr0u9V8rheGQnBGWHf5MiGcUVNnlsENjXNKLI3rnGmMWgYnhHDGCAEhhABCSim6ndmEEnBKQykaHb/S7FQS1nqhsVFsUkImepMTvQmNkUY7aHYCLwjDCJDwgiiMIkOjnBGiyvoURVEURfmNUWGfoiiKoiiPE2N06sDU9ntbge83m83Ll3cPnkdfbx8BNIpnnh5ttb7z1pWlZrM1MzPWbrdv355dXFyUQevqlSuF7bV4PP6jHxweHRkplarvXXzPbVtDg0Oj0z88esw&#x2B;yE7M3uqXpr69tZ1I5BLJ5Pj41LWr127fnueaNjc77zjOc08eOzbTg/2xdgRAFEaEMzCkEziWsAcHn5u7V3Qc07FtQmi73Qbw9aHel6lUor0CwoCPjurPPk2/910cOoRUEl&#x2B;R5ezuRTdnOz9/KyruaCPjppR0chIjI6Aq/vkC11eKP/l4RUqkYvrpyR5gP&#x2B;xzI1y9V37j2vpHCzvVlhez9LRjNNpBb9Kqu/Z7c1vv3tpstoNj49lszCw1vaXNygfz26mYEbe0VicE0M36GIXGqMYZp/cvANm/elEkOn7kBVEkpBAijES3IE9ISYCkbQz3xEpNb6vUevfW1r2t&#x2B;tJ2dWmr2p&#x2B;xT0/2HhhI3d2udYKIUqJxRimIRDZhHRnNJB19su//Z&#x2B;&#x2B;&#x2B;nuS67jzB/84517v0rrKyvIO3BOgpkZIo0y2tJranN7pnX/ZlZ2Pe92Uj5m&#x2B;Zt42d2Z3pbnWPzNA0RYoS6GAIU0BVoapQNrPS57157TlnH7IAkhIlERLohPMJBKJIJLIyE4HAzW/&#x2B;zu&#x2B;bUj/96QqCIAiPDAdgAAkHzkH709byCsLXlgj7BEEQBEF4aBFSI1AowoAw5hQDljkQBDwBGVE/jDgmN&#x2B;810nnr&#x2B;s7t45h&#x2B;66WShiFJWEHDP3x6fjIvdXvdIXF83z/YW93eWjl68Tsbm5s3rrQlqR&#x2B;qyb/7&#x2B;5qnp5tgkSS8uXL79uXbL35jEQHM5Mj8D55/5513Gl6629w5aDYo0G23mermXn9v1/f9e03tqXb&#x2B;7DFaTBELZAJEBsAcLArAwZCaRQuKp/LDGNJBrrlQKzq6zGDIE4wxAPrYHjUE6DNM9sUx4oAsi0xO4DOn4fx5kP7glr84hq2t5O7dZGuD&#x2B;h7WLZAIZLMi6QOAQQz1TtAcBEGUGIo0XrBVGbf6wUHf1xWZ8k/suLu11f&#x2B;nS&#x2B;uvXtnseNF43qoVLFWSwpiu7Hbv7Hb/x&#x2B;V7q7vdJ5fK//a5hWrOvLre3GkONhr929udctZ0/RghwAgBAOfAATjnCWNBlCCE4oQBQgghzjljjHPOGB/48U7L22667UEYRJQjmCw6li6v13t7be&#x2B;fL60bqtwZhrosPX987MVTtaylRQk9UsuqMlqoZgwVMMD5uaKjKxlbPTNT&#x2B;LJeZEEQhL9IDCDmECcMY7zTCtqDoOuFwyAeuGFvGBWy5vPHq2OOqLcSHiMi7BMEQRAE4ZGRJAij8Nq1a7VaLaaFmyt7u7u7/7S3Pjc7N7NQoxQBgGVIx47PhwF3Mer1ksU7jU6nPTc/77ru&#x2B;u5qkiSvvnL9Wy99ayKnnD51mnW9Wzdv3rp16/TpRTdo311by01MXXjiwt5A0jTtv7&#x2B;6TAjhnIdBEMexoij1ev2VV1452I6OHj367NExMirY4AAIOAMGnEICALIMU1MZSi&#x2B;WbZNRkBSJAMCfsEgNYaRp2LaRZYNu/JGkDwCiCBhDpkmyedQj8uICXlqC8bGH/r5fc14CQQw9L6SMd9wg62ien1y9e3BlvbnX9oIoKWeMl05PTJedMKaaItm6rCuE4I8GMz7caL56dWujPpgdS52YzE8UrcEw9vxkr&#x2B;31htHKTncYxrOV9PPHixqCKGGWroQx7Q8j21ASxkZ3wjlnHBjjjPEgjPe7w4Ty/jDkcNigIUvEUCXG&#x2B;epu92fvb947GNzd76VMRZPJ4nhaV3Iru9br17ZXdrpeGFu6emam8I0T40/M5QgByko5R3d0&#x2B;fhUbjTH98R85uRURpFBlLAIgiD8OWKAmEKcQH8YtwZBqx&#x2B;0Bn6UsPV6v&#x2B;OGbhC5fjwMk74XdpruwI&#x2B;fPFNbrKbHHOfLfuCC8MURYZ8gCIIgCA8txnJEFIYQIIQhwYAkziREgBMVUV1TDV0tTZ189Z1/qDf7v47Q21tgz4KqolEPRVZKwIIEpFBlP3x6Ycr0p2bHVK&#x2B;5sbLVbA4aO8b6HV59GqYXlw52rytNvtLYXWm0t1Y7N27U5Xe8v/qrb55cgJo9wwbbnU6cyx9DCKcyxrHjx5GUfuutt1bW92ZuDzLG9xZnFEeGYQQGCRHhEngS8AgAQjBUWBjPm5QCZQqMUiQOHO4P9H22UTvLxIU8ajZh6EG3Cwn9I3mfLEOlrDx5EadTfODJi/Nw7OhH6/z&#x2B;EvkMEHx0fqobwNu39zfqfc6g3vPu7vcLjv7ssep&#x2B;23vnzv56vZ9Q1vXCtf2ersp&#x2B;lHTcAAHIEkYIPfgzoQBukFDGLU1WJKnrheE27Q5DghAhdhjThDGCcdpUNAQAIBM8WpInS0RXJFnCnANlnAM6dAkWAAAgAElEQVRIBOuqJEvkoBe8t9IIYrrTdBPKOeMYo7SpVDJGylAaPf/S7f2OGzqmsjSenR9LH6ll8o42lrV0RVqv9XVFKqXNoxPZ41MpgwAAnJqwl2q2&#x2B;tGjBhlAlr/QF18QBOHrjgLEDGIKfsge5HqtQdDsB61B4Pqx60duECeUH/R9148AQFckVSZhTNf3ev27B5Sy6ng6iOmX/VQE4Qslwj5BEARBEB4dBtms/eyzz7zxxhuy3ao36kTTdF3f3NxcXjYmJ3IplROCJAKUJ4AkiUhnz0xNTkwMVZwkRwrv3Ol2u5qs1vfrvd4EIZLrDihjvUG30WjcubOxvb3le7xYLC4uHLMt&#x2B;M7Lz&#x2B;/vdStj6cuXbxJCZqankZx57bXXNu/d9X3/0m8y5dJ3HANUFT7axAZAYPR/QFEAwsMUKogDmTz8xFU&#x2B;h8bG0N27tNGQ9vYhDEEy/tDtFQVmZyGfl555GgYDME2YnHzob/qVxwE2W9Hydme7MQgSOlV2zs4WR&#x2B;enbu/0/p837lxbb5qaHCW0N4zmKmldlfww6Q&#x2B;j2UpqsuDc2m6/v9q4vdOxDaXVDyjlv1VoQQCmivaTi6Xlrc4woqu7XUr5IIhSpuqYiiIRgjHjyTBMhhRkAveag8EwcgylVrAqWVOTyTBMhmFMMM5a6njOShnKTsf79fIeZeDHSSGlZx0ta2tpU/Gjgh/RZt&#x2B;3dEUmuJjWF6qZ0zOF6YJGANJjxlhuxg&#x2B;pLGFDRcbHYlsEoInD2YIgCJ/ZaL/eaGSv7YYfRXv9oDkIel40Gtlzg3iU8QUx1ZTDj3BMVR7LGpriZC017&#x2B;gZW2t0hv8U3e3cPUAYqaPlqYLwOBFhnyAIgiAID40hzBHmh0vuOADHkCAA4AQrsDg9tnrTee9Xrx6drqytrbVzZ&#x2B;6p8/94pVHagyzf&#x2B;va3TwMQGUkSHypIIpQUcyQCyFeJ98zEPxx8EPBsFQ3DVtK5t6Wmpny276vVOquuD9qhc7Scw6ubPbcOqRRM8DitU0sHef7o1oU9Fe8eOZ0bq0pbd3PttvLelYPnvglFE/yYZmQfADBUGGcKAgCQRmd2ySiP4ZqsAoP7lbyjtwSfIarJ52FiHKkKO2iygwaO4z/&#x2B;W2wbbPvhX/IvCP9MTxsAIODQHiR&#x2B;SFOmkjc&#x2B;8ZuW94Y/e3/ztWvb9YMBlsnZuWIUs2&#x2B;erGY0aA/8m/fa1&#x2B;/U7bQxWbKXatnposM5hDEtZczF8XQpZe52XMr4wI/7XuTHlH3ad68V7KVaNk6YFySyhMOY3t7pHPT8rhtVcqapScMwXq/3X7myxzl7e3nfj5Kl8ezZ2aIsYYyRHyaUckuTJ4o2Y3x9v8&#x2B;AKxLRVamaq8xVUhcWyvNj6ZSp5B19puzElDuGkjJVS5NsnVgfu4JOq5BW/5JnMwVBED4PMUBCIaYw8JOP53qtQdAeBIeJXhAP/HiU8ckS1mRJV4imkKytjmUNx1Byjp53tJyt5xwt7&#x2B;gZS9MVoimSKqOb9zpXN5q3VQkYUz7qYBKEx4UI&#x2B;wRBEARBeHQYAIZKxZ6dndttbkctmk6n0&#x2B;m0YRjrN967c&#x2B;d2kexnMtnvn59gAARJAEAISSijGJfKyjPPPq0oyu3NwdzcHEdoe2dHyWdyuVyjyxFCrus6jjMzOX7nzp17W51FI7O9fndldWX86AsLi/aLL77IOU&#x2B;loVwqyfJ6HMcDd&#x2B;B5AACSROCwcpejP9CT&#x2B;yewbRivItvmYciHPnx6MPU10PTh9nZno95XJHxiKrdU/r3ziffa8cped&#x2B;BHg2G8ttcFBE8dGfvG8aJ6/3XdH7A3b&#x2B;y&#x2B;fm17o94HypKY3rjXxgiZmvTUUolgRAgGzhUJn5jKv3SqljLUjUa/4wYdN1ze6tzd6y1vd4ZhTDAiGOHf8wfWG4ZdN3AMZWk8W0zrBz2/6waDYWxo0kTB9vzoFmrf3unsttyEsr4fZyz1&#x2B;WNj5&#x2B;eL7UEwUbDb48F8NT1RsKeKdtpUGecnpnOaQjKmmk/p4zmrmjMcBQCgYGjzRe1zeMkFQRAeFxQgYRBTCGM&#x2B;ivNag6DZ90df9IfRg2E9N4jdIKaMazLRFElXiKlKOVs1VCnn6Dlbyzt6ztFyjp63NUOTLY0oEtGUT5mkztqaRH6reksQHiMi7BMEQRAE4aFhThFPRgEaQ4g/uJiOQyBqRYHvv3C&#x2B;bBau39xaVfs346AXDjsxCkPuBvy/vX6lUq4oilxQkaLIRR0IwXwYabpyYgwmnp9fq&#x2B;8szPP9ofROEu5sSuEgOww5lqxQCoaYlKbQ5eX19TW1Nv7M&#x2B;oet9ZXWXvdKJf/cTAm5FBGAF54/sb/eX11dJZzHIQAwCQEFnECCqIYxSL9z2f/Rhj4EH2vg5Z/pLUI&#x2B;j2wbEALG/mh571dT04dXr2z99L2Na&#x2B;vN2UoKAIopI4jp&#x2B;n5/r&#x2B;NxzjO2tjCWnsjI/Qh&#x2B;&#x2B;v7mv7y3HicMAPba3kTBPjqRe3BXFOD6ZuuN6zv17vDsbLGWN7ea3p3dzqXb9VLGWKxmFImYmqQYynjBfmK&#x2B;9OyxMc6h4wUDP946GOy3PUUm7UEIHCxNxgThB1kfH61UPNTo&#x2B;vXuEDjElLUHwb2DQcsNs5a6NJ55Yr5UTuuaIq3sdpa3OhJBtaJ9cbH8/InqZEZO6fLLZydPzxSO1rKL1VRag4ymFFPjfgwSBk3&#x2B;aL2gIAiC8LD4g5G9BLpe9FvRXtcNPzayF7lBPAwSTSGj07iaTEppY1IhGUt9MKyXs7Wco6dMdTSypyugEfgs09RBlFD6WRfwCsJfHhH2CYIgCILw6MgyxAkoUlqFp56aLI1N1iZq27/ZbNTrsiynUik9gt3d3WsfXnNs572tm8Vi8eVnL2oqVpTDfXmWZR7LHUUIsgqcPnXqzuv3dnZ3eargOJDP55utJiYYEHR7XQQQRVEmk6kP&#x2B;tdv7JSWUoPBwCxWzp6ZGLZzP/3pT6crlmEABz7qSODAP5dTPKaFLQsZBigKfA2PCTU89trV7Z/8avW1D3daHQ8h2DoYvL/WWNntvn1z7&#x2B;5&#x2B;L2trM&#x2B;XUM0fG1JPjzb7/7kr99cv3OEf5jJEx1elyarqUejDW1xjQq&#x2B;vNa&#x2B;tNx1C&#x2B;cXL89HT&#x2B;g7WD3bZ7fbO92Rh4Qcw4YIRMXZkq2UcnstN5dasT77W9naaLEFoYz9Ty1vXN9jt&#x2B;1BtGccLcIE4oCxMaU8Y&#x2B;NjdpabJjKPXO8Ordg54XHvT9hLKnjlSeXiqfmclOFixTV6o5c68ztDV5vpo&#x2B;PV04PmEDQFqD754bpxQs9aO3i6YEprgoFgRBeEgJQMwgScALaWsQtAZhexTt9fzWwHf9&#x2B;7neaNeeH2OMNIWMTuOmTaWcMSxNPhzWs/W8o&#x2B;UcPedoo&#x2B;BPU7Cu/On15ZRy/vX8BE4QHglxXSMIgiAIwkMjEEkQI2AAjCFMATOEATAhCOKYAFEApTCMTcAxu0rUaH19vSfRfm8rAp0QdXkf6336ys&#x2B;Wq9VBh2XOnVuqpUBFoCJIFElB4ftX3qvNPnPxTO32RkOPmFNVZhyYyobD/S3fq0nI9TDSCmDOHIm7XSMKrmxsqZ1Wr9cL6c1vfeulJy&#x2B;YinSyKA9rJdAAIQDMTZLEmACjwEeXP&#x2B;ijn0cVffx&#x2B;cSo/nPADDAzDHxv0UmTI58n0FKlWD4s/vpISAC&#x2B;CYUg5h5RBRtlWJ4A3Ptz5r79afefKVssNLUcvpY3&#x2B;MHrz&#x2B;u7ydmdtvxvHlAO4YZJQZukyRqjvRXFIAUHW1p49Wvn&#x2B;E1PHJ50H36Xe8e/We42eX0obk0V7vmof9H1dlRJK44QyAMYZAKiqlLP1YlrHAHvt4dX15lZzMFNOHZvMzpXSjd6Qcx5EiefHQZR03DBtKhz4xw/0zpRTrYF/C3c2DwaaIs1W0jNl5/nj1VPTeUcBJ6c45tj5uUJCuSphx5Csj9XgWpK4BBYEQXg4DCDmkFCIEngwrzdatNfs3z&#x2B;KG8SeH3th7AZxnDBNJqpMVJloCkkbqqaQjw/rjXbtWbqsK5KmEF0BDT/KOTyR8wmPOXGlIwiCIAjCI6VpEqBRzwNCkMtJFy7Mz8zO9rzkjTfeuHlnK45j13P7g36323Uc580332w2mxeXKrWJ2kROkTAA8KtXr23uS9//7sXnnj03OzsrZ9PpNKTTaUVWdnZ2ojgGDhqB2kSp2&#x2B;tKRNrd3W2tdBjnG1ubcRz/3f/03W&#x2B;9uAA95hjAOQOEPt7G&#x2B;4gRAlOTSnAB5udA/&#x2B;KWuy3v&#x2B;2v7PYXgM7OF3&#x2B;rHAAAKh2NrbsK3Gv5mc7DfHgZxQilLmeqp6cKJcRMAul60uttd2ek2e0PNUE5M549MZPvD&#x2B;PZOJ2Hs4kK5lreag&#x2B;DdO/Urdw9yjl7JmBGlmi5rqnx8MvviqfELC0X9fhyaAAz8aBgkjDGCEUZAKQQRjWJKCDY1WZUJ4xBTxjnHGI3W8fW8oOdFrh8f9ILlrU7XDe81XM7B1CRZxqYqlzPmVCk1ljVt/aMJj8mihnF5PGf3hqFMcN7Ry1mjkJIfrG3KapDVZBAEQRAeXgyHrbj9YfyxXC9o9f2OGz44hPugG1eVsaZIqkxUiWQtdaaUSltqylTSppq1tZyj5W09ban3cz2kSSKJEITPl/grJgiCIAjCQ8OcYk5HC&#x2B;44YA6YAWZACEsAE99tJUmSTuVhGICqHlN9uSbXQ93oFGnI&#x2B;/1&#x2B;urK0s7NLymdmn3xha&#x2B;X95d9sfnh3/ciRI3/z/fMpDUzQrOzxTneVw4Wzs8HiREzkBAF6dn6ifu3d7dstGxelbGkIgKbB3eeDttRG/MPV8Pjx49Vaam29d/3GK9Olb2VTLgBIvgkyAQY4UUAbYuAxmPDJwt3R5/8MAKGPFvYB52hUOPJHzc1CNgvFAqAvaN/bjV3vv7299qtbezMlp5I184YJALt9urbX2266jPNK1pwuOapM9trez97bfH&#x2B;t3uj6tqHkHW1pPLswlhndjy5LxbQxWbTrBwOQyVTRqeasa&#x2B;vNrYPBmdnC3z4/P1/JXL/XWtvrXd9o3d3vMcYHw0iW8VjOPFrLnpjMZT42y4gAFAlrCpEwDmO61/ZkCX&#x2B;40Rz4cS1vH6ll06YaxdT1o2GQ&#x2B;FESxZQDZC1tcTzd6A0Hw&#x2B;iD1YOxnAEAp2YKxyezM&#x2B;X0VNE5N1&#x2B;YKqaemC8WUx9duKoI5gradEHj4nJWEAThz0ABYgYxhSBk9/frjQb3/FY/eFCGOwr1Bn4EANoos5MlW5cLKc1U5dE5XMdQdEXK2mqtYDuGaqqSoRFNBvXrt&#x2B;JCEL72xNWRIAiCIAiPDsbguddvX3fdgXX8bNZKAYBMZA783tZurVZ7TltotVvpmYLvB5qmnTtXYsOxGzeu7y6vNBqNF87POBNZDHDu3NnlO9Fo244iKwQkADh1NPfKK6k7m/eOHTtaqVQogAUwXh0HFGYyGc&#x2B;7OzMzMzt1/pdv/PLGjRvHjx/PFg0A4IwhRADuR3qfx3xfpQLFIpDPsjH8z9XyYWWn89atvX95d&#x2B;PKWgOdrkUJBYCtTvLzDzbfvLGz0Rg4hnJiKn9iKpd39DvbnffXGm/f2h9G8bGJ3FwlNVGwShl9dG8FB5&#x2B;aLuy03M2m2x9GmkIY581&#x2B;EMR0PG&#x2B;dnsmnFAgqKcdQKOd&#x2B;mPhRElMmSySf0ipZM&#x2B;d8YpKRABRS&#x2B;lQxVc1bQUzfvrX37u361c0WZfzJhfJTS&#x2B;WciRjnEiaOodi6IhGMAKZKzosna7au7LU9RSK1gjVa2zRVcPJpXcIII2RqxPm0vU1fxCsuCILwl4IDxBxiCjGFziD8WLTnt/pBz4tGud7g/sheECUPVuxpilTJGtOyk7XVvKPf78bVco7u6MqoYUMi0BpEXhAZimyoUtYhf/LGPUEQ/kwi7BMEQRAE4aG5uOTiEuUOcFnhXRnkCA0IEOCFnQ76x0v6/n7vlQ&#x2B;u/V//5/ckAAPCBJIPfnH1Oy&#x2B;//LdH/F6fmEWo7u/4d&#x2B;uLasiOn/gf//wvA//M9VvaP7357v/&#x2B;9y87AJgEi0&#x2B;81Iggr&#x2B;gIdNttga5DGP3Hv3nylSOz9Xr9pfmxTAIOwPyYdU1SSmFp8912Hm699OS3DT7x7lu3d9frZ4qnAACZ9x80AaAGAGAC8Mma3VFmRDjAgzCQEwDMufRZt/58DkkfBegMgTJWsDAG6Edw6U7j8trBnZ3ORt1d3eshyjRF4hx6Efzm9v6bN3a2mx4A98Pkzk6n5wUz5XRvGMaUUc7TpnpyKv/88bGT04XxrPLgiZfSRtbRNUXqeqHnx51BOPBjjJCpyaoMAMAYJAkDAFWRLE1RZYIQwhjJ5FPGGMsZ9dR07m69uLzVfne1MXTDYcLOzxe/daZ2ejpFAHK2dnGxFCXsqaVyMWUAQMFETx8pz4&#x2B;lEsoNTTJV2VCJrv7pS9kFQRAEGLVnUIgpuH7y4ChucxC0&#x2B;n7bDd0H53BHs3tBLBGsyaPGW5K11LGsYRtK3tZzzuGKvdHXoxtoMlJl&#x2B;N1dCevD6PLawTBKCo52tJZdrIr2I0H4coi/eoIgCIIgPDoYWq3W/v4&#x2B;AF9bW6PAvTjgxDOxmc1lr169Oj19Ip0vuHEyPT19/ryay6lFBoVicdhnqqr6vn/ggxoPr127NlTyR5aOZEqSBACSBACgKGo2Oz&#x2B;fnpubKxQAACAA4DAxpgyH45TSMAxNDKdPH/XaO5&#x2B;obv2aaHis64aWrmQt0huy65ut5a2ObSgvHK&#x2B;OZ&#x2B;UP1lr/9Ver1zZarh/HlCWUSaqkSLjjhlfvtt/4cHuv452YzKVtdbMxuLvXrXeGB71wqmirMrE0ebrkvHC8&#x2B;tSRsUpK&#x2B;ngwyThPEkYZY4xHlFHGASBhvD&#x2B;MdlthxlaXt9sdN0gZylw5NVGwrtyVgogOQxolLKH8k6kpGAROTuW7XqgQvLrXMwguZMxvn5l4aqk8uuicH0v/3TcWNUWaLFrp&#x2B;0eACyYumCYIgiAIfxIKkHCIEwhj/lsr9lqD&#x2B;&#x2B;0Zo2JcP3KDmFKuKWR0GtdQpayt6op02J4xivZsLefopibrCjlsz/gMY/HdALYOBqt7vf4w7GWNjKWVs0ZOF4d4BeFLIMI&#x2B;QRAEQRAemgptBVoyM4EBojoQmUPMQAICRsb2SWIYBqGly2u9er3eSYbnz52pnLu4teUmWAIAEg0ny8X/&#x2B;YWSZYJjwPNLmZ&#x2B;s3Jb8LvaySafbUdNvXum8vXz9wgXv4ukjMzOp84UUAEgASIL0BCgYYgAOYGgxjSIAc3wsVa3M&#x2B;S4POKRMmJg4ahjmqGOXIQAALAHcb939nAwSaPfj/jDinGdstZKW//BlVi&#x2B;CzYYXJTRtKo6hNnr&#x2B;Wzd2NhuDY5O54xO5vbb32rV71zfb89XM3FgqjLW3buxeWW/KBC&#x2B;NZ7woGUZJ1w2GYXLvYNDzoivrB0GYIASM8a4bbO33AsZliYznLcq5RHAtb52eKYynfvtBJZRRxjnjCMDU5FJar&#x2B;bMVt9f3&#x2B;//7INNTSZX7jb7frxUy15cLI8OamGMZIJkCWP8KW/hxlLk6SOVjKXWu76C0VjeOlLLFszDWxYtXLTSj&#x2B;YVFwRBeCzx0dReAs1&#x2B;9LEVe0Gr73e88P6w3mjLXuQF8SjU02RJU0gpbUwqJG2qDxK9UbqXNhVdkTRZ0hTQpT&#x2B;yJCEBgN&#x2B;JEmKA7ZYXxNTSpJgmwNEwil0/zuliUFsQvgQi7BMEQRAE4ZFJEpiZyZXL5d3d3bFy&#x2B;erVq/v1/atry6srK3/zxL89fdqiFOKYWpoOALYJ23sDp2J/&#x2B;9vf3trSG42GbeuZbJp5MBwOr1y50um0d&#x2B;7eOnny5PT3Tmazsj&#x2B;MVVWOYlA0uHO3aVl2uogJkYIQLANOHD&#x2B;&#x2B;srLyr6&#x2B;vzczO9Hr9Uqn0BTzfQQw373V39/tNN6gPgvYg8EJqafJSLfPEfGlx3Bo11XoU1ve9zXq/74UpRz9Wy1q6dOl2/dWr2zGlJybzc2PpnZb7s/c2V/d7rh9jBPcagxv32u1BAAADP94&#x2B;cN9brSeUfePE&#x2B;Pm54t39Xs8N/SDpD6Otg0HHiw56fq/nvw2g6Uqz5/fcACRJkUaVuAwjlDLVnP0pZcGc84QyL0xiylKGMl/NIEBdL9xuuf/w67uMsSCmGUt77ujYxaVy1w0WxlNeEB&#x2B;bzE0VbVP93fsDAJjIyOVMKaagkE855CUIgiA8lAQgTMD16ScKNPrBZqN/f2TvcNceRkiTyWhqL2XIpZRu6XLufqh3OLhn6/roKK6CdeXhdia0A9ioD1p939Tk8ZxVSMk6AQDoR3Bto7W83el7cUIZwThhrOeFHTesZhUROgjCF0/8vRMEQRAE4aEpqKHCgcyqwIAkKmAAogOSKAKMYe7Y2PLd91md5wuTBwd8uWNvfNDcX3/zP/yH5/IZYJgYAGEIwdC//Obrc8eOvnRyzvq75&#x2B;/cvlOe6tW05EZHQuoYVasDmr21z9baN8oZ8wffX5IN&#x2B;eZ2tN4ZzM7mPri7TmmSf2Y2baVtAgBwYvHo9Q&#x2B;uvvazf22ebO/vrJlq5ki5DPen&#x2B;RKI4P4wwiNcB3d1vf2fXrl1c3lvEFMuEUIQA2Qo0r2DftcLCZ44MW4lAG/favz8/c3LK40gTJamcv0zEzlbe3t5/62bu4zxMKIJZe1BsN0cNLrD/Y53Z6ez0Ri4fjyWNaeKThjTG/daa/u9rKWdnys&#x2B;d2xMU6Tf3N5fr/f9MOkNozBOGOdeEPe80DTVSsYglEmqlLE0ieA4YQllnHPGP2UBIeM8iBIviBFCGUtbqKYrGWMQxO&#x2B;t1g&#x2B;6PueslrfPL5ReOFEtGGDr2rfPTJ6dKdUK9sK48wcKFhUARdRnCIIg/Bn2B2xtv9fpDg/ccLvlHvT8B/N6o9k9jNDhaVyZVHOKpkgPcr2crY/aM2xdHm3Z0xXQMPw5R2o7Abx7Z/9XN/f32l4lay5U0xlLM1UJEGwdDN65U99s9HVFyliaocuqRIKIhvHXcKeGIPxFEGGfIAiCIAiPjCwDADz15PRB4&#x2B;LlX98pFAofXL5cLBbHxsbe/ef3fvnLk4t/lXLdkOOoWLAJ1v3Av3LlyvFjc&#x2B;fP2xMT50BtAPCUAwiADQaoVJqZmdnaunft2rVvfWsJEfj1b359fWuPs5cajcbq2urFmpw&#x2B;engm9MhSemZm5uf/&#x2B;tZgMIjD3pEjRwDKn/fzXdntvnp1a3d5T83b85O5iaLNONQ7w2sbTTeIx/NWrWDttrxXr2796tZeve1hDmgb66qUsdTtA0&#x2B;TiRfEmwcDU5MTxhiAIuG&#x2B;H97e6W42BpSxWsGeKFgJZbttbzCMxjJm1tYyFjZVSSIYABACiWCCEQKUdfRz8&#x2B;Wjk7kgTvZbXpDQsZwlS3gYxm4Qe0GSUPa7BbYEE8dQZsopXZUWx9OTBQ0jLUpq5YzedkNdJtOl1FItM1fUAEBD8MxijoJozxAEQfh8dQP453fXf/7eRrvpdSn1wlhXpAcHcvOONp63psvOxws0MpY2WragKUiXHv1b/Z229&#x2B;5K418/3Gn0hhMFa7s54BwUiagqafeClb2uFySVjJG1NUdXcikt7&#x2B;gpQxHz3YLwpRBhnyAIgiAID41jnxOfcwwAiAFQkJBECAEIgbFpXf9f/vr8tGYslfMfEmY46veeuxDdOPjwym&#x2B;unHhibW0NuXD&#x2B;/PnpCqoe&#x2B;8bB7jvDJEkjqZoBWVWA9riZP17T0hlkQvf40VlLx9v7N3cOIJOD5e3u2zf3tNKu2yXL&#x2B;7QepfqgGDHIMuRN&#x2B;OG3z3ebu61Wu1KdGnNslQMASAjg/kwf&#x2B;qzdup/tRQDwgtgPE64pk2Ppl87UTkzl24PgtWtby9vtIErW93vr9cHltYPLawemKn/3/FQU062We32jqSpSMWUsjWfW93v77SHCyJAJY1yRpIEfd9xo&#x2B;2BQzpqVrDlRsLtuyBhnHBjnYUz7PrTdsOuFYUJVRSqm9CBWimmDUjZWsHRF6gehqkrlnFnJmh03opRLGKsKwfhT&#x2B;nMzlnJ2tmioUspULy6WR8N6F&#x2B;bSS&#x2B;PphHJFQpb6iYCQ/G5eKAiCIDxqzUH41o3dV95cSfoBKjtnF0rn54sP5vVyo25cWxsdxf0Dc9aPCgfYabp3drqN3pAxHlPeHgRBzFQJpywVY1Qr2JpMqjlromgVUkbO0copYywr6jkE4cshwj5BEARBEB4dzgHjAUDJID/4wYmgA0eWjlwdDMcq1tFjx65evbqxsXHt2rXedmd9ff35CydPnloq505okkRjiBOQVQBCAODJi0&#x2B;&#x2B;vOHW6/VSqTQYDC5/2Lx3r1mt5m3bZpRtbGxIfMg5UxTFSyAlA2PgBbAwn/vxj3989&#x2B;76dG3ctu0v4OkSjExNHqT0Wsk&#x2B;OpFbGs&#x2B;s1/uqRAAAITQMk5Xd7qXb&#x2B;3tt7xsnxv/m2bmuF/3k0t1f3dzjAJMFe6acavb9G/faXhDlHV2RcD6lxQnbOxh02l4pYxZT&#x2B;kTB1hWSsVRDlYZhsrzdDmP63mpjszEYDiOF4PG8ZWpyvTtc2&#x2B;1u1PsrWx0vTiaLTq1ozZRSu63hkVq2kjVPTecd41NiuqwOTy7lTs3kFAke/DoByGgAf9Z5L0EQBOFPF8RJxw3cng9BPFew/903l757blJXJE0BncCnfHTzOdsfsFtb7Z2Wl7O16bJTyZiKhAHAVOW0pRqapCuSY6hpUzFUyVAlS1fSJtG/&#x2B;AcqCAIAiLBPEARBEIQ/QYKUBCkU5NGwHALAPAbOgQ8hYRVZ5sBNTowsKBcn59eWz0H7F61rU3p7QNmd7Z1M5Vv/ePnDX2&#x2B;8&#x2B;wOv&#x2B;FfPljoAOQkYADACGKepf3Y8/o///tuXLl3S9W5o9m6zrhwe6JA3FYXhTMwdN7YanvfzX&#x2B;&#x2B;X5icnoM8wM1RTBvnUUvro3BlLBpqA9LHyXYlIAIDQo3zbgQAQQhgDQpBQ1u4Ha3u9O9udg56fs7W5atoxlJ2mu7LbDWM6nreOTuTag&#x2B;BXN7WYMoxQMW1MFu1bW23PCwcdj2A8N5ZyDHW93ut1hskwUiWctbWijVXZWqhmJjdbja7/6tVtQ93fbw&#x2B;bfR9z7phqrWDNllNJwjBCW7ZaJdcAACAASURBVAcDN4jSjn60lj09XRzPmeWMWUhpCKPFasb&#x2B;PYepVATq76naEARBEL4UBCFVlkAmwHg1b52d/ZQ69S8ABXAjCCN2c7N5a6udUHZ2rviNE9V8SpcwUiTyoOfXUGVDBYIBvhoz4BLBGImPrITHlwj7BEEQBEF4dBIKhGDAAMA5sAhqtRpJGYqqzM/PE0JkWc5kMqqqnj5z5lev/fQXv/jFfGHReeIM74KqguVgYAywhBUlq6ILFy6aeWQY&#x2B;t7aLUVRAWBmZoa8taYochgFvu9/eP3622/PLzxDVUlViAwAigyMA0ZA1PvdHJ8njBAAomGy0xi8eWNHkfDWgXvQ92cqzrNHxiYLztp&#x2B;tzcMAUAmmGBgnMeUUcZTtjKetypZ09RkFiVBz6el1GwlNZY1W30/8WPMuW0oaVPFABkNTk7l1uu9S7fr6/Ue45Ax1fmxtEzIubniVMkp2&#x2B;TJpbKmSh&#x2B;sNcopvZKzFquZyYIqAYylpMWqSeBLGAMRBEEQ/mQIIUIQEAwYAQBlj3INxWfXD6HR9TtusLrfixK2NJ5&#x2B;8eT4c8fHLA0BgISAfFWHwDWFEIyBAzzSDR6C8HUhwj5BEARBEB4a5TblFkUIEFACEgGGE4IAsAFR3EmCnK3JHDBtaZY&#x2B;oxMI2t99avZOjrbH87mSs9lVC4WCiwuX3t988ikbZ6tb7yzXarXnzk5nUmDzDiCwkGblUQxwasaxvnmuUjFxBLN508BgSYSaGcvMbO&#x2B;3/vG/v3GhOn9k7khy/7FhBRgDgu6//2AJAACVAA4nDuijy71Gd8jCpN72IsY1iVDGx3LWN0/Wnj9W1VVpr&#x2B;MBoJjyvh/dO3DX6/3tpqur0tJ4dmEsnXd0S5MxwTxKJIzmKumZivPhZkszFEWVZsupvKONvtHieOY5t6pIZKvpygRPlZyMpTqGcnwyV3UkAKg4xD5aevZoiWD4rdO6Yjm6IAjC1xgCxngQJX/8lp8DDBAnrNH1h0E8P5ZerKYvLpbyX4dFfP1hFMQJYIBRXCoIjxkR9gmCIAiC8Aih3sHB61dWq9Xq8eJELX8/V2NsZiabSj9xRyWO7bjbrud5mXSm0WoPh8Pd3d3XX389m83FvZPfeOF5XRpIlg0ADMANodcbzs3O5XJWNwbd0FOplOe5AdVTqdRkLbu6unrzZjw3N99zg16vN14dIwAEQxSD9EUMsyEEgDEyVbmWt&#x2B;Yq6VJanx1Ln5svzpQtL&#x2B;DVnDWWMYdhsrrb&#x2B;5d31tf3evcOBpMF&#x2B;5snq8cmcpRDztFKeWs/obWSvTCeni2lTk7lG6eHxbTx/PFqJWuOvk1GgwsL5cmCHVFma7JtKJqCVRm0j72DsUSqJwiC8JeIA/AvaTrNUSFlKroijeWscto8OpEtmF/F6IwCxAxiCnHC227Y7Pu/urm31/Y4QkjCIM7zCo8fEfYJgiAIgvDQpESXEgPLMQBQiRKJhAAEQMHGRlv&#x2B;f1/ZyGS63zjN//7HxxlwJ4xBUSIAM0vSAKoUljW0vb0tuS1DBQwJZ2GDOzv7w723mltq729OFfKqHimAAFoduHTp&#x2B;rEsr1y8WNRAtvgLZyaWby/v7A8USXruyefb9ZvvrKkLB&#x2B;qdtc7a6vqZU8qxY/k8hkQGAxgAABpNQxAAYI/6cp9xDgCyJs9W0z&#x2B;4MP3SqdpEwc7ohzOFhonmq&#x2B;kzMwU3iFd3u6s7nZ4bplL6hcXSN0/WSjb2KMyPZV46N9keBE8ulY/VcsW09OKp8fmxdD6lL45l8sZHDzhvQN4wH&#x2B;3jFwRBEIQ/AAEUUnIUp2rUrmT01FdgwSsHiAHiBOIEBn7ccYP2IGy7QccN24Og44ZtN2gPgo16f2O/xzCWJLG7T3gcibBPEARBEIRHCSG0v7/XaNQdGvyvPz6FAR60P1AGgAEhlMvnBoNBY2erWq0SjJM4sW1HURQvDN99950FsFRVM6pLJxZ1VYPrN643ksbi4mK6mLYd9bvfO5vOpIfv3gqCoFQqq6pWrzc2N9u/&#x2B;fVv3n3v3d3t1TB46TtPjH8BlzgcIIxpGCVAcClnnZktnJ74RAUwApgtW88cqwRJ8uF6q9X3iyn97FL5xZPj0zkFAEwCZ2cL5YwBCKaKdsUmAHBuKnVqKiWm9ARBEISvAg3BbOFLC/kSgJhCTMGPWMcNOoPDLO9BtNdxg/bHYj7fj3mUsIgyyqhEAAMQkfUJjyMR9gmCIAiC8NBkSmSKiRwBcE6GDOQQMAEcYYj1idA6JknSeog2ABiA1pXTaZIAJBgsAF2hdnBQ02OcQqdPzxyZxRijSEnNHjlSZ&#x2B;PvXr6c/sCPop6cot8cnp/NQTcwh9v3giAicSwhNOlIuRdnsiWr2WrmbLdaiPe8U5vd7PKe&#x2B;uE90g7XY215fn68lAYFAAA0nAAABwIACcjw6CoCOUAQ0yhhEkaGKunqpwR0tgzn5oqKhGfLKT9M8rZ2ZDJ3bMJ5cIPJrDyZTX/8tyCxZU8QBEF4/DCAmEOcQEyh635yWG8QtN3wQdg3yvV6bsgiyqOERQmPKIsSFlEgCCQCMgFNAoIhoYdD&#x2B;ILwmBFhnyAIgiAIj0wcA2NU07RsLqdBv9VxXdfdf&#x2B;9WpVKZPr1kaUAANE3r9XoAkMlkzpw5c/KC2mq1ZblZKVd0JfXTn9bbJnFdd39lww&#x2B;Cv37uiGEYFCHOOJakJI4pgCXBhVPFISvSXry0uOStOrIMqqaZhjHoN9bu3m2326V09vN&#x2B;sgggbaqL4xkOsDieSRvKp94sb6BnjhbOzBY4B10BTdTifp3FACDSWEEQhD8DB0AAMUBEIU7AC5LRUdyPfv4o1wvbA7/jhm03jIP4Qah3&#x2B;DPnh7meTECVwFKxTNKWmja1tKUCgp2m29juQExF2ic8hkTYJwiCIAjCQ&#x2B;PE5cTlXAGOILGRDAhRDESRQVbcmO9s7a4XtOzWvWTo0f/0bluWBy&#x2B;3yMsvzxck&#x2B;Ovn/k108NNOp6NlrLvd5afMC0Sp/B/fP0JpXQ9uXHH/77f7/z6fn1rvXu3ttsp9955h4rGp23Y2gxBVSCXuIUkqUQMAGMjzTz//9lgjl&#x2B;&#x2B;3po3Ny53V/eFwEO1thUdnQBvV7iYyACAiw2El7yOb7EMAp6bz8M0lXSHHp/JTJeP33VIBUL4Ce46Eh0IBej6EMUUI&#x2B;n68vt/bOhgQgmt5&#x2B;&#x2B;RUrmiJ1FYQBOEzSUbtGQlECZcwur3TbT&#x2B;Y0Ts8fht23KDnRR0v7LiBN4yTKGFhQqOEBYfHckEmIBGQMUgEHBkkYhlK2lIPf5ha2lKzlpq1taytpU11v&#x2B;P9f2&#x2B;vHdxrccYBRNonPHZE2CcIgiAIwiPDAXzfT5JEluUoioDzXq8XhuGtm7dIf0eW5XNz5Uxa&#x2B;9EPv3fpncvv31q/cePGjeVzZ5bI&#x2B;fPzwyHQ5tb8/MKtmI/uJAgCAJAVOYgiiRA43PiHHrQSYhVMMOcXpm0bFloLS0tLnWgFIZQkSfKFPN&#x2B;z06nFakqWQBfJz1dYJ4CtphtGdHYsldU&#x2B;/TYBA8ogSiCI6O2dTkL5Rr1/0PcxgrSl9bzwg9XG6l63mDKOTuQyppK2Up8&#x2B;ySkIgvAYOzyKSyFOoD&#x2B;M7p/DDdqDMEpowvjNzdbh4J4bdryw60UsSmiY8IRyxmnCWEQ5Z4AQEAwEg6GCo8uqlLHUtKmmLe1&#x2B;uqfmbC374IelZW3V0mRVJpqMFBmub/Z/eWMHMQ5MnOMVHkci7BMEQRAE4aExRCiSOGCAw&#x2B;ZZCWICnIAkJZ4c9SqVykSqNJWR6nf26h7vMfWD1f3g1Ut7ezVFUb/z4rkj58/0qfKTn/zkztVLTy49XTGAGWBmiv/bD1&#x2B;gt8NOZx9trfMOd7z5cRzfc3GKYgkAAFPkIA6j/0gkAAPGAQDg7ImM3z&#x2B;NNS7Lcj4NEgBgBgBAfAAAPErjHvH5SwLgiMjnq63usjdv7P7y&#x2B;g5j/N88PfvisQID8BIwJcAAEcDylnt7p&#x2B;P6cc7RKOOX1xrL211bl/c6w0Z3iDGaLjlhTPvDqONGu&#x2B;2hGyQzZSefNiYz4jivIAiPtRgOcz0/oodr9Qa/3YrbccOOG1LK1hv9MIgfLNfjMWWMcQBAGAiARIBgkDAoRFFly1DyaaOUMYopPW1pKVPJWlrW1g4DPktNmaomE1XBqgwaht&#x2B;t4LB0GSEEgOBTflEQ/vKJsE8QBEEQhEdJVTXOWC6Xe/mllysVxTRN3x9WKpXevZtra6slLdnb32/sbv3oRz8aHx8nhHS7XQbAALwhmBp65tlnOydS168vxwna2toCAEVWKKWMHd4/wcA5cM7R/Xo9BoABcg48/9wZOV0JgmBmpiYucQQA4AD3DgaXbtd/9sGmhPBUyUmb6u3dbpSwp5fK80Vtqxn&#x2B;06W7b1zf4RxOzxQkgt64vnPvoD9bTmdMbeBHw5A2e8FMxTk5lZ8o2G/f3Nttu/cOBq2BL8I&#x2B;QRAeH3R0FJdCnPDDg7f3071PNGnc/3owjFiU8JCyKOGMs2HEouSjc7gyAUsFgmWFWJqctjSMUd8LhzG1DGUsY06Xnfmx9GwlNVNOjecsXZVUmagyaNJnjTD8KEkoF0Gf8NgSV8KCIAiCIDw0iiQGEkMYEGAOGECCSAKKQ1Z2yHRWHjf5C0eVlATnatbc5LjrevWYJu7QpXJ17vjNjbvpd65WizmGJERjGUABYJgDjySJfac6PKErR7TZGzf8WRvt9LsHCdZ6TE5jjAAwIIAQIQ4QAUeAlMQFDrps6Ra8cL7seUl1VG&#x2B;LhgAAOAKA0SggEs0Kf9EoQGNAG51h348lgnKOpkqk1Q8Gw9DzY4TQ&#x2B;n7vZwn99a19RSHjOXO&#x2B;qDX7wY17nQ/WGoYiV7KmIuFWPzAU&#x2B;exsMe/o40Xrtavb3UGoq9KzxypdN7q11dlqDrwgiRP2xx&#x2B;QIAjC1xAfjewlEFMY&#x2B;HHnk324Dzo0um7Y88KOFzX7/v32jISNqjNCyoEfbtnDCDQZciZRpLSlZkbncE3V0KQgokGclNPmTDnl&#x2B;uHVjVZrEFRz1vxYerJg5xy9lNamS/ZE5k8ZoWdiVZ/weBNhnyAIgiAIjwznkM/ln3ryKSeV0jTgjB89evRHPzr&#x2B;zjtXw/5Br9drd9rnnzifsY1er&#x2B;/oCia41WrttyGXBU1DQAEw5sAr2XL2hZnp6Ska58IwrFarjPPDAj8AAEAAHIACA&#x2B;CWpDBgAwYqBlMGJS0BwBezs0/483GAvT71wtjW5IJNPmN9Ssih67EgpopEijYmAM0hf/vW3uW7B1v1gRclhZR&#x2B;eiY/U04Nw0RXJMdUwyjpeqEfJTe32llH88MEABjnCAHBWJawTEbH0lG1YD25VD47V3zz&#x2B;u7VuwetXlDNmeN5m2BPkwkAYIwIFmsaBUH4S/CgPSOI2eGp249G9sL753CD9mHMF/p&#x2B;dHgOlzIOwBLGhiFwuF&#x2B;gQUCTQSa2oaYtNfOgQMPSMpaate6fw7VVjNDNe&#x2B;2V3W6tYJ2fK7UGPkLIDePZcrqSNcKYru53b2/T3jB2ztTSv2fd6h8g9vQJjzkR9gmCIAiC8NAoSBQOd/aNyDwhiIMsAfDvvfAE51wNQZUGgPHfnrNOmXMfluj6&#x2B;npzELS3VkwnqygKkjUs69fWdn7&#x2B;1o3O4vj4eColWYYKUnigqboCcHKiFlFQovGSwvNmLGECcPg5vQTAgSdAOAAClwDoLFCwQgDHHGTEJbg/eIVG03yjfg/hK6c&#x2B;YG/d2G25weJY&#x2B;sxMIaN/ym0iAAkAAwQcNhv&#x2B;9c32Zr3nhQnBeLJoX1goFVLab5b3//NbK8tbbWCgKlJCWTFt6IpMGZckrEokiikAAEISwYpEJAkDgCphU5VNTdYVSSI4pkySkK3L1bw1VdRWMoalKapCOAdDlRnnhCCMEEYPDpELgiB8bRy2ZyQQU&#x2B;h64WEf7oMTuKMmjY&#x2B;N73Xd8KMVe1Ey&#x2B;gIwApmATEAhQDBospzSsikjbY6iPW2U8WVtrZQ2bF3J2upo156hyodHcWWQASKA9iC4td2mjBuaBKBPFh1ZxpWMGVN2a6v92tXtjhdst7yspT57rCiKsAThoYiwTxAEQRCER2roT42lAYAFAAgDgAxwasnM5M8uLC603ei//Jf/jLXW0tJSHMeU0q2trQ8&#x2B;&#x2B;EAaNvr92bItLSyMWaoOwP1gqCiKRKSFhfFiOu849z/WZxQAAcFodO8A4dBTDVOSpFEQiBEgAAyfcURM&#x2B;JKt7Hb/5b2NZs9vLZUdQzkxnVIAugHstLztptvoDhPGsrY2lrNsXT7o&#x2B;m/f2n39&#x2B;k67HziGkrG0/jCydWWrKb1&#x2B;bfv9lYauSCen8ilLVWUiYeQGEb4/gocQSARrMtEUosqYYAQAGI2GREFTJTza5Y5AJthQJAVAU4hEMMGAEcIIHENJKJMlkjBR7igIwlfdg/YML0xGuV77k&#x2B;0ZvxX2RWH88XO4LEo454fDehIGVQJLRRJ5UIbLON9tewzgqaXKU0vlnK2PRvaylpYylShhBUdVZVA/rT0DACiD3ba3ttfzgriUMQhCQZwgJNW7w722&#x2B;86d&#x2B;s31JmV8M2PdOxh03JzuiH/WBeEhiLBPEARBEIRHJ6Fg6BQAASijHTtJMk77oCq5lCbnrbUekJfO/uLSzbzGtJTdbR0kWmarHUxpUys3O2HMjvcKP56yshnAGgw5EABEIF9REh4BGvIwRLIKCcU0AwAqw4QA6BngoCIJ4DDhQ6N3Fnw0JDZKCSUQk31fPcMEfr2899aN3UFv6AWxqckEY0nCt7c7o1bc3ZZraNJk0ZkqOqZKtpre5buNnZZXThsTBVtX5Oj/Z&#x2B;9On&#x2B;Q6znSxP5l59nNqX7t6BdCNbjQ2EgQJkiIpUtLMlUa6d2asCM&#x2B;1w&#x2B;EPvh8d4T/IEf7kGMeNse94Yu7Yoxkto6HEncS&#x2B;NYDuRu9bVdd66qyZ6Q8FcJEoeSABAgnlLxDNRqMLOHWC1ZXnOW&#x2B;&#x2B;b8rX93upEEtb7WGUTlW8iZKrMTpM0yjhKRf6l9XgSYlRWudHadePuZBRnMrPdXcaPYYLGac8jHmY8FF1yzBKD7rDME41SrkEU/V9iqI8aRKUENP4bVEXf7gVN0pl&#x2B;4sp3mhDbsePRlNxDwdhsxf6w&#x2B;hBqPfgYypi/iDXGw3QyOrQmOvoec/Ku59uyLVGJXtFz8p7xvp&#x2B;/&#x2B;/eX4kT/v3zM3/xyjHbgKU9wn221R1/bb&#x2B;/3x0O48S9oxuM9oJEZzThYrc92GwOTEYzeauYMSWQcAF1D09RHoUK&#x2B;xRFURRFeXw0JgY&#x2B;cuYwQn60fVbToGkAhsEwpzv5HM6dOycyjWq1OoRRqVT6kchmM5RQKcXtpds3b92svDp37ty52oSmMRCCWIDHvmu5EIKYJgTAKDgHIUTFd18fKbDTTg66QZyKsaI7VdQ7Id69tfPurZ2dwwHvhTfWDufG85MVjwv50Z29ezvdMOG6Rv0gWdps39vuIOb7wyhK&#x2B;FjRPX2kPF3JDIJkEKZBnGqMeLaRsfXeML68vB8GSarRo7WsodOsY44qQSXAhUyFFEJyIYMoPRiK7ZbfGYZ&#x2B;mHimJoSMuQhjHsY84QJAnPBhlAyCJOUCACMk4&#x2B;jVvFPK2BqlKulTFOUPgxJiaJ9FXRKIJRKOw178haEZDzO&#x2B;9qdFfIPwsB8hFeBCcMHjVASJGMYSeFCvpzPYBrK2bmgPm&#x2B;uZBdcafVIc9dfzrGLGHPXa86zRVlxi6vjgTuuXN7d7QXxsLFd2Hu0ZBRy7nSElpJ53UyG2WwMhkAqpM8qFiFPRKHrHKtlq0Z0dz0&#x2B;UPcdUwYWiPBr1mlEURVEU5ZExpAwpwWcDSROiSTCNmHu9g7v97P3V1VNjU2dmPQDacA&#x2B;GUXBcSO4RNlvTSuUJStEc4LVT07mM02iUtlu9Tqd/95C3mk19f/j9ZGKu33AdTE/BNWBbHkAyFBQgZFR2pSNJKAAJ6AbwoJcf/ZXD/HQU38NOfwC4ymiesEiCCzifK8I48OX7S7sfLO1u7vVA6auLY6&#x2B;dHPPD9NbGYW8Y6xqjhuZZWtY2ALR6YbMXlrPWwkQxSvj1tdaN9dZmc2BJaXlWzjUtnXX96G7CD/uRaWjTtcxkyWsPomZ32AuSg27Q74cBIVHCEy6O1HOQ0NiD/1k0RjVKBkFya&#x2B;OQEHJx&#x2B;WCr6fvDOHCMOOVhnIZxKqQEIQAMnVWyzrGx3HQlk7UNIuU3T034YfLaYqNRcp/S2VUU5Y8MIWGc3t/rNgrO4Rf76y3vdH9lQm4YJJ821xvV60khYGowNGgUlMAxkLNznlnMWIWMlXfNnGPkPLPgWaPOesWHGV/eNU2dWTo1DZj0S&#x2B;6tuZYxal/KxSNPJ&#x2B;cCtqmfmi6NFZ1WL9zvBoMw1hm1DM3UmWNqOccseVa14JRz9njJzTvqnVtRHo0K&#x2B;xRFURRFeZykkL949&#x2B;3bt2&#x2B;vl8bO/C9/mQqpjSasMgagO4BpwtIhgVIGb7zxxvi&#x2B;H0bh3/3iWrPZ5JzkC4X7K3c/&#x2B;OCDjd2CxrS5Oe/lC8/NFQgAAUkBPvSZaYEAuo5Hvr5Qngg/xV4n2usMW72w7UfDKC165smp0mLDARAKfHhn979&#x2B;sHJ5pdnrBVKjEecJF/WCU807i5PF9YN&#x2B;oLEX5mrnZqvjJa8ziAiBZWi2waKERzFv98NBmEzWcyeOlqXA9uHg3nYXUnb8uJi1TkzmWTWb98zJSsa19LJn7TYHH6wcbDUHQsisbegai1POU&#x2B;laej3v6Bpt9aN/urh&#x2B;eaXZHsRBnDqGVnDNgme5tliYKCxMFAquCWCy7H3v/LQfps/PlhtFM82Z//GN46bGGmXDfNrnXFGUZx4BwCgY2WsP//791Xdv7hx&#x2B;vuPeIOq0/V8ZoAFGH&#x2B;7GZfAs6NS2dNvQuBApF65tHKnnTs&#x2B;UxsuZctYqZqzCgy26lm1ols5MA5b2b80IoiTlXHAho9H4o0fh6phr5CZKbpyKrdZgebfb9WPTYI6pZSwj5xpFz8q7ZtY1LB22psr4FeWRqbBPURRFUZRHxmRKkVIpICEIBJDCkNAiAXiVd278NIrYwO&#x2B;uRwgCMpEva0ACDBPc3WzGcXz&#x2B;ZIMSlCneOO6dHveazdaty4FxsM81NwyCMOdc2Vxtkti27Zsb91cO6J&#x2B;/eaY&#x2B;hiot6RSamWcMhKDfT2LouQwebBceHZkcXXJQAJwQPKzse1BkJsWnf6o8Ljs9cWll/6O7&#x2B;3e32p1BFHORcjlV8TqDSNcmJsrW0mb/7etbtzfbhYw1UXJbg2htrxcn4ttnJ1472ZASH93d6zJ6fLxwfDxfylr393qci7vbnbX9XsrFTmvYG8aGxuoVb36iGCfcNpgESVJ&#x2B;e7N90B3e2&#x2B;5WsvYgSDK2vjBZmqlkbtitmzu9fhA7pmbo2jBM2oOIEEyVvfGS9/yx6s&#x2B;vbe62h1yIStZ5YbYmIWfHcueOVTWNvjRXnapmJsoWgNkxZ6wwSylcAwwAQ7b&#x2B;ZdOCFUVRnhCNgYvt1uC/vHcPifi0y97oE6k9jPZMHZ5JDa3gmQ9b7Fn5h583e8HSVvugE4wV3T89N/XnF45WsrauE1OH9XsUzPGHg4p&#x2B;h3lFBCg7BI4OYKxo1otuGHNLp6ahOYbmmMTRvnysh6Io/0Yq7FMURVEU5bGRAoZuSCnHxsZ4y799ezMIghudgxMnTkxOFxwdzWbr4sVPcsabiwsNKUEJsh4yXukHP/jB0u2lTzYG165fHxzut9ud2bnZxcXFlTtX3n77X2l//fXXX7emvFyW2RoA&#x2B;IFcXllp9aI3Xj/ztJ/0syySWN0LVna7HT/SKB0vu3ONQtX97BJMABsH/fdu7fzjxfXtZr&#x2B;QsUoZK4jSu9sJAMboyenizfXDSytNAN85OzlTy1xdbf7zpfVr95unpouljFXLO4bGCCUaIxqjkAgT3vajZjcoZCzP1CyDGTqLE9EZxgfdYaPgPjdbKbjWYT9s&#x2B;9HhIIxTLiW4kN1hvLTZvr/XvbvdTQU/OVU6PVOaKGVW93q1vN0oeSdnSouTRVNnnqMLLqt5e7KUKWQsx9LqebdRtE0dQsJiD/JgHchbX35mFEVRnjQCgBFQEvkRegFSAZ1BY9ApLBs6m6xmRgM0Ct6DgO/TebiljFXMWkXPJIR8eGdPSMkInW3kXlscOzHmAIgkogSm8RgyNf77TSd3GI5X1Y9aRXnMVNinKIqiKMojo5Iz&#x2B;aBn32iNn0IHWEShefTYmQt7e3upYSztDnZ3d9/&#x2B;eOnllvsmK1Qq2OjLd66vPTd37/RCwwgOYRo6T0Hpdxey54pHz7TkpVL6n99LkiRmru6VsvOn39ja/&#x2B;nPfrnlxyt7R4qFQv7NV3KmjtAmB1x&#x2B;uHylfGLidLkIgCEFQEgM4GG3PhPAw1q&#x2B;0Z9GAADVbe1XNYfysB8FcWoZrJqzCxYApMCHdw7/6eLax3f3On5czdvPHan4YXp&#x2B;rlp8eF3GgUGY7HWGW80Bo/T8XG2&#x2B;kd9oDm5utK6vtQAMo3Rtv7fRHBytZc/NVhcnC1zKX97aub/X6/pxnIiUCy6ESGWU8q4f&#x2B;2GystPdaw/HS95bZyd1Rt6/vbvbGfaH/s6hv9f2865pGqzZC9b2&#x2B;81ekHONxani8fECJVjaal&#x2B;8t98fxrpOFyaKr54YOz1Ttg1WLzjjZbeed16cq9VzWt6dfOl4zbE0U9ccAwZTIx4VRfkKk4DO9FqumP3CYNy8a8428g9GZ3hWMWM5pmYZmqnD0h/UvI9sFNyCa45CQMcwAPRiXF5p&#x2B;WFSL7oztUzh92hMQAlhXzb0XFGUp0uFfYqiKIqiPDYaAyN47rnFv/7rG3pICaXNZrPdbn/w4Yet5sHi4uKw1QqCIAxCLjGa0gtI&#x2B;D5yWS/jna3SsbE3&#x2B;8XJZrN56/bWnTt3ziy8ODE5eXl5&#x2B;dLlyxvX&#x2B;vl8vpr73qlTFZ2hXq8FHwy73S7Kxaf8tL9WEoA&#x2B;3NfMgXu7waWVg5vrh&#x2B;1BGHMxXnRfOl576XitYJNr671/ubr5ixvbu21f12jSEgDxLL2UsdzprEkAgACUEgkQgvGS&#x2B;81T4y/MsAWs4QAAIABJREFUVq7db&#x2B;20/ft7B0tb7VLGPhwEUcJNg&#x2B;U9I&#x2B;cyx9AZJZQQQsClSFKRCiGk8MNks9mPEr601d7vhrONQj1vhwkHECWcx6nOaN61ooRfW23td4eH/YhzcWG&#x2B;/ubpiRMTRctgnWFc8CzBxUQlc&#x2B;ZI&#x2B;fR0qZozhcT8eFZImDpGx1zzaM1TVSSKonzVSQBCgItq0X3tZOP8bK2YMR&#x2B;Ox7VyjpF1dUuHSX9bdV4CDKPEMjTPNoSQ6wd9TSObzcHV1aYfJVOVDKOkMOH9DocXRCkIxO9X1qcoyhOiwj5FURRFUR4ZgSTAwOAwYUUCghqWr4FJ6TKCCzXob77xdx9&#x2B;aMdDl0dhaWaQydy47&#x2B;/2V/jWmuD1YVJMgET3OOeWkXCm6RjmbBiBXsvplbeO/c3f3K2cnLl69do/NAMh5G55bKM7rGaNwf397PuX82f/ZBLI5gr/6S9/yNOUS1CCBBoBIDUhYDAEQeg86K72&#x2B;T59z07DtXaE3cMgiJO8a02UDeM3f&#x2B;dhiP1OsN8Ztv2oN4wZIUfq2ROThbyJ5b3wJ5c3/vX61sbBQErhx2nBNRMuTF0zdfrurZ2L9/Y1Sr51ZqJWcLcP/WGYJFyECefiQV5IAEYeNEd0LWO85B6tZ9qD2LX0VIy&#x2B;U2CU63HpB8lBL9k&#x2B;HAzDtOCZY0XXMTRGicHYMOZ3tjqmxmxD6wdJmKR3tjo/u7JJGTnsh46hjVUzL83XXzxeC2M&#x2B;CBLPNspZe6aWfW1x7PmjpawBc6ZYzdtCSs/SHVN3DNiqYE9RlK&#x2B;7RICLibL3Fy8f/Xfnpk0d5r95gAaABLi/H/aDxDY1x9T6QXztfnN1r7vfGW62Bn6YtPvReMk78zuFfbahQQV9ivJVpcI&#x2B;RVEURVEem9FWnnIeJxZrHffNcSu8dft2uVQ6ffr09V9&#x2B;tLW1NcG0drvT6/X6fWSzlGoUIIRA8JQyTdc0AI6Jhfn5w/u9mZnpwHcvXbqUhGmpVgvaG8Ned2tza3sL1XG0O307jer1OiMAEMXQNBgUqZRxwi3rWS7duncQ/vTK5tX7TY2Sl47Xv3lqfCKvcWC3x/fafpyKYsas523GsLY3vLRycGXlYO2gPwiSIE4dS391oU4JKWWsq/ebd7baUcLnGjnX0m5ttncOh7c320XP6g7jD&#x2B;/sHvaiF&#x2B;Yq/80rs1PVzOpeb&#x2B;fQr2TtsaLzaY4mP/1IQCkhIClHEKVRkuqUFl2rXnB0nXqWPgiTK6vNpc32Oze3UyHOHq2cPVIpeJpr68WsdW&#x2B;ne3e741n6icnikVpuGKXDKN1s9at5Z7aRn6lls65xYb4&#x2B;P14I4/TEZIEQUs5YjbJX9uhoOZszkas9O2GuoiiKBMAFhMg6xvxEofiIP&#x2B;F6MbZaw5Xd3lZr0A8SIWSQ8Bsbh51BFKecEvhxmnLZGUS/4/GpzbuK8hWmwj5FURRFUR5ZQoyEGJyMFhIEAAOno4WFhE2QAV5eyMyama1r9qDZ//6pwuAalps7jefevLe1d7HJrIvx8RnD9XCinAeFxaUOYhCAgxJM1eu/uLSyMN4oiNz&#x2B;jY8ywPHx/N32SuR3WtvNQSsJxvS7a/7dpTu1Wve1F&#x2B;dLJeYaiAAKUI2kfmTqGmT62RGT0aF9pUlgmP7/V21s9fg/X9z4P99eunO/Va549bzbD&#x2B;JNgtsbhx/fO7iz3WagJ6aKzx8te7a&#x2B;tNn5&#x2B;bXN925t&#x2B;1Fa9Kwo5UHMHYNV807eM&#x2B;9ud&#x2B;JUTNcy840Co2S/G6wfDAbDdLPpr&#x2B;x1lzY7pYw1U8vNTRSm8lola222fEJIxtK/cIlHQEAoIUnK9zrDmxvta2vNVi8s5&#x2B;3njlXOHq3stP2Vne5ue/iPn6z1B&#x2B;FeLzw2lnvrzMQLsxWboZqznz9aCSKecDFdzZ6aLhkaOz1TGoSJY2qNolsvOJ5lFDJmJaeN&#x2B;koJZNVAZUVR/lhISIAL8UgPioGNpn/tfuvG2uHqXrcfJhlbtw3toDNc2e3ahlbN25bOLINZhqqCVpRnkAr7FEVRFEV5rIQIEnrz5mrX0s&#x2B;8OnHhpQvBem9iwpw9dmxzc9PzXM9zNzc2fuz7l7ODI0ePVr/7fMljbFSeRxGHKSwtm7V7/Z7RNEgpPzM904nE/Pw8TfwkSdI0iePYonqz1fzxj38MYP3u4vnz5189v&#x2B;CYSAU0CtP8PZqNPw2hxM313tX7rSQVF&#x2B;Zrn99RFUvoBP0YWQMAbu8M//ny&#x2B;o8&#x2B;Xrt8e3fQC0plzza1QZje2eq8c3Pn9la72Q00Rodx0g&#x2B;icsZu&#x2B;9Fu2z8cRFOVzMvzY7sd/5N7&#x2B;9uHw/WDfhjzIE6FlEGUbh/6QZxuHPSTlBs6TYXoDeNhlNTyjmNqGiUA2oPo3k43SXlYzzlm1tWAh4UdGiOMksN&#x2B;9P6d3Zsbh9fXWoMwWRgvvLbYeP5opdZ2DrrBe7d2VnZ73e6wWvJema&#x2B;/capRdgiAibL3p&#x2B;em58YLkPJIPXe0lnUsRgk4B2O/2mZ&#x2B;RCV9iqL8ESEQQoYxf6QHhTH2O8HyTndp63CzOTANVs3ZlZydcsG5dC097xmEkKmKN17&#x2B;XfbwKoryFafCPkVRFEVRHhknGocmCPt0Fw&#x2B;BoCBIQmgaS&#x2B;nyzStXd9b/u3P/89nj9YmK4bCotVC8/0Hv7vJSr9/eTqtar90b7M0dOFML8sQJWE1RKNCGDmJoQiKXx8kjk9euXRvcXS5ROp1xv3u8eD574qIV9P2wAJ4AUWJv9t0gDDvvXL&#x2B;5F/ZifOetBT2Ga0EjRAgxmsALQvHZyGDgaURFApD4bSNf1/fDf760/g8f3vdsrZq3R2Hf3b3wyv3mwaF/6EfzE4Vzs1VGyXtLu/9yZfPGWisIk2LRPT1TbhTd7dbglze2l7Y7Bc&#x2B;cqmQ6ftTsBe/d2pksZ0tZkxJ4ln56uvStsxM31w9vbbT9MAljbmjU0rVBkGy3B5utASRagxCArlFdo4ZGDY3GqWgPwv1u0PXpTy9vvH9nr5y1bEM7OvYg7BvRGNU0etAdfri061r6IEgaJe/lhbEX52r1DM04mTAas3Q2VekSLo&#x2B;O579xsjFfd0aPLVh4da7wwrECCKzPVwz&#x2B;esinKIryR0kCjzwGg0Cj1DK0gmdaOqvm3UbJtQ2tXnBeOFallHAhDY3ONnJH67knctCKojxVKuxTFEVRFOXx0TRArq6219fXm92mEAJgxUIxTuLFxfrzzz//T9cGmq5rmpbEybDTXVlZuXX7dhQdCe6&#x2B;PzY29tr8jGPbH99ef&#x2B;656T/50/NJkly8cTeT8SYnJufn3dmZ443GeLs7mJnJSkAKIaTsdXtHp6qbm5v/7z/&#x2B;44nFheMVAJCjq6Kn107owJcHvUBKEGDjoL/XGc428q/OFT7/PUOOOIWhIRXY6wzvbndvrh&#x2B;OFZ0o5gDWDuO//3Dlx5c2Op1hLOULx2tBwmt5O0q4ZxuMUdPS56ZLL87Vihnr2v3mJ/f2o5TP1XPlvO2H8fZ&#x2B;vz2MAJJ1DEqpobNK3pmqZA66gaFRISQlJE7FQW940AsgMV50PduIEr621w8TTgmpFZxBECdc3N5sG9p6GCe/vLnTHkTVk41y1s48LJ0cXX5SQighccqlRC3vzI&#x2B;bZ46U3zg1MZFnAFyG544WJ0qZhAvbYK6t5b44T4QAlqrWUxRFeXxcHeNl90xSGis6rqnVCi4B/DDNOkYpY8UpH0TJKPsrPssdbhXlj5cK&#x2B;xRFURRFeWRMpgwplfzTNngcjECjROsPhpfvbOx0Y&#x2B;6UuaN3BAqyb8m0YRs//PY5q9hcXbWbpLK5tfVR10z73d2dXppu337nRqm0m0ayUqn8zU/fbspvv/ly483vvTIzXfV9f76WnbbADMwtuL3YdV20gbEsK2btjeXDsbnvaJp27&#x2B;Lb1&#x2B;5uztUmOEAIYYxBjJqOj0bFjg4SePKVfVc3/X&#x2B;9trm82y15VtYzPrm7v3Po/8Urs6OwrxPi1mZ7abPd6ocZ2zhSy5Zzdm8YM0ZcS3MMTQJ7A/HB0t7b17Z2Dn2TEgnc2WpzIc7P1k5MFgyNbTb7cZIeGc/P1LJCiM2DwUZzINL0tq3re9rqTm9jrysoTbkAgZQgIJbBXEs3dcYoZVRyIZa3u5dWDtp&#x2B;eHy88PyxqmtqB53g3k6n60eUkBMTxXrOubfbubvVubfd5VLGMT85XXptcezUdP5XVpBcyJSLvGu&#x2B;ujD2nXNTY3lnspqpe5&#x2B;daYdhqqhK9RRFUf5AGDBdNrNOJUp51tYyOoYpBqHIONSmAJDCVlmAojzD1AtcURRFUZTHSWOMCw5I3x8mKQwN4ADTwgjTU&#x2B;VvFcobG3MHhF25Uru1cn8w8CWQxPH&#x2B;/n670z5acXvd3vr6xqVLl04vNso5TLxybGtXzBRokoJRgII9TJCOHJk5ceLE9vaOZVnPnzt3/9p7q6urw3MTGQeUPrU6saW98F&#x2B;ubPzf76&#x2B;s7fdOTpUmK9611VZrEPSGUQpwiV/e3P3RxftXV5tRwifK3vx4carqMUosTcu7pq6xfhDf3Dh859bOTns4P54/P1fdavkXl/cv3jsoePZbZyZcy6hk7Y2m79qGBA4HcT9MooT3esEy6ziuGXNecE1iaFnH0BjhQkhIAhACCQgpCBDGvNkLdzvDME57frJz6DNKNluDMOZCSM/Snj9aJoSUVq0g2tpp&#x2B;1nHODtTfuvMxCsnxrzPpXYSkFKGSepHyWTJ&#x2B;8bi2J&#x2B;dG1PrS0VRlKeOAWWHfHrJ72hwPncPRv2gVpRnm3qNK4qiKIryyAwR6SLSZPJpZV8KHdAiALaplY/eayVNy/7bd7ffeqPh0kwUccsCgBkHs4tskOKMXTZ2j966dauhRWl328vlT508VZid3e907oci3ti7cJAcz&#x2B;pVoFKnab&#x2B;fyWQQ7MMwXENDmOTtwovH6H/8k8Uytmg&#x2B;U/SsnGNtra0QvC4AQkY7eEdXNQQPd/Q&#x2B;oQgwBu7vBff3&#x2B;wfdYG2/f3n5YGmr3R/GccoBYmjUNjSN0UNfbjYHP72ycWn5IOHCNbU4FSu7ncNBWC84BNA1Gqdi53A4DNNr95umwb7z/NQbp8av3m/e2&#x2B;mu7Pb2On6UcEoJoQQEnMsgTpOUCylBYBnsSD2/MF0SQmwf9INUjBVdjdEw5kGUhClPUhElfBimABIuihlrupLZbg12O/7Hd/dsU0tSvjBRWJwqzU8UTs2UHEMrZsyia3WGUSljzTby8&#x2B;OFivuF3dESSLnsD2N/GNMKKWcttbhUFEVRFEV5utR6TFEURVGUx4kRTEzkpqamrl&#x2B;99uMf/ySb&#x2B;&#x2B;GR065hMCFBCMIIjg1Dw9EZ&#x2B;wff//7ExERjZm5vb&#x2B;/mvTuVauXVb8xubSb/x4/&#x2B;KQzDe/fuFYsnDBM5B5lMJoojyzAAgBAYBoAkwYmFmemp/3SjC9el&#x2B;UKBMhaGacbRAHDO2R&#x2B;kZ18s8cGd1k8ub1xZbfaGsUZJdxhHCTd15pi6bTDH0sM0jRK&#x2B;vNP98M7uxeX9rGO8slAvZe3eMG72AgAao4RAShmm6X7Hbw/C0SbfesGZqdr7XdcxNSkRJTxMuBBSCCmlFFLojNoGy9pGxtY11zg5Uzo5XT4cBJQQSkm94PhR2g/i3jDhXAJgjGYcQ6NkrODO1DPH6pnlne6hH2Vso5qzX5kfK&#x2B;fsqUpmfiLfyGoAXpjJzU/kOIepf3lbPQJQSlzLqBXdybLnWGqvrqIoiqIoylOmwj5FURRFUR4ZhWDg5EFdnwQIQCQIIRAA1WE6ngjiw56/tHz/g/xJAKbszM7k8w4AOCkHZd84SifouFX2tt3kWtWpZmnZQ9tDvjpmmNZGqyeubiYHq0eOHP3zF8YjZlo0lXFMRB&#x2B;mqYF5Jo6YFvK03kAvwDfPHkuShKaBjowAJAjIaJ3zWWWf9vBwH6ObG/2fXdn82dXNdj8qZc2MZXaHsZRSZ5RSQglhlAghW/3w5vrhB3f29jr&#x2B;vzs3/ZcvzxazZqsf7rWH/SD2w7TVC7iQaSqGETcFokTkXEiJMMEgSII4ZYxkHdM2WG&#x2B;YRAkP4zROhW1otbw9P1FYO&#x2B;i1B9FBL3jnxlY3jAuetThZmKpkdg6HlZwtgYmS59n6VMX71tlJz9JeOl6fqWXiVBz2wyQVWceo5OyMpZsGLPaFEkhP&#x2B;20LRg2o5uyXF&#x2B;rVvDU3VpiqZB7r2VUURVEURVEemQr7FEVRFEV5bEaxHxutLzg/eepkuVy&#x2B;d&#x2B;/e&#x2B;vqGQ3tB8NLLJ8YAgBCRJpTp4&#x2B;PVxEI2W/jOd76TL&#x2B;QB6Ibuui5jzHWc69ev99Zv3r17bz737YXZKcQJMQxIQIhP46j&#x2B;MKSOlbPx1lvf6vW6tm0DSFOuawxSPOnnu9FJ3rm188HSbpzylxfqL8xVwyh9&#x2B;8bW2n5PSgghADBKEi5bvWBtv7fV7AuBesGdG3ctirzrGRrbOfTD2AcBIYRSYhrMtTTX0uJEbLYGl5abF&#x2B;/ttQfRZDlz9ki5lLWbvbAfxL1hHESpqdPJiscoHUbp5ZX97UN/pznIZ61j9dzCZHG6kilnbUoJl&#x2B;KVhbFaXreN8njRyzp6Nac9qMEbc36fM0CAo3Un786EaZp3zKL9GM6qoiiKoiiK8vtQYZ&#x2B;iKIqiKI8sJmZELE40PNwqqyHWICJfOq55ooYXjpb/xYlOl&#x2B;lrJ6o/uub8/PpHLm2tDViu/GYu79V0CkZ5CMsEYug63jo/GUapDcwWBhXGDg8PHWYfbje93HSz1//p5e2x2Slp5AngEBcUXHBCCAgyjqUBEqhUNV4qShANSEAkIImGz/r0CQBUCgCcPLb1z52t7ju3ttcO&#x2B;ovTxf9w4ciF&#x2B;fr6QX/70L&#x2B;10e76sRASAKGECxlE3A&#x2B;TJJWMEkpJwiGB1T3/ozu79/f7OmOCS0IIo6SctQqeeaSW3Tjof7C0e3X54NZWO&#x2B;XilYWxN041KjntziaxdK2csSs5p5CxqhlW8DIg4xlHX93rDSai8Urm/Gz11Eyp4NLpqnNmpsQYMjoAVFxScR9zIGdRNHIMYI/3r1UURVH&#x2B;SAhAfu5dpBNivxuYOpssGk9t3paifM2psE9RFEVRlMfGMk0Apo5XX/3Gnx7s5Qv5eoU4rtPv99082dreunr16sLCgtChaVo9lwWQpogTGC6EoQUi8HTvwoUL7777znA49H1/vFGP4/junTs77ZdzBdxbbfLe9tTUVKmQB8Af/rs8FUyj7GGXPk2jEvgDtOzbaPbvbHWCKJ0sZ46PF2oejROnnLUcQ&#x2B;sHyWi/MJEggM6obWqWwVIu9zvDq/cPw4h/cHf3w9t7wyhdnCqGCR&#x2B;Gic5oJWufnimlXA6C5NZGO/CjSMjzx2vffm7i7GSGAOWc9epi4&#x2B;RM6cLx&#x2B;nQlQwGT4NR0pl5wEi50Sm2T5awHKafO4KgUTlEURfmq6kbYbPkaY0drD9q&#x2B;ru0Pbm8e5lzTNqtV9w/Sf1dRnjkq7FMURVEU5ZHF1EqIlRD904Z4BmIGARIglWbkXDhGtB9&#x2B;c0q28iL1yhq1S0ZJT1P&#x2B;y6Vta3Lx7ZvXwjD63jferFa1ogMhYCO2NQi5y6D/&#x2B;auT2fhcbOSC2fndfjIYkJDpy7vIZ/DzKzv3r7178mT3T7/5cqWkc4k0RYG0dQCBhKZDdwGkoKN5IJ8a1fRBpgDwmCr7JOCHySBIQGDrGqMUQMplGPMwSYUQo6HAiZAAsq4xU83ud4OOH63sdv/2veXuIFo7GKSpOFLLVvPORrPPGC1lrfGyd262bOpsEMS3Ng7DwKoU3TfPTFyYr4&#x2B;e0JGa99&#x2B;&#x2B;PqdrZKxg2g9rHgygkVXldYqiKMrXzEbTv7LatAyWtcfGsowDe53hym6vnLOOjeWqrvW0D1BRvpZU2KcoiqIoyuOTptA0SsEYTsyWswNTRvHEuJbJZoFASnF76fYrr77y8ccft1qt4W5rYWHhB2&#x2B;d1XWESWTppoTkSDwHL5w7HmiYman9b//5R/7QL&#x2B;S8IBDDIe33&#x2B;3eWljY3N2kyeO311xtjnqkDwximAU0DowDiMKSWQ8ljHsTxpRglhs7COO344V7Hzzr66l5vZa970A3SVHIuooQPwyROedYxTkwVDZ31/Xin4//yxnYY8UrOvrBQv3C85pi6bWppKiYq3uJkIavjzEyBUfriXE2ntF5yjo5lMg9XbRkd8zV18aMoiqI8C5rdYG2/71p6x4/Gsg4ASohtaI6pa0yV9SnK70iFfYqiKIqiPDKDQxfIJEOkcuhInREpKqCESSABtZEARQB2BsAcw//0J/n/9a/fcRynUH2u1fU61vmf3Pin5fb&#x2B;zK7TF96LLx1bLGQSwJBjMgjzDtxqaiIN7EB7Vfvwwz2jUT1Z6ndJrkusK8nkycbi392M75K9hbGgVqv86WxNShAGQpDEMCwnSaWukc&#x2B;HfZxowKihH5LPfZ1J4NMNvwIg0BiEAJEckjOZQmpCCM45fg0BSllruppZ3hbLu92fXdm4s9Ve2e0ubbZ7/RCExKkQUlJCso4xVnCPN/JjBdcPkkur&#x2B;/udwNK1M0fKr51sLEzkIclY0XnpeA1SztcdAK6Gl47mOHKqVE9RFEV5hmmMZmw96ximzgAwYLLiGTotZqxawXzaR6coX1cq7FMURVEU5ckygBMnTrz5pt9pt4d6Tdd1x7EZpWEQDH3/X37&#x2B;8yiKjv/ZImNAFBPLSkQCEEap57pnnzvrum6aOzo9lVtLQCmZmBifmprig8577713m4bjE&#x2B;PT3z0xOzujaQDQ6/VKpayukTQFZZASIJIQAkghpYQAAPIIAZokUtd1xr78IUfruQvHazwVG63BP368XsqaQkghZa3kWQY7UsvO1LKMEkJw9mi54pKKa3zr7MSxsVwQp3nPPFLLThT00U7cqufxX9uFq5I&#x2B;RVEU5UkIBRiF/rQPA8Bk2dM1lrX1RvFBtDdXt4/VbRVVKMrvQ72CFEVRFEV5srLAiYrr/MmF7Z0dn9Ysy7htRsnBsp0/sXhsfPnGRxevXv&#x2B;LP1v0gMO&#x2B;nqM2Ht7IJ0ClWCy/eD6lOoDUgN7bjNq7QbukZyp3N3f9waB&#x2B;mFom&#x2B;641U7DhuhgvZ30g7UeuazIIEAACEiCUEQgwCUkgADB8NuLv88P&#x2B;JCAJBCGMUE6pRogQQtO&#x2B;fMk0O5b95qlxKSCXdjr9SErZKLknp4sgpOCap6ZLjaIbxtyxtOON7Ogh83V7tm7jy4I8Fe0piqIoj10KxAIG/ezif2k32GgOxkruyTHnaR4ZAGC6ZEyXjM9/hX7xfVlRlN&#x2B;BCvsURVEURXmyYh7rTK&#x2B;X7UzmqDTRjzA&#x2B;Pl6ulHVDf&#x2B;7s2aS3u39wsL8Xe1NGq9V6&#x2B;1/fPvfmnxQKLKNBADxNmaYBSFIIDUKI7Z3tbC7rlWWaphpjjUZjZXX1F794h4S9YrH43//5BUvHz3/&#x2B;r6&#x2B;//lo59yWN7QgIHrGbX5IkhHx526CcgeeOlHTGxsveIEgKnjle9qo5O2MbWUd3LRhf9igV6imKoih/AALY7aVbLT&#x2B;I&#x2B;VjBmataAPYH4t1bOzc3D1&#x2B;aqy2OOaornqI8k1TYpyiKoijKk&#x2B;XSAHHPMPI6HxJkPYJvnayKv/rOlTvrNStyHLPbaV1bb9amGvcG5v/&#x2B;k09&#x2B;tklff/31PztvGwCjZsxhAhBcdEjNSstmMt/ItilzLNoh1vEzz/Va4z&#x2B;6fM&#x2B;lsa53YWfn5uZ&#x2B;dvFOZFX&#x2B;4jvPUwIDVAiAJ5QxSoTknDHxuaMjAOiohoBQECJBJAEnFIQmhI5yQSHErz&#x2B;vkYyBC7P5UzN5IWEwWKoaQVEURflq8FNstfyrq832IDo1XZqpWjqwute7vta6tdmeLHtDDlfdgFKUZ5EK&#x2B;xRFURRFefKkBGCaVgwIgdlZp1j890dubGey2Ww2k8l4cRxJYDDo7&#x2B;3t7/Q/CobDdHtybm72&#x2B;YZZyFkUoIyJATdNw7Ks&#x2B;fl5s3HCsqyPbyxns9mC57z//vuTCzOarr/77jtxHA8Gg5/89KffvnAqk9UBUAqA4netXnAc50sHdHyKAJ5aUimKoihfMRoFAQ4H4dpev553ogRDKTcOBnd3OlHCB2Gytu8fq7vms1jdR8jv/LavKM8CtTJVFEVRFOUJEwzEgBSEwhQwNS7ACkXUv9EYDpH4x/So2agUNKDvD13PY9XZpbXm&#x2B;vLq0WOb33/t7EsvzdRsCMDOM6/U8Egw2Ft96/VTpyoXTtWNsZyvOaWb417WMWq16nW/f3F59/4wF4XR2xui0cBsARTIUQZAEykhRDxY/4&#x2B;K9jgAAg4AhAJEwgCEIASEcAIC/PakT1EURVG&#x2B;mmyKSt5xTV1IKQEJtHrx9bUWAZkqZyihd7Y6BmOz1S/pevF1pzNG6ahxx6P17lCUZ4MK&#x2B;xRFURRFecIoBSGQElJKkRKmAYhjCIpsBs89N3VwcFAo5gGEYeh6XrHRWF9f625vLi8vf2IlBDg9O14s6FkHR44cKZXKV65cef3b3507qmcK55MEhosXX3zxg08uO46Ty&#x2B;Zu3Li&#x2B;vbV5fO74rVu3kvhYAZlsFomE/ruueqRU1wmKoijK11Ilq9fyzl5nWM7ZSYrtQz9K09lGbm6s4NhamPAweTZvaBk6JYSMsj75YIOBovwRUWGfoiiKoihPVkIckAdTKSgFACqFpcMiVCSiZtD/4fsvDAEGvDxXvfKzfsFIBlrC89VzL774o3c/XAnvbvO8Pxz&#x2B;4I3G&#x2B;HzxL3/wvZ/&#x2B;7GfDu&#x2B;&#x2B;OHf3mVAYQIgF1TtrJtvbxu38vxl8olcpXrm8vjp9eFWM3rrb&#x2B;6ReffOvbb/77kxgIlKGlqYwMLUhEQacANBFBYwIJAAYBQgiEhPiVvT&#x2B;/aRqvoiiKonyVOQwTZc8Pk1reNnU4pr4wUSxmrCO1bJyKNOXl7DNY1hcD6/v9Vi8QcQougijlv7n3rqI8k9TKVVEURVGUp&#x2B;gLt9onJideffXVJqseHDRDycbHx8uVyvLKchT0KaWi0/irv3rpB989VyyVZnI0jEAQa4bBCCYnJ86d48NhsCYzlJDCsWOWZVm2fenSJX/1oj8czpALi4slnkDXSQTYOhUABaAxcM4ZZ795Ru6f5ZL8AAAgAElEQVRwOEyS5ImfCUVRFEV5AsaKrqGxsaLjajhSzxQ8s&#x2B;AaOQuRQMrh6k/7&#x2B;H5vfgo/FIMw8cPED5NWP2x2ww/u7C5vdyWXhBBKwKian6X8cVFhn6IoiqIoT9YoJxulesboS2T0u5gipVIH4KRS17XjRWa8cWp74NX41tUds5EhzLSX1zZ9oZ8&#x2B;ffrtj67PnXmpcQaN8emaHZs6NBiQoHHHM7TvnJ&#x2B;dzpKPDnQAPpyw3&#x2B;Tx5GGzedgOostLP6pmOnjFGO5VK5XMpOFQdJup52mTppZyLQWRYAwJQAgkBagEhNQENIpcLpem6VM4cYqiKIrye6vn9aytexYAFEwUzAdvxRYd3fX6Ookk/BB&#x2B;mIyiva4ft/pBqxe2&#x2B;uHoY3sQJZzHqej6kamxI7NV2zXPzVZLz2IBo6L8FirsUxRFURTl6SEP9ssK&#x2B;WB/zczUTAHwvG&#x2B;aK4f5QsF1XF3X87nczMzM9Y2bS0t3ztWPf/TRx37VmJudrZccABACTJoGTp06pscgQMsY//CjD6Mo8jxvoOvDoX/79lIQBKy347jOi99&#x2B;a6xRvn3xYq1WmzwzTSl&#x2B;S1kfACklIWqmn6IoivK1ZBAYX8OkiwN&#x2B;DD/ko2hvECStftjqBa3&#x2B;Z9FeGKcJF0kqEi7iVCRcaJRkXSPnmjO1bC1nV1yznHcWpksTZfNpPyFF&#x2B;YNSYZ&#x2B;iKIqiKE/W6BLjQVr2hf9QSR/EfYZGeBoxTQNQ5ChO6qVCQwjcPz1mDyaFLg5uvWelA9k7OOgc&#x2B;&#x2B;TqnXdisXAifvEb5&#x2B;t1zNnFvo9BO6xVrCkDBPjhKXaCju20e944/4eb7TiO1w6y7WjbdLLBftD8aGVyIrn&#x2B;3tLExOD4&#x2B;HSpBAkGwIQACAOElJoQkFIT0ATSNFU9&#x2B;xRFURTlyRly&#x2B;KEc7cMdhEl7EH0W7fXCVj/sD&#x2B;OEfxrq8SQVqZA5x8g5RiVnZx0j55g5xyh4ZjFrFT2rkrNreafgMevrVr2oKI&#x2B;FWrkqiqIoivLUEBAIAUoJpYwSKQShNAoC03ULGQB45ZUTpVJxZav17jvvJAOfc845b7fbN2/fOzg4OOiGi4uLuUWr1Wqtb&#x2B;6cf/G8m6MUKOXw4oszG/uoVWu77XB9fZ0DYRiOTcwwRm/fvt3v9ZeXl9vtw5XTR/L5I1TDb2ncTVWjH0VRFEX5NaMbd49a&#x2B;54AgxB&#x2B;mI6ive4wbvXDw17Y7AetXnjYD1v98GGxHh8FfEkqLIPlHLOUsbKOkXWMnGvmXaPoWaNor5ixShmr6JLfVqivKH9MVNinKIqiKMqTRdMYeHg1QBkASSgAAQoKAUkf1vtxGWtgph6Ax47MMl0/UyEzZu3wSLkwXFteEbNlM4WRwlhJ68Nh8f1L8UynO4j7QRBsXLnCihPfPdsgBExEAMarBs/a&#x2B;R9&#x2B;&#x2B;&#x2B;atW9f6uTAMe1aDaVp3Z9&#x2B;KjNQobHfS&#x2B;zvtRXnEBDgAUIAAkkgwKUc9&#x2B;yCgaZrq2acoiqIon6czSimhhFjGb0wVJOAnGITi05K9X8n1mv0wiNIk5QkXXEguRMKllNKz9KxjNhw36xo5x8g6ZjFjljJWMWM9DPg0m0G12FCU30SFfYqiKIqiPE0EhEvOCJMQQggwgDFImaYp03UKuC68LHvllVdq9Ym52Tmag&#x2B;O4hLQ5Tzvr6ytSrpbYcDj85P0Ppqam31qo2Q6DGDXyI5TSM2fqpXJ5Elqng7/5&#x2B;d3NlZWil7Ftu1wu7&#x2B;3tDQaDUQj5my4YJJNxHMdx/Ac8JYqiKIryVWdobNTQVsrR0C2EAn4oB2Eyqtpr&#x2B;9FhL/xsgEY/7PjRqGQv5SLlgnOZcOHaetY2yjm7mLGKGSvnmK6l5xy9&#x2B;Fm0Z&#x2B;bMr90oEUV5ylTYpyiKoijKE6YZv/KFUbL22V6bB9tuqKZbACDLAEwdSJGhAgQA/8a8e3LmpG3SgwSL08Vbt3fj/sGk9Oz91fXBRD5f7FrP/ewGn5jduXBhos5MpsFNQAyzKLlbjGc8BI0g3BP/9d7F0Dx&#x2B;eu7onf6636XHF451B8jnQQAORgApIcEo4YRwsD5gCSEcx/lDnChFURRF&#x2B;TpIgc1mv9UP24Pwo7v7GqPtftTqfyHaixKePsj15GhPrsZo1jHynpl3zYJrFjJW3jWyjllwzWLWzLumZxtZW7cNqEZ7ivJ7UmGfoiiKoihfD5ZJOaBrOHfuXI83lpeXL98&#x2B;GAbDTCaTz&#x2B;czmawQ8hdv/2J3d&#x2B;5//N7JrGPLFEQH1ZgJMwVxNXdhYX44HK6FuXK5uJfLblIqhCjnwYFBgvyXdfohUBt4FUVRlD9qfgo/FKN9uH6YHg7Cg27wixvbqzvdfhj/7bv3fnlj&#x2B;0GuJ2Sc8jjhXMqcYxa80S8rYxuepecco5AxH/TXy1g5R7cMGOTBLUABHAxEEKWOqWIKRfl9qVeRoiiKoihfMZ9fnpAEACAAMOgEwiH0&#x2B;VPVXLl6967nOJdWVlamvaSS4R/bWjFrLx3s3Nq7dPzsCcNMx6hWqaJIAJ2Z8AFcmHRPl55f7kLX4W5ZnRvN4frV/PnJgIAgZNKCBGeAREp0g&#x2B;oJtTWiFkuKoijKH4tYjqZnPGix1x3GrYdbcQ/7YbMXtgfRaB9u2488W897JueyH8R516zlnaxreJbuWnrOMUpZu5SxRnV8Rc8qeET/tX8ukg&#x2B;SPg5cud&#x2B;7ttYydfb8sep8zfpDP3NFebao9auiKIqiKF8PcRobmgHANjEzjfHG0Uxp5vLlS9MzZc/zkuRjxlitVrt///72zk6r1cJ&#x2B;PD8//8rpQqmoA0iREMB1MOUAAD13bmd7J4qiXi/Sc6atW6MhHYqiKIryx0AAfoxByEfRXj9MDnthqx82e8FoJG6zF4ZxOpqHy7lIuYy5oAQ51yxmrOPj&#x2B;WrOyXumbTLb0POukXfNnGcWXbOc0&#x2B;2H&#x2B;3BDiThFRv/V3rj7vry90R6E8ZFadrzkLG/3/p&#x2B;P79/f75&#x2B;ZLnEu/uAnQ1GeNSrsUxRFURTlqyUlMQAKCYBitOInAAykOgigc0gNBDreep4erx/VNWlbds2lvLurzUwHZO9W14Q29l/&#x2B;4f&#x2B;auX5wf7v6xjdfe75BNZgs4hKybGgAag0r/&#x2B;3n4tZ2lh/Gka4bBkTmwchgICW6QbSYaOqCQ1EURXkGBPzT6RmJHybtwajFXtjqBa1&#x2B;2OqFvSAeTc94&#x2B;JEnXGQdM&#x2B;8atbzzoL&#x2B;ebWYdPe9ZRc8sZa1Kzil4msYQJ0g5JGBoyHyufi8G7mwNNlsDx9BmatmZ4oMevq2h/Mml9fdu7zimPgoTL68evL&#x2B;0OwzT2Xo2TDj/fGNfRVEenQr7FEVRFEX5etA1HUAYx5ZhcCDiYAyTY4UolbZGXnv9tbW1tZ6m&#x2B;b5/8&#x2B;aNWq3W6XQuXrxk92Ba1vhb1Wq&#x2B;wgwGQAApB6OYOnZM5i1kMoYuf/M8XkVRFEV5ysijvEclgB/Cj9JBkPhh0gviB0MzPjcb90Gix0Wc8lHAZxks65jFjJVzjKxj5BxjVMFXylqljFXwrJxr5F1mUlBgkCBKZdYmOuCnaHajZj/sBTEjZKKSmauYAARweaX7yb39O1ttTaMXjter5yccBgD393uXlg&#x2B;urjareedoPetZ&#x2B;l4n2Gv7HT9e2mofqefGCs5YVsV9ivK7U2GfoiiKoihfLRwCgAQFQGACIPKzsXx62tUNoiMVYd91bQAO4TqMv3zryNKSd3sYtdby&#x2B;7tr3b1103KiMOxLsxnQ63up1W271CwW6YwLpiHo&#x2B;7bnEdsFAIz&#x2B;fgkAkgAgkJAgKgJUFEVRnjZGiG18&#x2B;ZW7BPwEfiT8MBlFew/r9T6r2htG6cOpuCLmIk6FlDL7INEzP432ilmrlLFKGbuYMQueWcjoDvvCm6B4&#x2B;GYJYKcTru33GKGaRgZB2u6H24f&#x2B;bmdoavSl4/XJUsOiWD2Irq42b6y3rt1vplwwSubH82NF1w&#x2B;T7cOhrtG8Z3Ihu37khwkl0Cjd7/iXlg/Gy97J6dJY1n3SJ1ZRnmEq7FMURVEU5etBppxoTNd1SIDAcRxAxjKxmDUMh&#x2B;WSY5yuGAHi&#x2B;Bu/uHr13t277VarXK3Mz88eO3Y0jndv3rwZdYxyufLDN07lcvqD6X&#x2B;GAS6gsySJddhP&#x2B;ykqiqIoyudIOXrL&#x2B;//Yu7PvOLPzXOzP3t/81TygMAMEwW4OPXdraFvSkmPZx8eOz4rXSm6Sm6z8J7nMRf4QJ8srseNJto512pIstaSeRzZnzGOh5m/cQy6qCqgCySbZTRIg&#x2B;P4u0GA1AH4oFsmqh&#x2B;&#x2B;7Hz28IdLohZBK1TvR&#x2B;n63X5pR70QHnXC/HbV6cSpVMraNq/K&#x2B;Vc65U1m/4Ds53846Zs53KjmnnPMqebeSdUs5u&#x2B;h83VVEGre3g42DXn8b1zTYym77/Rt7O41Aaz1Z9F3LXN3r3NhqZT1roZbfaiSuZX62Ur&#x2B;&#x2B;2byx1by2fpCkKufZs&#x2B;XsZMlXSmutL86VUilXdjuNXtzqJf0UMmyGG4wftCOl9NddECHkQSjsI4QQQshp0z/ThwPQGgCYAgDGDSgYhg8NsMRgDEhdxoDEd01LIZtBMYcXfri8nO98lGv9/KAXxwczk7XvvVW83ij&#x2B;6l8&#x2B;eO&#x2B;zJJfvGAb/8794LZfL7kao2VkArTR0rVK/oIMBjMGCAIQNYdCpQYQQQk6CUhpSIZW7zfDdq9thLPq9Ge0g2W706u1o46DXj/OkVFJpIRU3eM61illnsIfrO4WMXc175bxb9J28b1VyXq1o2o94Je9dP3jnk/XtZm95umgZfKrsK4WdRvDu1S3L4D95fWGy6CilgyjNeVYnjH97dTuRarPerXei3WZ40I6YZpsHvWsbzVQqy&#x2B;DlrGOZXEjd6sV77Wi/HbaDJBbSsYxy3p0s&#x2B;gX/Ua&#x2B;REDKGwj5CCCGEPOOUBDc0Bmu45TzeePP16enpfHZzc3NzamqKMWggjqL9/XoYhZ98Gr7y6quX55hFLyUIIYScSlKpOJWQClKt7bT/&#x2B;hfXfvr&#x2B;Sn8PVyktpEqE9GyzkHEmi3Y561RyXiFjZz27mLHLWbeUcyo5t5yzMxYYkGh0IkipKll&#x2B;vwhAA4GAUjBNeEeHZ6CZ4Mu1g998td3oxLZpRMvCMQ2l9Ga9e2e3c366sDCRm6tmP72z5znGucmc71hX1w/aYerZhmNx0&#x2B;AAYwyOZVbz7sWZIhjiVK7tdbcbPam0aTCDs5xnX54vTxe9i/Pl7744OVGkv6EJ&#x2B;VYo7COEEELI6WIOTuvD4dvBf0Z3erQNDE4sVwg4YGsoiTwTjPOCH764nL2UfePWrWKYK04Y2C&#x2B;iUq6ECMJW&#x2B;vsvbn9/q7k0V9IcAgCgmCsAZ&#x2B;RoIqYVoAwt6cw&#x2B;QgghTx9jLONa1VrBhnaKXidMlNZK6eXpYinrFDN21rPmqrlKzu1HewXfLgzbM&#x2B;620xTXtxphJCp5d3EiP1EwLCBSaAXKNnnWxV5L3thqNrqxZxuzlez5qYx3ONeuYZnct80mjxOhTINzzuvtaH2/mwo1VfTnq9mMZyVCeY55cba0WCsIoRhjpZyTca3dVnTQDgG8cq7yh5env/diLUzkre3WbjOYyHsTBe/CdHF5uqA1ztXynGGhlr88V8o81al6OqGXnEEU9hFCCCHk2aaU4hwAuAEhJdeaGwBQrcJzl7Y1GFC2cPHixervov07dzqdTq/b0ygBkAoGh/lINYeEEELIE1b07bcvThVcq&#x2B;RZ&#x2B;bwnNZRWLy9Wyzk371sF3ynn7MLI9FsgIRX4vaK&#x2B;9ab81ecbt3ZaJjc8x7i61liayteK/vZBb/OgN1HwakX/9nb7g5u7e61wquT/6KXZy7NH5RhZB5dmS5vLPX1DS6W7UbrbCjbq3UY3TqUEdCJl0pPtIHEsY2Ei98b5aiFjHbQj0&#x2B;QHnVhrZFwz51o/fGnmzQu1goOCY0iVF1JX8p5rGzOl7GTRsyyDAbbF886988ong4FxMA5GR3aQs4bCPkIIIYScLsZdp3L3y3jHb7YAMBgAtG4Dqv&#x2B;v8qZlAQAkAK6Q8&#x2B;ECpgYYfrzoXl12frvfnMoavu45AAccCQD2SBkvOLSGYobBDMFMOrOPEELI0zdZMP/ye0t/&#x2B;sZ80XeU1pbJJzKDEKwVQyjkR5K&#x2B;gxC//nKrEyWX58qX5nLueFq2utv&#x2B;9E59tx2WMk6cylSqrYNe1rfv7LT2WtFsJVMremt73U/u7Nfb0QuzxdfPT4x&#x2B;ARMo5dyMY0VC7jaDrzYa7TBtBbHvmVnXUhqtIAZYzrdK2exiLV/2kDtXaAX5KJW7zdC1jAuzhZlS5tJ8uTLswZopmJ5duTBdsC0j6zL3KcZ7Y7jFmMEYp8k&#x2B;cvZQ2EcIIYSQZ5tlOQCUBADO9eFTdh2BuTBNpClg48KFc//5zyYrlYps3MzlcoNPpiiPEELI6WMASxV72Fh1ZK2ZXttoRomcm8i&#x2B;Npft3/j5av1fPlxp9eJ6OzL53MtzmdFPaQXxdqO3Vu/uuxYHs0zeDZODbrRZ73HODjpRxjX3WuGdnXaQiErB3WkGt&#x2B;tJ1rNKPjMBDey1wlvb7UYnynr2TjNwLCPn268uVS9MFS/NlYoZhzP&#x2B;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&#x2B;ugl/fsld12kM7krKNP5IxpraHhOWbWNYNIbBz0elE6WfKXJvOVnFvvRhv1bpIqBhbE6X47bAcxZ3mD9T8d5Zz3&#x2B;tKEXFSzE9kLU8VCxg7jlHNeK9i&#x2B;AQAK9z1o76STPgVIQAAREEHHkBFUBDNFr6Obq0lr3VDaOVhBwYDoIZ044esl5DGhsI8QQgghp8zggPGjFwjHf3xcFYBpAEdbuSYAWP2T/frPdmb7/9vODj&#x2B;mH&#x2B;5ZOQAxAMBmYBwK0AxcxZC2LWDScyVCCCGnQJiIZjeut8NOlJoGmyr6AFLg2kZzfb/LGOOc7bXC65vNL1Zbi7WcZfCiDw5owDL5hZniizNFbvCv1g4yjvnKUvXSbGlpqsAZYzss41qmyeNENHuxYxkLtdxcNZO1AMAEzk/mC75tGbySd0suAOicMfpPZCed6B0SgATiQbQnY6hokO6JADKEDCBDqBBWhG5PNvZEpwEIHJgoKIgE4ocn/S0Q8njQE1hCCCGEEEIIIeRU82yzVvSLWWe93o0SMVXM7HbVym7nN19ubR30KjmXMxYl4tZW69dfbm7U8xN598pCpeDDNY35au61Jef18xN77YhpnJ8uLE3m56pZznmjE8WpWA4LlsG7YXJuqvDqUvXKfPmwDwRALcsrWX90NfgUDMMrQADpINdTI7leP9QTw2hPBpARZDj4gP47doIgUd1ARZG2JAKgK6EUZHSKoktCvgUK&#x2B;wghhBBCCCGEkFPNd9hE3su4ViJUlMjdVvjuV9tfrh18eHNPKVyaLQmltg4CxzT2WqFjGb5jKq05WK3kf&#x2B;eFyflqdnm6sNsKy1kn59mLtZxjGQedeK8VlrLu4mS&#x2B;GyRS67lq7s3lianc8fqqE62z0sORvf4qbgQVj&#x2B;R6w1DvMN0b3D4S7akUKoVOB&#x2B;8gRaoQKiRKC6WlhgCkhj4FGSYhjwmFfYQQQgghhBBCyKmmNeJUCqmyruXahu&#x2B;Yt3faa/tdztmVxfJ3LtQcy9xq9JRS1bxXK3gz5UzGZRyYn8jkfXuiYHkced&#x2B;fLvk5dxAElDLeZNFLhVIaBmeew7InnxD0j9hLgAgYndeLjnI9GQzWcu&#x2B;R6yXHoz0tAA2tAQ2tAA0oGIDmQH9GkYMZ4IBmNNZHzoyT/61MCCGEEEIIIYSQryEVlNalrPvSYmWi4F6YLmZdSyq1UM1dnC&#x2B;9tlTNOFY7iONU2Sb3HSvnG/3N24KNgj0o7LAB2z36mhZQcnFyCVe/PSM93p4hx0f2Bm/D4e2HM33xSKJ3OLU3TPS0BhS0BgDGAAYwMA4wMAbev0EDGgxgHIwNmrsIORMo7COEEEIIIYQQQk4128JsJfPmhVqcyqmSvzxdgNYXekXHMmbKmbIHABMZ90Ff5qTo4chePBjZG2R28V2hXnCvXC8aH9brv5XjoZ6G1iO5HgNMMAb0x/cOV3QZhh8CqJO6Owh50ijsI4QQQgghhBBCTjWP48WZQq3op1KVs06/FTepuhY7DXUZx0hADldxR4/Yi&#x2B;4V7Y0s4Q5yvRhKjEd7YiTROxzcu9fI3rFcj5DnFYV9hBBCCCGEEELIaZd3kHes0Vvsk4&#x2B;z1HBkb3wVV8WQIURw71Xco&#x2B;AvGmR5o9GeVuPzegq4V66Hu0b2CCFDFPYRQgghhAAA49AKMBAnImNZEMI40fZBQggh5JTpt&#x2B;LetYqrwmG0d2xkbzzXU8ld0Z540CouBzMByvUIeTQU9hFCCCGEEEIIIWSUAsSwPSOGOsz1opFK3JGRvePFuPHI4Xri0dozBjf2Ua5HyDdBYR8hhBBCCCGEEPLc0sORveEqbn8cT93VntGf3Rsb1utHe&#x2B;nxaG/QnjEa7eGh2jMIIY8DhX2EEEIIIYQQQshzon/EXnI0sneU64V3HbF3VzGuSu6K9h6mPcOg9gxCniYK&#x2B;wghhBBCCCGEkLOn354xXMXVh7nesVbc0faM0WLceLwSt9&#x2B;e8Q1WcUHRHiFPGYV9hBBCCCGEEELIM00PR/biQYHGWK53bGQvGM/1hqu4x6M9&#x2B;aD2DFrFJeSUorCPEEIIIYQQQgh5tkggvEd7xvFK3JFV3KNcL7kr2nuYVVxGq7iEPCso7COEEEIIIYQQQk6tfoGGONrG7Ud7aWO8EjcYO1xvtBX3WLSn1fi8ngLut4oLivYIeRZR2EcIIYQQAgDQYBwasG0zTYXjeVLCpOdKhBBCnqp&#x2B;Me74Nq4a2cY9TPeSg5FcL4IMj&#x2B;/h9gs0HrCKy8EMgEb2CDlT6AksIYQQQgghhBDy9ClAHBVojG7jHm3gjqR7h3u4/fE90YESY9EevkF7BuV6hJxBFPYRQgghhBBCCCFP1GiBRnS0iqvuWaBxr27cw0m9owINMRLtUXsGIeQIhX2EEEIIIYQQQshj1M/1kkG0d5TrRXe14t6d60UjB&#x2B;2JryvQoPYMQsh9UNhHCCGEEEIIIYR8MwqQQHo0sqcVRGe4b3t3tDee68no&#x2B;EF7/Xm9sZG9&#x2B;xRosNE4j6I9QsgRCvsIIYQQQgghhJAH6q/iysERe4ftGTI62r1VMURnbBV3rBs3vSvakw9RoGECtI1LCHkEFPYRQgghhBBCCCHHyOHIXjRYxe3nev32DHH3QXvRWDdufxV3LNoTY4keFWgQQp4YCvsIIYQQQgghhDzPNCAe0J4hxtszjhXjqhTMgOgcRXtajc3rQUGDCjQIIU8HhX2EEEIIIYQQQp4fApBAPLaKe6w94zDaGx3W6/9QJWN7uP1T9hiHEvdqz8BwZM&#x2B;gAg1CyFNDYR8hhBBCCCGEkDNJAWK4ihuPr&#x2B;KOL&#x2B;GKYKw0Y/B&#x2B;fPyIPZWOJXpQAIPWwxSPVnEJIacChX2EEEIIIYQQQp51/fYMMcj17rmKK8dXcY8V46oEWtyrPWO0GPdYe4YBcDBaxSWEnC4U9hFCCCGEEEIIebb0c71ksIqrDotxw/tEe8dyvXiwfnvv9ozDdO9e7RmU6xFCTj0K&#x2B;wghhBBCCCGEnFpqpBU3hj7M9e5axT1sxR3N9WR0vBJ30J4xOq&#x2B;ngPu14oKiPULIM4fCPkIIIYQQQgghp8HhKm48iPbkcBt3bEzvMNo7luuF470Zo6u4I8W4x1dxOZgJUK5HCDk7KOwjhBBCCCGEEPL0SUACCRABh5W4X7&#x2B;KO5rrJXdFe2Is0Ru8f7&#x2B;RPcr1CCFnFoV9hBBCCCGEEEKeKDXSnhFBD0f2&#x2B;qfsieCuqb3Dwtx&#x2B;rhcfr8QdrOLq8YP2MD6yZ9IqLiHk&#x2B;URhHyGEEEIIIYSQx0gA8h6ruCqEDCDuWsU9yvWGI3v96oyjaE88aBWXgRkAtWcQQghAYR8hhBBCyAMVi8WTvgRCCDmdFCCG7RmHq7iH&#x2B;V0/3QuONnOP53rxyOF6w27csT5cWsUlhJBHRmEfIYQQQsgDNJvNk74EQgg5cXo4stdfxR1W4o7mejKEGL5zPNeLxnszxEh7xmgxrqZVXEII&#x2B;ZYo7COEEEIIeQDXdU/6Eggh5CnrH7E30p4xyPWisfP1xP1yveSuU/bk&#x2B;Pl6&#x2B;r4je5TrEULIt0NhHyGEEELIA0RRdNKXQAghT87hKm4MDHszDktvj1fihke53iDji8crcb/xKi4o2iOEkMeCwj5CCCGEEEIIeU7o4che/HWruGPvjMzryeh4Je7RKu7XtGfQKi4hhDxVFPYRQgghhBBCyJkkh624w5E9GY&#x2B;v4o6&#x2B;Ha7iHu7kDtozxEi0J2gVl5xZ9DglZwiFfYQQQgghhBDyrFOAPFrF1aO53v1XcUfP2tMjiV7/Ha3G5/UUcL9VXFC0R55h/VxEn/BVEPIYUdhHCCGEEEIIIc8QPRzZiwbRnhxu445t4Ab3zfVUMrKKKwZvH7CKy8FMgHI9cub0W6YHGGV&#x2B;5GygsI8QQgghhJDnkQL4SV8DeQj9XC8ZRHtqZBtX3L2Ke3euF991yp4YS/Qetj2Dcj1y1gwe3WMPbfeZ7fcAACAASURBVEr6yBlBYR8hhBBCCCFnWT8rMofRngRu7UabBz2T8/mJ7ELJOuHrI0f6I0ZikOvp0VP2QsgAYjTaOyzNGOnGPVaJe/cqLhQ0qD2DPO8YgEHKfexGQs4GCvsIIYQQQgg5vVoxGt2Ec1YtWP5DTOIpIJaQGnGCnWawc9Bt9hLNWK3gXVkolz1c3w7//ne3b2w2F2r5P351dqFUevLfBLknMWzPiID4aBVXhfeO9o4O4Ovnesld0d7XrOJiOLJnUHsGed7db1WXpvrIGUJhHyGEEEIIIadUCrx/Y//aZrOSc9&#x2B;6MHG&#x2B;6oz&#x2B;30QjVXCMo&#x2B;f0rRjv3dhb3&#x2B;9qYL8VXtto7O51eqnyM/aVubJp8JfPFa9vNt75ZH3roJfxLM4o6Hk6FCCA9B6ruKNLuGK4intsXm/QniHGor2xPlxaxSXkoVGoR54DFPYRQgghhBBySu135M8/Xnvvxu7SZMG1jLw3Vc0wADtddX2jubbbjqRanMi/uVwtugDw1Ubrr39x7dPb&#x2B;75npanab4cySiVjzOS9ML28UK6VvPV6d32/axhscSI3W8me8Hd4BunhyF4ERNDDSlwVHz9frx/tHZvXk&#x2B;HY4XqDhlw5Hu3d3Z5xcqu4TA9/Kg0NgEGfskiRHUY7/dXNk7sScmpRLkLOHHpQE0IIIYQQchpFCu9d3/3l55uf3tzd2u1kPdNzzAszhW6Y/PrL7V9/ubWy1VKcvbVck1r94eVaxsBOM/jo5t4XV7fMvLs0WVis5SoZJ5bq9m57txl8td6YKnuru51elL44W3x5sTJdpJcD35IExFF7BjjSg5H8bjzau0eul9wV7Y22Zxyme/ca2TsNq7hMD6M0DbDhurAe/FCddOrXjyCZGqxtaj68EacukSQnKz3pCyDkcaO/3QkhhBBCCDlhsUarp1pBctCJABQyjtZY2W3/9P07N7ebnVa4msov1xovzBRTJW9ttX/x6cad3XYYpLHSH7Bdy2COabyxXAGggUQqzzReWqj86OWZ2XJ2vd755/dWPlutf7XRyPnW9Y1mItVcNXthumCc9Df&#x2B;TFGAHK7iRtDx&#x2B;Dl6I9EeM5E0IDrj3bjxeCVuvz3j2LyeAh64iovTso3bv0zNoPngkpgGl&#x2B;AK0FAcjJ9kpnY00MehADCwfvCnoQFlUN5H&#x2B;rh9Wn5LEfIYUdhHCCGEkEfWlEx4WSnWwLZNg0noLp/mQJkDgN9/varDwMgAsCEAsMF&#x2B;FzCsBB1uVPGjtxj734ScPbFGmEBr2CY8c/Bg3&#x2B;3p313b/ujm/tp&#x2B;pxMmlZy7NFnIeNZeM9yo9yyTm7bpO2bet23T2Njv/ebq1nq9&#x2B;&#x2B;JscSLnbTZ6t3bav/pyq1bKLE0VHJNnXNPxnfmJ3HdeqP3RK3O1ovfZivP&#x2B;jT11Z//mZlMpvbLb9h1zsZarFe0TvjtOLz0c2YuBCDqCGm7jyvFT9o6m9uKRXC&#x2B;CSqETaECG46u492zP6Cd6HMwETn0rbn&#x2B;ajyswDWVAOEhcrUwGDSOFkYILMAU&#x2B;/EjNTmBzlikYGgCkidSGNME0zARGAnY4hKgBGvEjUDTWR84iCvsIIYQQ8shMwzANk2sOxuj4I0LuSQCpQpQgEUprSKX2W&#x2B;H1rdbafgcataL/0mLllfmsBD5fPfjZh6sf394PYyGkcm3zxlZ7fiJ7YarwyrlqoxMFvfTcdOGN5YmZSubDm3tfrTd8x/zxy7NXFiof3drbagTXN5u3d1q9MAUYZ9z37eWp/OX50oUpzwTO1fIzlYzB2dpOu9tLBLA4mZufyDkUrA9IQA5XcaOR2C6COizNGGnF7Y/yHeV6CVQKxge3j63iAlDQZ6s9o5/0cQXJdeDVu4X9Xr6b2FJDslQz4Rliwo1n8z2e6cFQUACebqZ2dIUmIr/ZK3QiVzLJjcgy44wl846EE8JIoQFl0il&#x2B;zzVNxziSs4nCPkIIIYQ8MkNLUwk7KSMu2dJRCqYFA4CZAgDbAgDU5ODlbX9T8H7PpkcPUXqiV03Ik6IANfLEup3i6lpz86AXJnLroNfoRMWMk/Gs3Wb4&#x2B;erBnd22Vnq2mtlrhY616FrGza3mbiucrWSrebfVS65vNr5YrVsG&#x2B;8vvnMv69u3t1tp&#x2B;d3YyvzCR42DbjWCvFV2aL16YLl5ZKDV7Uc61UiHjVCqtpdYAPNeaKHjlrNe/pJmSuVDN5n1nc6sVRWmlkp2fyM&#x2B;UM89l1icBBaRHI3syvvcq7uCH0fEOjdHejMEqrhrM6wGAhpIAxkb2mAF2&#x2B;AfdsxbtHRqcf6ehORIrjZ21ln&#x2B;9WVxtlrZ7uUZs9wSPlGLApJVeLnbfnN65WGNOpgdTgAHyqa2MazBAmWlkbbZyd&#x2B;rV9U65HrqxUokSjp0uZ9PXqu3zlR34XXA5&#x2B;Hia73tuPZd/DpLnAYV9hBBCCHlkUkohhBSAVuzYWVKEnHWxRpz2CwjQjeR2I9hq9KBxfqpwedrTwPvX9v76l9dvb7csy6i3w2YvqRW9as4zDR7EgjPsdqLdVsAYmyr7C9VcO0h8x1yqFSaK7upu5&#x2B;rawd5BL5wtTpUzed/2HcswuW0ZUulmELfDRCptcm6ZnHNIqROpLMPIOJZlcqWU1JoxcMbV8IJNYL6aW5jIrqw3unHqO&#x2B;Z8NVMr&#x2B;id5Jz4l/VbceDCyJwLodDC1d3xe7165nkqgxfBtP9oTD1jF1QC3hluiz2yud0/90&#x2B;4YEFvNZvn9rdovdkofH&#x2B;T2en4jsdup2UtNLWEzNmmL28Xuds&#x2B;ph9Zbc1v5UgtcD5Znn&#x2B;i/6DCASXBAmnEn95utyn9bm7y2X9mO/J4wY8mSlDm2fr0QN4L9WLKlyr7rd8HF4HQ/yvuePyqhf2UkZxaFfYQQQgh5ZKbsctE1I4WkBWlyIKstABAWAGnnABiM9bOGw4JGPPAl7&#x2B;Az6N/ZydOggGaEdpA4hlHIGv7XDh61EzS6SRCLRjde3&#x2B;/W26EGbMsIE3Frq31nt&#x2B;1axg9fmsn7y75rXN9s/eKT9Y29zsxk3rUNrfX6XrfZiV9Zqv7wwoyQ8j&#x2B;&#x2B;2Prdte0bm831/e5kwecMcSJubjc3DozdRrDT6IlYcMaU1omQqZRSKiGVlMq0DdcyLJMnQu40Q3ejfXWj0QmTmXJmebqQ9&#x2B;04le0g6YRpnMhUyMPrrxa981OFz4v1sNEtZZxztdxkwXvid/FTJcfaM1Q0doieCMAtRNsjq7jHcr14rDdDCah0sOB3OLj3MKu4jA2KaM&#x2B;YQRzGEdubB5X31&#x2B;d&#x2B;dmf2nd3ina4jBZeAUkwrDqDHEKRmSxibPfMgNl0r/QNbwIvBJfCkAzUNpqFMhLkPtqb/9qu5f1yZ3OxkEwAMUBySWxZ6QdKVPJI8kebl2padbYGrpzh4SE4R7pz0FRDyxFDYRwghhJBHZpqmFCIIIwQBRAEmPaMgz4bdnl7b6wRxWvAdodQHN/ZubLXmq9kfXJl&#x2B;aSFnAbFGoyt7YdroJWCYLHqVnLXTiP/1o9Wr6w3XNKJUrO33dpuBkLqQsTOuddCJNus9oZTSuDBduDJfSaSMUqEZmy5nLkwXWr3449v7YSJnypn/7pVZqfV2I3j/xm6YCCFlfxpspxm2ekkhY6dCCak5Z5wxKVUilJBaSBVEaaqk72Ymi/5E3gti8e7V7d99tf3BrT2t8f2LU999cbKU5UIqoZRtct&#x2B;1XOsovyhlnNlqLpt1jHZQzrvLU8Va7tlNNzQgxtszDrdxh6u4YmQVFxJaId4/6sYdrcQ9vop7OLg3vooLc5jr4UEje2cx6WMaykp7mU/3Sr9am/z95sxH&#x2B;&#x2B;VbXScRHEyBKxgahup/64nGbmi3Q5MbWMzHVRdLE7tmtgOmoJ7MXxZMD4YHpRW0Sx9tT/79rbn/tja51sxKacKQ4BoaMFSqsBaa4V7eVEaOp5OZ5lSuBa4hH/yTkLOGxvrImUZPzQkhhBDyyHwrhmik3d&#x2B;jlUGYQS5nqu&#x2B;CMcQTAJhRAgAj4dgHwHX1677W4HWxGnlLk33kibi5F/3z&#x2B;6u/vbZtG/w7L9QMg//Du7c&#x2B;Xqn/6MrM0lR&#x2B;upyRSn9wY&#x2B;/dr7Y29rqJUuWs&#x2B;72Lk68sVm5sNv&#x2B;vX1z/crW&#x2B;WMvPVDJC6TARa/tdzzZfnC1NFDyDs1tb7a/WD66uN85PFVzL8D27DHZhqvDKucraXvfLtUYiVCXvnpvMp0KWc27WtU3Oo0Tut8LV3U4nTGermSvz5SAW3TCpt0OpdSqVz5nvGELqld321bWGb1sTBe/SfGl1t/2bq1v1ZtCKxR9emvrJ6/OvLRVtoJxzv3uhJpX&#x2B;zoWJqXLm8HvXQH/tNOPaCxP5c5P5ZyeROlzFjYFoOIU33oo7Gu0ddeaGUBG0ggzHo73DVVwNfZjuHRvZM8DO4iruN8A0uIQ2VJD7ZHv6/7s59U&#x2B;rEyutbE&#x2B;ZCZOw5PAsv6PP0AoSrAe2GvjvbU1VPVHIdGr59mAL&#x2B;EnEK0zDFFCm7BZ&#x2B;t77wd7dm/utG5XbHlYaGlRwV7wJQTCpeD6zPdGYp578xZ05hOLdInjfURk7ONAr7CCGEEPLIOOepEO1OB81G0ha2aWgrYfx5fTFMTo4CDgIdJbKcM79mD1cDaw3xs4/W/uaX1z64tj01kZss&#x2B;lnfWq/3dhtBLxZhIrcOgrV6979&#x2B;uPIfV7fSRGrGLIOHqRBSr&#x2B;62b2416wfBbDX3wkxprpq9un7Q6iVRKio558pCeb8d7bXCVpC0gkRKxRizTV7I2BNFv5rz6u3IMjgA3zFzHo8T7tmmYxtSqr1WdG2zdXW9IZW6PF9&#x2B;80Jtba/7W3tHpLIbJqlQvmNOlzOeY67udz&#x2B;8tTdbzizUct&#x2B;/OOk75vWNpm9b52aKP3lt/u2LUx4HgMtz5f/tT65YpnGulpvOD&#x2B;6Rgwif3K5/tlLvRWKxlntlsTJVOp3ba6pfYgxEQHx8FXf0fL3&#x2B;iXtje7gRZDw2rNffw1XpSKJ3tlpxn47&#x2B;WXtR5sv9iX&#x2B;&#x2B;M/8vd2qf1TNCclgSXN93tNFQADuI7Y/r&#x2B;cl87rVZq4Ynk6n1pw65RmqE7eJ76/P/eGv&#x2B;Z2vVmy1HKMCUx6&#x2B;QazAlJN8OzNs9q5ka0ACnsO/5Q7/LyVlHYR8hhBBCHp1OXJv5xh1En&#x2B;neNrQfOF9kcjngf4BhcD4HAEI4psPBNKTWGuCMMfaA59f0ios8glDh85X2b65u1bvhj67M/OSlGvo1qwJRohOh2kHiWoZh8I397m&#x2B;vbf/rB6ufXN&#x2B;NDgJjstCvx835diHn&#x2B;I4ZJ&#x2B;LWduv6VrPRiy9MFaaK/l47&#x2B;vj2/lfrjWrOawUx59zJ2HPV7PcvTl2cK1km&#x2B;83VbaFUKevMlrOcMd81g0RwzjSgtGaMOaaRcSzXNg3OGWOMMc4YA5TWSmshVRiLbpT2orQXpe0gWdvreo650wjaQQytDYObBi9mnCsLlbeWayu77cmCP1HwX5gpLU8XF6q5reWeATZTzb68WJkpDHK92aI5W6yM3kuRwie36&#x2B;98uv7pnX3fMd&#x2B;&#x2B;OPXG8kTm5F8EaEACYpDr3XMVd6wVNxyb1xsM64mxaE/L8WG9u9ozHmEVl2BwBB4YUnerVXlnbfqfVqtfNTMCHJbq36n3xgCmoRAJvhqYN7tWIzGh&#x2B;BPI1DS4giEhzFaj9Kvbiz9dWfjVTvlOxxYah2vF97g2wbqS76VmqOhXnxByNp383/OEEEIIeeZIKaUUQgqkaRzHADpJRymVQxOOC1v0X1rz/itFxhhjg&#x2B;Xc4Wu9wWtwQoY00IjQ7iW&#x2B;a9YyHIACNlui2Y2zrnWuco&#x2B;Fq51m8u5X2//3L6/vtwOD8Remi80gub3d3u&#x2B;E3TC5td1hDOcn8xNFf/ug9/7N3a82Gr0wyZQzb16ovbxYiYXM&#x2B;7ZtGpyxTpjstsPdZpDzreWpiamS/&#x2B;md&#x2B;id39tu9pNmNoyQ1OM979lQpc34qP1/1s65tGtw2Dd&#x2B;xfMd0LMMyDdvgBuOMMa2htQbTWmsptZAqETJOZZzKVCKVKkxEEAtAFzP20mR&#x2B;&#x2B;6B30ImurjfaYeLbxnw1V/SdP7w0PV3OlLP8zeWayXknTGYrmRdnS9MlywQuzWYZg/UQd2wQo9mNhVSzlez5qcJ/emPh8kLxcf/qPVA/10sGq7hquI17FOQdi/aisQ6NfnvGYbrXL9A46sO93youo1Xcb6U/MSfNbjv/m/Wpn61NfH6QDQWHJR9qRo9pLdEFO0jNTmIhtcD1YOH3cdV09I98kEa7mf/V7bm//WrpnZ3KZmwmSsPQX3&#x2B;RUrNAM0H/wPR8ekLr5IScJhT2EUIIIeSRSW1KbZtSQggnuWNIg9m3NPMSdts2cmn6HctxkbxtpksA4HUBDJ919CMbfpj06ZG3fXRi3/NpuyM/vr2/stt5cbZYu1wF8Pl67x9&#x2B;f/vOTuv7L079z3&#x2B;07N31yOgG6Xajt7bfOWhHN7dav/pi6/pW84Mbu71YQGPzoKe1Xp4uXJwr1wrubCVTyjiblnF&#x2B;tvjDKzOvLlVX9zqObTBAa90vwZBK98L05lZzrxV&#x2B;tdFsBUk17xoGA2MMcGyz4NuFjOPaMBjnDAaDwRnnDGDQWimttNZaC6mCRHLIXixiIRIhYyGFVErrfvzt2eZU0S9mndeWJt5Ynsi4ZsazgzidKvlz1Uzed3zbWprKn5/yLODChLM0MXtsR9l&#x2B;6LTEs7E8XeB8USm1WMtdmMnnHiYj/ObUSCtuDH2Y6921ijt4O57ryej4Kq4W0Gp8Xk8B91vFBUV7jw0DuEZof7Bb/qc7tQ9382HKNVePsI3LoMASZfYSD7EHQ4GpxxCy9C&#x2B;AKzCO2N1oZn&#x2B;xMv2zG4v/sVNZCRwNBX6vmb5RGtAwmBr8ofJkO4IJIeQEUNhHCCGEkEfGGTc4N7gBbjDGldJCiDiO47iV17ohDwqFvCdCeP0P10evummij9xLonFzq/0vH6x&#x2B;uXbw45dnl2p52zI&#x2B;vLn3T&#x2B;&#x2B;t3NpqZl07Tpe9u06Z04DBeda1o1i0g&#x2B;SzlfqHt/aubRxU8/7SZB7A2n7n&#x2B;mbTtc3vvTj53RenNuvB7Z329ET&#x2B;4lxppmjWO5bBmNZaA6bBbW0Iqdb2u0GclrJesxdLpQzOTIMbjDEGDmZwZjAGQDMtlE6kSoRKhYpT0QnTTpSmQvYjP6U058zgsA0j79uLE3nLYLOVrGPBYPyVxYpWmCx5P7gyvTjhTZf8KwsVrXUh41Tydv6uMO7b9OZ6Bl6Zy1yZy7DHn6QfruLGg2jv8Oy8sTG9w2jvWK4XHq/EPVrF1SODe8dWcTmYCVCu90QND&#x2B;MT5k4n&#x2B;&#x2B;uNyi82i7tdW5vq0VZxGRiD1GaQeFHsuU4MM348k32GAGNIrd1G5ae3Zv7m2uxHO9WmNDW/65C&#x2B;e14X1x6X044oWAoYVkOR5weN9ZHnAIV9hBBCCHlkAo6EazIOzm2dAjorhS1lHDWE7LaaypWTHtdwe7AsYBLgg5m&#x2B;QdjgAoNn23dP9pHn0FYj/d217Xc&#x2B;Wr2z04aG75gTBX91v9ONkm6UplIZ94qpGINtcsc2DJMLpdtB0uwlcapfWqj8yZsLu43gXz9c/eT2XrMXV/PeizPFUtaxLO7YhtPvy9BaQzPNGFgi5F4rWNvvxomaKWeXJvP1TtTsxqlUqZBS6UQoqXSSylQqoRAnMohEmMhUKqm00mAcGcfMuJZjGZWc&#x2B;8q5SsaxLs2VFyfzWd8qZtycb333hUmXARZ&#x2B;cHnmzeVaIWP2h&#x2B;ymcsZULvtE7&#x2B;FvExcOSUACCRABo5W49ztl71iul9wV7T30Ki6oPeOpYxrg6GWv7U18vFfZ6LlCs0dLxfoDr4BSTChT6McRNfdn&#x2B;piG4kj8nUb556uz/3Bj7rdblU7kwJYwHnSFGtDMMvS5TPpKMZ5yxeNcKyaEkFODwj5CCCGEPLJ&#x2B;vqFUfyHrMKljjLH6fv1as6M1nOyMZzbhOLJQMcwnuzdInhWxRioRp&#x2B;iGab0TpkJV8l4151zbaPzis42bK/UwFlfXDzzXfHmhwjkr&#x2B;E7edzKu6d3rEcT76&#x2B;AajDHXMg2Dc4a8b1&#x2B;aL/3g8vTaXufz1fqnd/bjREqp&#x2B;qmc1rqf3AlAaQ0NzhljqLejz&#x2B;7Uv1pvzJYzr56rXpgpXl07eI/vBrHoBmk3ToMoBYNQ/UFAGJwXfDvjWZNFv5JzNfAHF6cZ8PJipZJ3XzlXdWyzmLEvzBTLWUuqwtsXp7Lu0e5txQf80/w8XI20Z0TQw5G9/il7Irhrau&#x2B;wMLef68Vjw3r9d7Qan9ejVdxTjGlwhcRebZY&#x2B;2ppaaRWlNmDcp3v3QV&#x2B;LMZhc2IYAV8C3SNaYBpcwFJSBXu7a7uQ7azM/Xau9t1fsCgvWw00dagbFCq58o9r&#x2B;3mRjMhsCgPqathFCCHkmneYnGYQQQgg5pRQMCQ7WA7rQEcCceM7WDut87&#x2B;D6VzdXb1W4s3Dpfan&#x2B;XyMxm63/03Vdzy1xwwIsQB&#x2B;e3DfyJQehzYl8O&#x2B;RJCCQSATBkbZhAIPHZSuvmVjOMZaMXre93G73INow3L0y&#x2B;dq5yZ7ez0wwZmGEbtmVUct5MOdMJE601ZwAQJMjb0EAs0YmUZ/OsBcc0GGcALINLpTiHBmzTqOTc6ZIVp17Oty2DK60SIRMhpdJaQ6nB2XkAlIbUOpWqHST1TtTsRp5tbtR7jLHVvU4Yp55jMQ7T4NWCl/WsmUrGd0ybY7GW&#x2B;9M3F1zLePvi1NJUQUh1aa5km/zcVK5oozSbeXk2c5L3/qMRgLzHKq4KIQOIu1dxw7GZPpWM9GYMT9l7wCouAzMAas84rRjAFQS/elB4d6ey2fUV7x/C8ChfRA&#x2B;&#x2B;ksGEb4e2G8AQ3zxWY8PCDckQeF9tT/7b7XN/vzb1ft1vR6Y2Hjrpk4ah2ILX/e7UziuT216mCwDaoPFyQsgZQ2EfIYQQQh4Z55wxztjh63YwxvpTVo1GY31t/YUXXhDSTLs9peS&#x2B;Wc/4GZmzPN8zuMM4p1P7zjAJrNTj6xvNtb1OK0hsy3xlsXxprrSy1/nrf7/23vVdy&#x2B;CcI4hFsxenUvdiYXKWJGKxlmsc9PZ78eW58l99f2l5uvCrL7eF1KlU2wfBf3y5rTXu7LQbe13lGD9&#x2B;Ze4HlyqubRicR6lI5XB3T8PgsC3DBmzTMDljDFpDAdCQSsWpjFMllNZ62IobiVSorGctTeajVLaD5NM7&#x2B;41uJLQ&#x2B;P11YrOWvzJel1hemC&#x2B;W8&#x2B;weXpqt50wReXarMVHzPtmpFc9ATXHNP6j5/FHKkPWNkFVcNV3HHpvbCsXm9w1ZcPVKMq9LxJVxFq7hnAdOADlLjy7b3QdPfj0xtiEc7ra9PA9AmFxknhB3BkFDmN4nVBq0gBiJvu&#x2B;1/tFP93frcu1uTHxzkGjEHHlC8e3QxGibTM17ynYmDN6c3Z8v7sCMog9Z4CSFnD4V9hBBCCHlkBo84D6TOQmc3ynkAs9fyMM3Qv&#x2B;PNtt65/ed77Zf&#x2B;RP3r//EPb73xxhv/xfnfWS6H&#x2B;HtwHNSmYeSBlxVSLl7HcLpPWAcaOobPwCQEABM2AENyAJAAhuvC/bPHDAEALAEA&#x2B;E/xWz&#x2B;zJJAoWPxbPTuUwMcr7Xc&#x2B;3fj9tZ3dRq&#x2B;XCNPkm/XZRMjbO&#x2B;1ffr559db&#x2B;RDX70mJ5ebq4Xu9&#x2B;eqd&#x2B;c6u1PFVYmsy/vjSx3wqCjdbydOHtS9MFH&#x2B;/fNAyDCalubLX&#x2B;&#x2B;b07zV7y8e092Qxrc6WLc2WFCmNMK&#x2B;1aZlMn0FprKGilobQGIJWOhQxiESai37QbpzJOpZSDQIpznnGtyZI/Xc5cmitdmCksTxdWdjsA5qrZasErZZzFidxkyTc4B0Pes6uZQV5VclFyvcdwvz9Bejiy11/FHVbiqvEj9sTwnaNcbzi7d3wVVwzbM0aLcY&#x2B;N7Jm0ivvM659hJ&#x2B;x6kFnp&#x2B;puRGUv2DQ991DC4zplp1kpgCrBHL8JgGkzBlNAcsbdRn/iXO1P/uDJxdb&#x2B;0FzstyQY54IO7dxk0szg7n49&#x2B;WNv/s/MrV6a24UbQrB8CEkLIGUNhHyGEEEIeG601YwxAEAT1en1j3c/4mfRyavd6jajuuo5wfd9PQ95yXZePlPQycDZc6iNP38pB&#x2B;ulKPYzTpcn8xblCbnhAXqQRJQDg2XAe4hdntZ68f2P3gxt7e&#x2B;0w79vc4Ld3O&#x2B;/f3C1lnf121OjGirPJov9Hr8y9sTzx3o3d/vRfO0j6u7eeY3GDO5bhDC/AMrjWuhXE&#x2B;61Iau2Yplf0z03mp8q&#x2B;CaRSKWipVCpVIlQiZBiLIBJRIiUgpEqFlkr1tw85Z8WMc66WW5rKlzKOxVDJuj&#x2B;4PH1xtvTm8sTLixXHMnovpp0gNTgr59xS1i44z9Ajsn/E3kh7xiDXi8bO1xP3y/WSu6I9&#x2B;bDtGZTrnSl6UM0RZrba5Xovm0r&#x2B;TUI6AIDBddGS047MW3JwYN8jGczrMQhTBv5qo/aLlfm/uzHzy51cJ7JhKBjqoRqmNSA5Z2zBTX8yU//LC7e&#x2B;t7BaKHQAQHEa6yOEnEkU9hFCCCHkkRk65UpYwoQ0M4kFMLhtmBZTSyavsfTVTr3yy63/6Ub983CF6ZeaYLbdvsl6Zi5yYBhu5cCcmkS8CG6IPAdgyhKAjAQAYR/9RMpQAHh/jm&#x2B;AA4A2AUCZhzeQb0wC//7Zxt&#x2B;&#x2B;exMaf/GdxelyJlcwA4kvVltfrh3sdyLL4MtThZfPVeeLX/fUMVS4vtG8td1WWr&#x2B;yWLk4W1yv9&#x2B;qdaK8Zru5141RwhnzWWajlXj8/8daFif126FpmnCb9MCmVKu33vmgtJLQF6H4bBitn3deXJ2Yr2W6YmtBzk4WXFysMCKI0iEQQizAWqVRKQWtwBtPgDLBNPl3yXz1XXajlZsqZUtZ5&#x2B;9JUreC9fK5yfqrAgLmq/VdvL2voWsH2B4NLz0STjAIEkA5O2VOjxbh3V&#x2B;KGx3M9GY9X4n7jVVxQtHcGMYBpCKMT5HY65V7sMwbwRz9PVQOaOaZazKQXs3HJloPxuof85P6hgVz3B/qanewX25Vfb03/&#x2B;1bt/f18JzHB8dCruwwajqFmsskfTbb&#x2B;fGn9R4sbbqkJ/8IlxwAAIABJREFUrpGalPQRQs4qCvsIIYQQ8thwg1uWaRhmr9fb2d0BoJRUUsF1HeFGUYRuF0CDxxO2BdmBbSVZ2&#x2B;LDhOUbjo&#x2B;QR6OAWEEoWBwuR5ji5lbr99d2fNv8/sUpIXUnxXvX9//&#x2B;d7c/vLkbxMJzrFcXy3GqzIuT0/n7rvMFMfY7URCnhsE8x1Qa7SDphallGUIqIRRjzHPMSt6tFryCA8cyDM4MzgzOtVKJUFJqpXWcyFaQKmVFqYxTIZSaKvk/emnmykIpFZBaZ2yWtQBAKm1wlvNsgM2WM/PV7GtLVYOzpck8B8pZ5wdXZs5P5WdK2UvzxYKNP319Qb6qyjmjnydbwGL5lKd7ejiyF3/dKu7YO9FYh8axStzByN7Xt2fQKu5zrL82q1kvcVuBHwoLenCE36N9Hc2gmWeLF4vBy5Vu2U2hOJh&#x2B;qC/DhsW7jCFx9hqV99Ynf7E6&#x2B;e/b5S86fk8YMNXD9jlpBsFtQ72Qj/94bv/PFje&#x2B;N7fm5ptggDToUU0IOcMo7COEEELIo2OCQ1hKQ&#x2B;l86AKIvK5pWkbXMoVtp07UiX62/t8n&#x2B;t&#x2B;5u7Qn350yJ&#x2B;2cMhBj/yMA2cw69j3EHlwvLpUMx0fyGjiHmgZgSgDQBgCkSABI9M/mYwBMuACs/ivG/ll&#x2B;NNn30Foxbu90VnY7rV6cKj1V9L/34iRn0NBawzQNzlmzF6/utd/5dP39GzvdUGRcM4jSL9Yb5bw3WfKLmaJ3n7jP4PBsA0C9HTU70c2t1upe56Abz1WztsmFYAzM4tyzDMc0&#x2B;sGShtb9w/YYMw1mmVxIdX2z&#x2B;fOP12pFf78dJUIBKGadc5P5gt2vcT56fZ7z7ItzpSiVnOO1c9WZavatF2pZ13ppoQyg4OBHV6oGqocPkIkMwzc8e&#x2B;zpOFzFHY7syXh8FXf07WFpxrH2DDES7QlaxSXfhGaJZJHkQj3M&#x2B;Ny9KAawnJO&#x2B;UGm9ONH03KQf/z3gswan72loA5EdhN7Nevn329O/36i9v1P8suNFkg2Sx4dK&#x2B;sA0M5layAV/PNf4H19Ye2t23ckdwBAQJsDoqD5CyBlGYR8hhBBCHhsphVKKcx7H8dbWFjNi27bTNNnfr1cdz7IscAXOLcsKw9BtNZkbNZtMZMVEFMJxKLa7nxTQ/aTr4T74oCvbQRrEIutaMxXH4wCw2ZL/9snau1e37uy0tYbrmJfnylOlTClrc8Z8x8r7tpDq05WD6xsHH9zc9Wzz7UvT89Xs2l53txXapqG1Zvf/NTI5tEY7SA/akeeYOd/O&#x2B;47vGMAgYtLQClpqLbUCkEoVxqIbpmEsTIMVfKeSdzljn68eGMat15aqrm3MlrMG58vThVL2HiHdVNn60cszr5&#x2B;vurZRzTu5u6b0TvHYnhq24g5H9uTXrOIGg3m90bP29Eii139Hq/F5PQXcbxUXFO2Rryc1U/qbJn0ANLeYnnLjFyqN2VIDTvSgpE&#x2B;Da3AJDigTgb9ZL76/Vf3V1sR7B6U7rcx&#x2B;bEXQMB8u6etv7yqeM&#x2B;S5Qu/H87v/ZXn7OzNbdqEBnkI9ROxICCHPOAr7CCGEEPLIBIcwAB6AhTyxACQG1wbL6d2yeXC&#x2B;8st9Xb&#x2B;a/tViGM1y49Pef968vjlR6Z0/f/6tws9hGGmpFQShd/CviC2/Pmv3POhPkMkgfwWOA/wAQL/9kcEGIJHHcIus/xLNem5eqUng09XOre2271qXZovnKkeJX6wRp0iENjizTWRMAGjFePer3V99vrFR73qOdXGu9MPLM1cWc0GEf/t47f/5zY1rG03HNOaqWccyolTst0MpZRCnnDPPMXpR&#x2B;v71nY9u7fYi8falqb9469yFmeJuK1jZ6WQ9a7aSce9/z7cDcW2jcX2zKaS6slB664XJjf3uXrOXCBkkop/rSaWCWAihJCCVkhpaw&#x2B;C84DueY16ZL&#x2B;83w0YvZgw53zo/WajkvFTIty9O3fPndYC5gonCKX9C21/F7bfixkA0mMKTx1Zxg7Ej9kZzPZWMr&#x2B;IKaPGgVVwOZgKU65FviD3UJN59aHCGiiVfzAXnCw0724KZQhhfN0nHho/V1EyDzO392nvrMz9fnfj1XmEtdGLJNNMPe3SgBhRnivlMv5Tv/fHCzp9dWP3u3I7pdgEJaVDSRwh5Hpzy50aEEEIIeZZwy3Jdt1QqKa3dlmvDzmazjUbjo48&#x2B;qk0E&#x2B;UI&#x2B;NQLLsqRUWitwDiXDMIzj2BOGHScabeZ5yJ70t3GarOzHf/MfN967sXtxtmQbS9XChG9i7SC5td3ebQV7rajRjfK&#x2B;/cq5yutLE6aBj27t//T9O&#x2B;98uqGULmTsRjeyTS61Wtvr/N1vb71/fTfrWZfmSxdnS0IpAJ0wMTjiVHIGy&#x2B;BhLG5tt27vtKt5b66aW6zlZgvGRCGXcaxESIPzQMIyEKVIBHLe2LBhoxtf22iu7nZyvm2bhsV5ImSYSq10msowlUIpzphjGZbJOVDMOC8tlFOpXjlXOTeZz3mWY/L5ai5ORTXvLU8XagUfDI7JCs5J3f3fQD/XSwbRnhrZxhV3r&#x2B;LenevFd52yJ8YSvYdtz6A4g3w73/gRpBkUsw15Id/77sTBQqEJMwHUPTbo&#x2B;4ODbNj/K2wVOhud7Bf7ld9tT364Xf28nlsJbakYmBqmgQ/82QHNOEPJS69kez&#x2B;Z2/5P59e/M7fDcm1AQQH6azNHQgg5KyjsI4QQQsgjS2EkzBBGALPXH8ewRMZiFqyVcr774&#x2B;8etJrN2m754J8/PB9XNmf&#x2B;199vy7hV/H08//llPjM7s9RddRynWvgEzeZ82BZCaiOFV9pv&#x2B;2ZglkIgk4E/D84tNg&#x2B;gv8AaK3B&#x2B;tOmrNZgRg7GHXm99NghAAdbwhe3e/8/enQXJeaVnYn7POf/&#x2B;/7lnVmbthSrsAMEFXMRm761eJI8l2TEeRzjkcYwvHLbDF760w771zdhX1o1jwhee8NieiRmNI2YkRY9kqaVutbqbe3PDVthqzX3Pfz/n&#x2B;CKzClUA2ATYYDfRPM8FA0GCYGYhs1j14vu&#x2B;dxi8fbP5s2t1ndGhH3eHyfVR&#x2B;Dcf7Lx7sz3wo0bfb/SDlbLLhczahh&#x2B;lf3e1frM&#x2B;qBbs5aI3jtL9rv/mjUbKxVZrfKcxBJB1DJ3RwSTuTyJdo5MwdUxNSACghHApgziNU8Eo1TVKKRHA3Wb41mYz5WJ1LjOJ3Djhe90xFzi/Ulw7XnBhGcwy2NCP3rnVag/D3jikwHw5M190ComITs1lbeP59blSxibAqYX8f/K1M5ahnVrILZVNA1goFF86XXx6fjvFwZW9EIggj17ZC8B9pA9c2TuW64X3V&#x2B;I&#x2B;uIoLAQnVnqH8OpBP&#x2B;bISBCnJuuHz1darS/vV7BgABL0/YptmfERA4yBAakWj/JVm&#x2B;c394o/2S2/2crtjKxSUEwENj3qkT5Bp7cack/zW3OCbi/uvrW6dq7SJE0LK2aiiSvoURfliUGGfoiiKoihPTprCtmtOyfO8rr7orbQl0G63KWNB4Nf39&#x2B;&#x2B;6W3e3tnYXbl&#x2B;8cAEkgmEw16NBMAl93m63jVapVB70el4cszQH04SeQtNAwDkoPfbtHjkWdjz1hgn2u&#x2B;F&#x2B;d9wdhYSQSs4&#x2B;u1gsuxACQgCAxmiUiJv1wc9vt//6vd297iRrG0GU1nsTjaI1CG7s9W/Vh29cr0/C5NJaabmcvbLVafb9OOWmzhilJ2q5rGOECb&#x2B;&#x2B;1xe825/E80V3Yz6vazSMuZRglFBCDI3ZhpYK0ez7W61Re6j/&#x2B;dt337jRWC5nDJ0lXNzcH7xzq&#x2B;VZRtbR14rFw6dQytqXT86NgvhWfSgl/DCp5p0T1ezGfP70Yp5S8s14Ke&#x2B;ZJ6rZWoYCWC&#x2B;b6&#x2B;WFox&#x2B;Ez/cXpinAZ3u4OKzEjSCCh0V7D&#x2B;Z68QPR3i9YxcXByB5T7RnKrwUFGJF0&#x2B;nKTAMijFvIKYjFxKj98Zal&#x2B;odaEFYE/cOnzcGlXMsQMid4YFN6vL7yxW3ujnn&#x2B;z6zUDg0uACVDxqC/56Z0&#x2B;wDOTl&#x2B;aGv3di/5sn7ixW6jBDcApO1XtHUZQvlM/311SKoiiKonwuMcE0wQShAEuNlBDYQwPQIDuwnFIJpaK7yP5q9xQs7c33xdl81ti5e2HcF/&#x2B;fc7nVbr9w/S/G8ZdWz/zcNI0TyQ0CY8zWO53OR6356tzcxepfponL0tNwXdgBHEcnp3QhIAv3Nrkol5AECYDPz2RffSzagyCI00rOXntgQE0CoUCUIIh4lHBCSTmjTw/t3e7Ef/P&#x2B;znt3Ovvd8ShIbFM7Uc1OLiVfOl/VGck6RtYxLIP1JuFOZ/zWjUZ76K9VM8&#x2B;slpsDP&#x2B;FCZ1QIudUcvX69/v7NpqFrjqG3BuGdvX57EFBKwpifWszM5Z297rje9aOEx0naHcf7Pf/Gbg9SDiZRyrkQ0DW6VPbilPtRcn2nJ4QME/7mjYaUuLRWLmdtP4rfvdX&#x2B;m/d3l0rel8/PH32ClQx97dx8MWPt9yYapZWcXc7aedcoZ52CR036FH2rLYAUSB6yinsY56VHVnGP5no8gIiO9WZMo71jfbhqFVd5ou6V2GJ2be&#x2B;XZrDUMWJDSyAdSAL5CLN1gkBQjYjTheG3V&#x2B;svLzY0bwQqwBnkwdIuJCgACRCkBkJnZ&#x2B;Rcb2ffaRbf75Sv9/PbI7MVa5wKAI&#x2B;a9B3UcThULGb9S9Xu7642v768t1hpwwohJe79n0NRFOWLQoV9iqIoiqI8UaNhX7eKxWI2m2WrBZ6mWZZ1XReEhGE4Go0JYBhGvV7fdrZMw1yotsxMljE2HA5v3rzZbrfWMz4XnEYdx/eZ1zW4gBXP5voOhjOEFFKCUvFpN82evOuN8E/fuP3mtbppal&#x2B;/tJR7&#x2B;UTBmv2jUYLt1mSnM&#x2B;kMg&#x2B;442mmPwzhdKnuvnJl/YaMggffvtn/w3u5OZwzIME53O&#x2B;lOe2zq2mo1Oz1yZ2qMUdLo&#x2B;df3&#x2B;tf3&#x2B;qWM&#x2B;dULi6&#x2B;em7&#x2B;y3b2y1R36sZCy70c77XGjM9F0lkoUPDONkqyjl7JWIWM5pjYOkoxtVNbsat6N4uRvPtj7cLvbm0R&#x2B;nEYJH4VJdxxqlD57orxc9q7v9W7sDq7u9lIuLF370vn5rz2ztLGQu7rdHQVxbxQWPVNM&#x2B;14PMODMvLMy50jAfUh37ueTPBjZC4EQ8qASV0T339ebXty7V5h7MLt3rDdj&#x2B;mN&#x2B;PNp7sD1DreIqT8h0GZaKWXwmDl5Fv1TeR0B5xgoq7tA18kAWggHiE/4lCaSMSSzm/O&#x2B;s1n9vY&#x2B;9EcQAiIA42Z4kEJBgHlRAMkRFOsrc6lTf2Kj/cLrzV8eqR5XM9FuDTLo5HJAFJIYghcdIJv7HU&#x2B;tbJ7ZcWGuXMAHoEzlT3rqIoX0wq7FMURVEU5bE5iXRiQZMC0vzQ2iSEFPoCIk212tbu1g83L507f/57xv/ZW0wNw3hl&#x2B;Gdp9cfFzsr&#x2B;/v57/X9YLhZfOVmLovG/3PyWaRgO&#x2B;bNFfeHd6OWPGgutTkkzajn6I8YZDzoipDLYMeIcMlehG8ichWQgiyCEIg&#x2B;CFB4B&#x2B;ZzESu/cav2LH15/672dYiWTcYzn1iuFJQ9AP8Lr15t/&#x2B;&#x2B;He1Z1eECcpl1utURTztVo24dK1NMfU7jZHQZyu17LzBbczDN6&#x2B;1brTGH5wt9MaBJ6lMUoYpRSkOw5v1QedUXhyIXduuXhqIdsc&#x2B;JpGp8FRwmWUCglkbHO9lt2o5QQXzVFYLbgn53Oci84wjFNe9EzP1oIoCWNuG2yp5K1UvLvNEQHCJM275uWNOSFFKWulqbxZH2Qd4/xy8dvPr7xwsmTraPTMpbK7MZ87UcsWPOu&#x2B;DwIBnM/J78fDTU/sHWnPmGV24UOivYfkesdXcWV6vD3jMN172MieyvWUJ44cJGKCQlIICgBUgHEQeXDA7jFJAkFAhWuPF3K9ea&#x2B;YNcr9CFwSiMMRwqM/H8A0ziMm4zUn&#x2B;Ppy/XfWd56pTafqCCS59zglRcqQaOPQ2upnb/bKV1pzr&#x2B;&#x2B;X3mlmtn1NEoBOK3cf566eJBqQt5ITdvC1&#x2B;dbvntx5ZXnfyA1Ak&#x2B;m4n0r6FEX5YlJhn6IoiqIoTwwB6Xa7H1z7IJvNYk1QSl3PW8ouvfji5bnyuQ8//OhW07NtZ2Fhodfrvf7OlqZpg7lBLpe9cefGzVu3HFKq1WqWZWmMJdKMkzgMAgAk7RuGwcgEug4rhqaDTrOTz8t3ca2J3Nzrb&#x2B;720R73TbbTHm/u9VcrXs7EYJJ8cLfzg/d2btYH8wVntZqt5Jyd9uh2ffjWjcZyxVspZ8IodS2tVnBLGWvox2HEB8NwMIlSLmbTXxQgCGM&#x2B;CZM45RqjBmOEQHAhhARACDEYKWWsoJJZnss&#x2B;vzG3MZ/rDAOqs/Vq7vRiYTCJ9np&#x2B;fxJd3em9fbNV705aw/D0Qu618/OnFvIjP&#x2B;mPw0revrhaOruc0xlyrjlfcEdBXPCs5Yq3XvM8DQDyrnlxtWTqbLmcWa1mf70f9l9ouoqb3hvZO7yyxz&#x2B;mFfdYh0Z0vBJ32p7xKVZxoaI95cmbLu1SAUmRGoitSWSlnFl6ato&#x2B;2ASEQ7JZavZYaZckAAWRsIKaNzyXmzyTiz5KzHZKhAAoDsZUDy74iek4IbWYvJAdfWmp/t2Td19caMDyAYFpfjf9ZbmG2B777u2u91438/Nu/kYvvzPydidWL6GSTUcUD3/dT3ycmF7io1RW3eTFucFXavXXlnYuzrcMNwDlEARSJX2KonxxqbBPURRFUZTHZqfCTiVL80gKgZGAkAIiQBtr54e0fe3uf1Beeg1zr&#x2B;/gZp&#x2B;6J7JvnjjJUHpjM7dptDZGw2tr2b&#x2B;rav4fxf&#x2B;d3/c3g2Yarf14b3GzLr8015bmUPotYjuGFRgkNXibccqjHcK1iOyalsX5bzHHkfrzhDIOAPg8TJLdbQ532mMOsLzjulZ/El3Z6Z1dKuYWHADjIOmMwpSLjfnct59fnYTJD97befdW625r1BoEy6WMxugoiK/udE2N1XuTencsUm5olNHZiMussoEQSigBGfrxnebQsdlWezIOEoAwikrOeWGjUs7YXMrmwA/jtDuONEbLWXul7KVFx49SzsWdxnCvM0k5f2at9PVnFn/rTK2c1SlZPrWYL3jmmcVC1gCAc/POuXnnwWdqG9rGfG65nFkoeSufl&#x2B;JceTCyFwEhZAhxMLXHw4dFe&#x2B;H93bj3VeLeW8V9aHuGWsVVfu0OVndTPRrnt/qlvZEXc&#x2B;qaQdEdFexx0Z7oVggj/TSjbZKACtC0YIeXyoP2qMtA3u46w1DjKQCAiIMjeJIQECZtlpzxwu8sNb578u6Ly3tmZgyWHlToEkiC2EiDTH1QvNoqv7mf&#x2B;0kr&#x2B;8HQ7QVmyEkCAiKhfdKa8IMPUhAdomhHL8&#x2B;N/v0T9W&#x2B;s3V2q1GEG4AycPKnbhYqiKE8pFfYpiqIoivLEUEoty0o5D4IAUrbbrXa7xd3hiRNrxMysrqy&#x2B;dvq1zc1N03xL1zXDNFrt1ng8ieMk8H0/CIIgabVaDadZKBQ8mgUhUoiYp7EIKKXjsOs4jhTjLCGJTHQdgoJ&#x2B;Dr6ba/u4utPb604sQ8vWcpmCE8Tp9d3e7cZwveYwSjRGKSEZxzi7VPjyhfmhn9yqD9670w6iNE0FIUi4aA3ClIty1gKIxijTKD14blKCCykkXFNfKnuUoD&#x2B;OfvTR7ma9f2Ov3xwEBc9klK5Vsxu13Ob&#x2B;4M3Nxo29vhRwLP3SidLqXKZWtAwNwFzeNU8vFoI4LXjmUsk7uZBfyDIAl5bdS8vuozxZ29RWKpmMrWX0z&#x2B;4j&#x2B;otxgB&#x2B;s4k6P633MKu60FXdWmnGY60X3jusd3tpTq7jKU2T6RwCpNvGtrW7xTq9yrVvZHTshJ5oWuXo0b/qX5lovLNTd/BjT&#x2B;3fycef7AAkY8dlKmwgmScpF9WrfbcVEAGBSp9Ki0mTSY7xkRavZ0Uul3lcW688uNM3MBIzPQkbBEOv9wNwdZe4OCrd7lSut4odt98rQ6saaFNOl48d5M02fiCSMoejGy874YqX3zaXOV5daS5U27ABSAOygPlhRFOWLS4V9iqIoiqI8tn6m38/283GCOCkN5wByp9zQdFLr5Vhg7xWqb4by/WTu//jwv&#x2B;50Ot/1Xj9dP/PN5/93veJ8R/w3XzsbZ259BZz/t9n/pRE0/ln3P13cXhR92widgbN3OzT/p5/94dLy0n98YbNYKgX0rwzTyNuj0Wg0P/w5IhPpTzE2Eu/3DM&#x2B;z4q/BMEThBACCQECCZwkhdHa7CgBA6wAkbAAyyUkJpn/MRGAKEBgMEEhIDCSxHohH&#x2B;GJptzP&#x2B;cKvbHATlnDWXsV1bbw39O83R7cagN67EKQckIcTSWClrL5Yc20hyjmlojAs58KPt9ujW/iCI03NLxec3yu1hOAri/iRKhUyFFEJECR9OonGYXFi2s65xu25t7vffvNG0dNafxP1x5Nk6Y3S14i2WvfmiS4jMOoZO6WLZe36jculEabqBe6Zmr1ZsENj00//W5y1Q61f2BaQAOJDcG9nj0ZFc78FV3OB48Bce682YreKK4/N6Avi4VVyoaE/5PCKA1HpD76&#x2B;3qj/aWbjbz9dDtx/rMQeH1Djm9bgxtokkl9DMZkYwEsjHvN83zek0ns11L7E4lZJBVtzsdqDxVBfQbCYyGnd1MWeHG4XeM3PNM6X2Qm4AOwSVSHVEZhg6jZGzM3Cu990PBtmbw1x97LZDqxeyMaeSCrDHKeIAIAFBkGqgqNjpV2vDL8/vXprfP1fuFr0QWoyEQWoHHyNFUZQvNBX2KYqiKIryxHAhDMOQUu7u7mxubvqBv7e318g1SqVSq9nM5fM0kzMMHYwB&#x2B;NrXvvb662&#x2B;Ew3B/fz8XzGcymXyh4Lrue&#x2B;9t7e3trY5uXL58OTdHpJBpmjLGQAh4ijBEnIzkSEiZTSaweZJNGGMMoCCEMSnlNMCRs8RG3PvGjxy/pfaEbLdHH211u&#x2B;NwuextzOeEkPW&#x2B;3&#x2B;z5d5ujrfaIUcKFpBSEENNgjg7fYLpGNUqjlDd6PiXkVn2QpKJWdJYrmTiVQiKK0jBOhZRCgguZcEmBxZKbcw2D0fYwSFLh2bok6I7ChAuN0mLGmnNpfi1bzJijIHEMrZS1iva9x0kA&#x2B;5feef4lcsJfQALkoBU3mo3s8SMFGunHrOIezuvxECI&#x2B;0ptx8INPWMWlIBqgcj3lKTE91SepmDhv7s3/q2trf7VTHUSmoJCYnc8jnDU0Thk0QiShr6ymhhkDOHiXPZrZZ08BIzEz4lKt7hrR2arb8J1x4IWpZVKeMeKMntQy41Ol9mKlCWcEPYEgiE0EbmNQ3GwXr7bzVzru&#x2B;1376sTpRlbICchhg/DjxHyYNYFoBKae5pzoS3Oj31/f/&#x2B;ryVq3YhB0AgKAQRL1/FUVRplTYpyiKoijKYwvk4kQsxtYO7G0rTQAyF&#x2B;maridi23R68&#x2B;g36s2/u/1sS3OudP3XrCw3FsAW49TWCCEEmHsbprlQe/N85cb3rjmD4dC8/VwYhs&#x2B;ZH61WVv8f&#x2B;z/b3dkZR9&#x2B;47r72XPf7jLEXyh&#x2B;Vy2XZ3SGMidwtSojO/l8IIyUtjdhm&#x2B;9swDVgbYAwUBCQyEikkpzEAihxADGkRQuk0qSIRgFlsxTQAs/E9engbDxAGpEGETT4p3IqBrdb4dmMwmERLRTdJRH8Stfr&#x2B;OEy3W6Nru/28Y6RcMEpSDkgpACFkykWYpH6chjEXQgqJURBf3&#x2B;klXDT7wWASWaZW9CzX1F1T35jPBnHthZOV1blMKoSu0VrBOb1U2Kjlru32Rn7smHopY2VsA4BBsF42AfMz&#x2B;Y1/Yg5XcSNIDsKR9u4d0bs/2jvM9Y6u4h69spdCJMeXcB&#x2B;xPUPlAspThXAQSN96Y7/8JzeXfrxb6wxdSQCNz3Z7qQS4T&#x2B;TVoUdAsk58qjyoZQKwBHT61qCPWIABSSApOECEmx1csienYmsUun3fC1JDp6mjx5ae5CzfdicwA6RMhsY4Mnpjb6dfvtGqXOkUb3Qztwfmlq8PUyantbyUzyLLRzRdyBUEgjKGBTs6nR1fqLa&#x2B;uth&#x2B;Zb5dLXRhhtMAFFIlfYqiKPeosE9RFEVRlCcmTVNCiOO4uqZPJhOtqAkhLNuqVCq1ak0IHpJJEic8EcwwfN9fW1v9cuUr3W436J/Y39t33DuGYWQzmaauT/zh1tYW2f&#x2B;5lNJZvbuxsWHv72cyGTvDqWUTQib&#x2B;JIg6pmnSsGPblu4O4bowJQhhYKAAUjnrlZyOtDzOYMsja/TSreao3vOH/eC2zgZ&#x2B;PA7iTs&#x2B;XjO51J&#x2B;/fbi2WMn6UplwGURLEPOFIuYgTHqdCo7RWcM6vlEZBPPDjRt8XUjqW/sxa&#x2B;bn1ymvn5xfLnmdqv/Pi2lcuLK7OZSxDu7LVHfixrrFq3sm7pmWwctZencucWczn7E9&#x2B;tL8O8qAV97A943BqL4AUSHpIj6/iHsv1wmO9Gfet4t6L9qDaM5TffFRCkLsD9/t3an&#x2B;&#x2B;Va37ljSnPRjy3qubApJ0I/2jobvey232SnNuRJ0RtBiQEHiM5gpBAAYiocfQY9uKbTucywylJISKWbwIIGGTcbExdrZG1ubYuTPKbg9y26Ns0zd7oTFKaCiJ1A5/vny8N6IEBCWcalRWreS1yvDrS/svr2yfrbQ0KwKbtu5qAHn0/FBRFOWLQIV9iqIoiqI8tkguJHIhsluw9pFKgDgTBp2Gbj9i9bP0ZsFs7ISvQh9kiuIju1LWChcm32NMy7n/UqNsIE2/6fvdy5Vy5aXc/40Fmf1eq9loBqPvhZ3tibiT6vtXDXSj7e3mSV3XWHzpSrtAw/er1erLuVs1t1ZKfyb88YT8iMWaPXqfJCbCv4fQg/dbsCzNsQFI5ABIFAgwK&#x2B;7VJgCm1/oEJABKUgAcAgAom652SglIHVIn/BPWfkOJa7u9rdYojFMKybmIU&#x2B;Gaeq3gDuNkqzVilASRIEROkyhKCCFglBYy1umFfM41XjxdfX694tl6MWOnXFRy1nzRK7imY2lLpcxyXgPwtbOl6X9uEOE6I0LI3jhs9Cbv6lqU8qWy9&#x2B;VQRW1vAAAgAElEQVQLCxdWS5&#x2B;HVuIjq7gREB5M4R1vxT2M9sCRDI/nevED0d7hKu6RwT1yOIE5HdljT317xmFuovpDlYc6WOBFaF3vlH5ar9wdeFxQ6MlDf7qA7HF6te/99XbVoOnlBcEyHJSDiAd28X9hTEZwb2aQJtBjMEEkEJsIXR5bo9Bujrxbvcy1jvt&#x2B;z/1g5G779jAyQnEwQkgAKu&#x2B;9wh&#x2B;RPHhgBLrG83a04E1eLI&#x2B;&#x2B;sdB5bWl/qdKAPQEAwSBU666iKMpDqLBPURRFUZQnxrQsSmkul&#x2B;Nc7EWcUloul3u9rWvXrl3xr5aKRd30i4WiNNjNmzdHcE3Tiq1I1/V8seg4zqCz2O/3y5XKYDj0B636fj2bDFaWlzMZiwu&#x2B;ffeu709q1pZlWbWSpIapQyeERFGkcZ74AzuKg7hre54wKWXH91in3wxKCSlBn1gsttOOXr/euL7b0zXt7HruxTPVuaKXtYzt1vDtW&#x2B;07reEoiAFZyTkXVkqAPFHNWhRZh710qlrO2pWc9eLpuVpGm8vNXzpR1hnNu8z5&#x2B;EeXNbFQ8haL7rTTw9LZifncy6drXz6/UMt8Nsf0fhEBpEAChEAEcXxk78Fo7/55vfQhU3tfkFXcafAxm8aSIICUs13Fp/HpKL8KEkQiMTqj4u1epRF4iSSg4mPmlSWoEMDNgfNndyup4BpNzwtqWSH0CHoCwiHILCkDQA7yvuk1vXuvzKNTeBJ0uoQrEVnjQX6vX6qPs42Rtz30bvbcGz3rxthsRkacMgCgAlSAyk8zyicJJAEnkMQzxYVC8MJc&#x2B;9xc41K5c7owqWTG0ONZ269a3VUURfkYKuxTFEVRFOWxGVzqXHIARDu4vpRCItA15LJfXuyOc&#x2B;MftL2S&#x2B;3o1t/&#x2B;vkku326w4vJzNZZ&#x2B;/PTp37pyph81Bud58b3n&#x2B;3IZrCsGRCIOzYuXdbJH/j5X/6qNK&#x2B;8/f/J&#x2B;73S4oTNcKLt42dP3H&#x2B;6/RkHaurp&#x2B;n5/4jctX18ro5lFJqxrsgYPEQCTMHd5C6NL0Ey9atS2AUpAA6m2WRMCUkFQaAo8f4prtts0QJkGQ6UiLpJ/VR7HbGV3d6nWF4opr5ey&#x2B;v/cGrG5W84&#x2B;jsg61eteje2OvnXfO59cpC0X32RNmx9GdWixTI6PjSufKrZ8uHdRk5EzlT/8QPOwFWK164MWdb2tmlYsbW1mu5c8vFE&#x2B;XP&#x2B;kKfPBjZC4Ho/lXcj2vFPdqhcaw3Y/pXfjzae7A94zdyFVfOppyIAD2IVO7FFr/6xFZ5SlABAiRmY5hvjfMx18Hkx07kEYAJSNILjGFMCYQk2J&#x2B;4Z4rj9UKPZvrQOQSFOEzlOIgAeWCwlAApA5EyNkTKxok2SdgwNupj906vdLdf2J94Ld9s&#x2B;lY70LsRGySUA9APfrXp43vct6ycfvYFgXTM5GIh&#x2B;N3VzjdWts/M7RWyfWgCdFrT/fkYZVYURfm8UmGfoiiKoihPTJKmruuura1FUXTdzLuFZDwai6YYjUZNntTrdT/6cZomp0/WAIxGI845pUQKAkLAGKGUcH769GlN01r8&#x2B;a2trXbjapryOI4NXXccp9fr7Xb3MhmvV&#x2B;5apgkTUkoY0yEwyZM45L7FBU8HphWiGIExsBT6wRc8hMyGxZ4QIWXeNZ5br1xaK/97r5y4tJyZ/v2XThfmclZvEnuWVs27WQf3JXnWp011ChaeP5m/sJYHwChs9lmkXxxIgfjeyN50G/dekHdftBce69CYtmccpnsygUiP9OEKgEBy4GEje091rnffSbLpgBIeSE8gIQm4Ds4kp0JQLjQKqlEJPQaLQcRjXFVTvkCk4GwSm36iCzk9RvrxLxICEMk54Vy70sv4qbY9yL1SHTQn9kLOzFq&#x2B;w6ilSWgJjBA0BRXgDIkGziRnKWdpyuJUm8R6kOh&#x2B;rCfAW63itZHTDcxuZLV8pxvYg1gfJyzmREoiJEDkLJR87Gd2&#x2B;KBBCRxNFMx0zvLXC/1X5gZfW&#x2B;xdmmvRTB9aDEkgmHp3KIqifCIV9imKoiiK8thcXvfEPo1riOal1iUA7A502Y8yXT/RhleWlpZ&#x2B;J//heOv1Zaf9f0WLGic7kzNeJtOztn60ab2naZnc5ZuafxUXN8goEpHHwqjXNbOWMfTPbvbOGuVTl/&#x2B;4s9q&#x2B;tm1dvfqD9lulufPns9WeMPul8sL79Wtv&#x2B;9&#x2B;ojqsf3n57cXHpJb6ayWSodXc4GLryJxqztO4umIbhTZRKMN5GsQDtAiCDaM0yDfjAdCQRB6NUGpU4&#x2B;IZz1uSRgCR4IKu5z2ol87svrgFYm8uemr9XkGEAp6o28JlUZpgEjzAF&#x2B;IgEwO&#x2B;t4srDXO/4Ku7H5Xo8PNabMQ34pDg&#x2B;ryeAI7neNNojDPiNGNmb7jziYC139lcyO68mjlxDIwcvr9RMQ7sxdvZGbj8wEqF5Glxd5u1wPtdxMjEYB1dfoisPISURkjzGWqwmAIxi40pPG8d2K7Tf7zrzdnE1E53IRWU3tI1A1wOixRQyiY0o1v1E9xNjEumT2BjHxijW/VibJMaeb707cHdjrTOxuWBCEiGInA4XHm7&#x2B;Ps5DO/KsMC3bhaCEoGLHp7PhudLw2WrzQm3/VKE350TQE0Ag1Q5mYBVFUZRPoL6SUBRFURTliWGMdrud3rXrICR7spRdWHBcd7G&#x2B;1Ot200E6V6mcLZ&#x2B;N4miSRJ12u9lsXLly5euFSSaTQRKbrovBALqOGCAwDaNULq/rcwDujKgQwjDNTCZjmqbjOIE/7vW6V69e29raLp0cLiwslLPC8zxDcnCBJIWUYjymhglrAsFR8kGppunAtJ/jWLj0qc8&#x2B;rZfN9XL1l/6w/WrIg5G9aBbt8YNt3GNjeocB3325XnB/Je69VVx5ZHDvvlVcOktVZx9fcuSvT4/7R/bIrD0Ah6NM01k8CkEOTqHR2RDf7J9ittiYWv4of7tXvNnJ3e65g0hnhLo64SCFzPBlEl70BqAS4hcObSlfXJJRqRFBH7HvYvpHFxRc0t3Q6Lfouy27qJVP5aKTxaDgBpRFiUwjKXVBXEEhWMj1cayPYn0UG37KAs5CTmLOWrG&#x2B;FZhhpAEE0yre6VW&#x2B;g&#x2B;MHs//cYz&#x2B;hw91hCY1Xrfil4uiV6vDyfOfZ&#x2B;f1KuQFrAkFVzKcoivK4VNinKIqiKMpjo6xDaZclWaTZiA0JEFhE16nBc0FPvr4TBXnxD565Mna8rO3&#x2B;55fe29rauuJ/I5VsVBpIIW/KM/V6fT/8R3tXCxfW/nR9fb2s/XlmIePe7KNQADdAtJW4BcZOrbz7ite93RBJEheCf9RP4v1BbAwHfzuszdlz//bq/xZFUXjnnbUTJy6ee71cLq/kf5yIxKBNjWrD4e0MMiJfNFMzlk0znzM0G9QEigAAHRKAgcNLaRI4PBhFBAgHjZ7aL5Y4wA9WcY9W4j54Ze&#x2B;huV78QLR33yqu/M1sz7gv18ORDo3pP5XTGg02G9kTFIkOySCoECxJtTDVg1SXkjh6nLV8YgaghzN9eqtfeL9e2&#x2B;qVw9BgSItmrFOtFXrv9TxzzEq5xsV5HPx8RbkfYyJjhlnLZzQDbj3SvzO734dEkH6oEa63KbqpecO3NS2NpfRT6nOWk3JO4wZFImnAWcBpwFkikUqkQCpJKBFLCSO5F&#x2B;1RAJ/2tTor2yWQMKjMm7xsR1V3crHQv1zuXyyNThRH2ewARgRJIOgv8ScyiqIoX1BP6deviqIoiqJ8HlFKCSFhEHR73ThOGo2G4zgnN14sl0r7O/mtrW1Or5dKZZmT/mSSy62B4MaNG0KIHruxvr7uUjo73CY4eArOIYRRLK5abhD4fWd9Z2f71t7WYDAMERumkSRJHMe3bt8ajUbh5K21tTX3dMdzPU3TdMMYDAbtdttdFvl8fsIHeUJS1tc0zTQ9EAKNgd67nPc05yviYGQvBELIg5G96ZW91H9gau94rsfDI8f1DqI9KY7P6x1fxT2W6&#x2B;E3cRUXR/I&#x2B;AkHAKeRBjQYBiADlEDQJ3OYoOwgcCSoECxJ9FBlcMMdIF7M9R090BCACkoHrnX7hL&#x2B;4s/XSvpgvjpUr/bGk/Y/tJYv/t7sIPmm46MnuhLiUhxz6kinJAEuhxNdObz7q2kQeyEATgH1PIe9xszhSSyJSgkbBWwiABQSWnUtAuEw0t1ZkUwDTj44fJ9/RPQYBPeY/v/mcBSAJOISgAk/FFM71Y8p&#x2B;f61yoNk4XWwuZScGOoCegAgkDtKf6s7OiKMqviwr7FEVRFEV5bBOdTgxKqA/qAxwEKVxAL8ZRIY4&#x2B;pN9ujSq/N7j5b3bKXIiX1n&#x2B;0YFlGgSDcp8MkTPpFepOjlWTrCwsLe81v9Xx7e3T5xM6J33/5f8jblmtlCSGVYciThHU5TM3KvGPpyZetf9zX21r8h5sD7a8aX9rjZU3&#x2B;MGORPrvcnqTXP1yrdeebRmF9fb3i7uu6tovcdn37nF6JZZWlO9Fk7Fl/TC0LpTPQNOg16AbkIgANNQkJqQGHsR&#x2B;FZPLzGAJOW3GjWbQ3q8SNIAJwH&#x2B;mDq7jHcz0RPxDtpZ&#x2B;0iktAGPCUt2d8nGnSd7hsKxnE9NYemZXkcj1M9CDREq5JyUwmXSPUrTGMCLHRD9wbrdreoBgLjBI2iPWUa2UzWS8MFzI9Rvns1xcUoftBo/b9W0tX&#x2B;94rc4Nztb1nl7agxYjtRsyW9rN&#x2B;SjJUEvJ5fM0pv36SAhJ6lM/2Vgv2iWz1dq8wCvVEHrxiHiXvI7PpZSnBBcG0dZwJaEISMQbIwZXJ&#x2B;1&#x2B;DT/LtTiABQgwt9fR0xQmeL05eXei/vNg8Xanr3gBaAipnV/wkUW8HRVGUT0eFfYqiKIqiPDkEXPAoCuv1eqvdbrXl9ta2Nb5aqVTCcOXkyZOnc9Vms5Ga5lylst9sra2uBvHgzt0713eT/f39c/nry8srS/ky0zQYBjMMjLvgHFJCSlCan5t7MftioVi8/uFyt9MhIBrTFhYWOp3O/n6v3&#x2B;8XvAkIwlybEHA/6HQ6k2Ku3en43X6cLKJIXSnlcKjpOkQWUkKfBluzKOtzhh9pzziyiisOVnHvTe35R/7&#x2B;Ya4XHevNmEZ7x5ZwxW/oKi6Ojenh4CjYQw9&#x2B;TYf1uAZBwbUo1ZJU40ITgqVCC1NtFBuTyAgSI&#x2B;Ya55pjxPPZ7slKCMZBZZrqfuS0Rm7d16&#x2B;PjU6i5Q3xamWQN4Oc7VM9ml03S&#x2B;neIPvuXuVKvchpspTprZWayAwhASPeKLZereX8WF/1AgAQVAUcyv2mr16WwuSrmcnL5XFv5L/fdVoRlSCzqPoRTd8X7OBFdvi2kJD3fyL8tJf4HkoCEozKgs3nHH/eGa94o7O54YXi&#x2B;FxpvFIYwJ5ASwGAT2M&#x2B;9UZQFEX59FTYpyiKoijKYxvpzkh3pNYF62oyIQBLPUY0KxlUSNDyvt5qtd69Gf9U/vaHww&#x2B;X6qciXqn33bmVS9985p90Op2i9sFwMLg2XH8WN9/Nnfp54603xT&#x2B;QfcnfWHkmuPhq9t9RSr9S/etyqRyW9yghmnw2jINsZIDztZP/uFjoDdZzm5ubz33w20EYDM94Xq8XpMv1&#x2B;r6/dXHbOl30ltM0mRNnGv0LZ&#x2B;Lzo7pIb//Tqu5mMz/BWB&#x2B;y27qhQ27YwoURwTRh2BQUyAOz70il1ABNgslZncdnTQLpvfYMeVCJK46f2EsPfnAv1zuY3TvamzFrxeWzRO9etIfjI3vab8gq7r0a3AdWcadmN7&#x2B;OOAz&#x2B;BJWJOQi8XuBNIj1KWcz1ONXCVPMT3U&#x2B;1JGWQDFILEm0Y6RoLz1bT&#x2B;XzLpRJUemZcdifNkX1rmN0cmvVEO50Lcra/mOsXnDFYMpvs4&#x2B;z2wLnRzgwnZjUXeHosBMAptARaMp8dvrJYT1JtrTCc/uSn8ndB&#x2B;Uwd6YSputGXa72J7/Sj8jDyQkmBxwn78AteX5&#x2B;qTvcRCUIgi3r6csn/0kLnVLG5kusuZkcVJ2JGDMYBgB&#x2B;cVlBdHIqiKL8cFfYpiqIoivLkSOm5XqlU2tvb297eTtxECFEoFLKZTBQF/X7fsuwzZ87MWeGtm7eiaI0QypjW6/fNgimE2N3Zma/Vruxe4ZxXV66Lk8IohZZlERAhJAw92e8EPZ8xdv78hWwuF7svNxqNj1zX0PVazej3&#x2B;/7Eb7fa0WgYRWGYREII27YH/cFgMEhTDikxGY/YWNM0GQ3SJNWsoS28REt0qv8KP0zp/e0Zs1wvPHZfL/24XC9&#x2B;SLQ3S/R&#x2B;QXsGm91DfKpzvYciElQCBwfFZq24021cOttepByMg2C2ojs9vSeBVGuNstdb1e1eORFMIzJMWTfW9gOjFWhMkpLBF9wkb3EuSdPXxzE1TeelmLkAiMw4/mqhHcTk7tiQJBdL2Ho8nx3WMkNqRmDTNV4knLYmZss3fE7HXLvdL3xUr17WhJXrQY&#x2B;ZkVystqWEYUWznV810KQ8lKQATDs8X2k0J9pm32yPzb1YT6brrr9ktctn&#x2B;vlAggIZnV/KT7630vz26u5ysWU4I5gRqICYDrTODvkpiqIovzwV9imKoiiK8tjyMbIRhnQJbJEbPyQghHWIpsH/D8OoWa3/6cn1zL/u//2z2db&#x2B;ePMOS3Mnnl1rG5TUT3X&#x2B;hIki0nOnPHbq7J8xxlri9y9fbP1k64eMkGvL5673&#x2B;VcaX/Y874cTfp6cfzm6sLZ2osr&#x2B;0ixl8s1NfZ6I9prp2EPDL&#x2B;Qql1/6t&#x2B;PbtxNxuV7f/&#x2B;&#x2B;93zaMrp3ASf2X9V6ulP1nN&#x2B;cznpcW/7XPW7v289vmpRXzAyvnzY1f16QW62/TCdN33oFtuyuvwnVhfAOaTvgGTdAoctOcOFRLftkPlQBSIJmN7ImjxbhHj&#x2B;sFSP2H5Ho8Ol6J&#x2B;6lXcfH0RXtHi3HlLOZ4OEHBCSQFCDgF18JU9xM9SHVI6ulpzgqhB2AJqDgcjwKREIynxv4g&#x2B;&#x2B;7&#x2B;3O1usWDxOSfyU3praL7Tt7ZGRlVPXiqP8pXRanEUxKwdlBoTdxAaqaAQFETCnFRzMki0hX4&#x2B;b/EuJzkzKju&#x2B;OU36Dp/K9AYkE5yJ7dD&#x2B;yV7NoSxK9Ys1Yy47hJ7q2dF0ixJCtY4qH09QEECP3Uz3bEl7pWr3QmPQzvVDA1SCis/pxUcJAK4uzufDby11vr6yu1HbgzUBnU7zsVkEryiKojw5KuxTFEVRFOWJkUlimmY&#x2B;l2cak1Lqmlat1Xr9D/r9PkjJskzGNJgGdD3l3HRsMFYulzc21tfIarvdHgehjOIwDKvVKrEyd&#x2B;/cYY1be3v7l1e3Tp8&#x2B;DQIYBg1IMJ40&#x2B;UAIftkde5WKCLO6rp0j58MoijrUcRzHtnO53Mb6&#x2B;q3btzWN1eZrb/1l9&#x2B;7du6&#x2B;dhZRSNwwQkiSJEJEehiBkMhyaUSSdoW5ZsCAl6EFMxsF/8VM&#x2B;&#x2B;uwPWnEPV3EPCzSO9mYc/UF4rEPjvkpckUDyT2rP&#x2B;I1YxSVydrb/vr9JxCzy&#x2B;7hhNyIhKSJrELiT2EwFS7kWJvok1sexEaQGkcQ1I0v3qRbYejTnJhU7hhlCiwABqQeJ1Rh7uwNrksjlnD&#x2B;fmfQjTYzpXug2J3rGS4uWf6ZSP7nUSCLmJ0nI54p2pFMJwSABLYaFvBNmrdRi0IhkVBJy/y6kRmXVjZZzQW4Y3xpZVzomQCYx60ysi7XWYq6fdQNoHDQ9iCNV9qE8zHSCT&#x2B;MwotXC4NWlRj/V6wl7L8lyySQnAEA/y1XcT0FOF3hRcuOXq8NvrdTPzNVhD6dp&#x2B;&#x2B;x9rV7tiqIoT5oK&#x2B;xRFURRFeWxmwqyUmdKHCIwkA8CIXU3TSdKbz5JnT38QRVErrZxAJVcYvXHtFQtnomgnb2du&#x2B;d&#x2B;qhTWnuJWmhhlwEHph9Z8u5QfzpY3NGzf&#x2B;7m621WwW3WcvZd3QPv/B&#x2B;&#x2B;93J3/Qf5/U187f3jn/vfU/qbiVkLX2GntXbv/9yWSyvhCfPn0a9h95BecPc//kq97d251nfN/3t79zazM&#x2B;MU8ncZD4A8Mw3/b/4Mb1zNySVqvVzjk/sywrFDtRHGf5GHGcjN6QvqZFQrcd5FKaJLlw1xAG4wOIjzuGNc314nsjezw6vorrPyTXE/e1Z6RHor30SKL3cau45DdhFXd6TY9gdmiMEMgjJ8kOSQLJIOksCJgGf8dCAQkqkGh937vbm2uOMv3IGMaan2pCUB2UgcWCjFPejdOJTHN2/HzFf7XaWy62YASAANc7k0zbz&#x2B;qUnCz2nplvnciPWr573WeGlgGhOUMsZicb5Va1sodEez6kth6X3CBrRUgpcPCltJyN5UlASMIP&#x2B;3wJZj0DTKzm/Geqgxu&#x2B;04tpf2K/23X6odb0zZtD50Qpe7owOZUfe5nB7IHJX82lSOXpJAFJNTc6X&#x2B;uMJRsLwoi40s2OY2MWkX&#x2B;mp/c&#x2B;BUkgUbDCi&#x2B;XWhWqdeCNQPkv6VMynKIry2VBhn6IoiqIoTw6lTqFw0jrlTyYda8H14yiKOE/363VdHwvOO&#x2B;1OEARztO15HgBwTggpFovPPHNxvlbjVXNzc5P7pWKpKLPz21tbC5XVdrt96&#x2B;a7zUbjDL3juC6VstVs3rlzZzgcftgbMsZWziSGEK6bWd/YKKy90Gq1P6jrd&#x2B;7c6Y91z/OCIAiCoFKp9Pu9H//4xwsLC5kze8vLy3pGl1JCExAiDENdNybJIAxCL&#x2B;1wIUbjkeu4rpTQNACQKeADIRBBHs31Hgz1/Pvn9XgImUDGB8N6CXgCiePzegex10NWcfEUR3v39eECsxhimtxNK0QlhTxeSTH9t1IjDtxJbBEC1wx0awwtBui9X2rayCFJwvVRYG31s9e73h3f9AWZM9OzmahkJ4kknZB82PVuTgxK2V7PTxP96/poIStARZzo7YmbcuN0eXKqUj87V885kTsozLVzGSNlTLqayJqxZ4TQYki5Ue6V3dDSU9OKZguVQkBQLiiX9yYT759BFASM13LD52rNbsJSTt&#x2B;ps8bEuJlQn&#x2B;evDM3FZuGFsv&#x2B;lhe5zNa2S68IMAQkiINVKr/Iw08N2Wmp442drxGQ8o6ca5df72STVJ4JyQQEJKn/ZK35PiqA6S&#x2B;dsfznXMb0&#x2B;aAquzU5nKoqiKJ8NFfYpiqIoivLYzJRZKdOlD/gkzQLQwpymaxBdWNYz5Z8PR6NC3sdmsD3c&#x2B;mHmvxiEooyAwftB8N32drva6547d&#x2B;472R9qTAu178dJshb8r2t5/cX1M02v&#x2B;e/GP1ia/xsefCOwxErNaZvu3f18D/ir619Kql95pvrHgcmIJk1Hv5VsiHb59MtdmJO1OytIknDlo7gQy1eueNU77/xwdXlluSb0JE3DNZaOrbvNr/z8o76WOJfNy/NGg3NR0X4GIWy5aTFbRD0k0HiPpKnRIE4uj/EJ2DYAySNM3nxYtBccm9fjwUNWccm0Znd6Tms6skcg2JFcj4JowFOe6&#x2B;HBVlzMfiDJvZBuOscn2GzkTVAIDZKAcmgxqAAwnfoZjjPXm/ONUc7Wk/VyY82YgHHw&#x2B;wICAiIdPfbMQCLZm7B3e3YAvFQclZzxqdIwIVHWYynL7kRzm91sElnM8NfnzAUiQSSXoDRdzA/mvdF6uWF5PRDYWkan4iB2hZSEC4ZUh9CoHRWcEJh2aJDDWO8XBSqSQBBQDmd8ukwBWASeHr/VcYLI8Lne6OXuDr3mKO5EVixxGajlejB8UHFvyVFRjpq&#x2B;BaQATTOZ0UtGYmqJZQTv1Su3u4Ubw0wr0QQkAZFH55If2C7/laEEBV2uueFKdjTLsoX6JlRRFOWzpT7PKoqiKIry5HAOKTVdD8PQcez8Qj6OI33TCNKAcxHH8WQ8uXP7zs7OpmEY/bW&#x2B;6zqEUtMwQCikRCYzZ9vP6XOEkEHLzufzIGRa71uZmxvcfa/T6bAFVioVa7WaEKIYaJqmDQaDYrEATQPngieGYayurMxVKll6PggCL9Mbj8ftdiefzz373LMffvDhzs5PlpeXCasLKc&#x2B;4AUzz8OEnSQLuR1HU70shZHE4mH17zH20f3g81ztcxU0&#x2B;ZhV3Gu0JUAFCICmkNttLJQcH6XCYKT1tyAMR12ElLp2GfQRyWolLDzoxBEAgKBIjiK1JZPqJGXMNgKvHRWdk0nRWakGAxLjeLf753aWtbqHqTDRttFYGmIQ4/iAkQIVrT2rZ/lzfNfW8z8kEcK1wo9y5WGto1vgiFyuF8ijVdge53aH5877djHRICkhbj5cL7cV8r2AHujMBS5EaCWdczgaihJyu5ZLZ0cCHrBJ/kun4EhVgkeENLlLYWlLNdp7peFu90tVu8aO&#x2B;24/0j7ramEhPF3k9zRuRZQT3hiIV5aEkAZFgKSz/mVpSdEYX86M3dxbKreSm73RCYxAxP6ESAJFg8iCeJvcy6tmfLnyWIaAEQBxdnMqGzxSCvJECeCo/4ymKojxtVNinKIqiKMqnIQFBOWgqCAMIpyCEUBZBSjmmO9c2TS97ec0skO759veDIDCbtuMPbpRXrpn5ve3/crTzymrunwf7YTBeXFpa&#x2B;u3MP0ccAX8Mz9yosk6n6040Y7VN4j9KveR9Fp4&#x2B;efrq3cvtvVK6quWMqpvrRFG8W5wEhcJWc12Yy2XWhR47vgZCFss/lS7Ofndve3v7fLg0JMMF&#x2B;ZHsSlY&#x2B;s7qa3795&#x2B;Zq/cefWKE3T59d5Zj6nYw8Jt2XPEDEjH&#x2B;giDENKpIluEUkGIOAhem/dH&#x2B;1JcWwVFwLy6CouAAboSHURm2FqJlyLU40RePbEcEZg4unooLw3r4d7UZcEyJHSjOmTEARSRzqL&#x2B;STXo1RPONMptywfRggCxMbQz&#x2B;wP83vDbGvixamWs4IThW7O8mcZqCTgxsjP/Lxd&#x2B;ovd0nY7s57DyYoVxIYtomOPAZjlaGZQ9rTF3GQhk2Q6QghZdqOl/LCQ78HrZyi3CN7Zq/3E4jciGnGaimn2KmDE5UIXlINIUDG9EigkkQ/J2Q6yy8P/7uORAEBT2KONuXCliMtVb7M9en03Nlj5nVa2NzF3hvaHrdyF7PBkwbByAJWP0Q2jfAHdeydy4sRLVlgy07Idr5fGNweFq&#x2B;38ta61F&#x2B;ghiABLJfycw5QAACAASURBVEJOeXowKzrtgSESBIQcDgDKJ/9HD5JAkqwTP1vpvVBtF91wNtKrKIqifMZU2KcoiqIoypNj6CAkDMO7d3rMufXdU5cqlcoLL7zg&#x2B;37/g1EQBIQQwzDiOBoOR2mafvThh1tXbz///PO/vTgAIZAchj4ej3q9nivlyspKMqZJHDtB0zJNL&#x2B;MNh8PRaCiFCMNwMBiEduA6jp13NKaBh4hjGICuE0IIwFM&#x2B;X6uxTqZgWufPnfvpz3729ttvLy8tZXO5lPNucz&#x2B;MovHcJMMYZZRzAcIoIWCMUiqECMNwPBzaaQKUIBMEOx/biguAUIAda8&#x2B;YRlepPpjkt7uVru8GqebHhqlHp&#x2B;f2TtpjMA7xOR7rm6V7AlSCyHuDZtMxt6MDQdPhtVRPYnMSW1Gqc67FqTZJjCjVCFD2xktaQiwfACSNEr019q61Sjc7BS5wptJeLQhTS0DFYbvubr94tV240rX7AyMh5q1RpjXOr9gcWnRw6e8gJyUCLNWMqGDHeSt1NBmk0mTcZBxUTGfxNFCDUIOCMVk2pMvkrBmA8tk04qwSlE57Nj7Wp0xmCVIdKYUkYBz2WGfpkhOW3djVk1hyP2bvcJpK0piY9bE1jrWqmupTHsW0BGY6r0eFnR09Z8UbpfHeYPRBbnilYG9PrG7iBKHdC/SdwOjFREpJmSBUShAhQSSkIKkg6fQPKqh8kiOlEuCUQFbsybO1/Qu1fWb7ByvwiqIoymdLhX2KoiiKojy2iJGIkUiTYIi1BASRCIWm6SnHeDAW34mi5mSyGFstIcQ/fPZfNJvNVCw1Go0/jk97/z979xEjWZ7fif37N8&#x2B;/eC9s&#x2B;sosX12uzbSZaXKaRqRILqmFxB2uoJMOggRBgA67WF0EQTpKBx0F6KYDQUDYA8GVVsTukEtyOIamZ3qmfXX5yqz0GRk&#x2B;nv8bHSKyqnvasKu7pmeX/H9QqGpUZUa8eGGQ79s/k9/S7kpOjyW7djQ8ulU&#x2B;f&#x2B;eQPP8bveeeey4Ofn8y3ZT5t&#x2B;7ffJ0WN597/vmNzr4cDL51uVEWtwpX5nm&#x2B;4Z55//33Y/yibWff7v1hVschcaW2os47lFsYn4YomgWUUtmsMirJoPFPzv3R&#x2B;fSdO2/&#x2B;Gt26P7n84sN0OBnRRmNFOX2V84wsBIGPbEIYA51qNXZtQghR5M1SWMBvQWuo6pO2Z3xsxN6j/laiwCQK516/8f2ttb1RlEo2KawonHBveH4RoPoTmmG/Mo8G6uHTMiw9n6A3a8WVjxpyKagGL&#x2B;cFcbO8Uth5HhyO63vj&#x2B;Dj108pJBS0F85heDNK6m5NHsSBVNi&#x2B;FlocJ3xlbgV06Vlb3pszO5zcIkqb&#x2B;Zq95PAosCcnkSPGtafxw0F7ySjuqwMUnDLMjj6f9E4AS0FnYCorSPZzGW0l4XPGAq/N&#x2B;2bHFyRpQAkkACmCeIT71k6wBSVXp5JWrNfWcjPoClIBXbty/BllJ5IKMoLfG4aSw0opKE4UYn5/GycZqDSbhJzVHXHLLVti/tsyP09rhtNEf1/YT527Cd0uqNeGEa8WF4HlFq4qUUmcKBchAsUpTOZtA8JRegxSocXkhnl7pHPvxAJZExU3YZxiG8RUwYZ9hGIZhGE&#x2B;P66rhsNvrjsdjv37GdqTWOpFFFEXRxul6vX5JXsrz4k4SSSn7/T4lZGGhw7l13Ds&#x2B;PDp0VnKtNWNsPBlnfXp6NERAmOMEPKiFtdNnTne7x5RSEJKm6dLS0rPrz&#x2B;7u7RVFEQSBKEQ2nsR6FZ5PbHt6fEwDTeksmEO9Xr/8zOUaebEsyzuN5mg0qsrKdVzLsiilFud/x9UtIaDWZ23PmNW&#x2B;zcM7Mq&#x2B;4obqU9NYw&#x2B;POdxvYwzhRJK7bSEi9nsx/Afh4537xG76R&#x2B;hwCKfGTF7aOv0QTC1qXTT73u1BsVdiW5zxE7aqU2tq2MOSm4OCkFIqWw&#x2B;kl497h9o9fYzaxUwif6mXi6HI4iNwWvZnVzsKrISxjLk0qDyFP10cV2b6E2Bq/md62wn3h3&#x2B;jVZWpejzLJFX7HdabjZb5yPR0vh8OQhfPQpUFRqKjWZnX4CzakC1SicZNR852jx7qTGbfFiY/KLi93VMJ19C/SH55c99QDi5DQqmpX2wThOK6tTGy056fzBcumF0xdWjo5L68fjYHsS2EzVvdK3K5AvXEVo/IM0b&#x2B;ml0BqQcCdtf9jW9GI&#x2B;GU6SYeqNCnpUkpGgQtiVCLLCTwprUtBCqErLEnoonBujer&#x2B;w9jNeSTr/XxFf6pAATVxLn4/Kl9rT9SgFE/OPR8MwDONnz4R9hmEYhmE8MUEcQRxJK9BS0QIEigrJLMAvmT6Yrh5n67b/yoPqZq0WnRr8MSiBO62R4vcc&#x2B;nyyp6w/dBxnaXwqw3azsRxF0ebRN&#x2B;Pe8xur71JaCXlxOH3n1vZrtY1vPrv4B3CiU/bfcMuKrqrt7W0n&#x2B;PXTqxHr/aRM6&#x2B;u1/&#x2B;To&#x2B;I27ox&#x2B;cqT9zb/N3b9&#x2B;53RRXlpaWzvgldddEEVuWhTxCWUbnvrv0jPdS/a9Go1Fe/t7m7dtcJYsNN/AJaEFpSwhwxSmhIBNJoEEBAtYHs04e9KfPmaIKTD5KduaD8wFQLTTt5Wxryu&#x2B;NLamolCQKqVL4Ge7leNSF9/Hr6tlkOjrbCEznJXsf2ip78jUSREM6ZRJvDhsPevHDUTDKLa1ZzSKRJ2wrbfjD1drodGPq1lIwAaocXjJaFQLbU/7joT/KaceqOt6o5o1a0RB2MW&#x2B;85RWxCSGilGh66fPLR1eXum6Qgp7MBFRkZ&#x2B;zcG7ouF19fycLE/puj&#x2B;GDq3erXnum4S218UpvhR8oUpcYwtzeHgVStUcXeP178/u5SIe3Xlge/vLz/2vr2Ym0yP5ifTdxKgMeNz0SBCQVsj4K9cXhGqKXGMaieL2emynMqm6uy4pyo9Xh8oTXoBOl84a9hPAECBYACGkyAShBCkDaYaNQIiNRaV5KVlZcWYZJ7qaCZgNICvCQgx0n8zlH1r7cWj3KrmgfNX&#x2B;7toQk0iZ3qhc74laVhxy/mFYimRd0wDOMrYcI&#x2B;wzAMwzCeniRxHCcMQ8d1e/3&#x2B;3bt319fXTzECpVDkqKpau3bh4sUXGiuWZce3q3oc50HQaDT2H9zOs4xzTghBBtu2sjw/2N9Pzwz9ep1xDq1934/jCFK1T5/27oi333pLn7&#x2B;olNrf3xdCKKW2t7fvbk9brRbhW2fPnh0OFJ0t&#x2B;R0M9vYO1lZXwiAIhODKyrLccZylpSXf86E0ACG&#x2B;xDYETVBZkAySgSpYFZic5WwU2qOqxhQhWmjNqO7wKprtnH2KYd&#x2B;jer3Zf89KC/Gx62pNIDgUg2RS8byySslcq/S8WeUdmc/sB0FpTyeNO93Fh8NGP3VKqWyqoemodN/qO/1KurR1rTX8hVPdl1aO3XAMKhw3aYWj9brbGFmTgd2d1nJOh0rZTgo3BVOo2MmhopSskjT2snPtflwfgVeQswOmqKzDxB0UfKOWfH2taw&#x2B;CG/3gaBK&#x2B;2Q&#x2B;uTNznBeU4qUn8WGpAoDnVhWB3&#x2B;&#x2B;Gf3V1puI39zH1rWN/Lgstx8Z9udH/x1M5y&#x2B;xB2edL5&#x2B;HTOPKWaEU1PBjaSeRw5WxaswSsk8sHE&#x2B;clBcwxcXuzV/Qq0AhQq62BYv320MEiC1SB9aeXgymLXCbKTyj5TA2U8CX0yLVSyk7BYwcrgSFBFCGzJbFGFVQ5FZ6V3oAJ2CWkNBrIs6292y7cHzmfex&#x2B;cmKaBjJ7/a6V5bOOJeZvZyGIZhfJVM2GcYhmEYxhOjMmDCt5CBTG0JQiCrhqU59B7xLHtR8Y64f9v9iw9OLQ&#x2B;XorXf8H1/yT4CqWJ54JJ8rRbVotoLgxtL4mCv0fcd/0bZvr138M3NlTiOK&#x2B;euV&#x2B;/eq367ez&#x2B;6uvHdZ2rPrDjvamCKvvCzO1vZ&#x2B;fOrl5/9/e3DO9ndTqMseuK53bsX20VLJd0fDzbIkByF3mv&#x2B;a&#x2B;c7/5PyPQT/5d1y/Edv/bP13qn/&#x2B;uy/cG243dXG9P2W3z5fK4i9j7KkWKQQmtogDFRoKiAbIIRJyqj1WSeCaGgqM/9oGh1PQqH0QjhZbfbhzaNDTtG2xKor7tuyJAipXHOruqWecowzK9kj6mRp7KPlFRp41OJHIKxxFvSTWlY5heDTwiFEnWr0150cVEGReYKWe1vdzpt7K1uDusPJqXi8GPc8Xh2PGw/G8QfT&#x2B;t2R10trD4bRIA&#x2B;EZC&#x2B;uylp9CLtcrA9tVh0I9cbIP&#x2B;5FiWBDSXNNoRm0mpffKYbKmRZupVjgJLGXwi6g9fyH0tIZJNE0rwUc51rDywuHI1XvWIu7Bbsxdu9M/GHut4PicYfsT70siWZUC0W6iXOX1m3Ub078d6c&#x2B;d9QvdJIrjelyfQovB/Q8eXwCf0dXowaRGhIQkpSSQXJIBkhwBauSRD3MrbeHoWD0673hs7YiVlIqfdTr/GRn7X63s&#x2B;pVlxYOfuX0zqnGALycD2IzjC/g0fsdOJktQCFnLycCKuFkIApUgQBEgQsU4FQJTSpF2dP6aNLEImrJT841uo2oB6uApCa/NgzD&#x2B;MqYsM8wDMMwjKfHdkCI4zi1Wk0qOZlMRqPRO4PR6spKe1lz26qK8ujo6EGPhmH4m41GGIbM98qyqoXhw4fb20vbURQJUVkWz/JsMBhsbW0tLS21o4pzrrVWWt&#x2B;5dct13fNXz2ut3/3R6QcPNlMh3r9x4/n2s67rdTodKeX&#x2B;/t9ubW1eXKJa69l24Ae7D5Lp9DhCu40sTT3PazQanueBAFoDoJTiSWv7ZhGbYP0kvHGwevOoNan06UbvJUHPtPrMT2EpTpTPtc80o6BUh1zHtnTZbJ/s0zvtikFYUBSKacW1ppSXsHPwEpIBbDY/qyyc/WHjXm&#x2B;hm4TTkgvJlmrpQpjOC/ooQBUKd7PX&#x2B;ct7Z360u&#x2B;BY1deW&#x2B;1eX9lfbRxwgC8P4sFPQVNHmX&#x2B;&#x2B;1PxjVxqVNiAic7GUvh1/wYNrxk&#x2B;cy&#x2B;/ru0kOvOi7YsHIOJvViMnXCMVgBAKXbn8TTLIosshDmgV0Can4Amso82B83pQjO1/Pri8frzeODlJ0PszuW7JV8ZxoeTRvtoIKTgEqQT6jO0yAWVZ0gP91I8swlE1opSpTKJemVvKiYo&#x2B;ln7&#x2B;J4tE4Zs1GNRLPZmuBPfMI0gWJZaY1zNilpJmgmrHHhjjI/ogVxFFgFojW0pDrXfHdcf2N3dZTalGeTihwOWw/7HY/r3zh98PLa1nPLXeJk0J&#x2B;QYxrGF/F4bw0AnMzrBID5ah1KIDQqdpzaexOnnzM5n0LwZT&#x2B;eLKZXXHGtnp6OJ3AzUAX5sb06hmEYxs&#x2B;MCfsMwzAMw3hiXPhcBJYGdMqFB8DJFzjnsPYB2O29cLmbOZdo7bd6x93f30yjQfyNvj61tvbiqT/uKufWret5nv93v/06C71lsALFygudvTfuDvZDeXrZqh1byt63MS3Erekv20fXkwm1LZtuPDwcqDsPn4sXXrp2/c7L1y&#x2B;cs96727n7k&#x2B;Frk6PC5W4w8cdr78ZxfPt208rdX5erWaKGnnPfsb99/F&#x2B;FWfDfxoP2M5cv1rac1Vo9tDsYATtglc2opppoD4yBFITkVNYIIayyGT6jsm9&#x2B;SaxBC8HuT/z3&#x2B;n6zF/RS65dKfn1tH24FAk4VZ4oTTQg41RbVT612BrPSQqIL53ASj7JQKSYUB3TTn6w2eifdxLNsi0hF89I9ntZu9uJuxmJbrtSSml2CqnnTqLD6w&#x2B;Z3t9b/dHslL8kvLxxdX9471TxmQQKiUBXXFqvFcLQQpIXi3930bg6jzmH7Ynu6Uc8XeB/&#x2B;FFQuesXVOPsgyqZjb1h4W4P2wTDdsHMEKTQVubc9aGZluFqrzjXSwBbzfkOqIOnxNNjqN4lmVzuDq0tdHk6XvMaZqGgF1U5Fjqa1e73Oip/XeTbvO/5oKKY0kYp4lryyMH5ttZfmdsaqPd3cTrzbfe/1w6AT&#x2B;8&#x2B;EFqzqIzWPHz2fhMw2iTx&#x2B;gpX&#x2B;8HDDj36L5CL3elP/OHFyQTghRPNRFhxMIkmqJpWwBACb6dNh&#x2B;Uxc5ol/6yg&#x2B;HHHGy0oRIWzG1PWFwxfX9i52DkmQmqTP&#x2B;BmaLQ7SBI/ibq1AKBQdZHx/Yg0zLh/1An9hCgAJbXmtlX59YbISFsBsH86XO3jDMAzjSZiwzzAMwzCMp6fI4bq1MKzValqjs9DRWm/eu7G3v0&#x2B;2BtXXvvbKBqs36gCOjo7y8cRValBKStnpjdO3bt4qil6aZrzJCaWMMc/zOOeDweD&#x2B;/gPGWMMbbu/sZNlFUVWHh4edTmdp6Vwcx2z08vvvv&#x2B;/5XpIkAzqIoihN0zRJABRFURaFENV0OsnzfDqdAnptdZUxyuFzzkEJOCMEWn&#x2B;BK9H5kLuWP12r9&#x2B;zD2k4e3egtpAX3LLUcZW1PAPAtWXdlYEsqKLSmVFP6FApngJPSQkUnuXf/ePFBvzOuWFIyULXRGLyk6BkATgZeQVEoZTERuXnNy3IZ9nMeu8ViNGiE4/l2EcHzafzGztq3N1c/mDjfXNn/pbMPr6wcMSeHBEBBK16rloP0ZU03h429fvPNytrJ/Zu99pVm2nByy5tCI7LllTi72Ew2Kz7Jna1htDcKV&#x2B;uc1xS0Pkrdd48b3dw&#x2B;1xiebw0cu4KiIAAV0DiYuLd6oVDkGTfVWhej6Hha05pzJlVp7Y2D9w&#x2B;ap6N&#x2B;vU7mOy4&#x2B;SoNIRThFwy3PtUYOqTKW3CuwNVm50fV9p7EcNVb8JKqPYBcAIPjHkzWlSaVppahUyAVNSmuSe43SPWmUxnwBy6yPuPAOxvWdYSMpnQVHRK5YclRROUdJaFt56Ga2yiBJwOXX2mO7Otob&#x2B;ZUSFhW&#x2B;XbmWCKxhJyjONodnm0N4GaA/nmAaxtP0ia8uTZKSDTOeCaY/Fmh/kbvQtOZmzy70X1zqxkEGbZI&#x2B;wzCMr5oJ&#x2B;wzDMAzDeGKc7HK6W8oYcg1sC0DmJtyypmmdlCTKj19ab/7z3/nrP//eeqez/PaBarZaavlP3x8epcW4kgXnjSzb/4P7v/mNb3zjL975t41G458u/Ku1K/dfv3/5maUNF2&#x2B;7rLjkvyltcV6eahft/3v6vz148GA7/fbS0q8tN3dEm/8vGfDePZyllkh/afmtl6Lk&#x2B;9Uv73d/ePtH/2Lr0L6mNor3XPrqNbuq/k2/sUPPXwmn0&#x2B;n0buhEgX0&#x2B;&#x2B;D/X/QpJABCFDjihyRlGSLd2lzHWVFZJbIv0KCWatfEZs91muQxVLJhuNOlGPY6szlYRvT&#x2B;KzvTbzw/H7SgHROyKplf5luIELteRI31&#x2B;0sb75S&#x2B;AiQaBlPYkD&#x2B;4P4xtDZ2/KwfS5kVcKi2h6un0ILkAAqrldLsSDMyW/2bP7ebQQTk41u04wAhOARmXd7rb/8uHaTw5bNX98ffH4&#x2B;sohjyYQbDZrHwCYAisX/eS55uRBe7xX8JHgt/v1e73R2Ua3rSmgfKc60xyfbY7iodedencH4c2Rf6HkbSah6V5iv94NhdCvrPfX6n1Y5Ye2CtDdxHmr72vN4qBWyNVpyR/2m3sTVyoNhf2J&#x2B;043uLroXJf0M/IIqUgpmcOrxXrvFZbcnXgPBo2tQfjmcbSxvbzmyJeYCFrFx7b6amgCydLSmhZOLphWpBBkmPndSbxQy11/CiuDJtAMAKiC4NM0eDhoHkyjmq1fXphwLpuOiJ0CRIFoMquikgxcXmwMmrbopbzQyqIydMqaU9WcInBKyuU8bzXVT8ZXjwCA0kTPRxp8aZICJHTy883js60jONnJyiDDMAzjq2PCPsMwDMMwnppms3nv3r0bhzdqtdrG6Y347XgwGDQaTa304sLi6uqqbe&#x2B;XZen7QVVV49GoyAut1P7eXn4pX15ZOa1OCyGoTRcWFi6cPz8YDrM0e/jwYU8uU0oHg4HWKpxM7t67h5aA7YBQSKGVdh3XApdCOI7daXfc4ah71H3w4EGn0xFCTCYTrTUhNC8Kxii0AgBKQSnl8zFSWn6hbbyzAXCWiNzslJ&#x2B;uu8VtLgaKbWfh3qR&#x2B;Nes73tS3ZGBJi2lOVd0Ti2EVOfNdvfPZWF/yMljDs0TdyynLdzP3/b4rNdtJHCm5xUTNzVpOBVqBKFhlYA3PaLXerQ0zeylMOuEITgbJAJLmzpvd&#x2B;t8cxdOSvdTJL0UJ5&#x2B;JDtWYEGpAAk5ZdnY2n55vT5iDsDf2dsbs3caYlbSsCRmCXK43h6WYt2o3vHddu9PzzQ&#x2B;/rud1WHIocpc79idNy8tgfUm8KJiFneSqB4PuZcztxRWmHrL03iKUmpWAEuu0Ug4IPcvvWxN1M3aR0Apk/PoEAiKZEU6IJoDQRigAKTr5er35ltd9Pj/8toQ/G7o/2Fju2ctziJbfidgkNkA8tS1FEFM4gDdLS9SlpeVVs61y4e&#x2B;NWKyhOWwXs9CNVT5oklZUL7jvVM2Hi24VnCZsJl1eRl7X9qcVLAJAMRPnheD0Yr&#x2B;uTekyqwCSYAjQUnf8ySZ/xc0LpfK7o07gxYjO97GWr0YAFY/AKlWVe24ZhGF8xE/YZhmEYhvHEdmLsRHiuXEW5hvQdEMTOX4JbffIbm331pz/6z&#x2B;I4&#x2B;sa1vd9&#x2B;8V/u7uxePviFg4ODX3Pty51oaeIPBkWTNiIVPRyNtsdJJpe397f1VDfXTn3T&#x2B;nFV/q0I1KmV9De/9uODg4PxZrS9vb03XeWcV8evdKdunLDRB86D67/quG6Km6yxcOaQE8dp6aqRFy&#x2B;u/R/PP/98M9m/efODu/diy4mL7frgluOXd6jIb6bH53i1JDe01j6pQKimOQEBEUQLLi0GBmUxKZVm0ETTQn321e&#x2B;s5Y0owmXERUAloEtFpqU1Kty8shwPNlMWVxTaYjq0VexIh500oM7Wg3wk6yNPdlWsCQhcNz3VON4YWs2uw&#x2B;BPBPKJ/de0Fnitjp983Sr92giWAFXgMhas7haBJVwuOBPzflhhdZPgnX7t3tQObXE5ztb8CkQ/Xuz76PEqCqoaftYOk9CupCKTkk5LWqnZFmAKu/SjwVoULnpLRGM/s&#x2B;5MvP1peCWNIWmShy7IglvW3RxcPL7Zyh5ltUnpU8I8CxalLiOuJQIrk0QHA18I9k5uHVR8Ow0PJ9FZr4SVg8r51ETMNwnPfglF08pCZcGqXlgcpOV&#x2B;N7MHyfKDSfi9g3YzLOo2VuNhzUlgl&#x2B;BynrgV/tE06iY1rvilWnnOr1acKrDItHSHuVfJT1jM7FjlSn2wUBtFblFzCocJSiVjwuICTIAqAFAMRIMXJyMUT57lWdGfPikRNaVPxs/P03nxacyTPre6FOTLfg4un&#x2B;LNG4ZhGJ&#x2B;fCfsMwzAMw3hqsjSlhPYH/c3NByS5/7v/eHVxYfHw4bUoipqNkR8ERBCplNbodDogo6NuV2ullKrKClLYfkCyNBcT3/dX19b8IOhWdr/flyNZVSV8irKU0i7LcmtrqxZFh5Nbly5dgtZQilDieV47ap89e&#x2B;YMW2y1mvntewSYTKdpmsTNU5ROjo&#x2B;PB4MBaRJCCAiBlEIIxjglFOwz&#x2B;nU/E5ltydCZoP2SZYJSJrUipWCFogBsLj0uLaYoASNgRFMKYJb1UBACJkHVPPSZL4L4fNfGjxIiN1uqd883nIu1xnEU9mU1qPjDjP9gpxnQirH8F62UOTk0QDWgtYbWRCuiZssxFEXhHU6j3WmQSdJxxWJYhrYEPt5oTGbVcK5V&#x2B;VbFmQSgNQEIIQAotAIVsOVSkFyK8veD6mHi9HJ3d9Q4OJZKEVWGz4TyfD2rO/Lk1jQ0RebvjZq6DK9G5ZKfPdsZLAeJa4maUwqFjtfMS3s/dweaPRzH93oLi14Z1EtYEorMTkUuaFKypKKpxLiwj5NgOQ3dcOSE42sL1iu9aHcQ3Rz7x6V7b9C55RFZOUtxrxWNYCUgGpU7ysJ&#x2B;WiskW/Gzjpf6lqhxwamuubnvZIxJaDq/u9lJI6j709hNyaxMbzbUb1YqSBQer/WYnUYKifl6BHz0d8P4&#x2B;0EDgMvluVpxLc5ajgDMi9wwDOPnw4R9hmEYhmE8sbAqw6rM3WO4xwgsEDItnufEqueXO4KeYyp1qUz27h2fWl3d&#x2B;NW172ftrGPv2uIOWKuphB6O12qxPHXu1ijtT64MycrbB62O6Jxb/ZOo2YnHLQ7&#x2B;teB/Fby8HV7zG/cGr3&#x2B;j3&#x2B;/n1ZXRaMTy2xtnzvy76nJdxEfvb5fxtXPBdwCsq5em0fIpdetqYi0s7i9vlNtuw/f755vf887t1jdqh4eHPz5&#x2B;7Z2HF15plowzx94qykKoW5wplxSg2hYW0wzStSpSaEI0ESyn7HO092oqhd0tnL3SFpLaWhEQrWcDsLTHRWiXDheUaEqVzaRFJTRB4aCywRR0CYr5uo/5dPxP2RX7SXcNaFgldWXdzdpOdbWRWm61m/MfHNa3&#x2B;rU/1cq1k6Y3vcYreAWYBIjURGmo2cA/aGhW5cHxND5OA05J0yt8W3H2KcegAQJKFYgi0JRoTrVNNSWP/xXQbVc830zvtJOhJmllPxg0PrA5J1pX3sW4uNhMak4FRYDZjhFylIS3jluqsr&#x2B;&#x2B;MLjS6Z5tDSI3Z0xaVqUEoxqHafheEvaH3oN&#x2B;/Ob&#x2B;wqKXPOslYApQ0FSW1jC1&#x2B;6mVCaq0Tgp3fxotjLN1npNg2glHLy4eDVIn7jdz6djgvbQW2pXrFHGQ8NnZVkxpypjo1MbtYBw6Zc0pLCal1hav6m5KrfJD4R2ZL&#x2B;e1C8IkiDopyTz5XTHojxZpPhr2Zxh/X2kCEM&#x2B;Wp6Ps3CzQfxx2G4ZhGF8pE/YZhmEYhvHUcMbTNLVs6xvPvuo0q1tbD8qyPOtNV1dWWDmCEOCEM5amiWVZC8vL7777zs7uTlVV7733XqfdQX7vEudc&#x2B;SAEhHDOOp0Fz/f7&#x2B;pWj7tH93WZVlsixuLAgxFaaZf1&#x2B;f3dvDxcJqsoP/dOnTwelpJSURenY9uLiUlVVa2vtZrPZOP3swcHBzR8e3b13b3hmWKvVCGOcc0mIVgrqY4tdPyeiAQJhjbPgIAuOKltroqFtJj1L2EyCKpeL0C5cJhjRHheR6n6jvgAAIABJREFUm/t2CVBZ2P0kHFe0UNKiuu3IRlDCLsAEtJove/076ZPSQqBUBARn4uSZheFhxUfCejPx7o7C7zxc7FjCJri4egA/B9GEPOod1rNe3UnhHiShlJwScKYoUZ95ga4JFCEaACVwmfa4tmf9zidNqXWnutoav9cevDO1JoV9pxfVpOVx5VhqrT461RjbTjXPxbiAJrsT971upCReXu0&#x2B;u7znBxMwBSpBFRV8OfLPNKcLR3nV97eG/luH8emosRJP2pYELyBZPw2OE78SvG3LFlM&#x2B;ZcM06Ca1mp80nZzY&#x2B;TOdrtR0JSrGRRBx2XQL1y45k3T2DGqAqtBNV5hY0rCZ9K2K8ApUYRaK0pM9vD/9AgAUfRzUwtTrGf&#x2B;AaYAQj4vFWrZUSx27evymMAzDML5aJuwzDMMwDOOJhYUVFlxbR7AOC8siBOnkZUtzX0ZF6lb0u4sbduvixnf/6Jdu/2QcXvrfXz4db9RvlWXpZF00y6u1XcYZXT5168bBbn5BCPaHD3/rDDvz9r3V5XT5tdo7a2trK/QBiiLqFK0g&#x2B;C&#x2B;u/w&#x2B;TyeTMcvtOfEc8&#x2B;PXT3ls/GL3a7YmO822vkvBvIE1s9bWVOlYmTSgHZQZZpeEHkpWvnC7SNI19WawWP2i/eufOnR&#x2B;&#x2B;V6ytLfhLLuc1cKIJoEsoZUnOwCB8JiTRFTTVNNOfMbOP6Hkkl/sHo8buJJoICwAhOrDLppfWnAJUESYdq2JMMqp8q4zdglsVNClK78Gg&#x2B;eNubXNih5Q828gudYYr8SAKJrDLeTfo56yI0QSK5YJLjZafPtPpngPbm4STSXBrat3stf6M0pql6n6x4FUAOJ2FXCePAmRcuEoyqanWkJJWkkr1qMzwEx85lYoKRRlFzZF1V7iPVwxTaDCnXK8PNhq11kG0NajdGfpFbjGurnSG18PhUn0w38M7Syol3x57twfuglfE3tQPJ7CzWXM0AIB6loidMrSFTbWoyHFmbY/ih8NWzS0dX8rCO5w0pmXQ9OQrncSxxIpfulxIjUoySAu2iGrj6wzLtSwpXUalxYRvl3UvpbzErJeZCstNYm/6eIHGfPsHmWWb0PQTzoT63D3XhvHvt6fxUibQcLhseGkzSMErE3wbhmH8vJiwzzAMwzCMp8ay7SAIpBwMBsOmbnq&#x2B;/9777x&#x2B;3jtM0JQ3HIRSjElHt9JnTWuui2ao36p7nFUVRTBJuWb1er9vtLrRvhWG40qYA8jynlLm&#x2B;b9v2c63n4zhWnVeKopjen/Z6/YvXGo1mA5xDQVclAMI5LAtK6SJVfo0x5jWaWmshRNBoLC8v3blz58aNG1rrc35Zr8ecUkLIfFHGE9OgCpInSXDnuPVwFJeCg8BmsummS9GIe&#x2B;lsGB/RINCUKJsLh1VgAkQTQselc7vf&#x2B;PFRTKS11ctv9uOLS&#x2B;5Ly&#x2B;RUawCqAA3yBPs6pKYaYKyM/XHDr34ldUY5z3ba93rh273Gwl61GpXf9KRNKk4x67qdX4hL7jBBqWYEWpNc0LRkuaCPagY/9riJlLwQdimZzdRCUCzVstD&#x2B;0OpeDVhlHA3Xo2jNXdhVte3U6aa2YqJVP675Qx6MQSUEgyIovdG4vtlvHEztyC6FZtAcoIAACCRFaU0LOyutmOvLUUFFuejLUroH4/pqPFh0k7R0s8oJHXltYWBR4VmVw0XNydtBEjoZqATRsEQYjkN3NrhQgihQPT/JszyCKDB9EuCerCKZnSQzX8/4&#x2B;44A9Mu/xDUBgUVF5KaRO4VVPZVjMwzDML4AE/YZhmEYhvHEena95zT8dBnpsjO9A4LI/o7F&#x2B;UP&#x2B;Sr9z9P3x6cOt6JfarUD1nPLoVvUfn3X&#x2B;Uce6W6hirdVHcfha&#x2B;21ofSAmi1eOqApef/31rfCfyuWWoP/sO9/5zoMHK7udf9Rx9GDQD9tnEokV9f/SLLtY615cr9Ia0jT909Hv9of3Vtwzi/ZGLtYQrlnVLQBMjFABhBBmuZWvlMLR2CcO2BYG&#x2B;hvPTM82j&#x2B;797eKd25srJH/xxReZhhDCZRRl&#x2B;XihK9GP&#x2B;zE/sZ5rZl6Vxh6Owp8cNjeHoRQUUCEVS/50KRrASyEoNKFUUaoJNCOKzbInqlw7Wwim5&#x2B;LaURrcGvjf2/feOvavTDkjouUKP5yAVYAG6OfM&#x2B;zSI1lAaFqvcev95QfoZH2Rskll9wX7cbS34su0X6/FQS4toQoiaZ3lslo6Vvl0p7Q5z6yi1koqCKDAJwT9S8UM0NJkUTj/x0sIOmdiIRxuNgetm81xstmCEVXD1ajC9EGT3bHk7swYVDT0V2lXk5OAlFAEYFM2S8H53&#x2B;WjSoLAoeD&#x2B;tDSdRnZawBUAheVHax6k3KdxVV9aWhz6TsS1CW3JeaiKhNaWyGUwDN3N4FVilzQWlkjPhWyW1SjAJTUA0mAAvT0r2PlSvN484TjbkPnp2zaAx4x&#x2B;M2cqip0CDM1lzU9&#x2B;fgpWQn/fjyzAMw3i6TNhnGIZhGMZTk&#x2B;eF73u27Wxubnrq4YL3Cud8Z2dnf2&#x2B;vbBae60JwoIRtQynOueu6K8vLly5dSgbt0WgEpur1Oh0cdbvd/XB/e3tbZ/12u73SzhHWdNInUeRHtclkkmc5Y8wP3CiKPu1ghJCUnqzZVQqUhmFICGEXw7t370qxI6XgnGuloDQYA77I5D5d8duj8Ie9cHvqSEUsptbccj2cNr0peAllwyp9J3N4SYgmRLNZNRkVxE0udo48S0aOmEp80Os8GMYTok4HxSlPXiHSiUagCvIJuuu0JpWiUhM4WaN5/FJmTXPWK&#x2B;n3D1p3emFgydV4XAg&#x2B;SCKhGKeKEAJNQXTNydrBJHSyStWOptbDsd3L2Mk0Ov14gCBRsARKfTh1twdBkVpL4fRS62itcQwnA/A4OyMatOp4xaV69l6tvF86QuuLcXW1nsezsf2zAsCKH4/r24OWkt5qoCKL9ZLocDqph4OTLmYiNas08e38WrsKnSKwSotLQlRgZ3UvAZOBk603DzmThIuTlbh6Pmvvw/kjOZm7Ny/Zox9N90ztnvEPV6nIVNBcUuBLdPNqAgLOhO9kcHIwCfkU6gUNwzCML8CEfYZhGIZhPLGw0kGlIWPIOhgDIYpvKsvyE6fpji7U1obDYXrU05farbXxzs0r999euelfX11dtdj7whZN6xB53tYftJ0k2ugeuod/8LA8PDoaT549RfPR2fCt8u3G0X&#x2B;&#x2B;ub85vrd66tSp5KX&#x2B;uXPnYv79iMe71fXbI0dWfjM&#x2B;Ha38f25rOFVNAC1yDABMAACJALiFzTmHYpASGILzc86fE5eML3&#x2B;LJDqUpVVNOGwFQDMwVvGRYowhkSzRxCIgRHlEWZ98CmZBkrRGmX9vHNycuqOcwVIdr7pSz85FqWUJaIAouGkjGPlORqniTLhWOW8j5cKN5AW3KiTeOAwc2iy13c28tw87G37VCifr87DvyVa4Kk3U7OraLjfa/dckOSjpZmo9OHJujpzv7LbHmZNlbl6BU81mKR5Vlpt2glHLT2yiRoV1f&#x2B;psTWpfS8PAqcA0lJyvl6UaQFHYN7q1ewPfp/L5Zv96p1sLx2Bi/jUzGgBit7rQmp4bTG8mDtX0mwujZ9vTwBJQ86CtElZSOJVky2G&#x2B;FKrQFi6XWp&#x2B;kchogcKyqUxuGTupyFdiFwyvGFCECTM5bdG1puY&#x2B;m7J0MOtQnWZ5&#x2B;dDwEIFAmejCMDyGAxlDQ3ZwNK6oexeJfjCaEaM7kbFiBmWhpGIbx82LCPsMwDMMwnhrP9RKenD171nEckG1p1ZaWlwfbZb/fu3v3blEW8PbCWtikdWgNIWBZzbjp&#x2B;8EF96LSuqw8y7KaZ05vbm6O6IgQcnBwMBlPVq23KaXXOjLPszRLkyTRGoyxPMurqsKnpGGUUgDQGkpBCSglpeSc1&#x2B;vx6upamE4oIUpKMmtge9KZfbPr2NI9mtT3kmhUWlITi6qNevHC4uRMPQVTEAzQsHLfzi0mCFGeVdTcBFYxbxBmAt50IRhuBMlGWNzSViH57UH0VjR5bs1axxe7UiYaBIJDAV5&#x2B;dqH3q6Xdzb3vKOvm1H/jID6cOC1GTgWJO1vToSmIgpt1wvGZIF12xHiCndy7MWg/e5w&#x2B;yzW8CZgAkwCgiZzW3thd&#x2B;ovthYeJfa45&#x2B;tWNwyvtIbj46So5RaHhOuXZVv/yILwzcC2w6&#x2B;3BWjyard&#x2B;drfLQII5VLEeDdm3kW5XFpMPLhdoIVEJRaAKimFN07AIE86o9qkEUiJqtJYEijzelPFqX8YlT9kyFkWH8FILZvNJ&#x2B;yXYKPq2Y5gqfPrrg89weJSD4fMvEDcMwjJ8ZE/YZhmEYhvHEQrVXU3ullcBKNDsFQnTBlLQ6OGrRybcu/nmr3U7Y4M3d1&#x2B;5N&#x2B;teaUUjHtw9/7UHf/lfxhYWFhX/enDihw5FbjmWXBzbUb629&#x2B;ZJ7nNT30jQdLfzm92/97XE8qW2Eyf6lrePj3q3/5l708mF/x/P8XiQOPGc5fFiWpT4YsMaUrh4AIKNVAAADUFgjAI7KIRR4AQ7BOQiiUUwIrdgbF9pZWLqEjsscnFsgDqQoec4Yc0lZWROQuiaEyYjRT6rsm6VLkhVZsD1sdKehUAwAZXI9nlxf7C7FY1ANReflZkRDE4uowC5CN4VVobChKagCE4FTrgbFqaDcL&#x2B;Sg4HupdS&#x2B;1huKL99NpPc/aQDSc6oXFgVK7FDzbWt4bBtOCdyzVtHNOZ1f6ADR41XDzy3HyQmsyKu1UWm8cdhoOMkGvLh6G8RBWDqIxDe/uL//V5saNft33slfX91/dOAyjFDi5x8cHQaABO1&#x2B;Oe5db3tHY9ji53DlsBmNQcRIEaNsqF6JR5GWcKdeqLCooq8AkqJqX5hENKuYVfLMzMt&#x2B;ewU5WZ8ym75lwwTC&#x2B;EAKlSaLoSHKl6BebZnByU8SCqhFpz8efmrekYRjGz40J&#x2B;wzDMAzDeHqkpL6/ZC/ZjgNWLiwu3rp9u9lsNFutYZk9fPjwtthrNZs3N3Dq1KmWJz3mQShUVVSP4jgufT9Jki1rcXlp6b4mnYWFer2&#x2B;u7s7GU8ODw4/OPigLMt&#x2B;LDm3LixdqEVRTfwwy7LPOhwlmVLgFrcJtIakACaTca1WIw5Fnimt2bwW7Mkr&#x2B;zSOE/fBIDqc&#x2B;FJSAJyqhXC03ujyYAwyi6s0NIVilkZIZMCERR9dS8/HyTGC0NJNR3pc9TNkih6XLJ0Nz/pCw&#x2B;0fD9qXDIBVS15Gd1h6wzz4N4nXLblWulJEaaL1o6ZX2HZ5td3rn/IKpd/uNW72a6UmuaAU7BnFbHdSShz2O&#x2B;/unuol0Xo9eaZz8CtntpcaQ/AK6mPrLDQFNJiAk1xqH1tEBJY60x5QJzuZAEhANewqsKqAAESdjNsDFP3pUV&#x2B;aQeuTVtxPChFMrGAYX9RswqUC/VJLOjQBVMCrOlXOl2kENgzDMJ4GE/YZhmEYhvHEdlrdnVb36l0CTUi/BYJAVbAs&#x2B;LchpQg&#x2B;UIxF6e1flLHL3rjVypZXVr638833hz95h/0qhn5o3VzF6pUyWV8/9Wv5jwHU8wlhHPIGHH2mfPjy6s7/VV47t&#x2B;RsdtZ2re4&#x2B;u1Ic&#x2B;aI8m&#x2B;fFQTimlL64Nrm2vHG6tHwiiFQAkC4CQHQAIPf2ADjjDSbplMeWZU38sZRqsVcHoxF9yHWAyoaqHOYSTSEJqC1YpZkCkZKnIDVCCJEuZZ9e2afpILO3x&#x2B;5xaklJCdExFwte0vQnsHJIC5KCEgAMus7Uki1iLj&#x2B;2FAIEhM0GZ&#x2B;nZTYNS8Ce&#x2B;6NYUmhLNiKJEgipICkVAAFYyP3mu09vqN9OK/9V&#x2B;I03tacUmFRGacIL5JDurOtM&#x2B;VlorKIvqt/rxILdv9xoLXB1PXMLTccmHk3pWRGfqyav1o8uLe5daQ/Dq8Vy8jxwO5mkm1YvxuB0mjEswCao/cgaIAlOzszD/&#x2B;/lWkI/uzXgU8xmG8e8tAqJJZFfUvFkNwzB&#x2B;3kzYZxiGYRjG00NoMhpkJKvX6wQAIaurqzvD0PO8sirTJEWdQsqdnZ1&#x2B;r3d867svvPDC83EvjiMqpCxLtywR&#x2B;IATXLywNlxbWlpqNBqO4yit9vf3z7l5q9VSTffBg82bHxyGYbi2IMKFxQTbn3IwACWzyX1CiKqqICpQh3s&#x2B;pESSgDFiOZBSSUWtT1nE8WmoBnQi6KhgSUUBWEyv2NWSU3pWBaohAcwzL5vqFb9Ko2LJE6Af3RFBIDVGFTkuWC4ooahZatXRkXWypOJz0bN8TGuiQIRiEByPqvYUAa2W68PfOrupIMepfauwMkHHFZfqpFBOURCNIDkHTYiqucXp49ZhUreUtTsOjhMmiSwEdRjZiJNrS91nFvaC2izpo9CfPuJrVt/nlIwpEAX5aMPv4wM/2Y2LJ3m8hmE8ZU/hvadJrulO7jAmNQEhX6Qw2TAMw3gqTNhnGIZhGMYTa40WW6NFZe/C3kW8C4IyP21Z&#x2B;tD79Q8mH/zJ3d/pdDovtd55xX9Yv8BeLW4Q8sHL&#x2B;5PU/e5dJaCdH1bfgmLfyDLn4Jn/efP5KIpeeuntjfX1b&#x2B;LPkKYI9iGqf7L2AYSurvzGM/LdP7m3ORj0Jf0mdeJfOjsKhw&#x2B;OhvaD6ag6&#x2B;oVfiF7Nl8A4O7XxFgi8gw4Yj0cXkedwbBCbEwqFBbENAth1IIMuQaBrTQCZSkDg6xxlXs8ZY0zSJSGnkriEkgbZI&#x2B;SzQkCtoTSRmgBwuVixq5YlLPrRwjRFXKbXa4WNbCUsT5pYAcy&#x2B;SlVKHxR8K7WSknKm1sPi2ThdcquTmXSfg6aQLBc8FYzmziCprWUJWAkiQfQ8yPOm6039csqnUxsFJxRCUfXo9mc1gADc/OxCt1XLri&#x2B;Md4ft/bE3KYmEZFTaXHb8/HRjerYx9GtjWAKKfHJZ3&#x2B;MDw6zaB4oA7PECjcc&#x2B;89sNw/gPBdHQyBUba3Zc2ISaN7ZhGMbPkwn7DMMwDMN4agiQZ9lbb71Vq4XT8Ee//HvX8yS1Lcvz/AsXLvT7/e8MFkfjMaSEkLVO6Pt&#x2B;v3ewt7dH8Eb3qPts/SBaXoEagM1&#x2B;RNHNZvPa9eu9xvn9/b2D44V2q9VsksXFRZ9Rymivd/z&#x2B;&#x2B;&#x2B;&#x2B;rye2wVmufSuO4DsZ1kROpwT5lR&#x2B;/TpjWkJoB2mIpt6bFHBXWzfwYUsblaqeUBTzr&#x2B;h8M&#x2B;DQCS91N3c&#x2B;ruZVZRMd&#x2B;uLjQmL3UGy0EG6I/UAH6i2b8rVhXeNHeSwhbS3h83F4Oq4Y8tO4MlZv2xIIJ4yeXOUVWxomLd3I1sxemsSfakvk8yUA0/jz0R&#x2B;&#x2B;VamHZTO5WaUuVZVWhXkVtwS8wXaMymCn6eOFLTLzP03zCM/1AoTcTs80&#x2B;SLzUB0DAMw/hyTNhnGIZhGMYTU9qX2lfag/agHWgwZRFpobJtEqaJa9vh&#x2B;wfVnf1avb7eqX4AoX9n8Y9ffHGnfXv88OHDO2Pa6/VeOnvvSoN8/&#x2B;jsTrf7PfYta9PaOb3&#x2B;HHnuPwpu&#x2B;L7nhP9OCnERb2ONvujtdevdv9kZhWHA66dEc7yjns3s8G9j&#x2B;1203Nf/e0LI0dX/58rVqxfDPyvtMmL7sG1dhgCIrgGgVR0AkD/d80AARjWjmhAQkFSRVBOtP1Ttpgk0KFVNP3MYak4&#x2B;j/CIBlMAQRLePV54MIrTytaK1pzycqd/dbEbBBkwW3H76RfMs70WmqByRkltkoWEcKXo0aSx7Ugh6VKsKFegAgRQDEQHtcmzy8gFO5jWzjbGLpMfWYUxO3BNoDWszI&#x2B;LjWi2D1eBKnA5P3hF/47u3Z9iSnwM4x8MCtDZVFPTxmsYhvHzY8I&#x2B;wzAMwzCeGkoopTSu18&#x2B;fvxBnu2&#x2B;/886rr74KxtR0SmvO0sbGK/VX1tfXw1sv3Lp1y/f34zheWFjo9XrF8vLm5ua7776bTJPL19NWq9WuScY5oKGUFcYrnnc1viKETMLQ930p5XQ6VUpBa6X0/fv3WPK6HwSXrpEgCFAxCPmzfagaADyuGo6MHbVbIqv4w9zez61McH/WOTtrZNMEVNW9xLeKmpuCaoDMl8/m3u2jxdd3T90fNqRikVddb49eXDo61ezDzj9H0dysZI&#x2B;gcPppTSt30VeUKqXpuHSawi6k7eli/oWKggCWCKLp82v707xf9zNiVZDsI3ekCDQDAKJgiQ9drhMoBoX5Ng/DMIxPQn7qT8MwDOPnwYR9hmEYhmE8MQVPw1XwABfKAiFMMlBqKUslKku9NHGvXfnH7/zVv26Pz8UX/3owGJ6aAFH0jdq/hFM&#x2B;X9vZbG8OBovrVW9Mbge1Pfes&#x2B;870dn/3hXQ//nEknUPHKy8sLCy8qu5Cw5V3wXnYujaZTBp8cLo1wvZ7g&#x2B;FwS3cc1Zm0/se7t/6mOriwPn524mxblhXkTErpMA2Asj4AFCsAoGa9vdlTOAUaIKh71UY9Wx1ltxIrSa3N1N1KwuMkWg8L2MXjlbhM&#x2B;l7ia4AJUIXZAtzMu3ew&#x2B;O1763/2cOnhKHS4fK4z&#x2B;Z2NoxeXusxPQD9ac/dpiIZGIZnStBPkkVdSKn2rrLu552Q2E4B6vBgXGoqCqkY8asT46cW4jx/ao0F&#x2B;9CN/Y7ZnGIbxd1EgpbBQ2SD6ZNG2&#x2B;egwDMP4qpmwzzAMwzCMpybPc9uxCSH3799frgV5UYxGI0JoGIYobWQZaAbGFxYXGo3G3l7kea438FzXi6OoXq8HZC0Mw&#x2B;Pjt/r9frH3g4uXLl5ZKxuNBhTB/8/enf3IlaZnYn/e7ztr7Lknd7KKxWZt7FVSq7s1kkYzGhmGB9bMlW1d2LAAw/4PDIwN&#x2B;M5XtgHDNgzdDGDDGMMwDMOSpdHYHo2kGXVPt9RLbazivuYamRn72b7v9UUkq1gbM8lKMpnk80OikJUZcU7kuQjwPPEueXFn487W1tb82fkTJ06kxdyd27fvljOtZmv9dpZlWWUrr1pVlXqfeBcEwVPsHlWBGojONyavzW&#x2B;d2KoHq41JaXaK8O6gc627NJ9WtfYWghIArAIFwgLmweA6bzFJb6wv/D/Xzv7x7WMf9pPQlOdne79zbu3vnV450enBOPh93iELFIGtZuv9epxZ46ypFGglk1qUIywh/pN&#x2B;2&#x2B;l4PlGE5e4d&#x2B;CPyRN33ehAiIkyL&#x2B;bRydpQnLqtZ4wHHsI&#x2B;I6FAw7CMiIqLHplAFvCgEMG66mQMIQz&#x2B;phy6NEqh&#x2B;eHswm37t6nbr1Ohcq9WamfmnGI9RDAEj5mazHS90tr33X4dvy82T6KblT&#x2B;Ol99rt9n/3we/f6d75YLt2Oj/dDn/01sLFt6OtLJv88KNL165f&#x2B;5X17Ac/&#x2B;Pr3T/1oaNc7WInj6GYl8fG/CvL7Ym9LlprAxuNvIY7htwBI7QMA6lsARKerddcP4hIIxNdqg7OzGyfb9U7SKcO48vZqd&#x2B;b/u&#x2B;0rla&#x2B;XdrHZxzRxM363yKUKNY/6k/TG5txPbp/6V7ePd0e1k83xmVbvuydWf/vM2vmFLcQ5oPuaiKcCbwCxUb7Y7n4yXE8enG43sPvcAlz/YLcGb8KJXnoH&#x2B;y5QOTvJ0zxPakkG&#x2B;5THKRAR0Zdg2EdEREQHpl6vj0aj4XD4&#x2B;uuvO7c6E/rNzY3u1laapvAeYtBsQLWY5EWe50ktiqJjx44ptB3PJknSarfb7XZZlt770WR0&#x2B;/btGzPXT544obMqYsbj8a1bt9rZ9utvvH7ueNhoNWethGF44cKFmzdv1tZWxYgxJghCiKAs8fT28T6o7EM8WWptf32h/psnmu&#x2B;I3BrVrm7XK5VBaSZ5/LX5zZl6z4SFKNSbrAz7ebQ6rF3pN9/fnLvfnSvy5I325LWF7jeW77&#x2B;9tHJ6ZoCoBB7qn93PKwFgS4Qe8vHKW3ko5vt8ly4eY7cGEb0EDibvEwXgVQof5C6sefMU34SJiOiRGPYRERHRYwskDySDKSEFTAEAZgAJqvxuIx52alk&#x2B;uPXt7731/o9/FobhH/7z9sXXT3XOfq9er7eymwC891tbW1s1v7i02Ehuzi5n8eiDX/tu7U6xUZX3d5bO3u1f0eJ3R6h9dHl&#x2B;eeFvXXq7NRwOx&#x2B;7MuFpZq67smAHq7vb61k9XflOMfO3Cj1793frtP&#x2B;2fiT5YMMN8MEH0dfT7SBoAFBZAFQ4B2HACHNDt57QfVnyQZL&#x2B;0vCU&#x2B;PhG5f7Uyd2NY7xXmcncmceGHW02JRpEtU4g4W1Q2c8H9cXxlnGxk8aytLi1tfH2h9&#x2B;by5vmFtaSxg7CAGjj7JLfeKoCdbuzYfTqr9ohoH/RAN2Y7byZlNCqSGWcRgtu4iYgOBcM&#x2B;IiIiOjBFXjQajXanMxgM7ty&#x2B;E0bh6urq/fs/z7Ls9fz2sWPHW&#x2B;kEs7N2nK2srqyHwyiO59reWhvHcRiGHadVWZ49d67b7a7tGB0OepNe5Zyq9no7WZYlaVqr14ui6G1tb2xs3Lp9azwen0wGb799afE734njGGZsgwCDMYwB/N6v&#x2B;IlNMzVvYLDQGf4tu9qJisX64Fq/3S8avkhXhvG7/bmRtDu2PBG5pvVp6ALj4qA62Rqem9s53xx9Y3bwame03BxIbQTr4C38PpZyfAGBylP9c4noRTN9p/HwTpw3H39M8NVo6exOlnbHteOt0CSAUb41ERE9ewz7iIiI6LFFvox8JdOKkGlLqM1hfTM2Bnj1mFy9unr/yq1jM4smv/svhr93&#x2B;e7Sdnhytjv7ffunFy9ePF3/v7J8Y&#x2B;vy7Nnwrfr5d73C4n0EwXz0psbRf3zmH/&#x2B;0&#x2B;zd/Ppq7d&#x2B;&#x2B;ebjWwFXxUXbq8Fb1XzXXbX6vNdt&#x2B;T041xdCMPe/3OcBS2/&#x2B;XO3OzJS692B4MB/NUgUKCLegK/DMD7GQAIVwAYswEA&#x2B;bEDugyy2w8blvVm/1tBdqK9szVubw5n7vXqt/qBzW1p/LEkf7WWLdbyZlzUwjIIyyAs2kmxXJvUowqBg3EQPGnMB4ClM0T0pFwwLpKsjPx0YfdXsbscPOiO0s1ROi7DBsuLiYgOCcM&#x2B;IiIiOjBhEjcEX/vahXqtduPuZWttLa01mo2yLHq93mg0&#x2B;uHqD7e2toI37xtrhsOh917CEEWBvIB1GvuBiZaSAAAgAElEQVQgCJYWly5d&#x2B;rqZ/80PPnh/6xdd51y/119bXev1emVZjsfjjY2NrWJbVecXFk6fPr313ofvvvPuxfmiXq8jyxDHsBbWPvVyEn3QKmuAoIibxena5HQ5GU8Ga8N4I7NDRRSUi2m&#x2B;mOaNqLDWi3GwHtYhcDAe3sALvPlKSR8R0eOSaTYnKKP&#x2B;pDEuEq8G4r9y3ofC2a1J1B1Hk8o0oJjuceIHEkREzxbDPiIiInpscRXElRUfw8eQFEAlQSC2mmxbY84thIu1xeXmps39h6NRvZwb74x/uGTrce2D4b/zo5szlZm31m7qX27LstqBRh69CN437V9Dg1f6r7&#x2B;C5Adv/de3m7f&#x2B;bL5aPvbna8nxO/5fBsHFIJr0Vr5/S06cWOwaYy6d&#x2B;Z/On3/t/fHb196/tnZh9dWvXfD9yAQpmiVcplETDyr7QrkJQCazAHDg2yl0eufsEQBmXAsn5xpyThSisA7WwXoA8NM4T3a/d8HuGo0vWJhLRPRUKeChFlU8Kmp5FelX/7xBFEDhZGMc3BuGg8IugO9tRESHg2EfERERHRjvvauqtY21zW7XVdk3L76Z5/nS5tLtW7d3NjYmk8liUY1G4&#x2B;3trUajWeR5d2trY2Oj2WwGSQL1EAPv4DxEYO3x48e&#x2B;1VlIkmQnQ5okZ8&#x2B;d9c4N72b9QX/TbM7MzCRJ0mm333777Xv37o0nE9jAGAPvEYaYTBA9qz97OuxKLQCIQ&#x2B;gggNHdX6mgCoCHwj79&#x2B;L9ERIfKG6/WH8hHDgIo8krujMJro2inNLv1g0RE9Mwx7CMiIqLHFrgwcKH4BD51WgPgAIMwirS3vX3/xuXbt25Z3fj&#x2B;qye&#x2B;feHYfzX5gw/Dj/7b7B8Meze6wetVaD5K4plm/ab&#x2B;26t3Fu/JrePHFv&#x2B;NhauNZl31uHoN6oV3LvB/HNSCt4LfBTKbryydLqvafzEzM/Pz98&#x2B;&#x2B;8847xc7vB/UTbnJs436ctH70yjc2kvl&#x2B;KTegb5nS2qAo/MibGID6OgBTJQDQ/wYAdN47&#x2B;CvycFGMtwDgH&#x2B;rzZYsuET2fVJwX541&#x2B;9VBOFEBe2VUNb0&#x2B;CoROIZ2UfEdGhYNhHRERET0jkCxpi8zwvyzIIw8HW8M6dO5cuXZp9683Z2dk/67599eqV8UYqgvF4HEcRNL137z62fr69vf2ti9s2OBGHKiLqvbEWCjgHhSuLJE3efOPNO73uq6&#x2B;&#x2B;uj088cEHH5TDUoxkWXb3zp1aODlx4kSrtTkajxoyIwKohmGYP/srAjxoyyUier4JoFK5YJAnk&#x2B;mCjul8va92TO9lpLbvbLWbHrKyj4joEDDsIyIiosfWr9/u1e8EZYgqtM5BZFS/6cPQ95dml0&#x2B;1fzJOonDu2D9w8uNJEXZ/8I/H4&#x2B;K//6N0mAz/6G&#x2B;2bt64&#x2B;f7FNwZBeKPeWF9fu7Lzn8Td2A/&#x2B;xW/Wf&#x2B;Pvpv8EIqjd9d4j/w7CEOWWLctjUgDRfMNi8&#x2B;4rjfFvf0N/sXWlxEd/fvvvra&#x2B;vj9C&#x2B;&#x2B;Prr//65P46jyGZ/EMdxNDgu1iTZDIC8fhNAJRMAQf3u4V43IqLnhShUJmXYz5NxGfqD&#x2B;pRCoJBKbVZFKGOgBKY7OvgpCBHRs8Owj4iIiJ6Q6mf33YpInmWnz5y5d/du3suOz84OR0NjTLtdn19Y6MzMfAsXFxYWBidnB8NBEFhrrXNuNBqNRsO8KBCU8IqmMapQYNpXJgIRqKp6sUjT9NixY/322eFgcLlb3L9/f7vYDoJg5a2Vc2fP1ut17z1chTB56tt4iYiOuNIFWRmWLlAc0Hw92T1sb9LMRq2k3odxgDLsIyJ6lhj2ERER0WMzPowktmrhLXwEAXwTPkS0dP/e/YFdWM23768YV77Skc4PrrebzSaW/0kg8q2F3zhzZvOEb41qo9Oba/fG9/5i/B9ubG7&#x2B;cPvSUv4rv/Hqf2aMqVVnK1TeF8ZUNs586C1GECM&#x2B;hwlm47y95Nrmem&#x2B;n19v6aVb/yc96J8brH/RupNKpmfAtlCVwG8Yg3AKg1RIA42cBQMaHe92IiJ4bCkXpZVTarLIHVtkHBVC6oD&#x2B;pjyaNJJnAVAd0ZCIi2i&#x2B;GfURERPQknP/iwrnhcLiysiIicRTduHH94sWLo9EoCIK0iqDw3nmvQRCcO3duDXONZvOqOd7tbg36g9FoBCBJEozEGOM9VFUBMQYqu1V&#x2B;znl4Y20tqUVh9PrrJ8Moyt9LgyAsyu7a2tpibatWrxtjUZWwybO8IERER4kAKsPCdsdhL7POT2f2HUxxn/emcIFzlgV9RESHgmEfERERPT6N4WNRAQTeQMS4uphwlIWN1rE770/m5hZOn/jbP9z8w/795NjGvzc/N3/qxJ8YY/Le32wP73Rc8Nrym6de3VxrrHWiN380&#x2B;vGmf6OVd6/n5xJJXs1bALwZqqqzAxETqVPvp9UhSdWD95H7KwnDXzsZ/NJ8trS8NBqNlrLl7Y9WbyfJa6&#x2B;9Gsyua1FUUReA5icBmNICgHn/EK8ZEdHzQnRa2dfLgvuDqDsJKi8HuDlXBIFxoa1gOE&#x2B;BiOgQMOwjIiKiJ&#x2B;HcF3Rmicj8/HyeZ2tra2dflTRNb9269dPBu8ePn&#x2B;i0hq1m0zkXBEEACyBpNo5be6l&#x2B;yVp7vXey3mh0u908z0/Ovh6GoQmM9957NcZ/ss9RBNZCtSgK4yqptVrt9sWLF4eDobljPry8tt7fOHfuXBxGUpbcAklE9KWMAtrPzdo42M6tV0BwUHmfFZeEeRJmMA7AgR2XiIj2h2EfERERPbbSRFWQOlPBVEAFIHIaGG&#x2B;DXKFnjkVXr1698v6fBifH&#x2B;WDtf7j2Hyz0FzfSXrPZ7Nh/1mw1o9qHrmodH9wBar/W&#x2B;R&#x2B;/97XN1e1TYRC&#x2B;d/Ufbq&#x2B;syK9uhbUaAqPOTWQML14SKFDVoYoqgEgsQ1QeugFrTzV&#x2B;4lrOzX5t2BjKJNLKQGJn1dltAGKGAIAaAOj0Xz4cIEVELz0BIMPKdHM7Ko2KHEwPL0QU1rpamKXxBLaCZ9JHRPSsMewjIiKiA6PQIi/eeuut8Wj8zuV12wGAPC82NtavXburiuPNy1//&#x2B;tejVNfW12rJjjW20Wnamdnl&#x2B;FhVlVjBaDwuyyLVFCIioh9v/BXAWBQ5SiAKEcdwHhihLLNJFsVRp91eWFzIt7YVQFUZ4e0lEdGXU4GzvTLcKIPMG9gDGtgHAAiMq8UZogzWwVtW9hERPWMM&#x2B;4iIiOixldZWQeCCAraAmQASuInxQVTcigJ7tv5O/dLofCO6lt0KT0eXB7P3V1f/5Pq3Wq2Wu7n108m5X/rOXG9n58Ps2ttvvX0s/qcoSxv9kY1wofF7iCXVVUiGqoBzcVg5V1W&#x2B;HtdqmIQwIcIYChQjAAjrMJi3Oz6rqvyH5046Pd4IgtWyjAMbiM8ASHAXAHwdAKoaAKB/WNeNiOh54ey4iLpF3HVhpQZwB3VgBaz4KCwRlhAPBJypQET0jDHsIyIiooNjDKyt1xphFNWjM3aSeOeWNpeKPM838/6g3xBZW19bXe2tr6&#x2B;rrp08eRL1HiAwAmNarfaFCxfC&#x2B;CaMgQIKCESk8j4fj2M0vvik3kMkCAJjDHwkRhTilVPhiYi&#x2B;iChUUIW9SWMrrw2dPcgsTgGIm3bzGn&#x2B;A1YJERLR/DPuIiIjosQnUQCElTDnd6igwUAPdhjNt/MzUgqXF4ljezYviP7r4v9xKb/2f4Wnnqk5zeXtrIxkeT4b&#x2B;Z9u&#x2B;durspP734yj67vF34jgW&#x2B;cP2SaDaQTCENTBebByGobValBnCTQAIDABvACAPFEBaxEaAZNWIAEOouqqNCoG2AEiwCgBhDgB64pAuGBHRc0MUapCn3VF7Z9KovN1dzntg1BpYAMruXSKiw8Gwj4iIiA6OMXBuMpkYY9Iyi5I4CILz5893Op13zexoODqzdO69d9&#x2B;dnZ21gV3d2XDe3717dzgYLBe3T58&#x2B;XRMTxRGyAKpQdc7lvkjT1MZJqPrIJjOBALK7S3I67O9Z/c1EREeHKMTD20mWrvTbW&#x2B;Oa8wbGH9RUPREkxs8Yl4gCwryPiOhQMOwjIiKix5ZWPi1d4BXeQ2NACo1DhMaWEG/Dgfce5a04CGDNd&#x2B;z/jGXJ3dxoNFpOvtm5&#x2B;RdnzN8dh&#x2B;OfzR73rcX3u7/57rvvjvrhd6pvnz79s06rvaQRVCGdYTEcbI1r9fpyS6qyDMwqANgBADUpAI8WAOgcFPBrALwZAjCawAjKBAB8B4ALPIAyLAEkbPAlopeZUTjZmcR3duobw6TyBuYgtnMoADFG58LqRFQ2LN9qiYgODcM&#x2B;IiIiOjhlAWvDMASAPIB6eKnKKmi3z507V5VVUiyfPHnSGOO9G42Gk8kksHEQhoPBYHVtzZq7GxvrraZPkqReS8fjUbe7NRqPZ&#x2B;K2sfZLTyqAqldVVYUT7uElIvoyohCF6vo4vLyT3hvGlTMHNFlPABjRTujmQ5cYD2UnLxHR4WDYR0RERI8tLTWpEDrACTQFUCBRBBY9qzaXoYikFlDAORNW0PGl6i6sgb939uS9m2l7K&#x2B;wOr5&#x2B;6unm7OTl2Kp07Gf5quDX7Z5vn1tbWhm&#x2B;9s7S0fO74Nzf7Gzdux2manmzWm60WMAaAYAjAagDATiv7fAqoaq4A0FcAkgGAn/52EYBKBqCIJwCS/JlfLyKi54coFHcn0Tu9dHUcVao4qBUdCiuaWl8LfGgO5pBERPQEGPYRERHRgQmTBM455xSaeg8rAEwQuMmkzMdRFJnK1U6dWrZLURiePHlye3tncyWrNxpRKwKw2d28/OHlfz3&#x2B;8fnz5xOz3Nvpra6uNhrNSWabrdaXnVTVi4iIMSKwZndYH2f2ERF9xrTMTk2RJbeHtWvjuF9atdUBnsEK4kCTUAOjwIGu/SAion1j2EdERESPbSeq9cKaigAo0x1AmjsDIMyDHBbNbA6AMw1rugAKPw&#x2B;DJMmBAokDMKvvzs7gH10affjhh/9sNDMajf5y8m8uNNJb5uyVanul&#x2B;49m/Mzr/R81Go3W5N&#x2B;aSWZGc//NaG4xGpeT8TitziEIkN9GGCZiMeijtaZFYYJvlsNhGeW1ZmO8nUdRFIQ7AFAsAAiCywCa428CgF05rOtGRHSYRKGCvLbSm73T72wXoYM/oB7eXYHVeuibkYsOqlqQiIgeH8M&#x2B;IiIiOhxLy0tRFO3MHrt&#x2B;/frlynrn4yhutVr94dAY06v18iL3225&#x2B;fr7RaHjvEUWxcygA7wGgLGEdGk1gqKpSVjr9ufecEUVE9FnTPbxqx8PmhxvLt3ZmKhcc4B7eaRFfaLQZuVbkIi7oICI6PAz7iIiI6OlyxgNw3gOwpgAAHQCo693O8VpzMbo1m7623QW68/evGPeTa&#x2B;PfrqEKlmdiqa1FQSdJb&#x2B;/8u5ubm7/aGaVpWm/8bxCBcUWe93W2Xq&#x2B;ng8r4CkUeqUY6Ql5E3lrvoR4AZHrDmQCoJAAQHs5lICI6bNbBm/VB7Rdrsze2G6UzsApzYAP7AAmM1iPXiB9U9qmwk5eI6Nlj2EdERESHI8tyEQnT8MzZs9GpV4qiHAWDlZWVbZ0FMDszs7S0tD4sVHXl/sr7778f1LfffPPNel2hijSKjPiBH41GqSqshQJhhMCiLIAUwjtMIqKHiMJ4ACvD&#x2B;P1u7fYgKg5sD&#x2B;8DCiuahC4NnTU63ZV&#x2B;kMcnIqL9YdhHRERET5fAA9DpLaXxAKAjAM2GuuEomay342Q2uCqxnDnpvmvu/9/v/7zb7c6mr55qp389Z8vi7l9v/PL7G42/&#x2B;HDl78z81q8sFKp6we20Wq359EqWjSAdoEKWoFaDlChHVmN4t3t64wA41AB4cD0kEb3ENNCsdnvQuDKMtwurAgQHGMYJABFE1kd2GvYREdHhYNhHREREh8QYMWIlgDFFUaii1ZxpX3y9P/v9mzdvFEkjTdMw0N5Or&#x2B;p2x&#x2B;Pxndu3r1y5MpN&#x2B;VFWVT3rnz58/1Y5qxiC3&#x2B;WjY39iYm5szsVeFWAvVAxtERUR01E1Xc2S1ezsL13Zm7&#x2B;dJqbL76cuBssYnQVULy9A4AFC&#x2B;ERMRHQKGfURERPR0RU4ByLSqTiIAkAoAsoGxauIR7CQpVwFAYzj/g/O3LnY2q/5pAL52&#x2B;q65&#x2B;yOUG&#x2B;WVDxZ/&#x2B;c548a8&#x2B;&#x2B;k&#x2B;dc78z/t/fGLzx&#x2B;6f&#x2B;HPX61vLpmxu3Vm9XJ/zcxZnQRza1LRQFpuPhbQFAfAQgRHYYF4CI6FBNG3jVZMPGu6uL73Vnt8tQjR5wDy8ASGhcI85a8USCii28RESHhWEfERERHRJjoIqqxKRC5dBowgbo9YbDYaPRCKMFr/7E8eNVVcVlVJYlarXh9vb9rAJwY/OGtXbd3FtYXLQnXhmNRisrW0malGURRTGCQLNM7GH/gUREzwNRBBWq4H4//fH9mfc2G&#x2B;PSwugBDzZQAdQaX4/KWlRORyiAJdZERIeBYR8RERE9XaYSAJAQAEwEwE3v/sRBYFEhAsISDqhyJElDN&#x2B;EM/E2r&#x2B;N6JxqVWPtr8&#x2B;cLoo63NoCjy7vrvpUnaufQ7RbP1v/6seeb0mVt&#x2B;e2vrnLOvFsWxY9n7s2l7ydeGztUjAaAmB2B9AAB&#x2B;BICD&#x2B;4jopSNAFV7v1X&#x2B;62bg9iB1kt/b5oE9jxAfi7VNoECYiov1j2EdERETPGVWIQRBCFVHU6HTOd5YbzcZPrp7Y2FifjGqNemN5&#x2B;Vij0Zh8&#x2B;Iuf/&#x2B;Lnd/P&#x2B;aDxO7jfm5ubq9XoURci1lqZg0y4RkSggqJLxcObazsy1UW3kzNOY1rd7NsAYFxj39E5BRER7YthHRERET9nugHYDAN4CgDEAnAgAJx6Y3o4&#x2B;2Ns7uBCFIZp/oVUl/gaS6DesKU4Wb7X/8vr1639ZjquynDk&#x2B;X6/X/6T59291b7a2fwLpzExqJ8pTNklLMdm4jOPYqwGgpgCAsgYAWjzrv52I6BCJ7oZ9o8bVjcUPt&#x2B;Y2i8jLfgucLTQQVaDU/e3WVbHGp2HeiMYwJbdzEBEdFoZ9RERE9HyxxgBAVZVlqVkWq3dJbK09d&#x2B;5cs9n0rV/d2Nws6mNVr&#x2B;qLspifn280m&#x2B;nEhFEoIqq&#x2B;LMswDDkqiogI1sHZzUHtJ/fn393o9MsA&#x2B;1vNIUBDfM34ArLtRNXs8SwVAIGp6tEoTEYIS1SWM/uIiA4Fwz4iIiJ6yuz0Zm/a0uUAWAUAu/tTA8CLAPAQAJIYr1rirDMuqI&#x2B;czWwWwbm6&#x2B;3/rxpw515jM9q60Xa/Xe69RjZLLiXx7rt5u1mxDw3q1mQZpZBvwY5gKQGFKAA4NAFaGAADW9xHRy0EAo3Byu5/8eLX54XZaVAZG947gFJHoXOA6ttrywY7bx8IjBSCB8WlUIMphHBBwIS8R0aFg2EdERETPF1c5VfXW2yCIJIIICgEEEFQOkU3r9UZD4zi&#x2B;cOFCGIYfdLeccwtbtWazkedFkiQIAnjPRRxERFCDMrozrF/u1zay0O&#x2B;vrC&#x2B;EdsQthVUzcllhpAT8/qr0RK31&#x2B;8oTiYjoqWHYR0RERE9XEQCAVQ/A&#x2B;gIAfAUA6gEYMQCMWAAQCyCr/XOoBpNvW2MR3YcCZhGhRbvjhiNbeF/pK911pOlrp/5g2Bn851f/4ebmptkKZ04utKuNeDJCaeD9tIBQxQMoJQVgp/P7MHrWl4CI6NmbhnpVNBy17g5bK0VcqmAftXYG2gncmbg4VStU5H75GPV57sEEViIiOkT8yJuIiIieL1EURnEUhqGIuKoqitxVDkbK/iDLMwSBiWMA8N6kaWtx8dd//ddPHD9eq9U6nU6cpvAeUNh9NJ0REb2wFMZDgEl6c3P&#x2B;&#x2B;nanX4X7mtanEhg9WS8vzU1eaRVx4J3KPtM&#x2B;AaxMVyPtJ1QkIqKnhZV9RERE9HSF0zo&#x2B;AIBKCAA2fMTjZXQWgGILBgYtEwDBRIEArwUhVG/AAAmADLEB8Lvmv/ytt3v9M33I/9HvtZvNpjSsOjetE4yKNgDIGh6sBWbFCRG9&#x2B;AQwHh69UfqL1dkPN9ujItiN/x5BASdRpOc6428t9VDJvUk7r/axilchgrp1i2FVt3udhYiInjKGfURERHTERXGr3U6SxHsfBIEYA0CMUfWH/cqIiA6PAC642Wv8ZL1zbadeVAay1yg9FTgJ4U63e28srnf7NaetzBlV2TO/C40uxuW5tOgEDiq7n64QEdFhYNhHRERER1xZIgiiMIT3qCpXVRAYMSwtIaKX1O4K9ECz2rVe&#x2B;51ecyWLnCqCPXt4AZVmWJ5qbp9ob26PF3qlmVR73TOqQBEYPxtVS9PKPiIiOlSc2UdERERHW5FNtCjgHFR350Tp9FsiopeSeAAo4rX&#x2B;zLVe59YkHvt9VdqJSCPy5xv5xc6gnQ576u4W4aQKVLHnsD8RhKLBPlb9EhHR08bKPiIiIjraAhsAgHMQEWMCY6AKKPM&#x2B;InpJTRO3LL23PXN7p90rQsVeaZ0CKtbo6Xr5vcXhG7PjIPDrVXC/DHJn9lki4oFKxfOtl4josLGyj4iIiI42E0VijPPOOQfvoaqqrnKH/bqIiA6DAKJQdCfxR932rV6jqOw&#x2B;VnMIvITiX&#x2B;30v3d84&#x2B;RM31gduGA8Hdi3Dwrs85FERPS0MewjIiKiI857TIv4VJ1zzlXeOc&#x2B;yPiJ6SSmMB3B/FP&#x2B;427jaS4vKwOjelX1OYlud7Wy/sbiC1o6Ic94AMp2OQERERwjbeImIiOhoU&#x2B;dExAYhVKdlfWLEGlHPIfFE9FJSgbN3RvHPerW7o6iE7ue2LxCZj8ozrf5yexvxGFIDa0OIiI4mhn1ERER0xAkUCu8&#x2B;/b8HWYqiyhteIjoKHuzhLbP6vWHz3iSaOIHZewmvCNqRv9DMX2mObZJBpjs52JZLRHQk8V&#x2B;uRERERHsQYZEgER0JHgIUyfpgdmM4U1YhRPcI&#x2B;1SgYgTH6/k350avtDIYQM2Tz0JgQkhEdNgY9hEREREREb0Aprmeuiy9vz2z3m85F8D6Pab1AXDGGD3RGl1a3DrTHsJ4eHmCbRsCGOEdJhHR4eNbMRERERER0dE33cMLGWTRnV5jZZBOKgvRvfbwAiqxdSdag/Pz3UZjAOPhH/s&#x2B;UQBr1ApE9loGQkRETxnDPiIiIiIioheCKES7WXB5J73Zj7PKAthzna5VzAbV6cbgRHsb6Rii097exzqzAoWXQWUyZx/3uUREdLAY9hEREREREb0QjEJ0s7Dv9JObo7ioDMxelX1Aav3puDhdH3fSMYISgmlap3vGhB8TOC8beXgrizazCGUEbwGW&#x2B;BERHQ6GfURERERERC8KZ9fz&#x2B;MYk3i6s2zNqUxGgHbtz9eJ4mltbAbrvhO8BUUBLL&#x2B;t5cHWY3uy3R/0WihjGw3ju6yAievYY9hEREREREb0QqlAn9c1xfVCEqti7Mk9hjM4m1elWPl&#x2B;rYBT&#x2B;oXBOFftcyivwqhNvVibplc35j9YXi3ENAhiuMiciOgQM&#x2B;4iIiIiIiI448QBQRtujVn/cVLUwe&#x2B;3hVYGKFcyl5Yl2NpsWEMCb3YRQEIjG4kX2F9gZhfHDPH5vY&#x2B;5fry6sDOtQ7Jb1sbiPiOjZYthHRERERER0xE134FZRL6uPitR7A7OPojwVK9pOiuXGqJ3kEP/xag4r2rJ&#x2B;MawS60T2Mb3PKMSPi&#x2B;D97eaPNtu3hymKGM4&#x2B;1ug/IiI6EAz7iIiIiIiIjrhpEZ&#x2B;z4yKaVKHz&#x2B;7jRU0DFiDaiYiadNKL8oRI8CQSLUXW2Vrai6dy9vcrzBBDkztwZhx8M0hs7nVG/gzKGKPZZG0hERAeEYR8REREREdGRtls657wdl2FWBE4FwN7LcBUiiMOiEWcSFp9U9ilCwULsT9VcO/L7Xc0r8Kq5w&#x2B;YkubE1d727UE7S3TUdRET0DDHsIyIiIiIiOspkt/Cu8GZYhOPyQWXf3sPyRESToGgkI4TZJ49XiGgndov1qhlXAnxqccejjudh/LiILndnfrox080iGA&#x2B;rHNtHRPQsMewjIiIiIiJ6EZSVHRXhqLROZV/5msLAp1HeSkeIH5rZpwLj52rZ8fawlRQCwO3O8tuDURgdFuG73frfdOsbkxBquKGDiOgZY9hHRERERER0xIkCKJwMczsqbOn3sVNDARURxEFZizIEJaBQAQQqsH6pOTw3s7XYGEbWG9nfnaMBRLNSbo/Cj/rJ/WEDWQNVCHByHxHRs8Owj4iIiIiI6EWQV6af22FhKycf9/Y&#x2B;kgAqxhvjPwkHFfAC42uNwdmZrfPtwala2Qz8vnbyAgC817GTjUl6Z2d&#x2B;fWseGSf3ERE9Uwz7iIiIiIiIjjgBgNxhUJhRYZzut3dWAVVRbx66NxSogXGIJ8eavUuzvV&#x2B;aHS7VC4FiP0t&#x2B;ARiFoF8kVzbnrqzP5ZMIxk9/SEREzwDDPiIiIiIioheBUymclArdXwkeVEUh&#x2B;umHK6ACKExVTyZvz299d3njeGsoKnBmPzt5p5P7enn0wWbzvY1mdxLt/pyIiJ4Jhn1EREREREQvCFVA99luCxGtWVezzn7&#x2B;OdPILyzPzmy/tbx6qtULAm9213fseVzAYFjYq73kvZ3a2iRFFUENoNPZgkRE9FQx7CMiIiIiInohKADxn6zN/fJkTQFBGrjjUTkfusB87rFq4A2sD5uDs7Nb59uDM0nRCKeT&#x2B;/Yq0hOFaOFkNQ&#x2B;vj2r3Rw2dNFCF059/hT&#x2B;PiIj2hWEfERERERHRi8CpZJVkTpzfK49TCNAM/Zm0nI&#x2B;clS8a8ucNoAiL2XRysTn&#x2B;Zmc8l5QCYM&#x2B;Dy&#x2B;4ZRt6sFvG9/sxmv4MihoBhHxHRM8Cwj4iIiIiI6IgTQDDxslEGvTJw&#x2B;sgbPQUgECSBbwc&#x2B;NV/06IfKA9Ow/Fpn9I2F/lJjIgC82bu4D4CoBwZFfGu7c32rk&#x2B;cP1nQQEdFTxrCPiIiIiIjoRTB09n4ZbpeB97JbvPdIotBHD9JTgTcI3KlO//WFrePNUSR&#x2B;3xMBFeKHWfhBt/mLbnMrD2AcxHNTBxHR08awj4iIiIiI6IgTBTD2ZquyE2f2uY3XA5WKf&#x2B;Rxp5P7Wq3BubnNs43BfFiF07Ruz1MYhUE/D97bSX&#x2B;xnQmGBtcAACAASURBVG5kEdRyKS8R0TPAsI&#x2B;IiIiIiOhF4BSlyt4Vffs3Xb9rPNLRcrN3vjk8X8vbsRPsb00HNKvM/XFwY5isDxvgmg4iomeCYR8REREREdGLQAT2YKM0BVQgHrbsJJMLndHbc6OlWiGi8LKffl5VLbzZztP7/dnt3iyKBPAwj6wmJCKir4ZhHxERERER0QviqXTJKqAwgTs3M3p7aWe5OTa6j528U0bVYFgkd7Zn7m11NA9hWNlHRPR0MewjIiIiIiKiL6cCZ2HdsU7v1bnN&#x2B;drQqN9nZd802uvn0fXtxtXtxk7BNl4ioqeOYR8RERERERF9uenkPuvC2uBYa2s5HXZCF1pA9pH3CRQY5OHl7do72&#x2B;lWFuw&#x2B;5UBHCxIR0cMY9hEREREREdGX&#x2B;3hNR5TN1EavNLMLzaKznzUdshvqjQtzfRR/MEjXJzHKCN7u9gYTEdFTwLCPiIiIiIiIHkkFCohvRu5iZ/LN&#x2B;eFiLRcAfq87SgGAystWaVeyZG3ULsdt7uQlInqqGPYRERERERHRXlSgEoXVhZnB2wvbi42xAPCyR3EfAKiKeuiwSFb7s&#x2B;v9GZQx13QQET09DPuIiIiIiIhoLyrwBmF1vLPz6vzmYm0UwO9W/O1J1IhmRXy/117pNdUZCCD&#x2B;qb9mIqKXEsM&#x2B;IiIiIiIi2gdvYJypD461dpaScdu6/UV9gFE1OizC9WF0o59uZyEXdBARPT0M&#x2B;4iIiIiIiGgv03Zd4xHlnWRyqpadTot66EWAPUv0RAEZ5vYXW/UPesl2brmTl4jo6WHYR0RERERERPsjCvHNqDzXyi/O5gu1SnR/O3mBUWlujKMrw2RjkqKM4A0E3MlLRHTgGPYRERERERHRPkwn9KkkoXtlZvzWQn&#x2B;xngGAN3tEdgIFKi87pV2dpOujTjnqoIohnms6iIgOHMM&#x2B;IiIiIiIi2h8VOIPAne7svDa3OVMbGQBqsHc7rqqoVwyLZGVndq03gzICuJOXDo9ABGIACwRABNjDfklEB4RhHxEREREREe2PClRgy3ajd6LdXUhGifH7HbtnPIyOivher7XSa5RFAMOwj54VAQSwD6K9ADaACSAWCIEISIUTJOmFwbCPiIiIiIiI9mc37HNIxwu14YkkW46q2PjdXz2aKATDzN7qpbf6yagyMB77KQokeiwCGMB8kush/PRXBIRQiK/gCmCo6Cru&#x2B;Gp42K&#x2B;c6IAEh/0CiIiIiIiI6IhQgeh0TUcrKs418vONfOCCvDKqe8V2Bgr08uBKP7o6DL9bSUcUyso&#x2B;&#x2B;grkwX8f/uYz3wvggApwgAMsMAQGOrzre3ecTWBSa6773l03fs2xlZdeDAz7iIiIiIiIXlKKJ0rbFBBtRO6Vdva12fGVLN6oIvUC8&#x2B;XHEgCqKuPK3hqHN8dRrwhPuhD4&#x2B;BWwwI8e6fO5Hj6d6E1/og/letOvEsgUE/gMLlOXAR4u0&#x2B;0P3daNKmyICVDmunmtKpaB6HD&#x2B;OKKDxbCPiIiIiIjoZaRPVlc37eRVCUK/WC9enR0s9Wo3h/Hurt69IrvKS7&#x2B;y61myNW5i0keUQ9zuYYk&#x2B;Jvuo2gNQfS7ay4CJagaXwU3UZfA5fAFXqC/gS/gCxsA7LcY&#x2B;nEXcQNQWDBC3jWHSRy8Khn1EREREREQvIyMIDKw8fsymAm9g/OlO71iv2Yg7gEIt4PZ8JqCVmmGZrA87o&#x2B;Gg3tpBUAECtvO&#x2B;tJ6gFXf6VQATRQY32S3Zcxl8AT/N9R5EezAQ&#x2B;&#x2B;ArQBgjqIlECI/ZOWOCUJonbd7X9J5ZbQt6h3YZiA4Qwz4iIiIiIqKXjgCh1Xro01AheMysTaCArRrpcL7eb4dZAO/2eQRRCMZlsj5sbY2b9doQIXO&#x2B;l8bnO3Dx6UTv0a24GfzHud7koVyvhCvgC0AfyvUsbA1hGzaBTcWmCFLYFJIKYiAURAY1QQOA1K7rajC/7bjClF4QDPuIiIiIiIheMgoxqIW&#x2B;nbh66CD76L/99NMBgXVIxnO1wWI86Vi/UamHQHWPI4kqMCnC7jjdmqQnnDGiLOt7MT3NVlytPp3rxQhqsOlutDfN9cw014uAWBABMRAJjB0OGxvD1ka/sbHS3Og3N/pN/6C81RgThuGzv1REB4thHxERERER0ctGBFoLfTuuaqHbrezbfzvvdCev8TDFTDI5VctOpcXIByNAp7961JkBIK9sP4sGeVg5Ez1u1EjPoafUiltOv/9sK24Qw0aw6Se5nk0FyedyvQjluLExbGwMmxurzY1hc2PYmJSfnczXbDYBnDlzptVqzc7Onjx58hleOKKngmEfERERERHRS0ZhRCPra5GLA48nrK1TiG&#x2B;G5dlm8VonX3fxaGL3Po5ABbmTYRGMclN5rj89ap6TVtyHEr3db6q4O2xuDJsb282NQWNj2NyZ1D7/8pvNZrvdPn36NIDTp0&#x2B;fOXPmmVw1omeKYR8REREREdFRpxA14ve352K3jM4atUbNExfVKQBJAz3VKl7pZO8Na3cnRtXsOf9PgcJJPzeDwpbesKrvufb8tuI2N4aNje3mxmBasvdJK&#x2B;7HPpPrtdvtTqfzrC4c0WFi2EdERERERPQCUAB7Dcz7gmc96bg8gQoUJvBL9exYc9yIG0C8dy&#x2B;wKBS5k2FuRqWpvEC&#x2B;wqugA/SitOK22&#x2B;12u82SPXqZMewjIiIiIiI64rxBGU3K2HkzrfLbT&#x2B;in0xF7T2Y6408A6zq10Xyjn0RtQXM/g/8UKJ2MK5M5w5TvcLAVl&#x2B;iFxrCPiIiIiIjoyJpuw6jCYtzcGTcKFz5ebd9XWoQrUCAo27XeQqNeDxcATMv99nwNIhJYja0PjEL3bPylr2afrbifL9l7RCvug3o9tuISPYcY9hERERERER1dCgiqaDBpDLJa5exuZd/&#x2B;nuo/Vdz3mFV&#x2B;0yfaCsloJh3OhHlNdLifiX1AYP1CrTrWKNLQQ&#x2B;UxFgHTo7EVl4gY9hERERERER1h01zPm9JZ781jVsiJEZhPKvH2UZL3sOnDxSP0rSg/FhfLYXnbBTkE&#x2B;uV9xF5EMJuUr80Nzs0M4qiEZ9j3RA6tFfeTaG/vVtxhY2PAVlyiZ41hHxERERER0ZFnjVrjzb4bYgWwxkeBD63/qm20oo3An65Vp&#x2B;vluotyJ9MffvZhCniBmmbo3pgZfXN58/TcFqICahj27csjEj224hLRQxj2ERERERERHXHTpE8eozTPCJLAN6OiFlYQ/Qpxm0BRC/2pZn6uk18r4v4wUi&#x2B;A/9SeEA94Ay&#x2B;x0QvN/PuLW28triaNHVhW9n2R/XTjerbiEtEXY9hHRERERER0xHnJK5tVQTXdkPvo6EwBFQ&#x2B;Ng6KVZPUoh/HAkyZuKgDSqDo7O3h9YfvyMFoZRLk3EIUBAIhCIZBQUIvd2Wb2t493f&#x2B;3k/dOdLsIM3kDNk5z3hfHE3biDL2nFLaeFe2zFJXp5MewjIiIiIiI64qpwc1TbGtcKZyH72G6rIkAa5p10GMUZxD9pbZ3AC0QQFqdmupdG4Udb0UY/Wi3CUqTyUjhALYAkcKfS8pXO&#x2B;JePdf/O6TtvH78n6Rhe4F&#x2B;ypO/gFuNWA7biEtEXY9hHRERERER0RCkM4JFXwU5WG&#x2B;ZJ5e3&#x2B;nichfDvMZmsDxOPdNt4nGNyn2E2ngqLR2Hl9Hr92IgxFr42am5Pa9jhcmdiJlyR0rzYmvzI3/PaxnV85df&#x2B;t5btS60MAb1/kBt6nvBhXwsdpxX3wTTmuT&#x2B;O8jbVptMdWXKIXEMM&#x2B;IiIiIiKio0sB8d6oGvlkp648urhPFB1bLSXj2XSIKIcT7DMl/ILzP1jHEZZLnd4PzsrxVnZ1Z/7OTud&#x2B;P7o9Njui82n&#x2B;zc7wlxf6byz2zs13UR/CeLgXKOl7Gotx9&#x2B;rGjWbYiktEX4xhHxERERER0ZGlABDZqp1kzTizxmE6L&#x2B;/LsjsVeEnD6kJz8lp71EkyiMeXPnr/r0EAIC5PLHSXGvmZzmS1v7Ody8BpZavZpDhdn5xoTJppjqiAKioLHNkG3oNrxf1Ki3Gbj2rF3Rw23OeGIbIVl&#x2B;glwbCPiIiIiIjoiNoNlmxULNT7M/VhYGegMt2J8QVrOlTgDIDjjey7x3pvzQ9M6A5mGe70CMbDVoEZnQ7d8XYX4q2tYLxYD&#x2B;shfrdf2JsjU9O3n1ZcPMPFuA91476/epytuET0hRj2ERERERERHVkqgCAoZuv9pVp/Pi5uGVRq1HlYQD7dzKuwKo2k/NZS7wen1s/P9xD4A4ve9MG2DXFIRoHxsA7mQd2fl91U0ZsnGQ74DDxBK64HAEyevBX3oBbjshWXiB7GsI&#x2B;IiIiIiOjImuZ0YZmko1PN4ZutbHOnvDEJvBf1gDzI2lSgYoClqHpzfvBbp9a&#x2B;cWw1bPSBgwv7pi9GsNtarEAVQB68wukCkOenoO&#x2B;rtOJmqhP4EtVI3WTfrbifzvX2uRj30d24bMUloi/EsI&#x2B;IiIiIiOjImjbtikNYLNWy7y93qzKKt5t3h/Egt97jQeBnjPqltPjlhcFvnV3/WydX51vbsDnUwB9oADddD6KABs9LBd9T2Irrcmh1AK24XIxLRE8Dwz4iIiIiIqIjTgXiX5nZDmAaUTm/uvyTtc7lXphVIkas1chWS0n29U7/145vff9U9/zcJuIM0KeSxx1i&#x2B;d7ncz3s1Yr7uFtxDQCY&#x2B;MtbcRNBvEcr7uawuT3mYlwieloY9hERERERER1lD4blBfXRK1HZTouFtFyqDV4bBL0ysAjrgc6l4zOt3uszWxdmB0vNCeIMCqh9jvpqn8A&#x2B;W3GrA9uKKxZh64BbccHFuER00Bj2ERERERERHXHeQBTWIZjM2a1vBdVyZ2O7lEkRV1WaGszXR4vNXrveR1QADy3TOCr22Yr7mVDPAfluyd4Xb8V9sBh3X62403o9tuIS0XOPYR8REREREdHRN83vRGHKWnPrfNsDgiJ2RWoFCHPEGYICioPcyPE0fGGuh8&#x2B;14vrP5XrTVtwJfAaXqZt8Ntdz5RNuxXVqETqECVtxiehIYNhHRERERET0QlADDxiP0MN6QGDUhhWgEAU8KvvJbtznxJ6h3nS/yOe3Z0yATPWhkj2fTyfrfVKy98VbcaeVesl&#x2B;W3GLKri6schWXCI6Qhj2ERERERERvRCm2zamJX67XboKUwAABCr4XFz1TO2nFRefq9f7uBV3AvdxyV6&#x2B;VytuiCCBjT&#x2B;V6312K&#x2B;6Dwr1y3NgYNtiKS0QvDIZ9RERE9JLRBkQE11AWta1vIYm3Fl2eF8dwByZAcS6auLvGijFxNE6S5LBfLhHRY1L5pHBPPt62&#x2B;2xL&#x2B;b5KK&#x2B;5EkcE/WJ3xcCvudCWuLwB8USvutA93tyH3s624D7biJt1prrfd3Bg0NobNnQlbcYnoRcOwj4iIiF4yzsEYWIughiqB9877OI5QyPT&#x2B;MwhsFMdGxFqjqnsfkIjouaXyLGK&#x2B;J2vFrYD/n717jZHrzO/8/n&#x2B;ec6lTl9Nd3U32haRaTY5oaayhpNFlLpqJ7ZnxLb4kBpxdr6&#x2B;LAAY28b5xsIE3CBAgQRAgQbx5kXgTY3YDr71wPN71GmuPL2N77vbMaOTRXCSNRA0lUbyTXdXXOlV16lyeJy9OVbO6uklRFCWSh98PaE5jRuQUCQxAfv38nicWia0dO7I3KnqjI3uJWCNq7MieE4hbH01xR2lP77ye4e&#x2B;a4naisB2Fq&#x2B;thuwh8UWj27JeZ4gIoH2IfAAC4t2wHjhJRnlOp&#x2B;F42lWxtbXWn5uYOSHRAtJak58fdWpprR6tsXvGHJQAY93amuH0rseQ7R/YmpriJmFSUM7bGHZ/iXj2ypyTY0/UqkoxyXvF0RisK&#x2B;6k38dmZ4gK4R/DnVwAAcG9xHCfPsixNtNZev3/p0uVzW57n&#x2B;TPGDE/8KZXlmeQqz8XzJv&#x2B;uCAD3ipue4iYisZVYzOjpjP2nuGr3kb26eN6uJ3GdQKmqDF/P8NXVL9JgeFJvPWxFYTtqMMUFgHHEPgAAcG/xc89YZ91pWie4oo4/u7rxhejw0e6xnzigp6enlxsdE8ZB7TtZmtYSRxR39gG4N9ySKW5xZC&#x2B;ZPLJnzSjq6ckprltVTlWcQPTO6xnjXU&#x2B;5nbGuVzyjYZniAsB1EfsAAMC9Jctzz3Vdz6v4vut6GxsbL5zcuHz58vLRtaWlpbkjru97nudppURbMeZ2f14AuNXG&#x2B;528lSluPDyyl48f2Uv3meIW30TvmuIOu15VnEBJdU/Xq0gSNVajsB2FrcthK2q0OmGcMcUFgLeM2AcAAO4t1S0jgQ6zIJDqZed4lK98tf&#x2B;wt1Z/Oc0Xtxd&#x2B;MH99bnb2scFr9Xr4pF0T2e&#x2B;BjuJ1yz1HSwDgjvM2p7h9MaOnM4ZT3NTu7HCHU9zxI3t18XxxgrGuV1Uq2DPFrShJguKKvfZ6Y7UTtqNwK67u/fhMcQHgJhD7AADAvcfaJEkcxxERz/PEdR3Hef31U&#x2B;vr69PRy4sLCwcvnD98&#x2B;IiIiOsMf4hjRKyoovRZsVpyLVbvXwMB4La46SluXyS2duL1jPQaU9ydV3Eb4gS7juwNX8Utcp4/&#x2B;kLc7eLpjPVGq1OsccO9n50pLgDcKsQ&#x2B;AABwj/Ez8XQ42FZJPJ&#x2B;dPiTntXpPlmTZwZ9ui3x6/T7ZVOc3oiPukc7J7RMnTojESqx4qSgZpr3ckVyP/tIMALfDdbqevPkU1&#x2B;68ntEfexU3leIBDZvu6nraEx2Mul5w9cje8Iq98a7ny6Doep2rXW&#x2B;QTf6tkykuALyjiH0AAOAek6Xi&#x2B;6rii9Ja60OHlo5Gx9rt9tZARESMkV584eKFXr/33cpanuciD1lR0g/E6Dx3NmO/k3iBmy82elIZiFVi9G3&#x2B;FQEotxuZ4qr9ul4i0rdS3KzXv/oqbj7qepNTXEeUI25dtD/Z9dTkFXsiFWUH1eGruO3h6xnbTHEB4A5A7AMAAPeW9kyvGth60pcsq/c/95Hlzj8Nv3Hq1Km/faU9iAen7cNZol9Jf9rb8E6frjU3mj934mw39f7seyubA38zrqx3a12jH5lf&#x2B;&#x2B;lj56bqPckd4Q0PALfQzU1x0&#x2B;HTGSaWvC8mHk1xix1ueo0pblXcRrHDFSe47hTXeltRox2Fq&#x2B;2wPXoVd&#x2B;9nZ4oLAHcCYh8AALi3BJVKlmVirVgraSKzs48fff/c3Gw/fOT8&#x2B;fNr0fSmta6buq4zGAwuXLggJ2Qj9v/d906sx5U49ZJe1fppJuoT912c0pbSB&#x2B;Dm3cQUtwh8A5HY2r7kseSxNeNT3ETyREy6Z4rri1MVXRG3Kk5xxV5wjSmup&#x2B;LivN728LxeKwoTprgAcPcg9gEAgHuL4yT9fmRkQXuuyJZI&#x2B;mTzj47rrR9vXHpl5pUvnDlxqnvqa4P7dKrPHvlonuci61HqPXvmQJI7YpQkvjR6ncQzwmu8AG6MGvvixqe42ejI3miKm/etGZ/iFjvcdM8U1xW3ItobezojELeqpLrPFXt2UC1u1mu1G60obHXCziDY&#x2B;ysIw7DoesIUFwDueMQ&#x2B;AABwb8myLM9z5SrxPHEdGQz6/b6ImpmdOf7A8eTIR2dnZ8&#x2B;sydramljJskxErFWJ0aKsqJ2/sluxQu4DsL/xlid7ip7smeLufB9b6UtR9IrXM3bO6&#x2B;2kvetNcUdpbzjFrYj4SvzRF9bbjML2WNdrdxt7PztX7AHA3Y7YBwAA7i3hdhZmjsmOq8yxbseK5Por1km9ze8sutni4vYn5HL1bHjx4oXPHHFXW6siT4qI2PGwZ1XxN3bDe7zAPe9ah/UKes8Ud&#x2B;eivYFI39rRkb08FjMxxU3EZrunuBVxarunuMWruHu7nqf6UdiKwvZ2oxWFq52wHTWSnCkuANwTiH0AAOAe4zjiumZgBt3Y18apVSsVX0TEy2WQSpJIENx335G5udlLy4&#x2B;eO3du&#x2B;KO0qXpZ1cmDWn96qnN0qlN1czGK2AfcQ27wVVyz&#x2B;7xe8SpubCWWvC95bPPiGY2JI3uJiN5nijve9dyJK/ZGgc8MasXNeu1WuBqFragRXXeKS9cDgHIj9gEAgLcuuBDLa31HpBZ4V2IxVqY88XLJZ0VkrZqISOZuLXQqIqKsJzI6AVecjyu&#x2B;VkZERBsRMY4RkVwZEXGNfqc/vVhx3IuOK/1KV0Sar75HRGRm3c4YI52e6T&#x2B;9fdrk5kfv&#x2B;9&#x2B;T&#x2B;eT//u6vBU72A0fPzQaD2Uoy62WLU9HTh67MVAaSu2KY8gJltHeEK9ed4hZdz4gMRJKdKa7N&#x2B;8Mr9ia6nrW7p7g1caeKJ3GHac&#x2B;tiqqOFb3ieVxfifE3i9czWsPXM9aY4gIAdiP2AQCAt8xxnEpQ0VpLmkogUvFFWen1pNa83R/t5uVZZkWM5CbPVW60VtWgGlQCEZmtDn7jqeen/XTKT6e8tBkMGtWBaCP5O90lAbwr3tKruNnYJjcWia2NJe&#x2B;LiSWL7c4UN9/pevtNcZ1gV9fb/4o9dzjFbW0Nn8RtRWGaOxOffXyKW9Q90h4A3OOIfQAA4K3bdBrp1Fa9GVfqwYG6VCqbOk0z9&#x2B;C2iEilJyIiFS25JyK5l4uItiIiavx83&#x2B;iw3853Sm5nO7PWKqVEKWOMzTLXdZXnKc8TkelK8mPH3xBtRFnRVrSVXEnuiHG4tA&#x2B;4y7xp1Bt/FXe86yXD1zOuPp0xGE5xxYg1km5fY4rrF0f21M4bGhLs6XoVyfu1dhSuRmGr1WhHYSsKo0Fl4rOHYRhwxR4A4M0Q&#x2B;wAAwFtmcqOU1lo7jiOOlixNVRpUA9m&#x2B;3Z/sbVBKOY6jlKOUyvLcWitZJq4jIkqsVBKxSqwSUZJpMVqsovQBd7Q3neLu/P8dJrpeJtK3Utys17d5vM8UN09ErCgtIqIru6e4Y2lPVccWuJXRdXu5v1Ec2Ws1WlHYjsK1bn3vx2eKCwC4OcQ&#x2B;AADwls07S0H0vehynqw73tKMmDzN1iueNzqrlxX/UvxJw&#x2B;iBjKqYY0R2zveN/UVciRIRPTzxZ961X8i43BittXa00lpEjMmzLHPT0WIu8YroJyJjXwC4Y9z4FHe86&#x2B;1McXcf2TPpm0xxdW3sir1gNMUNdnc9X4mre8UCd2t4xV6rE2Zmnynu9PR0s9lkigsAePuIfQAA4C2z1kZRdPnMmcXFxe9f7rvNaVe5St3dT1XkWaaV0tqIiNZaRHZ&#x2B;RVaUvOPPhgC4YTc&#x2B;xZ3oesnwyF4&#x2B;cWQvfZNXcR1fnNGruG4gqqp0dU/Xq0jWr7d3Xs/ohK2o0U32meIKU1wAwDuJ2AcAAN6yXmz8YOrgetD79qprO3KsMj/jSFgRlYpI1khFZLOa1WMrIsMTLNaKiNFWRJQtvtcyuqdv/Gurbs/JPj080GesMUoppZV2HLnLCyZw19vb9WR30duZ4k50vVQkthKL6Use27x4Q2N31xtOcfd9FbcqTlW5gTjjU9yKEn9niltZjxqtKGyvhqudsB011ntMcQEAdwRiHwAAeMu0UsvLy/ni4tbW1ndfvHA8SXrHgqa1Ml293R/t5vmVihLJR&#x2B;VAiabzAe&#x2B;2G5ziZvtNcfvWjh3ZK17FzRNr0jd7Fbc69ipuMJrijnc9rbtRmORunLnfem25uGUv23Pad6LrFbPcd&#x2B;s3DgCAq4h9AADgLdsKvbVAPfnUR06ePJlHq61VlaSxrHaazVgW5t37G5JldrDed4zneZWuJ2KtGLHWqkxERFmllC3u5rNX7&#x2B;wTq0VGf5l/12Vp6jiOaBGlrBVjjbWWg33AO&#x2B;UGp7gTUS8XGQyP7OU7R/bGX89Ib2yKu/Mq7kTX8yXr1YeX610pbtkLtTJx6o/XPaa4AIA7GbEPAAC8Za7rPPfcNx5z89nZ2Yqpzc3N&#x2B;cuN577xjSOHm81&#x2B;z3Nzd25udmFuEAf9OK5ba60VLcOne8WaPM2yzHX4cwhwb9i368meKa7Z0/WKKW5fzOjpjImuVzygsXeK601fPbJXbHJVoKQiUhHxlfijL7LKetH1NoZdb6NX2/vxwzBcPMgUFwBw1&#x2B;AP2QAA4C2rv/eBxQ&#x2B;&#x2B;/3PffCOfCe976OPp0lLnwsXZH/3H&#x2B;qvPrq9lc2cvuYvKeazhztYqiaudqhgjWSJKiZ&#x2B;JKGVzbZ3dR/h43RYoizeNekrE7vd6Rl8ktnbsyJ4ZFDlvdMteOjnFdSri1sQZvYpbdD09ccVe0fW0040aq1HY2gjbo1dxc8sUFwBQQsQ&#x2B;AADwli153q/&#x2B;zM&#x2B;szcfP/v2zFy58ZRAP/tOPf2z1woX5hx5KrlxJ1l6LLlxYq&#x2B;v5J2cbc3MS9cXkYnLJsnwwUKLEs67nGnt7HuIAcMu8zSluX/J4vynuaI27a4rriRuIU9nV9SanuKODe&#x2B;lwihu2roTtqLHaCfupP/HZmeICAMqK2AcAAG7S3NP/6MMrH3rmzIlnn332O39/6ejR9/zU8nI025k756yvr3cvvp682K0uhlJV4lWlUhFtHKMkz0Snol1lU9l9ok9xvg&#x2B;4Y92SKW5/suvlo7S3/xR37Enc4au4/j5T3LWi620Mz&#x2B;tt9vef4vIqLgDgHkHsAwAAN695aOXHD/2XH/nwx377k//y2Wefff/M/OzsrLuyMj87K5vbp0&#x2B;fds6cOfrgoUYYymxVKhVxAklSUZlkuTi3&#x2B;9PfZexte7sE96C3OcXdObLXl1HRGx3ZS8QaUWNH9pxA3Pow5&#x2B;2kveEUd6LraacThe0obG00Wp3hLXvGTv7vgikuAOAeR&#x2B;wDAABvVygr/&#x2B;BX/vnLnc7/9r/8dw95tZ86PFVbXDiwpY4/d67Vbq2dW4/rg0a3GjSb0hRxAtGp5Hlxjm94lq/42zoH&#x2B;/alRMSKMiJKrJI9aQN4W25kiit7zusVU9y&#x2B;lVjynSN7g91T3ERMKsoZW&#x2B;PuTHF3HdlTEuzper4k3UYrCttRYzjIjcJ&#x2B;6k18dqa4AADsRewDAAC3wEpwYCU48OF/8ZvPPffc5//gfzh69OiHDpjZ5fu0o1/rnOz1eluxMxfHTacuU1Piu6K02Ox2f&#x2B;q7hLIiZniQCng7bnqKm4jEVuLrTnETEbX7yF5dPG/sSdxAnKpSVbla9IpnNHwlaTCMERH3NgAAIABJREFUeuthEfiY4gIAcNOIfQAA4JZpOvd94gP3HakufvrTf3oqHrzvxPH5Jw6e&#x2B;Oqvp/3&#x2B;&#x2B;cvVSxfXN1ruoUOed2igq3WZ9mQQ50lfiXJdRxxHBr6kqVJGtBYdi7Vi&#x2B;6KUaE8cR7Lifn1XRERnImJVcvXfefvU6MSctdZaZZWonfhxWxklxhPjitWiU3EzEeF8H97czU1xM5F4bIpbpL1k8sieNaKcq2lvfIrrVlXxPO6uKe5O11NuZ6zrtaJGmykuAAC3FLEPAADcYg&#x2B;e&#x2B;NDx48dffPGZr3/9i&#x2B;vr6yeWl7033pidmxVrz0Xbr7322rQyU1NTvsk8z/MqFVFKEivpQHItjhbtiCjRWkREXLFWrJUsE5l8TLNsirnuxDslVknu9ePadr&#x2B;ulJ2rbzleR8SK5cpDjBnvd7Kn6F1nihsPj&#x2B;zl/dGruNeY4hbfRO&#x2B;a4g67XlWcYGyKu9P1KpLsjHAvh62o0YrCmCkuAADvMGIfAAC49XQw98iTP/ns17&#x2B;&#x2B;emXr0&#x2B;qHn3rqqWblT06&#x2B;fLJy&#x2B;WKv1w9enM1nVWWhImEoC7FoLSrNs7xX7/i&#x2B;7/Y8ERGtlFZKu1bE5GKMccUREZ27IiJGy85Ff465bb/OW8OKElHFULcofUqkWO&#x2B;K5G7UrZ/bmG9FU/WgH3jxVH1btIideMnYFj/THXEUEe&#x2B;otz/F3el6/aLl2Z0d7nCK61w9tefUxfOHC1x39IaGGna9sbRXUZIE7ShcjcL2&#x2B;jDwbfWrez8&#x2B;U1wAAN5pxD4AAPBO&#x2B;dVf&#x2B;7WvfOELpz7/ld///d//6BOvPfH4E&#x2B;6BysVz5zxTuXTpUtxNpqenq9bKzIw0q47nue4gyzJtXWuMNZnWWntWK6WLU353e9O7jmGd0WKViBJlRIr8p0zqnd&#x2B;aObm6sNmvHW6ur8xqUaO0JzIKhXb0Vq/iXr&#x2B;yeTtT3L61E69npPtNcUdpzwnEbRRd7&#x2B;qRPV0c2ZvoeuJuF&#x2B;f11hvtKGxF4Won3PvZmeICAHBbEPsAAMA7Ri1&#x2B;5OM/f/hDH37j0oVP/8u/fqZ18GfftxA&#x2B;FOrg/w0P6rWX7GZnu7oxv7AwHTy0LeFU1e1KMhB3yhiTSWrEZmK00laLcpwsFRFxrRYRNy/&#x2B;C4op691cAZUVoyVxbe5nueuqXHmJeAPRRpQR0f3UX43CS50wyx1j7dgJvuKH75Q&#x2B;PToViLvWtaa4E7HvGlNcu3Nkrz&#x2B;a4qbDrpcnYtNdXU97ogNxAnGCsSludb&#x2B;u58tg&#x2B;Bhuo3Vp&#x2B;CruIJv8SwRTXAAA7hzEPgAA8M5aqa2svGfl8d947Pf&#x2B;7e9&#x2B;7ZmvHTx48IeOzYQr9x&#x2B;pJJ21tcur0enTp12zurS0VLvP1bWa5I52XF9nxuSJJMYY0Vrpu3adep1XdJUVJWKcbi9ci6b7aaXq9&#x2B;fDjcAfDA/3WcmtMtbxHKm5Sd1LfTcfbnWLn9MqsY7kruSuiBU3EScVUTzfcae7kSmu2q/rJSJ9K8VjuEXXi687xXVEOeLWRfuTXW/4Ku7VK/ZEKsoOqsNXcdeGgW87ZooLAMBdhtgHAADeDVOL9f/sV37i8qkTn/3sZy&#x2B;9/ngQBE8/&#x2B;lK32/UufGPt8uXq&#x2B;ebFNXt81ZX5pswMxPelprXoQMTmJndTx3VTSUXEaiUiRqyIaMlu86/qOpQdfhMR4&#x2B;zf&#x2B;4pfSu6udadebS&#x2B;0u7Wp6pbW/SP1bVGO5I6I9bRpBoOZ6qDiZI1K5qixn1&#x2B;U5K4k1c3uVDf1ql48G26Kl4jl&#x2B;Y47zE1PcftWYjHjt&#x2B;ztvJ6R7jfFdcSpitsodrjiBKMpbnXXSb3hF9bbihrtKGy1Rwf3Iqa4AACUAbEPAAC8S5YXVpYXVh5//PF//8nfvnLlyre/9a1Dhw6/7/7lAwfmOtnmlStXzryxOrW&#x2B;4T8002jUxdPiOjvH4pS6C4&#x2B;qaSvKSq6v/U9YUVas7iWVy53G6Y1GGNi5emOu1s&#x2B;N08/cZq3ru3nNy2ar/ThzM6Nyo0Y/0IjVSVz5Xvvgq&#x2B;2DYpyVmbV6EFXqVqy6q5fNd7frdL3xf3PivF4mMhCJre1LHkseW9Pf/SpuumeK6wwP6&#x2B;lA3Ko4VVXctXd1ijve9TwVR41WFLa3w9UobEWNNlNcAADKi9gHAADeVW6t/vO//s9&#x2B;92/&#x2B;4ktf0dXt6uXFk8ePH1/50DfzsxX18sz5S2tu79TMzMzS8TmZronSqjHtVpWsrfm&#x2B;EmtzZa1I6uRKaXFzpZQ7uCP/PGO0DCr91Fdig8pA3FSUTD6gUcx4tal4iefE/awe94KL2zOu8ttR1XHS9x26MD8VT1f7FzZtL3V7qZfmWpQSZURZyfTp7fpfvLH4zYuHF/z04xIfO&#x2B;BUlOXmvnfJ3qgnu4/s7TvFzUTSq1PcvG9NPJzi5qOut/8UtyHaGz2dMXpDQ6oTXU/EV3ZQHZ7UGx7ZCztxsPfjh2FYdD1higsAQLnckX84BgAAZfePf&#x2B;QnNp/&#x2B;2PPPP//yX/7F2tpa49DmkeX77Wb98OHDb7QubG9v9062Zmdnm0uu8n3RVkTEdcUYZZW1xlprTJ6bxIo07qg/zygRsWJFEv&#x2B;1tYOXtqdmq72HFq5ofzB5ld7wqQ0lTnqgsXm4GZzbrnQGQT&#x2B;pr0bees&#x2B;bqW35Ti5u6ulcxCaZE6duZvTwBV4RydxXNqb&#x2B;&#x2B;tz882cPHpvqPjTrp8aKNiJXT0TilnnTKW5hfIqbFa/iWhnucEdH9pJdT&#x2B;Ka9LpT3OKWvWA0xa2I&#x2B;Gqn64n1torXM9qNouu1o8bez84VewAA3FPupD8cAwCAe0mzXv2BD3/w6fd88ZP/6nf&#x2B;5vXV4GLwwY9&#x2B;M&#x2B;53ly/95PdeeeXK6suJrbu&#x2B;tu1eGBp19KjEkVijdaaNyX2jlTK&#x2B;o5WWwe3&#x2B;lUyyoqSX&#x2B;Kfbc2c3Zo8fbGl1SdxcMncywBXtz0vCcOPItD/fmFbiNqvx8uzG4rTxddKs9cUoK1arPDW2l&#x2B;nU6OFVgLnXj&#x2B;vntqff2G5sRJXL3mAzcZK8eJP3Lpw831He6hS3GE3HIgORvrWjI3t5LGZsils8oGGz3VPcijg10ZWxrlcVJ1AS7Ol6noqjcDUK29uN4cG9TpjkTHEBAMAkYh8AALid3Hn5h7/4D9Ze/trnP//5v/6rv3r8icetCb//qaeiS9WTJ19&#x2B;9dUrzWbTGN184w2ZC8V1xfPFGq1za43Wjuu6tzP2qVG929PXskz3Uz/JPVW0ob0BzmgREScXNxMnDYNB3ct7fjZX6xxuXrGO3YydS1GtIu4g045O4syY2B1kahibMi9Oalq8hWraa/SrTt5N3c4gWEorovPh6T&#x2B;q35u6iVdxs9GruLGVWGwu6bbNYzHxPkf2dk1xXXEror1dXc8Ndk9xR4HPDKe4YbsVtqLGahRGg&#x2B;tNcel6AABgB7EPAADcZgdWGgdWfmT&#x2B;48f/6jMP//YXvvwz75k6Eh6eWazXgwed1ovnr1xZu3LhwIH64e3Um67JwZpUfE&#x2B;2JU160jday&#x2B;16jWL42K4dBqHxU3tWHMc2q4NBNnC0s9mbmlai/ET06BlhoyXxjHG0k4kocRPPzSturqx0Evel9ebpnn&#x2B;pU6/k7gP1wbGZyHPjODfdzI0zPXrWQ3lO9uDM9o8ur77o5Ft9L039jX5D4o5UeqJySt8&#x2B;3uqruDvfx1b6YmLJY5v3h1fsmcSaRO3UPWt3T3Fr4rriBFfTnlsVVR0resXzuL4S6212wlYUtlrDJ3HXukxxAQDAzSP2AQCAO8JMZeUf/ecrH/jgB//u//mfzp079&#x2B;QDM8eOHg0XpFqtds9sDQaDU6cuz83NzeSz/uysTFtxXc9zxYqY2/f0rFViR4/tjl&#x2B;Tp6TqZQuNXpo2NrrhS5cPHZl1lw&#x2B;0pJJKrkWM5N5aN1zvhZ62C9Nb1camo61SZrNfee7coUjNv9ipnt2u10T94KHVmbDre7GxeS8r7uxTxU1/jVrn8UU74ycLOn/&#x2B;8pw2fjeux4MgcGNx8yII3qbflzvAW5riZmMH92KR2NpY8r7k8a4pbj46smczUVqsiFOx15zi7nvFnqf6RdfbGl6x14rCNHcmPvv4FLeoe6Q9AABw44h9AADgDnJs8fjMf/8vTr7yymf/6JPT62c/OD146OGPeYdWXv3mt5ye013Tg8HG9LTxj1Sq09Oe44pWVtZvz2fNHcldk7taWfEG4mZXX2rQRnuZ62Wrsftqe9b16h9W8fJsW7QRo4of2&#x2B;5OvdZeMMZp9&#x2B;srs24v1Zd6lVe3q2Jc7ZhB7G/3ahdTtTDV&#x2B;Zgxh4K05mW51a62w1v5lJFKv1lJHvGSbq&#x2B;y0aub3FXWTXMnsGp03vDe8KZRb3yKO971kuGRvXx0ZM8M9kxxExE9OcV1AnEq4gSjKW51vyv2KpL3a&#x2B;0obEWN1VbYjsJWFEaDysRnD8Mw4Io9AABwSxH7AADAnWWmsvDhRxY&#x2B;/L7l3/pf/&#x2B;dz5893e90PHfAf&#x2B;MjT8uoL663WpY0zne3tiqou5cZ1fc9z1eS5qHeF0ZL42/3GIPdr/qDuDUTnwzN3yoqTSWrO99wvXZ56&#x2B;cJcGG4vH/SH/1HxXK9YpU1i1JnN&#x2B;untyuVOMDDyzdbMK1Hlvmp&#x2B;LMgbbpKk3snM71sRnYeVdDFMGonUvVysEqPEiigrbuJUu0vTmw/MhXnuzdZ6jk5FRESX8zVetfv7fe/Xk91T3J3G17dS3KzXt3k8PsUdRr08Edk7xZ0qzusN055yRGlxDqjhArcyum4v9zeisB01VlvFk7jhWre&#x2B;9&#x2B;MzxQUAAO8CYh8AALgj6ZVf&#x2B;Ge/&#x2B;dJ3nv3UH/3Ri7p5QB/44Pt&#x2B;YhAP3O9&#x2B;YWNjo3Hx7LnXXjvedPXx47LgSb0uNStJkuY9EXHsrFjRaV20EndNrBX3slhrHFdr3RctItWuFpGqdkVEHFdEBo7jOE41ceqZk&#x2B;VaWxV71vP2NDNlxSqb&#x2B;u1oerM37WmpeZloI44Ro8Q6oqxoSVPn1Ebtmcvh6Su1eRu3Em2tKCWilBgRL1uaXt/suc&#x2B;vBq&#x2B;uz6z3Kr3MPdmur8XuQiUXI4GYUJkDbj7vZaFrwkq20uzG2WAmSMSKSDEftmKMONni1PajSxdz4xxsdANvIMqIVWWIfTc&#x2B;xc12v6FRTHF3H9kz6Z4p7p5XcZ3gatdzq6LHp7gVESVSV&#x2B;LqXtRoRWFrq9jhNtrXmOJOT083m02muAAA4F1G7AMAAHeo2crMRz/wY&#x2B;9//P1/&#x2B;2f/3wsvfDc/u33/8v1PPvbY&#x2B;oUL&#x2B;vWtIKhcufxG2OvpjxwNskxSq7XWvnZcV1KdJqk2xWsYmYiINmJtLrnJc/Emp5RvjbaS6U5cu7Q9s9Wfng7iahDVB4EYR3JXrBIvE8m7cb3Tq/YHbjfXXaMHVg2HtUWG8wehPzjcc7vZ4TNb1cvbUzNBZlI161rP2iizjsoPVKMDdfvkgc3F2qBRSZZnN3Kjpqr94Yy3&#x2B;KmMI6Lq1f5xNzGiHZ2LU9zW97Z/999lNz7Fneh6yfDIXj5xZC99symuP7xZz6mKG4gzPsXdeTqjInm/1orCQea9/MbiVlxtRWGXKS4AALizEfsAAMAdre7O//jP/PrS0S99&#x2B;4v/8e9eWb14tvv000/P3rd88sUXnXDh5XPnTvx5pz5flfcpaU6bgwMrKm6cM8Yos2at9aKjopQk7xdRKrhkrbV6Q0REGRExKhcRR&#x2B;UiYpWxSonY0WV3SolSEzffjZ7f7aeVdnfq3Oa06GC&#x2B;Z4/2/apn0tz1nbwZxK5rLm1O54PanCMXfNNwbVVL8XMPM5w2oiXJtaOtKBt4g4P13vJ0UvWyhp/U/bTmJ4GTz1QH75nbWGx0lZfNNHJRVpx017MbxfMgXqq8xBE1vBDwDr&#x2B;sb2/Xk91Fb2eKO9H1UpHYSixm9HRG3p/sem8yxa0qNxCneBV3Z4Hr75rirkZhezVsdRqtKFzvMcUFAAB3H2IfAAC4Czz66A8&#x2B;&#x2B;vD9z37ur85/4zPPPPO1&#x2B;/3uiccfz6/UG2GYfvW7a2tr3TOdma2ZvuNPTU05Ncf1XDdzTZ6LUsPdq1aO1tba9G1&#x2B;FGVFxFEqM87Z7eB8VDtYD9Y6zZon/dSpOFlYiV1tL3Vq7U445ajDtWwlyOb9XCkryoo2YrQkQXsz/OaVhTivPDq/dbS5fWx2fa7Wr7m572YVL6v7Sd1Pp/xEeak4dpj5lL16rK9QpEM1/D/Rd94LvDc4xc32m&#x2B;L2rY13T3ETycfS3vWmuKMje7o4sjdxxZ6ju8WruBuNdhH4ojAzeuKzT3S9Ypb7bv3GAQAA3CRiHwAAuEu4Kx/4sX/y1Md&#x2B;/Lf&#x2B;r9&#x2B;6km48943W049/wM6ZB1ZeO3fuXPTs&#x2B;zeyfOW12eDIYXngpPieXfKtmLW59dyYqf6WiATtR5SIWWiLiGgjIkYbEXF0LiJGGaWUKLFii39RRis7GYCKlzHq/mCu1qn69cRMb/TCc7pqjbM50Fbyqpt6Tj7I9SBXy9PRUth7YG7j&#x2B;5rb4qaiiqv9/NWNuT89deSZC/PTrvrE0SuPLV1caq77/mD4wbQdXgKojeRacmf4uMe1WDV69&#x2B;O2lr4bnOJORL3xKe7Okb3x1zPSG5viVkdT3Imu50vWqxeX67VWi1v2wl7iT3z2MAyFKS4AACgFYh8AALibKP/&#x2B;X/rlf/rSs3/0rW99&#x2B;zvf/na1VnvwwcaRI0fs5oNra&#x2B;1oY7P3vVOOPTU3N5vNBVpr13VdETd18jy/NZ/AKhFbDbrLc63HElX17CCpOsp201xryY1RTup7abOW1itJw09DPz0Udh6Y2xAlElclCda3Z545e&#x2B;hLZ45sJf5j969&#x2B;aPniwvxlqfREjBineKpXik1ucQmgHR1OvM6pveIfeNfs2/Vkd9QTEbOn6xVT3L6Y0Xm9ia5XPKCxd4rrTRVdT5yqKja5Ktg9xS2u28sq60XX2xx2vY1ebe/HZ4oLAABKjNgHAADuMjPzKx/5qf925ck3zr7&#x2B;3c9&#x2B;9rPn&#x2B;7&#x2B;0sDD/iQ/9m8CY5jcuXrxwwfvOxyUM1ebAC8Op46dUNRDdc20mzW&#x2B;KKG0rIkVQk&#x2B;FLFmp4yk9pJcpYVZQzpUTriZN9VoloUVYq/YM6e0rnhxvJZr/WS6Wfm9wa18nqXlb3k7CSTAWDsJI0/FQ5ueTuxsbcarc6SN1nzh5&#x2B;vnUwSSpPHNz68OErC801cQeSuWJleOmeHfv&#x2B;6n/1O/4be01vGvWK6wj3vp7RF4mtHTuyZwZFzrt6ZG9iiutUxK0VT&#x2B;Je7Xp63yv2tNONGq0oXN0I20Xgi8KcKS4AALjnEfsAAMBd6fDiyuHFlXq9/tUvPfPqq68&#x2B;lF84fPiIHD16qFbLBo2t7e1Lp84ePHjQPbAxIzOqklljlLG34PRbsahVufhmemorrKT91MmsVSqruJnvZqrY4Tq5aCNuJm4ucbC51nzp8uLFTv35y9Ovbda1lsfn1z9&#x2B;9NKjC6vi98WI5PqOuG7vpqe4g&#x2B;HrGftPcUdpb58pbmVX17s6xR3ver6kwylu2LoStqMGU1wAAIBrIfYBAIC72COP/tChQyunT7/2e3&#x2B;41Phe&#x2B;OiDX3/vR/6Lo4/&#x2B;n&#x2B;dfPHXfC6G5cqH5J&#x2B;9Xcwfk0TXVnDbLr1hrvch3HFekJnluk461IkqL76nhI7DW2NzmRrQoY63Z90CdEqvFKnFSXduqy&#x2B;jlDScXJcPV7dUpriOZt9mv9dJKd&#x2B;BPBfF75uIj070nFjceWVh3q5Eoe3tK3y2Z4vYnu14&#x2B;Snv7THGniyN7O11PVHVsgTs2xV0rut5G2Ioabaa4AAAAbwWxDwAA3N0OHFw5cHDlxHs/8Qef&#x2B;tza2vo3v/mt6tTlRx5/WPx5OXMmfjXx2q3O&#x2B;YtT21tr9bVms6m1Y62RPBetK9WqWCt9a7o968vOVlap0QO3ar8GZ0WKea8yUryxO3xS1hWZGOFqMVZyZ7bWeeCAWZ5RSqe&#x2B;mzQq6Ww10X4qKhdz3cv4bpW3OcXtj72Km4xNcYtXcfPdXS8Qtz52xV4wNsWd6HraiYZdr9HqDG/ZM3t&#x2B;N5jiAgAA3DhiHwAAKIMglB/&#x2B;lfd88Sv/9af/5q&#x2B;7y7/Z6Ic/svTng9m52cNfXl1d7Zxrrjvbze1HvEOHZOWSiJW0LtaK7olYsa52XLFF6ytu8RPRorRS&#x2B;8a&#x2B;HcXxvVEh3P9aPaPESaca21PhtuhcvEy0FRExIkaLeQfO9N3IFFf2nNcrprjFq7g7r2cMdk9xEzGpKGdsjeuJG4hT2dX1hlPcia7nS9JttKLhCLf41k&#x2B;9ic/OFBcAAOBtIvYBAICSuK&#x2B;y8ssfX/nhj//Ahb/96qc&#x2B;9YdLK9994IEH3KNHlxqNINXdbnd9fX19fb3pdKfCKb/SEN8XpSTLRax4RXW62t1UUcXeJMRdI/BN/APKiJeLNsMzgMXI1&#x2B;hbcKbv7Uxx&#x2B;1bi605xExElauyWPacunjf2JG4gTlWpqlwtesUzGr6SNCiiXns9XI3CdtTY7DPFBQAAeDcQ&#x2B;wAAQKksiSz9J08vn3js9/7tv//UV88&#x2B;/eCRJ5966vjxr116/nnnhfO&#x2B;55/51vnZ2dmjB6Zkfl7mp0VbSRLpZ05Va9GilFLKDse5VtQtegTXKsmd4RfqZp/WvbkpbiYSj01xi7SXTB7Zs0aUczXtjU9x3aoqnsfdNcXd6XrK7RSH9daL83qNNlNcAACA24fYBwAASmi&#x2B;WfuFX/yF06dPf&#x2B;mPf&#x2B;PKlSs/snD&#x2B;4ROPyMEH1194vtcLtre2Xl17Za7druVe5cAB8T3RWmutlRalinv6rBVrrbW3JPbtPgB4Iz/leL&#x2B;TPUXvOlPceM&#x2B;ruNeY4hbfRO&#x2B;a4g67XlWcYGyKu9P1KpLsjHAvh62o0YrCmCkuAADAnYTYBwAAyunQrHdo9vuefOzf/M7v/M5nzk/93Wbw4H36wZ/85Ye/88dbrdbm2e322bXMxkuLg&#x2B;b8rNRqjnKL2KdEjIiINdYYa97xD3rTU9xk2PXMTtfrFy3P7uxwh1Nc5&#x2B;qpPacunj9c4I5exVVq2PXG0l5FSRK0o3A1Ctvrw8C31a/u/fhMcQEAAO4oxD4AAFBmFaf5X/3qf/Ps537/i1/84lY4&#x2B;PKXv/xzx&#x2B;ena7VpJ2pdvnwmevXs2TNRHM3NzqqDSml19WSfWJFbdbJvzNuZ4vatjcemuAMx6X5T3FHacwJxG0XXu3pkTxdH9ia6nrjbxXm99UY7CltRuNoJ9352prgAAAB3PmIfAAAovw984hcfeuqnX3zxxU9/&#x2B;tOnup33ve8Hf&#x2B;ijrd7m1uJzf9Fut53v6l6lN3XyiDc/L8vVSj9&#x2B;fe5LjuPcv/WoaC0icnPJ71pT3InYd40prt05srfzKm467Hp5Ijbd1fW0JzoQJxAnGJviVvfrer4Mho/hNlqXwuLs3iCb/DMhU1wAAIC7FLEPAADcE6ampp5&#x2B;&#x2B;uknnnjiD/7w/3jhhReqZ84cO3bs&#x2B;GOPHVlb6z5/aXV19fQbz09PTd2f3&#x2B;8vLfqeHw8GYq1t1JW6gQdz9&#x2B;16sjvwqf26XjJ8FTePxRRdL77uFNcR5YhbF&#x2B;1Pdr3hq7hXr9gbTnFbnbAVha214RV72zFTXAAAgDIj9gEAgHtIpVL52R/9&#x2B;Vdeefav//wvL6aNKwdlaenE8uxLtfX1M//uc2&#x2B;8uha13ePHa5uxbTRmpXpacq31YzLR&#x2B;/aezhMRfQNT3L6VWMz4LXs7r2ek&#x2B;01xHXGq4jaKHa44wWiKW911Um/4hfW2okY7Clvt0cG9iCkuAADAPYfYBwAA7i3h4sqTiytPfvgjv/&#x2B;v/9Wp751qrba8Zuu&#x2B;I/fJe9/7kn2pt91744033ojP3n//suhQRJRSWilxrvEwrhXRe87rZSIDkdjavuSx5LE1/d2v4qZ7prjO8LCeDsStilNVxV17V6e4413PU3HUaEVheztcjcJW1GgzxQUAAICIEPsAAMA9yj/8i7/2Pz734h/&#x2B;3Zf/No/mvn7SvvfAD/TuXw7TVQmC7smXvnvm7NyLy/Pz82maKq3Eu8YUV0T6V6e4ed&#x2B;aeDjFzUddb/8pbkO0N3o6Y/SGhlQnup6Ir&#x2B;ygOjypNzyyF3biYO8vKAzDousJU1wAAIB7GLEPAADcu554388dO/bBy8/85ec&#x2B;&#x2B;7nvm14IgmBhduG&#x2B;Y8emmqsvvPjS66&#x2B;f3dzcVK4SIxKJZMWruFZiMX0RI8m2NX3Jk11P4pr0ulPc4pa9YDTFrYj4aqfrifW2itcz2o2i67Wjxt6PzRV7AAAAuBZlb&#x2B;51OQAAgBLptzu/87u/vbG&#x2B;9uDh1YcffvhYev7cuXPhpc7m5tZnDv/8rNP5h/IneSxmZ4qbDY/v2WxX1xsOcitjXa8qTqAk2NP1PBVH4WoUtqPG8OBeJ0xyprgAAAB4WzjZBwAAINUD4a/88i&#x2B;dO3/&#x2B;zz/1z&#x2B;M4Dg5kCwsLYX2xcv5cu91uzgRbp6xJd09xXXEror1dXc8Ndk9xR4HPDKe4YbsVtqLGahRGg&#x2B;tNcel6AAAAuDmc7AMAALgqyrI//Y9/euVrn1leXj7RXJ2anvrk834zj34x&#x2B;rxyxQnE5hIcVMUmV1XHil7xPK6vxHqbneHlesWTuGtdprgAAAB4lxD7AAAAJq195yt//Mf/4ah3&#x2B;vDhw1/of78Tnf8n939WtIgWaY4FPlf1x6Je8S3NnYmfbXyKW9Q90h4AAADeIcQ&#x2B;AACAfWyttr9x6pk/&#x2B;/SfeWbq/Q9O/&#x2B;yJv/SD7Mr6QjHCbUdhKwqjQWXiR3HFHgAAAG4vYh8AAMA1/f0Lf/vn/&#x2B;FzR5aaa5uDvf8pU1wAAADcaXigAwAA4Jrm6oeXlpYuXL588ODB6enpZrPJFBcAAAB3Mk72AQAAXFO3293e3l5aWrrdHwQAAAC4IcQ&#x2B;AAAAAAAAoCT07f4AAAAAAAAAAG4NYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQC4ru2WAAAOV0lEQVQAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPsAAAAAAACAkiD2AQAAAAAAACVB7AMAAAAAAABKgtgHAAAAAAAAlASxDwAAAAAAACgJYh8AAAAAAABQEsQ&#x2B;AAAAAAAAoCSIfQAAAAAAAEBJEPv&#x2B;/3bsQAYAAABgkL/1Pb7CCAAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMCE7AMAAACACdkHAAAAABOyDwAAAAAmZB8AAAAATMg&#x2B;AAAAAJiQfQAAAAAwIfsAAAAAYEL2AQAAAMBEYpggGklQzNYAAAAASUVORK5CYII=" />
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>